ASTY,SI,SRASSI,CEI,RELATTY,CUB,ASTIS,ASCETY,ASSCAT,Ti,Descri,ASSTETY,CHI,CONFSCO,BAFOR,ASI,DOI,ASSSUBCFR,ASSTI,TII,VAI,ASST,ASORGA
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,CHEMBL618647,1,BAO_0000218,7524,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,In vivo,CHEMBL618648,1,BAO_0000218,7525,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,CHEMBL618649,1,BAO_0000218,7526,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,CHEMBL618650,1,BAO_0000218,7527,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,In vivo,CHEMBL618651,1,BAO_0000218,7528,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,CHEMBL876497,1,BAO_0000218,7529,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,CHEMBL618652,1,BAO_0000218,7530,9866,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,In vivo,CHEMBL618653,1,BAO_0000218,7531,9866,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,CHEMBL618654,1,BAO_0000218,7532,9866,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,CHEMBL618655,1,BAO_0000218,7533,6351,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for solubility in water,,CHEMBL618656,1,BAO_0000218,7534,1465,,10116.0,,,,Rattus norvegicus
P,1,,,U,Intermediate,,,,22229,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,CHEMBL618657,0,BAO_0000100,7535,5182,,,,,,
A,1,,,N,Intermediate,,,,50597,Solubility was determined,,CHEMBL618658,1,BAO_0000218,7536,17847,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,solubility in water (ug/mL) at 37 degree C.,,CHEMBL618659,1,BAO_0000218,7537,15339,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,CHEMBL618660,1,BAO_0000218,7538,5202,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,CHEMBL618661,1,BAO_0000218,7539,1088,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats,,CHEMBL873807,1,BAO_0000218,7540,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in Dawley rat,,CHEMBL618662,1,BAO_0000218,7541,5353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after 3 mg/kg iv administration,In vivo,CHEMBL618663,1,BAO_0000218,7542,2864,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after 3 mg/kg iv administration in rat,In vivo,CHEMBL618664,1,BAO_0000218,7543,2864,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after 3 mg/kg iv administration in the rat,In vivo,CHEMBL618665,1,BAO_0000218,7544,2864,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in female Sprague-Dawley rats,,CHEMBL876498,1,BAO_0000218,7545,6362,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat,,CHEMBL618666,1,BAO_0000218,7546,6249,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rats was determined,,CHEMBL620440,1,BAO_0000218,7547,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rats with metabolic oxidation,,CHEMBL620441,1,BAO_0000218,7548,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rats,,CHEMBL620442,1,BAO_0000218,7549,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,CHEMBL620443,1,BAO_0000218,7550,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,CHEMBL620444,1,BAO_0000218,7551,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,CHEMBL620445,1,BAO_0000218,7552,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,CHEMBL620446,1,BAO_0000218,7553,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biological half-life measured in plasma of rat,,CHEMBL620447,1,BAO_0000218,7554,2879,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biological half-life measured in plasma of rat; 22-25,,CHEMBL621129,1,BAO_0000218,7555,2879,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biological half-life measured in plasma of rat; 9-16,,CHEMBL621130,1,BAO_0000218,7556,2879,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for its half life when administered intravenously in rat,In vivo,CHEMBL873808,1,BAO_0000218,7557,3184,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,In vivo,CHEMBL876598,1,BAO_0000218,7558,4891,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,In vivo,CHEMBL621131,1,BAO_0000218,7559,429,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life (T1/2) after oral administration in rat,In vivo,CHEMBL621132,1,BAO_0000218,7560,5656,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound after iv administration of 20 mg/kg dose in rat,In vivo,CHEMBL621133,1,BAO_0000218,7561,4413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,CHEMBL621312,1,BAO_0000218,7562,3598,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound was determined in rat,,CHEMBL621313,1,BAO_0000218,7563,17267,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Half life of compound was determined in rat blood,,CHEMBL621314,1,BAO_0000218,7564,4727,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life at 1 mg/kg was determined in rat,In vivo,CHEMBL621315,1,BAO_0000218,7565,17651,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life at 10 mg/kg was determined in rat,In vivo,CHEMBL621316,1,BAO_0000218,7566,17651,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats,,CHEMBL621317,1,BAO_0000218,7567,401,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats in hours,,CHEMBL621318,1,BAO_0000218,7568,4942,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,CHEMBL621319,1,BAO_0000218,7569,17735,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,CHEMBL621377,1,BAO_0000218,7570,6056,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was determined,,CHEMBL621378,1,BAO_0000218,7571,5213,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after i.v. administration,In vivo,CHEMBL876599,1,BAO_0000218,7572,6616,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,CHEMBL621379,1,BAO_0000218,7573,5937,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat plasma,,CHEMBL621380,1,BAO_0000218,7574,5819,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat plasma; Not detected,,CHEMBL621381,1,BAO_0000218,7575,5819,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats,,CHEMBL618515,1,BAO_0000218,7576,6803,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period of compound was determined after peroral administration,In vivo,CHEMBL618516,1,BAO_0000218,7577,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,In vivo,CHEMBL618517,1,BAO_0000218,7578,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat,,CHEMBL618518,1,BAO_0000218,7579,5948,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,CHEMBL618519,1,BAO_0000218,7580,1916,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,CHEMBL618698,1,BAO_0000218,7581,1916,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,In vivo,CHEMBL618862,1,BAO_0000218,7582,1916,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL618863,1,BAO_0000218,7583,4890,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,In vivo,CHEMBL618864,1,BAO_0000218,7584,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life time in rat the dose of 2 mg/kg,In vivo,CHEMBL618865,1,BAO_0000218,7585,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life 24 hr after 10 mg/kg iv administration in rats,In vivo,CHEMBL618866,1,BAO_0000218,7586,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life 24 hr after 2 mg/kg iv administration in rats,In vivo,CHEMBL618867,1,BAO_0000218,7587,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life consistent with the observed metabolic steady state in rats,,CHEMBL875828,1,BAO_0000218,7588,6597,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,CHEMBL618868,1,BAO_0000218,7589,17735,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life for oxidative metabolic stability was determined using male human,,CHEMBL618869,1,BAO_0000218,7590,6597,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,CHEMBL618870,1,BAO_0000218,7591,17670,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in rat plasma,,CHEMBL618871,1,BAO_0000218,7592,1696,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in rat plasma was determined,,CHEMBL618872,1,BAO_0000218,7593,1742,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rats was determined,,CHEMBL873816,1,BAO_0000218,7594,17800,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,CHEMBL618873,0,BAO_0000218,7595,12923,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve after oral dose of 0.1 mg//kg,,CHEMBL621602,0,BAO_0000019,7596,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve after oral dose of 0.3 mg/kg,,CHEMBL621603,0,BAO_0000218,7597,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve after oral dose of 1 mg/kg,,CHEMBL621604,0,BAO_0000218,7598,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve after oral dose of 10 mg/kg,,CHEMBL621605,0,BAO_0000218,7599,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve after oral dose of 23.4 mg/kg,,CHEMBL621606,0,BAO_0000218,7600,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve after oral dose of 3 mg/kg,,CHEMBL621607,0,BAO_0000218,7601,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve after oral dose of 3.87 mg/kg,,CHEMBL621608,0,BAO_0000218,7602,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve was determined,,CHEMBL621609,0,BAO_0000019,7603,5237,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve at a dose of 10 mg/kg,,CHEMBL621610,0,BAO_0000218,7604,4026,,,,,,
A,1,,,N,Intermediate,,,,50597,Area under curve was determined; ND=No data,,CHEMBL621611,1,BAO_0000218,7605,5237,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,CHEMBL621612,1,BAO_0000218,7606,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,CHEMBL622308,1,BAO_0000218,7607,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,CHEMBL622309,1,BAO_0000218,7608,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,CHEMBL622310,1,BAO_0000218,7609,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,CHEMBL622311,1,BAO_0000218,7610,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,CHEMBL622312,1,BAO_0000218,7611,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,CHEMBL622931,1,BAO_0000218,7612,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,CHEMBL622932,1,BAO_0000218,7613,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,CHEMBL622736,1,BAO_0000218,7614,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,CHEMBL622737,1,BAO_0000218,7615,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,CHEMBL622738,1,BAO_0000218,7616,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,CHEMBL622739,1,BAO_0000218,7617,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,CHEMBL622740,1,BAO_0000218,7618,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,CHEMBL622741,1,BAO_0000218,7619,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,CHEMBL622742,1,BAO_0000218,7620,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,CHEMBL622743,1,BAO_0000218,7621,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50594,AUC in mice,,CHEMBL622744,1,BAO_0000218,7622,11637,,10090.0,1969.0,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Area under curve was measured from the graph obtained from concentration Vs time,,CHEMBL624134,0,BAO_0000019,7623,11149,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve value of compound per hour after oral administration,,CHEMBL624135,0,BAO_0000019,7624,10016,,,,,,
A,1,,,N,Intermediate,,,,50597,Area under curve was determined after oral administration in rats,,CHEMBL624136,1,BAO_0000218,7625,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined after oral administration in rats; No data,,CHEMBL624137,1,BAO_0000218,7626,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined after oral administration in rats;No data,,CHEMBL624320,1,BAO_0000218,7627,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,CHEMBL624321,1,BAO_0000218,7628,12923,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,CHEMBL624322,1,BAO_0000218,7629,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound after iv dose of 5.06 in rats,,CHEMBL624323,1,BAO_0000218,7630,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,CHEMBL624324,1,BAO_0000218,7631,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,CHEMBL624325,1,BAO_0000218,7632,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,CHEMBL624326,1,BAO_0000218,7633,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,CHEMBL624327,1,BAO_0000218,7634,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,CHEMBL624328,1,BAO_0000218,7635,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Area under curve was determined in Dogs after peroral administration,,CHEMBL627848,1,BAO_0000218,7636,14169,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in Rats after peroral administration,,CHEMBL627849,1,BAO_0000218,7637,14169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in carotid blood of rat when administered intradermally,,CHEMBL627850,1,BAO_0000218,7638,14258,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in portal blood of rat when administered intradermally,,CHEMBL627851,1,BAO_0000218,7639,14258,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,CHEMBL627852,1,BAO_0000218,7640,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,CHEMBL627853,1,BAO_0000218,7641,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,CHEMBL627854,1,BAO_0000218,7642,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,CHEMBL627855,1,BAO_0000218,7643,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,CHEMBL627856,1,BAO_0000218,7644,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,CHEMBL875339,1,BAO_0000218,7645,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,CHEMBL627857,1,BAO_0000218,7646,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,In vivo,CHEMBL627858,1,BAO_0000218,7647,11195,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,CHEMBL627859,1,BAO_0000218,7648,10130,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,CHEMBL627860,1,BAO_0000218,7649,10130,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,CHEMBL627019,1,BAO_0000218,7650,10130,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,CHEMBL627020,1,BAO_0000218,7651,10130,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,CHEMBL627021,1,BAO_0000218,7652,10130,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,CHEMBL627022,1,BAO_0000218,7653,10130,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,CHEMBL627023,1,BAO_0000218,7654,10130,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,CHEMBL627024,1,BAO_0000218,7655,10130,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,CHEMBL627025,1,BAO_0000218,7656,10130,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,CHEMBL627026,1,BAO_0000218,7657,10130,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,CHEMBL627027,1,BAO_0000218,7658,10130,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,CHEMBL627028,1,BAO_0000218,7659,10130,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,CHEMBL627029,1,BAO_0000218,7660,10130,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,CHEMBL627030,1,BAO_0000218,7661,10130,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,CHEMBL627031,1,BAO_0000218,7662,10130,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,CHEMBL627032,1,BAO_0000218,7663,10130,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,CHEMBL627033,1,BAO_0000218,7664,10130,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,CHEMBL627034,1,BAO_0000218,7665,10130,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,CHEMBL627035,1,BAO_0000218,7666,10130,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,CHEMBL627036,1,BAO_0000218,7667,10130,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,CHEMBL875340,1,BAO_0000218,7668,10130,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,CHEMBL627037,1,BAO_0000218,7669,10130,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,CHEMBL627038,1,BAO_0000218,7670,10130,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,CHEMBL627039,1,BAO_0000218,7671,10130,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,CHEMBL627040,1,BAO_0000218,7672,10130,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,CHEMBL624663,1,BAO_0000218,7673,10130,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,CHEMBL625963,1,BAO_0000218,7674,10130,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,CHEMBL876799,1,BAO_0000218,7675,10130,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,CHEMBL626133,1,BAO_0000218,7676,10130,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,CHEMBL626134,1,BAO_0000218,7677,10130,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,CHEMBL626135,1,BAO_0000218,7678,6295,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,CHEMBL626136,1,BAO_0000218,7679,6296,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,CHEMBL626137,1,BAO_0000218,7680,6296,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,CHEMBL626138,1,BAO_0000218,7681,6295,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,CHEMBL626139,1,BAO_0000218,7682,6296,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,CHEMBL626140,1,BAO_0000218,7683,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,CHEMBL626141,1,BAO_0000218,7684,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,C24h in rat p.o. at 20 mg/kg concentration,,CHEMBL626142,1,BAO_0000218,7685,17686,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,CHEMBL627930,1,BAO_0000218,7686,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,In vivo,CHEMBL627931,1,BAO_0000218,7687,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,CHEMBL627932,1,BAO_0000218,7688,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,CHEMBL627933,1,BAO_0000218,7689,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,In vivo,CHEMBL627934,1,BAO_0000218,7690,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,CHEMBL627935,1,BAO_0000218,7691,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,CHEMBL627936,1,BAO_0000218,7692,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,In vivo,CHEMBL627937,1,BAO_0000218,7693,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,CHEMBL627938,1,BAO_0000218,7694,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,In vivo,CHEMBL627939,1,BAO_0000218,7695,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,In vivo,CHEMBL627940,1,BAO_0000218,7696,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,CHEMBL627941,1,BAO_0000218,7697,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,CHEMBL876800,1,BAO_0000218,7698,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,In vivo,CHEMBL627942,1,BAO_0000218,7699,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,CHEMBL627943,1,BAO_0000218,7700,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,In vivo,CHEMBL627944,1,BAO_0000218,7701,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,In vivo,CHEMBL627945,1,BAO_0000218,7702,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,In vivo,CHEMBL628584,1,BAO_0000218,7703,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA at 15 min,In vivo,CHEMBL628585,1,BAO_0000218,7704,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,In vivo,CHEMBL628586,1,BAO_0000218,7705,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA at 30 min,In vivo,CHEMBL628587,1,BAO_0000218,7706,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,In vivo,CHEMBL628588,1,BAO_0000218,7707,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,In vivo,CHEMBL628589,1,BAO_0000218,7708,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,In vivo,CHEMBL625304,1,BAO_0000218,7709,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,In vivo,CHEMBL625305,1,BAO_0000218,7710,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,In vivo,CHEMBL625306,1,BAO_0000218,7711,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,In vivo,CHEMBL625307,1,BAO_0000218,7712,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,In vivo,CHEMBL625308,1,BAO_0000218,7713,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,In vivo,CHEMBL627740,1,BAO_0000218,7714,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,In vivo,CHEMBL627741,1,BAO_0000218,7715,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,CHEMBL627742,1,BAO_0000218,7716,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,In vivo,CHEMBL627743,1,BAO_0000218,7717,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,In vivo,CHEMBL627744,1,BAO_0000218,7718,9866,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,In vivo,CHEMBL627745,1,BAO_0000218,7719,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,CHEMBL627746,1,BAO_0000218,7720,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,CHEMBL627747,1,BAO_0000218,7721,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,In vivo,CHEMBL876810,1,BAO_0000218,7722,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,In vivo,CHEMBL627748,1,BAO_0000218,7723,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,CHEMBL627749,1,BAO_0000218,7724,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,CHEMBL627750,1,BAO_0000218,7725,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,In vivo,CHEMBL618728,1,BAO_0000218,7726,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,CHEMBL618729,1,BAO_0000218,7727,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA at 15 min,In vivo,CHEMBL618730,1,BAO_0000218,7728,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,In vivo,CHEMBL618731,1,BAO_0000218,7729,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA at 30 min,In vivo,CHEMBL618732,1,BAO_0000218,7730,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,In vivo,CHEMBL618733,1,BAO_0000218,7731,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,In vivo,CHEMBL618734,1,BAO_0000218,7732,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,In vivo,CHEMBL618735,1,BAO_0000218,7733,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,In vivo,CHEMBL876602,1,BAO_0000218,7734,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,In vivo,CHEMBL618736,1,BAO_0000218,7735,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,In vivo,CHEMBL618737,1,BAO_0000218,7736,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,In vivo,CHEMBL618738,1,BAO_0000218,7737,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,In vivo,CHEMBL618739,1,BAO_0000218,7738,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,In vivo,CHEMBL618740,1,BAO_0000218,7739,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,CHEMBL618741,1,BAO_0000218,7740,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,In vivo,CHEMBL618742,1,BAO_0000218,7741,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,In vivo,CHEMBL618743,1,BAO_0000218,7742,9866,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life from rat plasma at a single oral dose of 25 mg/kg,In vivo,CHEMBL618744,1,BAO_0000218,7743,17752,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in male rat,,CHEMBL618745,1,BAO_0000218,7744,5610,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat after peroral administration at 10 mg/kg concentration,In vivo,CHEMBL620479,1,BAO_0000218,7745,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat after peroral administration at 5 mg/kg concentration,In vivo,CHEMBL620480,1,BAO_0000218,7746,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat at a dose of 3 mg/kg,In vivo,CHEMBL620481,1,BAO_0000218,7747,17771,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was evaluated in rats,,CHEMBL620482,1,BAO_0000218,7748,1974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was measured in rat,,CHEMBL876603,1,BAO_0000218,7749,4239,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period for the compound was determined in rats at 50 mg/kg dose,In vivo,CHEMBL620483,1,BAO_0000218,7750,6681,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period in rats after intravenous administration at 5 mg/kg,In vivo,CHEMBL620484,1,BAO_0000218,7751,17752,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period in rat at 10 mg/kg,In vivo,CHEMBL620485,1,BAO_0000218,7752,6046,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",In vivo,CHEMBL620486,1,BAO_0000218,7753,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",In vivo,CHEMBL620487,1,BAO_0000218,7754,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",In vivo,CHEMBL620488,1,BAO_0000218,7755,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life time in rat the dose of 2 mg/kg,In vivo,CHEMBL620489,1,BAO_0000218,7756,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,In vivo,CHEMBL620490,1,BAO_0000218,7757,1088,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,In vivo,CHEMBL620491,1,BAO_0000218,7758,5610,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,CHEMBL876604,1,BAO_0000218,7759,3032,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral half life was determined,In vivo,CHEMBL620492,1,BAO_0000218,7760,5199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",In vivo,CHEMBL620493,1,BAO_0000218,7761,14941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (t1/2) in rat,In vivo,CHEMBL620494,1,BAO_0000218,7762,4408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma elimination half-life was determined,,CHEMBL620495,1,BAO_0000218,7763,2552,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,CHEMBL620496,1,BAO_0000218,7764,5199,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half life was observed after intravenous administration in rat,In vivo,CHEMBL620497,1,BAO_0000218,7765,15662,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life was determined,,CHEMBL620498,1,BAO_0000218,7766,1465,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life following oral administration in Fisher rats,In vivo,CHEMBL620499,1,BAO_0000218,7767,1446,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life in rat,,CHEMBL620500,1,BAO_0000218,7768,6824,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasmatic Half-life after intravenous administration to rat,In vivo,CHEMBL873809,1,BAO_0000218,7769,17533,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,CHEMBL620501,1,BAO_0000218,7770,5979,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Terminal half life after intravenous administration (1 mg/kg) in rat,In vivo,CHEMBL620502,1,BAO_0000218,7771,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Terminal half life in Rat at a oral dose of 5 mg/kg,In vivo,CHEMBL620503,1,BAO_0000218,7772,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,CHEMBL620504,1,BAO_0000218,7773,2463,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,In vivo,CHEMBL876605,1,BAO_0000218,7774,4883,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,In vivo,CHEMBL620505,1,BAO_0000218,7775,4883,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,plasma half life was observed after intravenous administration in rat,In vivo,CHEMBL873811,1,BAO_0000218,7776,15662,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,CHEMBL624016,1,BAO_0000218,7777,3598,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound determined in rat,,CHEMBL624017,1,BAO_0000218,7778,4576,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean residence time determined in rat,,CHEMBL624018,1,BAO_0000218,7779,4576,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma half life determined in rat,,CHEMBL624019,1,BAO_0000218,7780,4576,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Compound was evaluated for Tmax in brain after intravenous administration in male rats,In vivo,CHEMBL624020,1,BAO_0000218,7781,4910,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for pharmacokinetic parameter maximum time period,In vivo,CHEMBL624201,1,BAO_0000218,7782,4891,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,CHEMBL872528,1,BAO_0000218,7783,429,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL624202,1,BAO_0000218,7784,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL624203,1,BAO_0000218,7785,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL624350,1,BAO_0000218,7786,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL621320,1,BAO_0000218,7787,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,CHEMBL621321,1,BAO_0000218,7788,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum time (Tmax) required to reach Cmax in rats,,CHEMBL621322,1,BAO_0000218,7789,4026,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL621323,1,BAO_0000218,7790,4890,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum time of clearance of compound in rats after peroral administration,In vivo,CHEMBL621324,1,BAO_0000218,7791,6571,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum time at the dose of 2 mg/kg in rat,,CHEMBL621325,1,BAO_0000218,7792,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,In vivo,CHEMBL875837,1,BAO_0000218,7793,17651,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,In vivo,CHEMBL621326,1,BAO_0000218,7794,17651,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax in Guinea pig (PO dose),In vivo,CHEMBL621327,1,BAO_0000218,7795,14465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",In vivo,CHEMBL621328,1,BAO_0000218,7796,14941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (Tmax) in rat,In vivo,CHEMBL621329,1,BAO_0000218,7797,5960,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (Tmax) was estimated,In vivo,CHEMBL621330,1,BAO_0000218,7798,5022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Tmax) in rat,In vivo,CHEMBL621331,1,BAO_0000218,7799,4408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,CHEMBL621332,1,BAO_0000218,7800,5983,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T max in Rat at a oral dose of 5 mg/kg,In vivo,CHEMBL621333,1,BAO_0000218,7801,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T max was determined at 10 mg/kg po dose in rats,In vivo,CHEMBL621334,1,BAO_0000218,7802,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,CHEMBL621335,1,BAO_0000218,7803,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,CHEMBL621336,1,BAO_0000218,7804,14180,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,CHEMBL621337,1,BAO_0000218,7805,14180,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Area under curve was measured after i.v. administration into Beagle dog.,,CHEMBL621338,1,BAO_0000218,7806,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve was measured after iv administration into Beagle dog,,CHEMBL875838,1,BAO_0000218,7807,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve was measured after po administration into Beagle dog,,CHEMBL621339,1,BAO_0000218,7808,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve was measured after po administration into Beagle dog.,,CHEMBL621340,1,BAO_0000218,7809,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Area under curve was measured at peroral dose of 3 mg/kg,,CHEMBL621341,0,BAO_0000218,7810,15675,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve was measured by using concentration Vs time,,CHEMBL621342,0,BAO_0000019,7811,12706,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve was measured by using concentration Vs time; not tested,,CHEMBL621343,0,BAO_0000019,7812,12706,,,,,,
A,1,,,N,Intermediate,,,,50594,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,CHEMBL621344,1,BAO_0000218,7813,9750,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve(AUC) was measured in mice after oral administration.,,CHEMBL621345,1,BAO_0000218,7814,9750,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Area under curve(AUC) value of the compound,,CHEMBL621346,0,BAO_0000019,7815,14691,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,CHEMBL621347,0,BAO_0000218,7816,14691,,,,,,
A,1,,,N,Intermediate,,,,50588,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,CHEMBL621348,1,BAO_0000218,7817,14691,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,Blood,,,22224,Area under curve(carotid artery) was determined by the availability in blood,,CHEMBL621349,0,BAO_0000019,7818,2939,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,CHEMBL621350,0,BAO_0000019,7819,2939,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Area under curve(carotid artery) was determined by the availability in blood; No data,,CHEMBL875839,0,BAO_0000019,7820,2939,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Area under curve(portal vein) was determined by the availability in blood,,CHEMBL620211,0,BAO_0000019,7821,2939,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,CHEMBL620212,0,BAO_0000019,7822,2939,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Area under curve(portal vein) was determined by the availability in blood; No data,,CHEMBL620213,0,BAO_0000019,7823,2939,,,178.0,,,
A,1,,,N,Intermediate,Plasma,,,50797,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,CHEMBL620214,1,BAO_0000218,7824,9552,,9544.0,1969.0,,,Macaca mulatta
A,1,,,N,Intermediate,Plasma,,,50797,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,CHEMBL620215,1,BAO_0000218,7825,9552,,9544.0,1969.0,,,Macaca mulatta
A,1,,,N,Intermediate,Plasma,,,50797,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,CHEMBL620216,1,BAO_0000218,7826,9552,,9544.0,1969.0,,,Macaca mulatta
A,1,,,N,Intermediate,Plasma,,,50588,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,CHEMBL620888,1,BAO_0000218,7827,9552,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,CHEMBL620889,1,BAO_0000218,7828,9552,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Area under plasma concentration vs time curve observed in rats for 0-3 h,,CHEMBL620890,0,BAO_0000019,7829,9552,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,Area under plasma time curve determined in male rat,,CHEMBL620891,1,BAO_0000218,7830,11911,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under the MAP curve measured over 5 min.,,CHEMBL620892,0,BAO_0000019,7831,16618,,,,,,
A,1,,,N,Intermediate,,,,50594,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,CHEMBL621079,1,BAO_0000218,7832,14387,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,CHEMBL621080,1,BAO_0000218,7833,14387,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,CHEMBL621081,1,BAO_0000218,7834,12836,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,100712,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,CHEMBL621082,1,BAO_0000218,7835,12836,,10026.0,,,,Cricetinae
A,1,,,N,Intermediate,,,,50597,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,CHEMBL621083,1,BAO_0000218,7836,12836,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,CHEMBL621084,1,BAO_0000218,7837,14339,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,CHEMBL621085,1,BAO_0000218,7838,14339,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,CHEMBL621086,1,BAO_0000218,7839,14339,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,CHEMBL621087,1,BAO_0000218,7840,10524,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,CHEMBL622607,1,BAO_0000218,7841,9994,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Serum AUC in marmosets (IV dose),,CHEMBL622608,1,BAO_0000218,7842,11325,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Area under the curve after intravenous administration at a dose of 10 umol/kg,,CHEMBL624481,0,BAO_0000019,7843,12536,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve after intravenous administration at a dose of 2 umol/kg,,CHEMBL624482,0,BAO_0000019,7844,12536,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve after intravenous administration at a dose of 4 umol/kg,,CHEMBL624483,0,BAO_0000019,7845,12536,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve after intravenous administration at a dose of 40 umol/kg,,CHEMBL624484,0,BAO_0000019,7846,12536,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve after intravenous administration at a dose of 5 umol/kg,,CHEMBL624485,0,BAO_0000019,7847,12536,,,,,,
A,1,,,N,Intermediate,,,,50597,Area under the curve for fumarate salt was evaluated in F344 Rats.,,CHEMBL624486,1,BAO_0000218,7848,15556,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under the curve for the compound was calculated.,,CHEMBL624487,0,BAO_0000019,7849,2809,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve in concentration/ time,,CHEMBL624488,0,BAO_0000019,7850,9511,,,,,,
A,1,,,N,Intermediate,,,,50597,Area under the curve administered intraintestinal in rats.,,CHEMBL624489,1,BAO_0000218,7851,12818,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve administered intravenously in rats.,,CHEMBL625184,1,BAO_0000218,7852,12818,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under the curve during intravenous administration,,CHEMBL625185,0,BAO_0000019,7853,15118,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve during intravenous administration; Not determined,,CHEMBL875954,0,BAO_0000019,7854,15118,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve during systemic administration,,CHEMBL625186,0,BAO_0000019,7855,15118,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve during systemic administration; Not determined,,CHEMBL625187,0,BAO_0000019,7856,15118,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under the curve was calculated for the compound.,,CHEMBL625188,0,BAO_0000019,7857,2632,,,,,,
A,1,,,N,Intermediate,,,,50588,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,CHEMBL625189,1,BAO_0000218,7858,14346,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,CHEMBL625190,1,BAO_0000218,7859,14346,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,CHEMBL621733,1,BAO_0000218,7860,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,CHEMBL621734,1,BAO_0000218,7861,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,CHEMBL621735,1,BAO_0000218,7862,11149,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Clearance of the drug was measured in the plasma of rat; No data,,CHEMBL621736,1,BAO_0000218,7863,17796,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The pharmacokinetic parameter plasma clearance in vivo in rats,,CHEMBL621737,1,BAO_0000218,7864,5247,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance at the dose of 2 mg/kg in rat,,CHEMBL621738,1,BAO_0000218,7865,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,CHEMBL622806,1,BAO_0000218,7866,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,CHEMBL623519,1,BAO_0000218,7867,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,CHEMBL623520,1,BAO_0000218,7868,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,CHEMBL623521,1,BAO_0000218,7869,17065,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,CHEMBL623522,1,BAO_0000218,7870,17671,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rate in rat,In vivo,CHEMBL623523,1,BAO_0000218,7871,6672,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rate in rat,In vivo,CHEMBL623690,1,BAO_0000218,7872,6673,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL623691,1,BAO_0000218,7873,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL623692,1,BAO_0000218,7874,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL623693,1,BAO_0000218,7875,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL623694,1,BAO_0000218,7876,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance of compound after iv administration of 20 mg/kg dose in rat,In vivo,CHEMBL623695,1,BAO_0000218,7877,4413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,CHEMBL623696,1,BAO_0000218,7878,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,CHEMBL623697,1,BAO_0000218,7879,2661,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,Plasma,,,22224,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,CHEMBL623698,0,BAO_0000218,7880,5005,,9544.0,1969.0,,,Macaca mulatta
A,1,,,U,Intermediate,Plasma,,,22224,Compound was tested for its plasma clearance rate in Sprague Dawley rats,In vivo,CHEMBL623699,0,BAO_0000218,7881,5005,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean (%CV) PK parameters for CL(mL/min/kg).,In vivo,CHEMBL623700,1,BAO_0000218,7882,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,In vivo,CHEMBL623701,1,BAO_0000218,7883,3747,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,In vivo,CHEMBL623702,1,BAO_0000218,7884,16366,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,In vivo,CHEMBL623703,1,BAO_0000218,7885,4199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat was determined,In vivo,CHEMBL623704,1,BAO_0000218,7886,17267,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,CHEMBL623705,1,BAO_0000218,7887,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,CHEMBL623706,1,BAO_0000218,7888,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined,In vivo,CHEMBL623707,1,BAO_0000218,7889,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL623708,1,BAO_0000218,7890,5960,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,CHEMBL623709,1,BAO_0000218,7891,5937,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat by iv administration,In vivo,CHEMBL623710,1,BAO_0000218,7892,5871,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,In vivo,CHEMBL623711,1,BAO_0000218,7893,5874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat p.o.,In vivo,CHEMBL623712,1,BAO_0000218,7894,6504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rats,In vivo,CHEMBL623713,1,BAO_0000218,7895,6803,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined; ND denotes no data,In vivo,CHEMBL623714,1,BAO_0000218,7896,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined; ND denotes not determined,In vivo,CHEMBL623715,1,BAO_0000218,7897,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,CHEMBL623716,1,BAO_0000218,7898,1916,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,CHEMBL622980,1,BAO_0000218,7899,5199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma administration to rats,In vivo,CHEMBL622981,1,BAO_0000218,7900,16367,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance of the compound in female Sprague-Dawley rats,In vivo,CHEMBL622982,1,BAO_0000218,7901,6362,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was observed after intravenous administration in rat,In vivo,CHEMBL622983,1,BAO_0000218,7902,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,CHEMBL622984,1,BAO_0000218,7903,6215,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,CHEMBL622985,1,BAO_0000218,7904,1466,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,plasma clearance was observed after intravenous administration in rat,In vivo,CHEMBL623631,1,BAO_0000218,7905,15662,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo CL/F determined,In vivo,CHEMBL623632,1,BAO_0000218,7906,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,In vivo,CHEMBL623633,1,BAO_0000218,7907,2792,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,In vivo,CHEMBL623634,1,BAO_0000218,7908,2792,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for the lower blood clearance in rat,In vivo,CHEMBL623635,1,BAO_0000218,7909,5213,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for the low clearance in rat (in vivo),In vivo,CHEMBL621195,1,BAO_0000218,7910,4687,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (CLb)of the compound was determined in rat,In vivo,CHEMBL621196,1,BAO_0000218,7911,3371,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Rapid clearance after intravenous administration in rat was determined,In vivo,CHEMBL875287,1,BAO_0000218,7912,4690,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance measured in rat,In vivo,CHEMBL621197,1,BAO_0000218,7913,5702,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for plasma clearance in rat,In vivo,CHEMBL621198,1,BAO_0000218,7914,740,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Low plasma clearance was calculated in rat,In vivo,CHEMBL621199,1,BAO_0000218,7915,4853,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Clp) in rat,In vivo,CHEMBL621200,1,BAO_0000218,7916,5789,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,In vivo,CHEMBL621201,1,BAO_0000218,7917,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,In vivo,CHEMBL621202,1,BAO_0000218,7918,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after IV dosing at 0.5 mg/kg in rat,In vivo,CHEMBL621203,1,BAO_0000218,7919,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after IV dosing at 1 mg/kg in rat,In vivo,CHEMBL621204,1,BAO_0000218,7920,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,In vivo,CHEMBL621205,1,BAO_0000218,7921,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,In vivo,CHEMBL621206,1,BAO_0000218,7922,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,CHEMBL621207,1,BAO_0000218,7923,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,In vivo,CHEMBL621208,1,BAO_0000218,7924,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,In vivo,CHEMBL621209,1,BAO_0000218,7925,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,In vivo,CHEMBL876484,1,BAO_0000218,7926,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,CHEMBL621210,1,BAO_0000218,7927,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,In vivo,CHEMBL621211,1,BAO_0000218,7928,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,CHEMBL621212,1,BAO_0000218,7929,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA at 15 min,In vivo,CHEMBL621213,1,BAO_0000218,7930,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,In vivo,CHEMBL621214,1,BAO_0000218,7931,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA at 30 min,In vivo,CHEMBL621215,1,BAO_0000218,7932,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,In vivo,CHEMBL621216,1,BAO_0000218,7933,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,In vivo,CHEMBL621217,1,BAO_0000218,7934,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,In vivo,CHEMBL621218,1,BAO_0000218,7935,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,In vivo,CHEMBL621219,1,BAO_0000218,7936,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,In vivo,CHEMBL621220,1,BAO_0000218,7937,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,In vivo,CHEMBL621221,1,BAO_0000218,7938,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,In vivo,CHEMBL621222,1,BAO_0000218,7939,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,In vivo,CHEMBL621223,1,BAO_0000218,7940,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,In vivo,CHEMBL876485,1,BAO_0000218,7941,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,CHEMBL621224,1,BAO_0000218,7942,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,In vivo,CHEMBL621225,1,BAO_0000218,7943,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,In vivo,CHEMBL621226,1,BAO_0000218,7944,9866,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,In vivo,CHEMBL621227,1,BAO_0000218,7945,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,CHEMBL621228,1,BAO_0000218,7946,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,CHEMBL621229,1,BAO_0000218,7947,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,In vivo,CHEMBL621230,1,BAO_0000218,7948,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,CHEMBL621231,1,BAO_0000218,7949,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,CHEMBL621232,1,BAO_0000218,7950,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,CHEMBL621233,1,BAO_0000218,7951,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,In vivo,CHEMBL621234,1,BAO_0000218,7952,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,CHEMBL621235,1,BAO_0000218,7953,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,CHEMBL621236,1,BAO_0000218,7954,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,In vivo,CHEMBL621237,1,BAO_0000218,7955,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,In vivo,CHEMBL876486,1,BAO_0000218,7956,9866,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,In vivo,CHEMBL622436,1,BAO_0000218,7957,9866,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,CHEMBL622437,1,BAO_0000218,7958,9866,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,CHEMBL622438,1,BAO_0000218,7959,9866,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,In vivo,CHEMBL622439,1,BAO_0000218,7960,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,In vivo,CHEMBL622440,1,BAO_0000218,7961,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,In vivo,CHEMBL622441,1,BAO_0000218,7962,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,CHEMBL622442,1,BAO_0000218,7963,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,In vivo,CHEMBL622443,1,BAO_0000218,7964,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,CHEMBL622444,1,BAO_0000218,7965,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,In vivo,CHEMBL622445,1,BAO_0000218,7966,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,CHEMBL622446,1,BAO_0000218,7967,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,CHEMBL622447,1,BAO_0000218,7968,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,In vivo,CHEMBL622448,1,BAO_0000218,7969,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,CHEMBL622449,1,BAO_0000218,7970,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,In vivo,CHEMBL622450,1,BAO_0000218,7971,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,In vivo,CHEMBL622451,1,BAO_0000218,7972,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA at 15 min,In vivo,CHEMBL622452,1,BAO_0000218,7973,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,In vivo,CHEMBL622453,1,BAO_0000218,7974,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA at 30 min,In vivo,CHEMBL622454,1,BAO_0000218,7975,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,In vivo,CHEMBL622455,1,BAO_0000218,7976,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,In vivo,CHEMBL876024,1,BAO_0000218,7977,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,T max was determined at 3 mg/kg po dose in rats,In vivo,CHEMBL622456,1,BAO_0000218,7978,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,CHEMBL622457,1,BAO_0000218,7979,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,CHEMBL622458,1,BAO_0000218,7980,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,CHEMBL622459,1,BAO_0000218,7981,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,CHEMBL873343,1,BAO_0000218,7982,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,CHEMBL622460,1,BAO_0000218,7983,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time for maximum plasma concentration determined in rat,,CHEMBL622461,1,BAO_0000218,7984,4576,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,CHEMBL622462,1,BAO_0000218,7985,6681,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,In vivo,CHEMBL622463,1,BAO_0000218,7986,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,In vivo,CHEMBL622464,1,BAO_0000218,7987,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,In vivo,CHEMBL622465,1,BAO_0000218,7988,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,In vivo,CHEMBL622466,1,BAO_0000218,7989,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,In vivo,CHEMBL622467,1,BAO_0000218,7990,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time of maximum plasma concentration in rat,,CHEMBL622468,1,BAO_0000218,7991,6824,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,CHEMBL876025,1,BAO_0000218,7992,6685,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,CHEMBL622469,1,BAO_0000218,7993,6685,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,CHEMBL622470,1,BAO_0000218,7994,6685,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,CHEMBL622471,1,BAO_0000218,7995,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time required to reach maximum concentration in rat plasma,,CHEMBL622472,1,BAO_0000218,7996,1742,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,CHEMBL622473,1,BAO_0000218,7997,2774,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,CHEMBL624282,1,BAO_0000218,7998,5199,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,CHEMBL624283,1,BAO_0000218,7999,12873,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,CHEMBL624284,1,BAO_0000218,8000,12873,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,CHEMBL624285,1,BAO_0000218,8001,1916,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time to reach Cmax after oral administration to rats,In vivo,CHEMBL624286,1,BAO_0000218,8002,16367,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time to reach Cmax when a dose of 1 mg/kg is administered orally,In vivo,CHEMBL624287,1,BAO_0000218,8003,16366,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,CHEMBL624288,1,BAO_0000218,8004,216,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,In vivo,CHEMBL624289,1,BAO_0000218,8005,6410,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,In vivo,CHEMBL873344,1,BAO_0000218,8006,6410,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax after peroral administration (10 mg/kg) was determined in rat,In vivo,CHEMBL619623,1,BAO_0000218,8007,6215,,10116.0,,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,CHEMBL621399,1,BAO_0000218,8008,3598,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,CHEMBL621400,1,BAO_0000218,8009,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,CHEMBL621401,1,BAO_0000218,8010,17670,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax was determined,,CHEMBL621402,1,BAO_0000218,8011,1465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax was determined,,CHEMBL621403,1,BAO_0000218,8012,2552,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax after oral administration in rat,In vivo,CHEMBL621121,1,BAO_0000218,8013,5656,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax after peroral administration in rats at 2.4 uM/kg,In vivo,CHEMBL872525,1,BAO_0000218,8014,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax in male rat,,CHEMBL621122,1,BAO_0000218,8015,5610,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax in rat at 10 mg/kg,In vivo,CHEMBL621123,1,BAO_0000218,8016,6046,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax in rat by po administration at a dose of 40 mg/kg,In vivo,CHEMBL621124,1,BAO_0000218,8017,5874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax in rats,,CHEMBL621125,1,BAO_0000218,8018,17596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax was measured in rats after peroral administration at 5 mg/kg,In vivo,CHEMBL621126,1,BAO_0000218,8019,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,CHEMBL621127,1,BAO_0000218,8020,1908,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax value after administration of 20 mg/Kg oral dose in rat,In vivo,CHEMBL621128,1,BAO_0000218,8021,2959,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax value at a dose of 10 mg/kg in male SD rats,In vivo,CHEMBL618263,1,BAO_0000218,8022,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax value at a dose of 100 mg/kg in male SD rats,In vivo,CHEMBL618264,1,BAO_0000218,8023,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax value at a dose of 50 mg/kg in male SD rats,In vivo,CHEMBL618265,1,BAO_0000218,8024,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,CHEMBL618266,1,BAO_0000218,8025,4186,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,CHEMBL618267,1,BAO_0000218,8026,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,CHEMBL618450,1,BAO_0000218,8027,429,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,CHEMBL618451,1,BAO_0000218,8028,429,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,CHEMBL618452,1,BAO_0000218,8029,5546,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,CHEMBL618453,1,BAO_0000218,8030,3173,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,CHEMBL618454,1,BAO_0000218,8031,3173,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,CHEMBL618455,1,BAO_0000218,8032,3173,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,In vivo,CHEMBL618456,1,BAO_0000218,8033,4257,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound distribution in rat tissues was determined,In vivo,CHEMBL618457,1,BAO_0000218,8034,6011,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was evaluated in rat,In vivo,CHEMBL618458,1,BAO_0000218,8035,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,CHEMBL618459,1,BAO_0000218,8036,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,CHEMBL876733,1,BAO_0000218,8037,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,CHEMBL618460,1,BAO_0000218,8038,14346,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,CHEMBL618461,1,BAO_0000218,8039,14346,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under the curve was determined after oral administration (300 uM/Kg),,CHEMBL618462,0,BAO_0000019,8040,15469,,,,,,
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,CHEMBL618463,1,BAO_0000218,8041,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,CHEMBL618464,1,BAO_0000218,8042,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,CHEMBL618465,1,BAO_0000218,8043,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,CHEMBL618466,1,BAO_0000218,8044,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,CHEMBL618467,1,BAO_0000218,8045,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,CHEMBL618468,1,BAO_0000218,8046,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,CHEMBL618469,1,BAO_0000218,8047,12935,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,CHEMBL618470,1,BAO_0000218,8048,12935,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Plasma drug AUC in rat (PO dose),,CHEMBL618471,0,BAO_0000218,8049,14813,,,,,,
A,1,,,N,Intermediate,,,,50594,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,CHEMBL618472,1,BAO_0000218,8050,15792,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Area under was determined at a dose of 30 mg/kg,,CHEMBL618473,0,BAO_0000218,8051,3579,,,,,,
A,1,,,N,Intermediate,,,,50506,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,CHEMBL621699,1,BAO_0000218,8052,12487,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50597,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,CHEMBL621700,1,BAO_0000218,8053,12487,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,CHEMBL621701,1,BAO_0000218,8054,12487,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50506,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,CHEMBL621702,1,BAO_0000218,8055,12487,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50588,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,CHEMBL621703,1,BAO_0000218,8056,12487,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,CHEMBL621704,1,BAO_0000218,8057,12487,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,CHEMBL624259,1,BAO_0000218,8058,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,CHEMBL624260,1,BAO_0000218,8059,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,CHEMBL624430,1,BAO_0000218,8060,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,CHEMBL624431,1,BAO_0000218,8061,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,CHEMBL624432,1,BAO_0000218,8062,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,CHEMBL624433,1,BAO_0000218,8063,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,CHEMBL624434,1,BAO_0000218,8064,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,CHEMBL624435,1,BAO_0000218,8065,12902,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,CHEMBL618570,1,BAO_0000218,8066,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,CHEMBL618571,1,BAO_0000218,8067,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,CHEMBL618572,1,BAO_0000218,8068,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,CHEMBL618573,1,BAO_0000218,8069,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,CHEMBL619267,1,BAO_0000218,8070,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,CHEMBL619431,1,BAO_0000218,8071,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,CHEMBL619432,1,BAO_0000218,8072,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,CHEMBL619433,1,BAO_0000218,8073,12745,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,Plasma,,,22224,AUC in mice after oral dose (50 mg/kg),,CHEMBL619434,0,BAO_0000218,8074,13298,,,1969.0,,,
A,1,,,N,Intermediate,Serum,,,50594,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,CHEMBL619435,1,BAO_0000218,8075,12226,,10090.0,1977.0,,,Mus musculus
A,1,,,U,Autocuration,Plasma,,,22224,AUC (0-4 hr) ug/ml/h,,CHEMBL619436,0,BAO_0000019,8076,12634,,,1969.0,,,
A,1,,,N,Intermediate,,,,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,CHEMBL619437,1,BAO_0000218,8077,14810,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,CHEMBL619438,0,BAO_0000218,8078,13889,,,,,,
A,1,,,N,Intermediate,,,,50594,Compound was evaluated for Area under curve in mice,,CHEMBL619439,1,BAO_0000218,8079,10018,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,CHEMBL619440,1,BAO_0000218,8080,8758,,10116.0,,,,Rattus norvegicus
F,1,,,U,Autocuration,,,,22224,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,CHEMBL619441,0,BAO_0000218,8081,8758,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,CHEMBL619442,1,BAO_0000218,8082,8758,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,CHEMBL875156,0,BAO_0000019,8083,2249,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,CHEMBL619443,0,BAO_0000019,8084,2249,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,CHEMBL619444,0,BAO_0000019,8085,2249,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,CHEMBL623464,0,BAO_0000019,8086,2249,,,,,,
A,1,,,N,Intermediate,,,,50594,Compound was evaluated for area under curve when administered through oral route in mouse,,CHEMBL623465,1,BAO_0000218,8087,15115,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,In vivo,CHEMBL623466,1,BAO_0000218,8088,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,In vivo,CHEMBL623467,1,BAO_0000218,8089,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL623468,1,BAO_0000218,8090,6249,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,CHEMBL622660,1,BAO_0000218,8091,2463,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance rate in Sprague-Dawley rats,In vivo,CHEMBL622661,1,BAO_0000218,8092,4969,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL622662,1,BAO_0000218,8093,17720,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (total body clearance) in rat,In vivo,CHEMBL622663,1,BAO_0000218,8094,3457,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,CHEMBL622664,1,BAO_0000218,8095,5983,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,CHEMBL622665,1,BAO_0000218,8096,6295,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,CHEMBL622666,1,BAO_0000218,8097,6296,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cl in rat i.v. at 2 mg/kg concentration,In vivo,CHEMBL621615,1,BAO_0000218,8098,17686,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance of compound after intravenous administration in rats at 24 uM/kg,In vivo,CHEMBL621616,1,BAO_0000218,8099,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance was determined,In vivo,CHEMBL621617,1,BAO_0000218,8100,5503,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance by intravenous administration of 3.4 mg/kg in rat,In vivo,CHEMBL621618,1,BAO_0000218,8101,4368,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,CHEMBL621619,1,BAO_0000218,8102,6005,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rate after i.v. administration in rats,In vivo,CHEMBL621620,1,BAO_0000218,8103,5031,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL621786,1,BAO_0000218,8104,4890,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,CHEMBL621787,1,BAO_0000218,8105,5182,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,In vivo,CHEMBL621788,1,BAO_0000218,8106,5979,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance (Cl) after oral administration in rat,In vivo,CHEMBL621789,1,BAO_0000218,8107,5656,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,In vivo,CHEMBL621790,1,BAO_0000218,8108,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma clearance in rat,In vivo,CHEMBL621791,1,BAO_0000218,8109,4839,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro microsome metabolism clearance in rat was determined,In vitro,CHEMBL621792,1,BAO_0000218,8110,5041,Microsomes,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,In vitro,CHEMBL621793,1,BAO_0000218,8111,5041,Microsomes,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL621794,1,BAO_0000218,8112,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,In vivo plasma clearance was determined,In vivo,CHEMBL621795,1,BAO_0000218,8113,5496,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,In vivo,CHEMBL621796,1,BAO_0000218,8114,5739,,10116.0,,,,Rattus norvegicus
A,1,,401.0,N,Intermediate,Liver,Hepatocyte,,50597,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,In vivo,CHEMBL621797,1,BAO_0000218,8115,5676,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Plasma clearance) was measured in rat,In vivo,CHEMBL621798,1,BAO_0000218,8116,4239,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (clearance) in rat i.v.,In vivo,CHEMBL621799,1,BAO_0000218,8117,5676,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma Clearance was evaluated in rats, iv",In vivo,CHEMBL621800,1,BAO_0000218,8118,1918,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance (in vivo) in rats was determined,In vivo,CHEMBL621801,1,BAO_0000218,8119,17800,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,CHEMBL621802,1,BAO_0000218,8120,6056,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined,In vivo,CHEMBL618596,1,BAO_0000218,8121,5496,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,In vivo,CHEMBL618597,1,BAO_0000218,8122,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,In vivo,CHEMBL618598,1,BAO_0000218,8123,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rats,In vivo,CHEMBL618599,1,BAO_0000218,8124,17752,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance rate determined in rat,In vivo,CHEMBL618600,1,BAO_0000218,8125,4576,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined in rat,In vivo,CHEMBL618601,1,BAO_0000218,8126,6011,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined,In vivo,CHEMBL618602,1,BAO_0000218,8127,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance value in rat,In vivo,CHEMBL618603,1,BAO_0000218,8128,5948,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,CHEMBL618604,1,BAO_0000218,8129,6125,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in rat,In vivo,CHEMBL618605,1,BAO_0000218,8130,4839,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total body clearance in rat i.v. at 2 mg/kg concentration,In vivo,CHEMBL618606,1,BAO_0000218,8131,17686,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance of compound in rats after intravenous administration,In vivo,CHEMBL618607,1,BAO_0000218,8132,6571,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance after iv administration to rats,In vivo,CHEMBL618608,1,BAO_0000218,8133,3364,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,CHEMBL618609,1,BAO_0000218,8134,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,CHEMBL618610,1,BAO_0000218,8135,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,CHEMBL618611,1,BAO_0000218,8136,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,CHEMBL618612,1,BAO_0000218,8137,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,CHEMBL618613,1,BAO_0000218,8138,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,CHEMBL621076,1,BAO_0000218,8139,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,CHEMBL621077,1,BAO_0000218,8140,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,CHEMBL621078,1,BAO_0000218,8141,17670,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in rat,In vivo,CHEMBL621251,1,BAO_0000218,8142,5970,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in rat after oral administration at 10 mg/kg,In vivo,CHEMBL621252,1,BAO_0000218,8143,6495,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in rat.,In vivo,CHEMBL621253,1,BAO_0000218,8144,4590,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rate following an oral dose of 20 mg/kg in rats,In vivo,CHEMBL621254,1,BAO_0000218,8145,6193,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,In vivo,CHEMBL621255,1,BAO_0000218,8146,2832,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,In vivo,CHEMBL621256,1,BAO_0000218,8147,1052,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,In vivo,CHEMBL621257,1,BAO_0000218,8148,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,In vivo,CHEMBL621258,1,BAO_0000218,8149,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,In vivo,CHEMBL621259,1,BAO_0000218,8150,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,In vivo,CHEMBL621260,1,BAO_0000218,8151,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,In vivo,CHEMBL876494,1,BAO_0000218,8152,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,In vivo,CHEMBL621261,1,BAO_0000218,8153,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,In vivo,CHEMBL621262,1,BAO_0000218,8154,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,CHEMBL621263,1,BAO_0000218,8155,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,In vivo,CHEMBL621264,1,BAO_0000218,8156,9866,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,In vivo,CHEMBL621265,1,BAO_0000218,8157,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,In vivo,CHEMBL621266,1,BAO_0000218,8158,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,In vivo,CHEMBL621267,1,BAO_0000218,8159,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,In vivo,CHEMBL621268,1,BAO_0000218,8160,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,In vivo,CHEMBL621269,1,BAO_0000218,8161,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,In vivo,CHEMBL621270,1,BAO_0000218,8162,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,In vivo,CHEMBL621271,1,BAO_0000218,8163,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,In vivo,CHEMBL621272,1,BAO_0000218,8164,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,In vivo,CHEMBL621273,1,BAO_0000218,8165,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,In vivo,CHEMBL621274,1,BAO_0000218,8166,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,In vivo,CHEMBL876495,1,BAO_0000218,8167,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,In vivo,CHEMBL621275,1,BAO_0000218,8168,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,In vivo,CHEMBL621276,1,BAO_0000218,8169,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,In vivo,CHEMBL621277,1,BAO_0000218,8170,9866,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,CHEMBL621278,1,BAO_0000218,8171,9866,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,CHEMBL621279,1,BAO_0000218,8172,9866,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),In vivo,CHEMBL621280,1,BAO_0000218,8173,9866,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,In vivo,CHEMBL621281,1,BAO_0000218,8174,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,In vivo,CHEMBL621282,1,BAO_0000218,8175,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,CHEMBL621283,1,BAO_0000218,8176,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,In vivo,CHEMBL621284,1,BAO_0000218,8177,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,In vivo,CHEMBL621285,1,BAO_0000218,8178,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,In vivo,CHEMBL621286,1,BAO_0000218,8179,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,In vivo,CHEMBL623220,1,BAO_0000218,8180,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,In vivo,CHEMBL623221,1,BAO_0000218,8181,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,In vivo,CHEMBL876029,1,BAO_0000218,8182,9866,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,In vivo,CHEMBL623222,1,BAO_0000218,8183,9866,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,In vivo,CHEMBL623223,1,BAO_0000218,8184,9866,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,In vivo,CHEMBL621445,1,BAO_0000218,8185,9866,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621446,1,BAO_0000218,8186,13950,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621447,1,BAO_0000218,8187,13950,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619681,1,BAO_0000218,8188,13950,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619682,1,BAO_0000218,8189,13950,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619683,1,BAO_0000218,8190,13950,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619684,1,BAO_0000218,8191,13950,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619685,1,BAO_0000218,8192,13950,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619686,1,BAO_0000218,8193,13950,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619687,1,BAO_0000218,8194,13950,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619688,1,BAO_0000218,8195,13950,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619689,1,BAO_0000218,8196,13950,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619690,1,BAO_0000218,8197,13950,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619691,1,BAO_0000218,8198,13950,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,CHEMBL619692,1,BAO_0000218,8199,6062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,CHEMBL619693,1,BAO_0000218,8200,3598,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Vc value after IV dose at a dose of 5 mg/kg in rats.,In vivo,CHEMBL619694,1,BAO_0000218,8201,1908,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,In vivo,CHEMBL619695,1,BAO_0000218,8202,17596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for pharmacokinetic parameter volume of distribution,In vivo,CHEMBL619696,1,BAO_0000218,8203,4891,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for volume of distribution in rat,In vivo,CHEMBL619697,1,BAO_0000218,8204,740,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume distribution was determined; steady state(ss),In vivo,CHEMBL619698,1,BAO_0000218,8205,16366,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume of distribution after iv administration to rats,In vivo,CHEMBL619699,1,BAO_0000218,8206,3364,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume of distribution dosing at 3 mg/kg iv,In vivo,CHEMBL619700,1,BAO_0000218,8207,2552,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was evaluated for volume of distribution in rat,In vivo,CHEMBL619701,1,BAO_0000218,8208,406,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for volume of distribution in rat,In vivo,CHEMBL619702,1,BAO_0000218,8209,12500,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,In vivo,CHEMBL620335,1,BAO_0000218,8210,12500,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution (VD) after oral administration in rat,In vivo,CHEMBL620336,1,BAO_0000218,8211,5656,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,CHEMBL620337,1,BAO_0000218,8212,17671,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat,In vivo,CHEMBL620520,1,BAO_0000218,8213,1094,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat,In vivo,CHEMBL620521,1,BAO_0000218,8214,5833,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat after peroral administration at 10 mg/kg,In vivo,CHEMBL875825,1,BAO_0000218,8215,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat after peroral administration at 5 mg/kg,In vivo,CHEMBL620522,1,BAO_0000218,8216,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,CHEMBL620523,1,BAO_0000218,8217,6005,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rat.,In vivo,CHEMBL620524,1,BAO_0000218,8218,1696,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rat,In vivo,CHEMBL620525,1,BAO_0000218,8219,6672,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rat,In vivo,CHEMBL620526,1,BAO_0000218,8220,6673,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rat by iv administration,In vivo,CHEMBL620527,1,BAO_0000218,8221,5871,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rats,In vivo,CHEMBL620528,1,BAO_0000218,8222,6803,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,CHEMBL620529,1,BAO_0000218,8223,5199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution at the dose of 2 mg/kg in rat,,CHEMBL620530,1,BAO_0000218,8224,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume of distribution was determined,In vivo,CHEMBL620531,1,BAO_0000218,8225,16367,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,CHEMBL620532,0,BAO_0000218,8226,5005,,9544.0,,,,Macaca mulatta
A,1,,,U,Intermediate,,,,22224,Compound was tested for its plasma volume distribution in Sprague Dawley rats,In vivo,CHEMBL620533,0,BAO_0000218,8227,5005,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,In vivo,CHEMBL620534,0,BAO_0000218,8228,5005,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean (%CV) PK parameters for Vdss(mL/kg).,In vivo,CHEMBL620535,1,BAO_0000218,8229,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,In vivo,CHEMBL875826,1,BAO_0000218,8230,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,In vivo,CHEMBL620536,1,BAO_0000218,8231,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,CHEMBL620537,1,BAO_0000218,8232,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,In vivo,CHEMBL618526,1,BAO_0000218,8233,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,In vivo,CHEMBL618527,1,BAO_0000218,8234,5739,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Vdss) in rat,In vivo,CHEMBL618528,1,BAO_0000218,8235,5789,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (vdss) was measured in rat,In vivo,CHEMBL618529,1,BAO_0000218,8236,4239,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,In vivo,CHEMBL618530,1,BAO_0000218,8237,4709,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rat,In vivo,CHEMBL618531,1,BAO_0000218,8238,6642,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The pharmacokinetic parameter volume of distribution in vivo in rats,In vivo,CHEMBL618532,1,BAO_0000218,8239,5247,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL618533,1,BAO_0000218,8240,17720,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Vdss in rat i.v. at 2 mg/kg concentration,In vivo,CHEMBL618534,1,BAO_0000218,8241,17686,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution after intravenous administration (1 mg/kg) in rat,In vivo,CHEMBL618535,1,BAO_0000218,8242,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,CHEMBL618536,1,BAO_0000218,8243,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,CHEMBL618537,1,BAO_0000218,8244,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution at a dose of 10 uM/kg in rat was determined,In vivo,CHEMBL618538,1,BAO_0000218,8245,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,CHEMBL618539,1,BAO_0000218,8246,4521,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution was calculated in rat,In vivo,CHEMBL618540,1,BAO_0000218,8247,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution was determined,In vivo,CHEMBL618541,1,BAO_0000218,8248,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution after intravenous administration was evaluated in rat,In vivo,CHEMBL618542,1,BAO_0000218,8249,2938,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,CHEMBL622544,1,BAO_0000218,8250,6679,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",In vivo,CHEMBL622545,1,BAO_0000218,8251,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,CHEMBL622546,1,BAO_0000218,8252,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",In vivo,CHEMBL622547,1,BAO_0000218,8253,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in steady state was determined in rat,In vivo,CHEMBL622548,1,BAO_0000218,8254,5145,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,In vivo,CHEMBL622549,1,BAO_0000218,8255,6467,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,CHEMBL622550,1,BAO_0000218,8256,6467,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Compound was evaluated for area under curve when administered through oral route to mouse,,CHEMBL622551,1,BAO_0000218,8257,15115,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,CHEMBL622552,1,BAO_0000218,8258,8758,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,CHEMBL622553,1,BAO_0000218,8259,8758,,10116.0,,,,Rattus norvegicus
F,1,,,U,Autocuration,,,,22224,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,In vivo,CHEMBL622554,0,BAO_0000218,8260,8267,,,,,,
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,CHEMBL622555,1,BAO_0000218,8261,8267,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,CHEMBL622556,1,BAO_0000218,8262,14239,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,CHEMBL622557,1,BAO_0000218,8263,14239,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,CHEMBL622558,1,BAO_0000218,8264,10754,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,CHEMBL622559,1,BAO_0000218,8265,10754,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,CHEMBL622560,1,BAO_0000218,8266,10754,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,CHEMBL622561,1,BAO_0000218,8267,14681,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,CHEMBL622562,1,BAO_0000218,8268,14681,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,CHEMBL622563,1,BAO_0000218,8269,14681,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Concentration of compound in Central nervous system,,CHEMBL622564,0,BAO_0000019,8270,13118,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of compound in Central nervous system; Not detectable,,CHEMBL622565,0,BAO_0000019,8271,13118,,,,,,
A,1,,,N,Intermediate,,,,50594,"Concentration of diester in the blood, following oral administration in mice",,CHEMBL622566,1,BAO_0000218,8272,13318,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Concentration of monoester in the blood, following oral administration in mice",,CHEMBL624515,1,BAO_0000218,8273,13318,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,CHEMBL624516,1,BAO_0000218,8274,13318,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Evaluated for Pharmacokinetic property: Area under the curve,,CHEMBL624517,0,BAO_0000019,8275,15692,,,,,,
A,1,,,N,Intermediate,,,,50594,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,CHEMBL624518,1,BAO_0000218,8276,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,100710,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,CHEMBL624519,1,BAO_0000218,8277,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,CHEMBL624520,1,BAO_0000218,8278,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,CHEMBL624521,1,BAO_0000218,8279,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,CHEMBL624522,1,BAO_0000218,8280,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,CHEMBL624523,1,BAO_0000218,8281,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,CHEMBL624409,1,BAO_0000218,8282,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,CHEMBL624410,1,BAO_0000218,8283,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,CHEMBL624411,1,BAO_0000218,8284,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,CHEMBL623531,1,BAO_0000218,8285,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,CHEMBL623532,1,BAO_0000218,8286,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,CHEMBL623533,1,BAO_0000218,8287,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,CHEMBL623534,1,BAO_0000218,8288,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,CHEMBL623535,1,BAO_0000218,8289,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,CHEMBL623536,1,BAO_0000218,8290,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,CHEMBL623537,1,BAO_0000218,8291,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,CHEMBL623538,1,BAO_0000218,8292,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,CHEMBL623539,1,BAO_0000218,8293,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,CHEMBL623540,1,BAO_0000218,8294,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,CHEMBL623541,1,BAO_0000218,8295,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,CHEMBL623542,1,BAO_0000218,8296,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,CHEMBL623543,1,BAO_0000218,8297,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,CHEMBL623544,1,BAO_0000218,8298,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,CHEMBL623545,1,BAO_0000218,8299,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,CHEMBL623546,1,BAO_0000218,8300,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50597,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL623547,1,BAO_0000218,8301,5408,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,High i.v. clearance in Dawley rats,In vivo,CHEMBL623548,1,BAO_0000218,8302,6827,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vitro clearance in rat liver microsomes,In vitro,CHEMBL623549,1,BAO_0000218,8303,17538,Microsomes,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Intrinsic clearance in rat liver microsomes was determined,In vitro,CHEMBL623550,1,BAO_0000218,8304,6331,Microsomes,10116.0,2107.0,,,Rattus norvegicus
A,1,,401.0,N,Intermediate,Liver,Hepatocyte,,50597,Intrinsic clearance in rat hepatocytes was determined,In vitro,CHEMBL875276,1,BAO_0000218,8305,5948,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma Clearance was determined,In vivo,CHEMBL621872,1,BAO_0000218,8306,4026,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,In vivo,CHEMBL621873,1,BAO_0000218,8307,6647,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat.,In vivo,CHEMBL621874,1,BAO_0000218,8308,1696,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rats,In vivo,CHEMBL621875,1,BAO_0000218,8309,6597,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,In vivo,CHEMBL621876,1,BAO_0000218,8310,347,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,In vivo,CHEMBL621877,1,BAO_0000218,8311,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was measured in rat,In vivo,CHEMBL621878,1,BAO_0000218,8312,2879,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,CHEMBL621879,1,BAO_0000218,8313,4883,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",In vivo,CHEMBL621880,1,BAO_0000218,8314,5328,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,In vivo,CHEMBL621881,1,BAO_0000218,8315,5160,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,CHEMBL621882,1,BAO_0000218,8316,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total clearance at 1 mg/kg was determined in rat,In vivo,CHEMBL875283,1,BAO_0000218,8317,17651,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total clearance at 10 mg/kg was determined in rat,In vivo,CHEMBL621883,1,BAO_0000218,8318,17651,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in rat,In vivo,CHEMBL621884,1,BAO_0000218,8319,6596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance rate determined in rats,In vivo,CHEMBL621885,1,BAO_0000218,8320,4796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance of compound in rat was evaluated,In vivo,CHEMBL621886,1,BAO_0000218,8321,6850,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,CHEMBL621887,1,BAO_0000218,8322,5932,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (blood clearance) in rat,In vivo,CHEMBL621888,1,BAO_0000218,8323,3371,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL621889,1,BAO_0000218,8324,2083,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rats,In vivo,CHEMBL621890,1,BAO_0000218,8325,4942,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,In vitro,CHEMBL621891,1,BAO_0000218,8326,6838,Microsomes,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in Dawley rat,In vivo,CHEMBL621892,1,BAO_0000218,8327,5353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rat,In vivo,CHEMBL621893,1,BAO_0000218,8328,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),In vivo,CHEMBL621894,1,BAO_0000218,8329,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rat; Not determined,In vivo,CHEMBL621895,1,BAO_0000218,8330,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.,In vivo,CHEMBL875284,1,BAO_0000218,8331,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,CHEMBL618699,1,BAO_0000218,8332,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,CHEMBL618700,1,BAO_0000218,8333,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,CHEMBL618701,1,BAO_0000218,8334,6211,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,CHEMBL876600,1,BAO_0000218,8335,12873,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance of compound in rat after 1 mg/kg i.v. administration,In vivo,CHEMBL618702,1,BAO_0000218,8336,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for Hepatic clearance in rat,In vivo,CHEMBL618703,1,BAO_0000218,8337,3341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo clearance after 5 mg/kg dose,In vivo,CHEMBL618704,1,BAO_0000218,8338,4891,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma clearance in rats,In vivo,CHEMBL618705,1,BAO_0000218,8339,1094,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Hepatic clearance after intravenous administration was evaluated in rat,In vivo,CHEMBL618706,1,BAO_0000218,8340,2938,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Lower clearance in rat (i.v.) at 0.5 mpk,In vivo,CHEMBL618707,1,BAO_0000218,8341,17853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Pharmacokinetic parameter expressed as plasma clearance in rat,In vivo,CHEMBL618708,1,BAO_0000218,8342,6049,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Clp) in rat,In vivo,CHEMBL618709,1,BAO_0000218,8343,5789,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in Sprague-Dawley rats,In vivo,CHEMBL618710,1,BAO_0000218,8344,4514,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance (Clp) in rat,In vivo,CHEMBL618711,1,BAO_0000218,8345,6448,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,In vivo,CHEMBL618712,1,BAO_0000218,8346,6062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,In vivo,CHEMBL618713,1,BAO_0000218,8347,5710,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after intravenous administration of 1 mg/kg in rat,In vivo,CHEMBL618714,1,BAO_0000218,8348,4709,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,CHEMBL618715,1,BAO_0000218,8349,4521,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat was determined,In vivo,CHEMBL618716,1,BAO_0000218,8350,1742,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance measured in rat,In vivo,CHEMBL876601,1,BAO_0000218,8351,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was calculated in rat,In vivo,CHEMBL618717,1,BAO_0000218,8352,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL618718,1,BAO_0000218,8353,5145,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL618719,1,BAO_0000218,8354,5833,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL618720,1,BAO_0000218,8355,6453,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL618721,1,BAO_0000218,8356,6640,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rats,In vivo,CHEMBL621477,1,BAO_0000218,8357,6305,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL621478,1,BAO_0000218,8358,6642,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was evaluated in rat,In vivo,CHEMBL621479,1,BAO_0000218,8359,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was evaluated in rat; Not tested,In vivo,CHEMBL621480,1,BAO_0000218,8360,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance rate was determined for the compound in rat,In vivo,CHEMBL621481,1,BAO_0000218,8361,5144,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",In vivo,CHEMBL621482,1,BAO_0000218,8362,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,CHEMBL621483,1,BAO_0000218,8363,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",In vivo,CHEMBL621484,1,BAO_0000218,8364,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621485,1,BAO_0000218,8365,13950,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621486,1,BAO_0000218,8366,13950,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621487,1,BAO_0000218,8367,13950,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621488,1,BAO_0000218,8368,13950,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621489,1,BAO_0000218,8369,13950,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621490,1,BAO_0000218,8370,13950,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621491,1,BAO_0000218,8371,13950,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621492,1,BAO_0000218,8372,13950,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621493,1,BAO_0000218,8373,13950,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621494,1,BAO_0000218,8374,13950,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621495,1,BAO_0000218,8375,13950,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621496,1,BAO_0000218,8376,13950,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621497,1,BAO_0000218,8377,13950,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621498,1,BAO_0000218,8378,13950,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL621499,1,BAO_0000218,8379,13950,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL618634,1,BAO_0000218,8380,13950,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL618635,1,BAO_0000218,8381,13950,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL618636,1,BAO_0000218,8382,13950,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619737,1,BAO_0000218,8383,13950,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL619738,1,BAO_0000218,8384,13950,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL624329,1,BAO_0000218,8385,13950,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL624330,1,BAO_0000218,8386,13950,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL624331,1,BAO_0000218,8387,13950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL624332,1,BAO_0000218,8388,13950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL624333,1,BAO_0000218,8389,13950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL624334,1,BAO_0000218,8390,13950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL624335,1,BAO_0000218,8391,13950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620016,1,BAO_0000218,8392,13950,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620169,1,BAO_0000218,8393,13950,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620170,1,BAO_0000218,8394,13950,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620171,1,BAO_0000218,8395,13950,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620172,1,BAO_0000218,8396,13950,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620173,1,BAO_0000218,8397,13950,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620174,1,BAO_0000218,8398,13950,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620175,1,BAO_0000218,8399,13950,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620176,1,BAO_0000218,8400,13950,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,CHEMBL620177,1,BAO_0000218,8401,13950,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620178,1,BAO_0000218,8402,13950,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL620179,1,BAO_0000218,8403,13950,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620180,1,BAO_0000218,8404,13950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,In vivo,CHEMBL620181,1,BAO_0000218,8405,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution of compound in rats after intravenous administration,In vivo,CHEMBL620182,1,BAO_0000218,8406,6571,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rat,In vivo,CHEMBL620183,1,BAO_0000218,8407,6453,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,In vivo,CHEMBL620184,1,BAO_0000218,8408,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,CHEMBL620185,1,BAO_0000218,8409,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,CHEMBL620186,1,BAO_0000218,8410,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was determined in Dawley rat,In vivo,CHEMBL620187,1,BAO_0000218,8411,5353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,CHEMBL620188,1,BAO_0000218,8412,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was reported in Sprague-Dawley rat,In vivo,CHEMBL620189,1,BAO_0000218,8413,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volumes of distribution in rat after peroral administration,In vivo,CHEMBL620190,1,BAO_0000218,8414,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volumes of distribution in rat after po administration,In vivo,CHEMBL620191,1,BAO_0000218,8415,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volumes of distribution in rat after po administration; Not determined,In vivo,CHEMBL620192,1,BAO_0000218,8416,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Volume) in rat i.v.,In vivo,CHEMBL620193,1,BAO_0000218,8417,5676,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,In vivo,CHEMBL620194,1,BAO_0000218,8418,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,CHEMBL876730,1,BAO_0000218,8419,17670,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat after oral administration at 10 mg/kg,In vivo,CHEMBL620195,1,BAO_0000218,8420,6495,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL620196,1,BAO_0000218,8421,5408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,CHEMBL620197,1,BAO_0000218,8422,4883,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,In vivo,CHEMBL620198,1,BAO_0000218,8423,6647,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rats,In vivo,CHEMBL620199,1,BAO_0000218,8424,6495,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,CHEMBL620200,1,BAO_0000218,8425,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,CHEMBL620201,1,BAO_0000218,8426,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL620202,1,BAO_0000218,8427,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL620203,1,BAO_0000218,8428,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,In vivo,CHEMBL620204,1,BAO_0000218,8429,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL620205,1,BAO_0000218,8430,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (Vss) in rat,In vivo,CHEMBL624664,1,BAO_0000218,8431,5960,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Volume) in rat i.v.,In vivo,CHEMBL624665,1,BAO_0000218,8432,5676,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Vss) in rat,,CHEMBL624666,1,BAO_0000218,8433,5948,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,CHEMBL624667,1,BAO_0000218,8434,5979,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL624668,1,BAO_0000218,8435,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL624669,1,BAO_0000218,8436,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL624670,1,BAO_0000218,8437,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL624671,1,BAO_0000218,8438,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume distribution in rat,In vivo,CHEMBL624672,1,BAO_0000218,8439,6448,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",In vivo,CHEMBL624673,1,BAO_0000218,8440,12873,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state volume of distribution determined in rat,In vivo,CHEMBL624674,1,BAO_0000218,8441,4576,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,CHEMBL624675,1,BAO_0000218,8442,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,CHEMBL621728,1,BAO_0000218,8443,1466,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,CHEMBL621729,1,BAO_0000218,8444,5182,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,CHEMBL621730,1,BAO_0000218,8445,5182,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,CHEMBL621731,1,BAO_0000218,8446,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,CHEMBL621732,1,BAO_0000218,8447,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume in steady state distribution value was determined,In vivo,CHEMBL621908,1,BAO_0000218,8448,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume in steady state distribution value was determined; ND denotes no data,In vivo,CHEMBL875347,1,BAO_0000218,8449,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume in steady state distribution value was determined; ND denotes not determined,In vivo,CHEMBL621909,1,BAO_0000218,8450,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,CHEMBL621910,1,BAO_0000218,8451,17065,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution at steady state was evaluated in rats,In vivo,CHEMBL621911,1,BAO_0000218,8452,6597,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution at steady state was observed after intravenous administration in rat,In vivo,CHEMBL621912,1,BAO_0000218,8453,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in steady state was determined in rat,In vivo,CHEMBL621913,1,BAO_0000218,8454,6485,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in steady state was determined in rat,In vivo,CHEMBL621914,1,BAO_0000218,8455,17655,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution after i.v. administration,In vivo,CHEMBL621915,1,BAO_0000218,8456,6616,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,CHEMBL621916,1,BAO_0000218,8457,1916,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50594,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,CHEMBL621917,1,BAO_0000218,8458,16438,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,CHEMBL621918,1,BAO_0000218,8459,16438,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of compound (oxidized form) in spleen tissue,In vivo,CHEMBL621919,1,BAO_0000218,8460,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",In vivo,CHEMBL621920,1,BAO_0000218,8461,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",In vivo,CHEMBL621921,1,BAO_0000218,8462,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,CHEMBL622401,1,BAO_0000218,8463,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,CHEMBL875348,1,BAO_0000218,8464,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,CHEMBL622402,1,BAO_0000218,8465,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,In vivo,CHEMBL622403,1,BAO_0000218,8466,16438,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,CHEMBL622404,1,BAO_0000218,8467,16438,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,In vivo,CHEMBL622405,1,BAO_0000218,8468,16438,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,CHEMBL622406,1,BAO_0000218,8469,16438,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,CHEMBL622407,1,BAO_0000218,8470,16438,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,In vivo,CHEMBL622408,1,BAO_0000218,8471,16438,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,CHEMBL622409,1,BAO_0000218,8472,16438,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,CHEMBL622410,1,BAO_0000218,8473,16438,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,In vivo,CHEMBL622411,1,BAO_0000218,8474,16438,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,CHEMBL627864,1,BAO_0000218,8475,16438,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,CHEMBL627865,1,BAO_0000218,8476,16438,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,In vivo,CHEMBL627866,1,BAO_0000218,8477,16438,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,CHEMBL627751,1,BAO_0000218,8478,16438,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,In vivo,CHEMBL627752,1,BAO_0000218,8479,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,CHEMBL627753,1,BAO_0000218,8480,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,CHEMBL627754,1,BAO_0000218,8481,16438,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,CHEMBL627755,1,BAO_0000218,8482,12467,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627756,1,BAO_0000218,8483,17208,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627757,1,BAO_0000218,8484,17208,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627758,1,BAO_0000218,8485,17208,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627759,1,BAO_0000218,8486,17208,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627760,1,BAO_0000218,8487,17208,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627761,1,BAO_0000218,8488,17208,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL876811,1,BAO_0000218,8489,17208,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627762,1,BAO_0000218,8490,17208,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627763,1,BAO_0000218,8491,17208,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627764,1,BAO_0000218,8492,17208,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627765,1,BAO_0000218,8493,17208,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627766,1,BAO_0000218,8494,17208,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627767,1,BAO_0000218,8495,17208,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627768,1,BAO_0000218,8496,17208,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL628422,1,BAO_0000218,8497,17208,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL628423,1,BAO_0000218,8498,17208,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,In vivo,CHEMBL628424,1,BAO_0000218,8499,5089,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,In vivo,CHEMBL628425,1,BAO_0000218,8500,5089,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,In vivo,CHEMBL628426,1,BAO_0000218,8501,4257,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,CHEMBL628427,1,BAO_0000218,8502,6679,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,CHEMBL626938,1,BAO_0000218,8503,5546,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,CHEMBL626939,1,BAO_0000218,8504,6141,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,CHEMBL626940,1,BAO_0000218,8505,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,CHEMBL626941,1,BAO_0000218,8506,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was reported in Sprague-Dawley rat,In vivo,CHEMBL626942,1,BAO_0000218,8507,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after intravenous administration (1 mg/kg) in rat,In vivo,CHEMBL876812,1,BAO_0000218,8508,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance of compound in rats was evaluated,In vivo,CHEMBL626943,1,BAO_0000218,8509,6848,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance of compound in rats was evaluated; ND indicates not determined,In vivo,CHEMBL626944,1,BAO_0000218,8510,6848,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,In vivo,CHEMBL626945,1,BAO_0000218,8511,6467,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,CHEMBL626946,1,BAO_0000218,8512,6467,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance rate in Sprague-Dawley rats,In vivo,CHEMBL626856,1,BAO_0000218,8513,4956,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),In vivo,CHEMBL626857,1,BAO_0000218,8514,5529,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The compound was evaluated for plasma clearance in rat,In vivo,CHEMBL626858,1,BAO_0000218,8515,406,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance in rat,In vivo,CHEMBL627018,1,BAO_0000218,8516,17655,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,In vivo,CHEMBL625331,1,BAO_0000218,8517,3293,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,In vivo,CHEMBL625332,1,BAO_0000218,8518,4075,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,C max was determined at 10 mg/kg po dose in rats,In vivo,CHEMBL877590,1,BAO_0000218,8519,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,C max was determined at 3 mg/kg po dose in rats,In vivo,CHEMBL625333,1,BAO_0000218,8520,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after repeated oral dose of compound at 1 mg/kg in rats,In vivo,CHEMBL625334,1,BAO_0000218,8521,17594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after single intravenous bolus of 1 mg/kg in rats,In vivo,CHEMBL625335,1,BAO_0000218,8522,17594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax of compound at 5 mg/kg after po administration was determined in rat,In vivo,CHEMBL625336,1,BAO_0000218,8523,4762,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax 24 hr after 10 mg/kg oral administration in rats,In vivo,CHEMBL625337,1,BAO_0000218,8524,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax 24 hr after 2 mg/kg oral administration in rats,In vivo,CHEMBL625338,1,BAO_0000218,8525,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,CHEMBL625339,1,BAO_0000218,8526,1466,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat after administration of 2 mg/kg iv,In vivo,CHEMBL625340,1,BAO_0000218,8527,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat after administration of 2 mg/kg iv,In vivo,CHEMBL625341,1,BAO_0000218,8528,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,In vivo,CHEMBL622687,1,BAO_0000218,8529,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Cmax wa determined in rat plasma at 30 mg/kg after po administration,In vivo,CHEMBL622688,1,BAO_0000218,8530,6515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,In vivo,CHEMBL622689,1,BAO_0000218,8531,11149,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,In vivo,CHEMBL620295,1,BAO_0000218,8532,11149,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after 10 mg/kg oral administration in rat,In vivo,CHEMBL620296,1,BAO_0000218,8533,17858,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after IV dosing at 0.5 mg/kg in rat; no data,In vivo,CHEMBL620297,1,BAO_0000218,8534,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after IV dosing at 1 mg/kg in rat; no data,In vivo,CHEMBL620298,1,BAO_0000218,8535,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after oral administration at 20 mpk in rats,In vivo,CHEMBL620299,1,BAO_0000218,8536,4426,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after oral administration at 20 mpk in rats; Not performed.,In vivo,CHEMBL620300,1,BAO_0000218,8537,4426,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after oral administration at 20 mpk in rats d; Not performed.,In vivo,CHEMBL620301,1,BAO_0000218,8538,4426,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after oral administration in rat,In vivo,CHEMBL620302,1,BAO_0000218,8539,5656,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after oral administration at a dose of 2 mg/kg in rat,In vivo,CHEMBL620303,1,BAO_0000218,8540,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after oral administration at a dose of 4 mg/kg in rat,In vivo,CHEMBL620304,1,BAO_0000218,8541,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rats after 20 mg/kg oral dose,In vivo,CHEMBL620305,1,BAO_0000218,8542,6113,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax after peroral administration in rats at 2.4 uM/kg,In vivo,CHEMBL620306,1,BAO_0000218,8543,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,CHEMBL620307,1,BAO_0000218,8544,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,CHEMBL620308,1,BAO_0000218,8545,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax by administering at 20 mg/kg p.o. in rats,In vivo,CHEMBL620309,1,BAO_0000218,8546,6402,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in male rat,In vivo,CHEMBL620310,1,BAO_0000218,8547,5610,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat,In vivo,CHEMBL620311,1,BAO_0000218,8548,5207,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat,In vivo,CHEMBL620312,1,BAO_0000218,8549,6011,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat,In vivo,CHEMBL620313,1,BAO_0000218,8550,6504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat at 10 mg/kg,In vivo,CHEMBL620314,1,BAO_0000218,8551,6046,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat at the dose of 1 mg/kg i.v.,In vivo,CHEMBL620315,1,BAO_0000218,8552,6504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat by po administration at a dose of 40 mg/kg,In vivo,CHEMBL620316,1,BAO_0000218,8553,5874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat p.o. at 20 mg/kg concentration,In vivo,CHEMBL620317,1,BAO_0000218,8554,17686,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rats,In vivo,CHEMBL620318,1,BAO_0000218,8555,5836,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rats,In vivo,CHEMBL620319,1,BAO_0000218,8556,17596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax was evaluated after 20 uM/kg of peroral administration,In vivo,CHEMBL620320,1,BAO_0000218,8557,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax was measured in rats after peroral administration at 3 mg/kg,In vivo,CHEMBL620321,1,BAO_0000218,8558,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,CHEMBL620322,1,BAO_0000218,8559,1908,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL620323,1,BAO_0000218,8560,13950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Frontal cortex,,,50597,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620324,1,BAO_0000218,8561,13950,,10116.0,1870.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Frontal cortex,,,50597,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL620325,1,BAO_0000218,8562,13950,,10116.0,1870.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620326,1,BAO_0000218,8563,13950,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL620327,1,BAO_0000218,8564,13950,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620328,1,BAO_0000218,8565,13950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL620329,1,BAO_0000218,8566,13950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Midbrain,,,50597,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620330,1,BAO_0000218,8567,13950,,10116.0,1891.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Midbrain,,,50597,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL875286,1,BAO_0000218,8568,13950,,10116.0,1891.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620331,1,BAO_0000218,8569,13950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL620332,1,BAO_0000218,8570,13950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,CHEMBL620333,1,BAO_0000218,8571,13950,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,CHEMBL620334,1,BAO_0000218,8572,13950,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL621015,1,BAO_0000218,8573,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL621016,1,BAO_0000218,8574,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL621191,1,BAO_0000218,8575,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL621192,1,BAO_0000218,8576,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL621193,1,BAO_0000218,8577,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL621194,1,BAO_0000218,8578,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL624204,1,BAO_0000218,8579,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL624205,1,BAO_0000218,8580,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL624206,1,BAO_0000218,8581,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL624207,1,BAO_0000218,8582,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL624208,1,BAO_0000218,8583,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL624209,1,BAO_0000218,8584,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL624210,1,BAO_0000218,8585,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL624211,1,BAO_0000218,8586,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL624212,1,BAO_0000218,8587,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL624213,1,BAO_0000218,8588,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL876611,1,BAO_0000218,8589,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL624214,1,BAO_0000218,8590,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL624215,1,BAO_0000218,8591,16434,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL624216,1,BAO_0000218,8592,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL624217,1,BAO_0000218,8593,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL624218,1,BAO_0000218,8594,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL624219,1,BAO_0000218,8595,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL624220,1,BAO_0000218,8596,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL624221,1,BAO_0000218,8597,16435,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL624222,1,BAO_0000218,8598,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL624223,1,BAO_0000218,8599,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL624224,1,BAO_0000218,8600,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL624225,1,BAO_0000218,8601,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,In vivo,CHEMBL622420,1,BAO_0000218,8602,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of steady state distribution after i.v. administration in rats,In vivo,CHEMBL622421,1,BAO_0000218,8603,5031,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Vss after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,CHEMBL622422,1,BAO_0000218,8604,6215,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,CHEMBL622423,1,BAO_0000218,8605,17671,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Vss was determined,In vivo,CHEMBL622424,1,BAO_0000218,8606,17752,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Vss in rat,In vivo,CHEMBL622425,1,BAO_0000218,8607,6596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Vss was evaluated after 10 uM/kg of intra arterial administration,In vivo,CHEMBL876612,1,BAO_0000218,8608,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,volume of distribution at steady state was observed after intravenous administration in rat,In vivo,CHEMBL622426,1,BAO_0000218,8609,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,CHEMBL622427,1,BAO_0000218,8610,6062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic (PK) parameter Vz in rat,In vivo,CHEMBL622428,1,BAO_0000218,8611,5874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume distribution in rats,In vivo,CHEMBL622429,1,BAO_0000218,8612,4942,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in rat; No data,In vivo,CHEMBL622430,1,BAO_0000218,8613,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL622431,1,BAO_0000218,8614,4890,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Ileum,,,50597,% absorption predicted from in vitro rat ileum transport studies,,CHEMBL622432,1,BAO_0000218,8615,15765,,10116.0,2116.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,CHEMBL622433,1,BAO_0000218,8616,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,CHEMBL622434,1,BAO_0000218,8617,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,In vivo,CHEMBL622435,1,BAO_0000218,8618,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),In vivo,CHEMBL618748,1,BAO_0000218,8619,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,CHEMBL618749,1,BAO_0000218,8620,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,CHEMBL618750,1,BAO_0000218,8621,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,CHEMBL618751,1,BAO_0000218,8622,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,CHEMBL618752,1,BAO_0000218,8623,13569,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL618753,1,BAO_0000218,8624,4576,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,In vivo,CHEMBL618754,1,BAO_0000218,8625,750,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL618755,1,BAO_0000218,8626,750,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL618756,1,BAO_0000218,8627,4590,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL618757,1,BAO_0000218,8628,1716,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL618758,1,BAO_0000218,8629,1974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 30 mg/kg),In vivo,CHEMBL621088,1,BAO_0000218,8630,4502,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (cLogP) in rat,,CHEMBL621089,1,BAO_0000218,8631,3371,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,Blood,,,50597,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,CHEMBL621090,1,BAO_0000218,8632,9099,,10116.0,178.0,,,Rattus norvegicus
F,1,,,N,Intermediate,Blood,,,50597,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,CHEMBL621091,1,BAO_0000218,8633,9099,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in rat.,In vivo,CHEMBL876731,1,BAO_0000218,8634,4590,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for its clearance when administered intravenously in rat,In vivo,CHEMBL621092,1,BAO_0000218,8635,3184,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,CHEMBL621093,1,BAO_0000218,8636,16456,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Blood: Brain distribution ratio is determined in rat,,CHEMBL621094,1,BAO_0000218,8637,4199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,CHEMBL621095,1,BAO_0000218,8638,4199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,CHEMBL621096,1,BAO_0000218,8639,4199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL621097,1,BAO_0000218,8640,8677,,10116.0,2113.0,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent dose excreted in 0-48 hours administered ip to male rat,,CHEMBL621098,1,BAO_0000218,8641,7449,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621099,1,BAO_0000218,8642,11977,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621100,1,BAO_0000218,8643,11977,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,CHEMBL621101,1,BAO_0000218,8644,11977,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621102,1,BAO_0000218,8645,11977,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL876732,1,BAO_0000218,8646,11977,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621103,1,BAO_0000218,8647,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621104,1,BAO_0000218,8648,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,CHEMBL621105,1,BAO_0000218,8649,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621106,1,BAO_0000218,8650,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621107,1,BAO_0000218,8651,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621108,1,BAO_0000218,8652,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL621109,1,BAO_0000218,8653,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL621110,1,BAO_0000218,8654,17208,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL621111,1,BAO_0000218,8655,17208,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL622541,1,BAO_0000218,8656,17208,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL622542,1,BAO_0000218,8657,17208,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL622543,1,BAO_0000218,8658,17208,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624412,1,BAO_0000218,8659,17208,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624413,1,BAO_0000218,8660,17208,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624414,1,BAO_0000218,8661,17208,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624415,1,BAO_0000218,8662,17208,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624416,1,BAO_0000218,8663,17208,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624417,1,BAO_0000218,8664,17208,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624418,1,BAO_0000218,8665,17208,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624419,1,BAO_0000218,8666,17208,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624420,1,BAO_0000218,8667,17208,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624421,1,BAO_0000218,8668,17208,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624422,1,BAO_0000218,8669,17208,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL624423,1,BAO_0000218,8670,17208,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL625123,1,BAO_0000218,8671,17208,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL625124,1,BAO_0000218,8672,17208,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL625125,1,BAO_0000218,8673,17208,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL625126,1,BAO_0000218,8674,17208,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626947,1,BAO_0000218,8675,17208,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626948,1,BAO_0000218,8676,17208,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626949,1,BAO_0000218,8677,17208,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626950,1,BAO_0000218,8678,17208,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626951,1,BAO_0000218,8679,17208,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626952,1,BAO_0000218,8680,17208,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626953,1,BAO_0000218,8681,17208,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626954,1,BAO_0000218,8682,17208,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626955,1,BAO_0000218,8683,17208,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626956,1,BAO_0000218,8684,17208,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626957,1,BAO_0000218,8685,17208,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626958,1,BAO_0000218,8686,17208,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626959,1,BAO_0000218,8687,17208,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626960,1,BAO_0000218,8688,17208,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL626961,1,BAO_0000218,8689,17208,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627589,1,BAO_0000218,8690,17208,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,CHEMBL627590,1,BAO_0000218,8691,17208,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Time taken for EC90 was determined when tested in mouse,,CHEMBL627591,1,BAO_0000218,8692,3132,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,CHEMBL627592,1,BAO_0000218,8693,3132,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),In vivo,CHEMBL627593,1,BAO_0000218,8694,16597,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in mice,,CHEMBL627594,1,BAO_0000218,8695,5727,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life period in mouse after 10 mg/Kg dose,In vivo,CHEMBL876813,1,BAO_0000218,8696,5302,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life period in mouse after 10 mg/kg dose,In vivo,CHEMBL627595,1,BAO_0000218,8697,5302,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,In vivo,CHEMBL627596,1,BAO_0000218,8698,6348,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Cmax value at 5 mg/kg po was determined in rat,In vivo,CHEMBL627597,1,BAO_0000218,8699,5964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value evaluated in rat,In vivo,CHEMBL627598,1,BAO_0000218,8700,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,In vivo,CHEMBL627599,1,BAO_0000218,8701,5206,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value after administration of 20 mg/Kg oral dose in rat,In vivo,CHEMBL627600,1,BAO_0000218,8702,2959,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value at 1 mg/kg po in rat,In vivo,CHEMBL627601,1,BAO_0000218,8703,5964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value at 5 mg/kg po in rat,In vivo,CHEMBL627776,1,BAO_0000218,8704,5964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value at a dose of 10 mg/kg in male SD rats,In vivo,CHEMBL627777,1,BAO_0000218,8705,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value at a dose of 100 mg/kg in male SD rats,In vivo,CHEMBL627778,1,BAO_0000218,8706,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value at a dose of 50 mg/kg in male SD rats,In vivo,CHEMBL627779,1,BAO_0000218,8707,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value in rats at 10 mg/kg,In vivo,CHEMBL876814,1,BAO_0000218,8708,17617,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value was evaluated in rats at a dose of 20 mg/kg,In vivo,CHEMBL627780,1,BAO_0000218,8709,1445,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value was determined after peroral administration of 20 mg/kg in rat,In vivo,CHEMBL627781,1,BAO_0000218,8710,6082,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,CHEMBL627782,1,BAO_0000218,8711,1446,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,In vivo,CHEMBL627783,1,BAO_0000218,8712,5407,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,In vivo,CHEMBL627784,1,BAO_0000218,8713,2690,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,CHEMBL627785,1,BAO_0000218,8714,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,CHEMBL627786,1,BAO_0000218,8715,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,In vivo,CHEMBL627787,1,BAO_0000218,8716,4891,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,In vivo,CHEMBL627788,1,BAO_0000218,8717,2807,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,In vivo,CHEMBL626579,1,BAO_0000218,8718,2807,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,In vivo,CHEMBL626580,1,BAO_0000218,8719,2807,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,In vivo,CHEMBL876815,1,BAO_0000218,8720,3634,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,In vivo,CHEMBL626581,1,BAO_0000218,8721,1881,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,In vivo,CHEMBL626582,1,BAO_0000218,8722,1881,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,In vivo,CHEMBL626583,1,BAO_0000218,8723,429,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL626205,1,BAO_0000218,8724,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL626206,1,BAO_0000218,8725,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL626207,1,BAO_0000218,8726,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL623882,1,BAO_0000218,8727,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,In vivo,CHEMBL623883,1,BAO_0000218,8728,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,In vivo,CHEMBL623884,1,BAO_0000218,8729,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,CHEMBL623885,1,BAO_0000218,8730,3032,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,In vivo,CHEMBL623886,1,BAO_0000218,8731,6295,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximal concentration in rat was determined,In vivo,CHEMBL623887,1,BAO_0000218,8732,6619,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximal concentration after i.v. administration,In vivo,CHEMBL623888,1,BAO_0000218,8733,6616,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,In vivo,CHEMBL623889,1,BAO_0000218,8734,3249,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximal plasma concentration in rat after oral administration at 50 mg/kg,In vivo,CHEMBL623890,1,BAO_0000218,8735,17791,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Cmax in rat plasma after oral dose (50 mg/Kg),In vivo,CHEMBL623891,1,BAO_0000218,8736,17791,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximal plasma concentration was determined.,In vivo,CHEMBL623892,1,BAO_0000218,8737,1360,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximal plasma drug concentration was determined,In vivo,CHEMBL623893,1,BAO_0000218,8738,2552,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximal concentration in rats after peroral administration,In vivo,CHEMBL877616,1,BAO_0000218,8739,6571,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration in rat after 2 mg/kg peroral administration,In vivo,CHEMBL623894,1,BAO_0000218,8740,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in rat plasma after 5 mg/kg oral gavage,In vivo,CHEMBL623895,1,BAO_0000218,8741,6567,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration of compound in rat was evaluated.,In vivo,CHEMBL623896,1,BAO_0000218,8742,3031,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,CHEMBL623897,1,BAO_0000218,8743,3436,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,CHEMBL623898,1,BAO_0000218,8744,3436,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,CHEMBL623899,1,BAO_0000218,8745,2083,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,CHEMBL623900,1,BAO_0000218,8746,3436,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,CHEMBL623901,1,BAO_0000218,8747,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration was evaluated in rats,In vivo,CHEMBL623902,1,BAO_0000218,8748,1974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebrospinal fluid,,,50597,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,CHEMBL623903,1,BAO_0000218,8749,3307,,10116.0,1359.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,CHEMBL623904,1,BAO_0000218,8750,3307,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,CHEMBL877617,1,BAO_0000218,8751,1916,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,In vivo,CHEMBL623905,1,BAO_0000218,8752,1500,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,In vivo,CHEMBL623906,1,BAO_0000218,8753,1500,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,CHEMBL623907,1,BAO_0000218,8754,4186,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL623908,1,BAO_0000218,8755,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL623909,1,BAO_0000218,8756,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL623910,1,BAO_0000218,8757,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL623911,1,BAO_0000218,8758,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL623912,1,BAO_0000218,8759,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL624616,1,BAO_0000218,8760,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL624617,1,BAO_0000218,8761,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL624618,1,BAO_0000218,8762,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL624619,1,BAO_0000218,8763,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL624794,1,BAO_0000218,8764,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL624795,1,BAO_0000218,8765,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL623921,1,BAO_0000218,8766,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL623922,1,BAO_0000218,8767,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL623923,1,BAO_0000218,8768,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL623924,1,BAO_0000218,8769,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL623925,1,BAO_0000218,8770,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL623926,1,BAO_0000218,8771,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL623927,1,BAO_0000218,8772,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL623928,1,BAO_0000218,8773,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL623929,1,BAO_0000218,8774,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL623930,1,BAO_0000218,8775,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL623931,1,BAO_0000218,8776,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL622165,1,BAO_0000218,8777,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL621249,1,BAO_0000218,8778,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL621250,1,BAO_0000218,8779,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL621448,1,BAO_0000218,8780,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL621449,1,BAO_0000218,8781,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL621450,1,BAO_0000218,8782,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL621451,1,BAO_0000218,8783,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL621452,1,BAO_0000218,8784,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL621453,1,BAO_0000218,8785,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL621454,1,BAO_0000218,8786,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL621455,1,BAO_0000218,8787,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL621456,1,BAO_0000218,8788,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL625145,1,BAO_0000218,8789,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL875847,1,BAO_0000218,8790,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL625146,1,BAO_0000218,8791,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL625147,1,BAO_0000218,8792,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL625148,1,BAO_0000218,8793,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL625149,1,BAO_0000218,8794,16434,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL625150,1,BAO_0000218,8795,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL625151,1,BAO_0000218,8796,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL625152,1,BAO_0000218,8797,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL625153,1,BAO_0000218,8798,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL625154,1,BAO_0000218,8799,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL625155,1,BAO_0000218,8800,16435,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,CHEMBL625156,1,BAO_0000218,8801,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624354,1,BAO_0000218,8802,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624355,1,BAO_0000218,8803,11977,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624356,1,BAO_0000218,8804,11977,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624357,1,BAO_0000218,8805,11977,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624358,1,BAO_0000218,8806,11977,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624359,1,BAO_0000218,8807,11977,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624360,1,BAO_0000218,8808,11977,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,CHEMBL624361,1,BAO_0000218,8809,11977,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624362,1,BAO_0000218,8810,11977,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,CHEMBL624363,1,BAO_0000218,8811,11977,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL624364,1,BAO_0000218,8812,11977,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL624365,1,BAO_0000218,8813,11977,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL624366,1,BAO_0000218,8814,11977,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL624367,1,BAO_0000218,8815,11977,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL624368,1,BAO_0000218,8816,11977,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL624369,1,BAO_0000218,8817,11977,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL624370,1,BAO_0000218,8818,11977,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625069,1,BAO_0000218,8819,11977,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625070,1,BAO_0000218,8820,11977,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626051,1,BAO_0000218,8821,11977,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626052,1,BAO_0000218,8822,11977,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL626053,1,BAO_0000218,8823,11977,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626054,1,BAO_0000218,8824,11977,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626055,1,BAO_0000218,8825,11977,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626056,1,BAO_0000218,8826,11977,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626057,1,BAO_0000218,8827,11977,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625193,1,BAO_0000218,8828,11977,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625194,1,BAO_0000218,8829,11977,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625195,1,BAO_0000218,8830,11977,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625196,1,BAO_0000218,8831,11977,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL625197,1,BAO_0000218,8832,11977,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625198,1,BAO_0000218,8833,11977,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL627929,1,BAO_0000218,8834,11977,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL627074,1,BAO_0000218,8835,11977,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL627075,1,BAO_0000218,8836,11977,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL627076,1,BAO_0000218,8837,11977,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL627077,1,BAO_0000218,8838,11977,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL627078,1,BAO_0000218,8839,11977,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL627079,1,BAO_0000218,8840,11977,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,In vivo,CHEMBL873824,1,BAO_0000218,8841,4573,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50594,Half life in mouse plasma was determined at dose 25 mg/kg,In vivo,CHEMBL627080,1,BAO_0000218,8842,3132,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life was determined,,CHEMBL627081,1,BAO_0000218,8843,17718,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,CHEMBL627082,1,BAO_0000218,8844,17728,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half-life in male mice after 1 mg/kg intravenous dose,In vivo,CHEMBL627083,1,BAO_0000218,8845,5961,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50594,Half life in mice plasma,,CHEMBL627085,1,BAO_0000218,8847,17731,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in mouse,,CHEMBL627086,1,BAO_0000218,8848,17592,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50594,Half life in mouse plasma at dose 25 mg/kg,In vivo,CHEMBL627087,1,BAO_0000218,8849,3132,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,In vivo,CHEMBL627088,1,BAO_0000218,8850,17729,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,In vivo,CHEMBL627089,1,BAO_0000218,8851,17729,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,In vivo,CHEMBL627090,1,BAO_0000218,8852,17729,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),In vivo,CHEMBL627091,1,BAO_0000218,8853,3277,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",In vivo,CHEMBL627092,1,BAO_0000218,8854,3760,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",In vivo,CHEMBL876785,1,BAO_0000218,8855,3760,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half-life by iv administration in mouse,In vivo,CHEMBL627093,1,BAO_0000218,8856,2862,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half-life by oral administration in mouse,In vivo,CHEMBL627094,1,BAO_0000218,8857,2862,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half-life in mice,,CHEMBL627095,1,BAO_0000218,8858,5980,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Half-life using mouse brain homogenate,,CHEMBL627096,1,BAO_0000218,8859,6159,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half-life was measured in mice,,CHEMBL627097,1,BAO_0000218,8860,6254,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half-life was measured in mouse after an iv dose of 1 mg/kg,In vivo,CHEMBL627098,1,BAO_0000218,8861,6062,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Half-life period was determined in mouse blood,,CHEMBL627099,1,BAO_0000218,8862,1574,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,CHEMBL627100,1,BAO_0000218,8863,56,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50594,Plasma half life in mouse,,CHEMBL627101,1,BAO_0000218,8864,993,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Stability of the peptide in the presence of mouse serum,,CHEMBL627102,1,BAO_0000218,8865,6652,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Terminal half life of compound was determined in mouse,,CHEMBL627103,1,BAO_0000218,8866,17852,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Terminal half life was evaluated in mice after intravenous administration,In vivo,CHEMBL627104,1,BAO_0000218,8867,2675,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Terminal half life was evaluated in mice after oral administration,In vivo,CHEMBL627105,1,BAO_0000218,8868,2675,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,CHEMBL876786,1,BAO_0000218,8869,499,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,CHEMBL873825,1,BAO_0000218,8870,499,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,CHEMBL627106,1,BAO_0000218,8871,499,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,half life period is evaluated by administering intravenously at 25 mg/kg in mice,In vivo,CHEMBL626336,1,BAO_0000218,8872,14239,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",In vivo,CHEMBL877462,1,BAO_0000218,8873,5506,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",In vivo,CHEMBL626337,1,BAO_0000218,8874,5506,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life after intraperitoneal administration of 100 mg/kg in mice,,CHEMBL626338,1,BAO_0000218,8875,17734,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,In vivo,CHEMBL626339,1,BAO_0000218,8876,17728,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,CHEMBL626340,1,BAO_0000218,8877,17728,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,In vivo,CHEMBL625377,1,BAO_0000218,8878,17728,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,In vivo,CHEMBL625378,1,BAO_0000218,8879,17728,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,In vivo,CHEMBL625379,1,BAO_0000218,8880,17728,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,CHEMBL625380,0,BAO_0000251,8881,14294,Microsomes,9823.0,,,,Sus scrofa
A,1,,,U,Autocuration,,,,22224,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,CHEMBL625381,0,BAO_0000251,8882,14294,Microsomes,9823.0,,,,Sus scrofa
A,1,,,U,Autocuration,,,,22224,Stability to porcine renal DHP-I,,CHEMBL625382,0,BAO_0000019,8883,6056,,9823.0,,,,Sus scrofa
A,1,,,U,Autocuration,,,,22224,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,In vivo,CHEMBL873828,0,BAO_0000218,8884,1317,,9823.0,,,,Sus scrofa
A,1,,,U,Autocuration,,,,22224,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,In vivo,CHEMBL625383,0,BAO_0000218,8885,1317,,9823.0,,,,Sus scrofa
A,1,,,U,Autocuration,,,,22224,Half-life of the parent prodrug in porcine esterase solution,,CHEMBL625384,0,BAO_0000019,8886,5229,,9823.0,,,,Sus scrofa
A,1,,,U,Autocuration,,,,22224,"First order rate constant, k was determined in in pig liver Esterase",,CHEMBL625385,0,BAO_0000019,8887,4231,,9823.0,,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Half life of the in pig liver Esterase,,CHEMBL625386,0,BAO_0000221,8888,4231,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,CHEMBL623571,0,BAO_0000221,8889,5318,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,CHEMBL623572,0,BAO_0000221,8890,5318,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,CHEMBL623573,0,BAO_0000221,8891,5318,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,CHEMBL623574,0,BAO_0000221,8892,3305,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,CHEMBL623575,0,BAO_0000221,8893,3305,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,CHEMBL623749,0,BAO_0000221,8894,2842,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,CHEMBL623750,0,BAO_0000221,8895,2842,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Half-life in vitro in pig liver,In vitro,CHEMBL623751,0,BAO_0000221,8896,889,,9823.0,2107.0,,,Sus scrofa
A,1,,,U,Autocuration,Liver,,,22224,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,CHEMBL623752,0,BAO_0000221,8897,1904,,9823.0,2107.0,,,Sus scrofa
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,In vivo,CHEMBL623753,1,BAO_0000218,8898,4186,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,CHEMBL623754,1,BAO_0000218,8899,2774,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in rat plasma was determined,In vivo,CHEMBL623755,1,BAO_0000218,8900,1742,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration in rats,In vivo,CHEMBL623756,1,BAO_0000218,8901,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration in rats at 1-2 hours,In vivo,CHEMBL623757,1,BAO_0000218,8902,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,In vivo,CHEMBL623758,1,BAO_0000218,8903,2081,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,CHEMBL623759,1,BAO_0000218,8904,3307,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at the dose of 2 mg/kg in rat,In vivo,CHEMBL623760,1,BAO_0000218,8905,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration was evaluated in rats,In vivo,CHEMBL623761,1,BAO_0000218,8906,6597,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,CHEMBL623762,1,BAO_0000218,8907,16365,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,In vivo,CHEMBL877594,1,BAO_0000218,8908,16365,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,In vivo,CHEMBL623763,1,BAO_0000218,8909,16365,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,In vivo,CHEMBL623764,1,BAO_0000218,8910,16365,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,CHEMBL623765,1,BAO_0000218,8911,16365,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,In vivo,CHEMBL623766,1,BAO_0000218,8912,2591,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,In vivo,CHEMBL623767,1,BAO_0000218,8913,2591,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,In vivo,CHEMBL623768,1,BAO_0000218,8914,2591,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,CHEMBL623769,1,BAO_0000218,8915,5978,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,CHEMBL623770,1,BAO_0000218,8916,5978,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,CHEMBL623771,1,BAO_0000218,8917,5978,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,CHEMBL623772,1,BAO_0000218,8918,5978,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,CHEMBL623773,1,BAO_0000218,8919,5978,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,CHEMBL623774,1,BAO_0000218,8920,5978,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,CHEMBL623775,1,BAO_0000218,8921,5978,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat (PO dose),In vivo,CHEMBL623776,1,BAO_0000218,8922,14465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,CHEMBL622191,1,BAO_0000218,8923,4723,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,CHEMBL622192,1,BAO_0000218,8924,4723,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration determined in rat,In vivo,CHEMBL622193,1,BAO_0000218,8925,4576,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,CHEMBL622194,1,BAO_0000218,8926,12873,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,CHEMBL622195,1,BAO_0000218,8927,12873,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration in rat,In vivo,CHEMBL622196,1,BAO_0000218,8928,6824,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,CHEMBL622197,1,BAO_0000218,8929,17065,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,In vivo,CHEMBL622198,1,BAO_0000218,8930,2932,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,In vivo,CHEMBL622199,1,BAO_0000218,8931,2932,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration of compound was measured in rat,In vivo,CHEMBL622200,1,BAO_0000218,8932,2879,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration after 20 mg/kg oral administration in rat,In vivo,CHEMBL622201,1,BAO_0000218,8933,2864,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration after oral administration to rats,In vivo,CHEMBL623990,1,BAO_0000218,8934,16367,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,CHEMBL623991,1,BAO_0000218,8935,17717,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",In vivo,CHEMBL623992,1,BAO_0000218,8936,17717,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,CHEMBL623993,1,BAO_0000218,8937,17717,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,In vivo,CHEMBL623994,1,BAO_0000218,8938,17717,,10116.0,1969.0,,,Rattus norvegicus
F,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL623995,1,BAO_0000218,8939,17720,,10116.0,1969.0,,,Rattus norvegicus
F,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL623996,1,BAO_0000218,8940,17720,,10116.0,1969.0,,,Rattus norvegicus
F,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL623997,1,BAO_0000218,8941,17720,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration dosed orally in rats,In vivo,CHEMBL623998,1,BAO_0000218,8942,4516,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration dosed orally in rats after 6 hours,In vivo,CHEMBL623999,1,BAO_0000218,8943,4516,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,In vivo,CHEMBL624000,1,BAO_0000218,8944,4516,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,CHEMBL624001,1,BAO_0000218,8945,5199,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration in rat after po administration,In vivo,CHEMBL624002,1,BAO_0000218,8946,17538,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",In vivo,CHEMBL624003,1,BAO_0000218,8947,6685,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",In vivo,CHEMBL624004,1,BAO_0000218,8948,6685,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL624005,1,BAO_0000218,8949,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL624006,1,BAO_0000218,8950,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL624007,1,BAO_0000218,8951,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL624008,1,BAO_0000218,8952,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL624009,1,BAO_0000218,8953,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL874387,1,BAO_0000218,8954,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL624010,1,BAO_0000218,8955,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL624011,1,BAO_0000218,8956,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL624012,1,BAO_0000218,8957,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL624013,1,BAO_0000218,8958,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL624736,1,BAO_0000218,8959,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL624737,1,BAO_0000218,8960,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL624738,1,BAO_0000218,8961,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL624739,1,BAO_0000218,8962,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL624740,1,BAO_0000218,8963,16434,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL624896,1,BAO_0000218,8964,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL624897,1,BAO_0000218,8965,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL624108,1,BAO_0000218,8966,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL624109,1,BAO_0000218,8967,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL624110,1,BAO_0000218,8968,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL624111,1,BAO_0000218,8969,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL624112,1,BAO_0000218,8970,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL624113,1,BAO_0000218,8971,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL619709,1,BAO_0000218,8972,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL619710,1,BAO_0000218,8973,16435,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL619711,1,BAO_0000218,8974,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL619712,1,BAO_0000218,8975,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL619713,1,BAO_0000218,8976,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL619714,1,BAO_0000218,8977,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL619715,1,BAO_0000218,8978,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL619716,1,BAO_0000218,8979,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL619717,1,BAO_0000218,8980,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL619718,1,BAO_0000218,8981,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL619719,1,BAO_0000218,8982,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL875329,1,BAO_0000218,8983,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL619720,1,BAO_0000218,8984,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL619721,1,BAO_0000218,8985,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL619722,1,BAO_0000218,8986,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL619723,1,BAO_0000218,8987,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL619724,1,BAO_0000218,8988,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL619725,1,BAO_0000218,8989,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL619726,1,BAO_0000218,8990,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL619727,1,BAO_0000218,8991,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL619728,1,BAO_0000218,8992,16434,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL619729,1,BAO_0000218,8993,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL619730,1,BAO_0000218,8994,11977,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL619731,1,BAO_0000218,8995,11977,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL619732,1,BAO_0000218,8996,11977,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL619733,1,BAO_0000218,8997,11977,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL619734,1,BAO_0000218,8998,11977,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL619735,1,BAO_0000218,8999,11977,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL875330,1,BAO_0000218,9000,11977,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL628465,1,BAO_0000218,9001,11977,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL628466,1,BAO_0000218,9002,11977,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL628467,1,BAO_0000218,9003,11977,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL628468,1,BAO_0000218,9004,11977,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL628469,1,BAO_0000218,9005,11977,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL628470,1,BAO_0000218,9006,11977,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL628471,1,BAO_0000218,9007,11977,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL628472,1,BAO_0000218,9008,11977,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625191,1,BAO_0000218,9009,11977,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL625192,1,BAO_0000218,9010,11977,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,CHEMBL875337,1,BAO_0000218,9011,11977,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626341,1,BAO_0000218,9012,11977,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL626342,1,BAO_0000218,9013,11977,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,CHEMBL621943,1,BAO_0000218,9014,11977,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats,,CHEMBL621944,1,BAO_0000218,9015,3748,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,CHEMBL621945,1,BAO_0000218,9016,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,CHEMBL621946,1,BAO_0000218,9017,4871,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,CHEMBL621947,1,BAO_0000218,9018,4871,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,CHEMBL621948,1,BAO_0000218,9019,4872,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,CHEMBL621949,1,BAO_0000218,9020,4872,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,CHEMBL621950,1,BAO_0000218,9021,5413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,CHEMBL621951,1,BAO_0000218,9022,5413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,In vivo,CHEMBL621952,1,BAO_0000218,9023,15272,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Stability (%) in rat liver microsomes,,CHEMBL621953,1,BAO_0000218,9024,4689,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was calculated after intravenous administration,,CHEMBL621954,1,BAO_0000218,9025,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was calculated after iv administration in rat,,CHEMBL621955,1,BAO_0000218,9026,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was calculated in rat after peroral administration,,CHEMBL621956,1,BAO_0000218,9027,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,CHEMBL621957,1,BAO_0000218,9028,6211,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,CHEMBL621958,1,BAO_0000218,9029,5710,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,CHEMBL621959,1,BAO_0000218,9030,5710,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,CHEMBL621960,1,BAO_0000218,9031,17853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,CHEMBL621961,1,BAO_0000218,9032,17853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,p value of the compound,,CHEMBL621962,1,BAO_0000218,9033,15765,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,p value of the compound,,CHEMBL876787,1,BAO_0000218,9034,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,p value of the compound,,CHEMBL621963,1,BAO_0000218,9035,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,CHEMBL622637,1,BAO_0000218,9036,6175,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,CHEMBL622638,1,BAO_0000218,9037,6175,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,CHEMBL626561,1,BAO_0000218,9038,6175,,10116.0,945.0,,,Rattus norvegicus
F,1,,,U,Autocuration,,,,22224,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,CHEMBL626562,0,BAO_0000019,9039,7991,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,CHEMBL626563,0,BAO_0000218,9040,429,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,CHEMBL626564,0,BAO_0000218,9041,429,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,CHEMBL626565,0,BAO_0000218,9042,6253,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,CHEMBL626566,0,BAO_0000218,9043,6253,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Clearance rate in rabbits,In vivo,CHEMBL626567,0,BAO_0000218,9044,3615,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,CHEMBL626568,0,BAO_0000218,9045,4059,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,CHEMBL626569,0,BAO_0000218,9046,5124,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,CHEMBL626570,0,BAO_0000218,9047,5124,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,CHEMBL626571,0,BAO_0000218,9048,5124,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,In vivo,CHEMBL626572,0,BAO_0000218,9049,429,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,CHEMBL626573,0,BAO_0000218,9050,4059,,9986.0,1969.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Liver,,,22224,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,CHEMBL626574,0,BAO_0000251,9051,9659,Microsomes,9986.0,2107.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Liver,,,22224,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,CHEMBL626575,0,BAO_0000251,9052,9659,Microsomes,9986.0,2107.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,CHEMBL626576,0,BAO_0000218,9053,3639,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Dose at which bioavailability of perorally administered compound was tested in rabbit,,CHEMBL626577,0,BAO_0000218,9054,3639,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,The compound was tested for its bioavailability in rabbit (by oral dosage).,In vivo,CHEMBL626578,0,BAO_0000218,9055,3639,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,CHEMBL625263,0,BAO_0000218,9056,5124,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,CHEMBL625264,0,BAO_0000218,9057,5124,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,CHEMBL625265,0,BAO_0000218,9058,5124,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,CHEMBL625266,0,BAO_0000251,9059,14294,Microsomes,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,CHEMBL876796,0,BAO_0000251,9060,14294,Microsomes,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,In vivo,CHEMBL625267,0,BAO_0000218,9061,429,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Plasma,,,22224,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,CHEMBL625268,0,BAO_0000218,9062,5124,,9986.0,1969.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Plasma,,,22224,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,CHEMBL625269,0,BAO_0000218,9063,5124,,9986.0,1969.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Plasma,,,22224,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,CHEMBL624689,0,BAO_0000218,9064,5124,,9986.0,1969.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,In vivo,CHEMBL624690,0,BAO_0000218,9065,429,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Urine,,,22224,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,CHEMBL624691,0,BAO_0000218,9066,429,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Urine,,,22224,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,CHEMBL624692,0,BAO_0000218,9067,429,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,CHEMBL624693,0,BAO_0000218,9068,4059,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,In vivo,CHEMBL624694,0,BAO_0000218,9069,4137,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,In vitro Biological half-life in crude homogenate of rabbit renal cortex,In vitro,CHEMBL877596,0,BAO_0000221,9070,11672,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Time within which only 10% of the drug was degraded,,CHEMBL624695,0,BAO_0000019,9071,12886,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Liver,,,22224,Half life period in rabbit liver homogenate,,CHEMBL624696,0,BAO_0000221,9072,3853,,9986.0,2107.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Half life value in rabbits,,CHEMBL624697,0,BAO_0000019,9073,3615,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Blood,,,22224,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,CHEMBL624698,0,BAO_0000218,9074,6253,,9986.0,178.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,Blood,,,22224,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,CHEMBL624699,0,BAO_0000218,9075,6253,,9986.0,178.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Half-life period in rabbits following intravenous administration at 2 mg/kg,In vivo,CHEMBL624700,0,BAO_0000218,9076,6077,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Plasma,,,50597,AUC 0-8 hr value in rats at 10 mg/kg,,CHEMBL622903,1,BAO_0000218,9077,17617,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC after administration at 2000 mg/kg/day in rats,,CHEMBL622904,1,BAO_0000218,9078,17594,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,CHEMBL622905,1,BAO_0000218,9079,6149,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,CHEMBL622906,1,BAO_0000218,9080,17260,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,CHEMBL622907,1,BAO_0000218,9081,17260,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat after oral administration at 10.5 mg/kg dose,,CHEMBL622908,1,BAO_0000218,9082,6644,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat after oral administration at 11.2 mg/kg dose,,CHEMBL622909,1,BAO_0000218,9083,6644,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat after oral administration at 9.7 mg/kg dose,,CHEMBL622910,1,BAO_0000218,9084,6644,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,AUC in rat brain after oral administration at 10 mg/kg,,CHEMBL622911,1,BAO_0000218,9085,6495,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat p.o.,,CHEMBL622912,1,BAO_0000218,9086,6504,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat p.o. at 20 mg/kg concentration,,CHEMBL622913,1,BAO_0000218,9087,17686,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat plasma after oral administration at 10 mg/kg,,CHEMBL622914,1,BAO_0000218,9088,6495,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rats,,CHEMBL622915,1,BAO_0000218,9089,216,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC value after IV dose at a dose of 5 mg/kg in rats.,,CHEMBL622916,1,BAO_0000218,9090,1908,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC value after oral dose at a dose of 10 mg/kg in rats.,,CHEMBL622917,1,BAO_0000218,9091,1908,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,CHEMBL622918,1,BAO_0000218,9092,6685,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,In vivo,CHEMBL622919,1,BAO_0000218,9093,216,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration was evaluated in rat,In vivo,CHEMBL622920,1,BAO_0000218,9094,6049,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,In vivo,CHEMBL622921,1,BAO_0000218,9095,2463,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,In vivo,CHEMBL622922,1,BAO_0000218,9096,6679,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,CHEMBL622923,1,BAO_0000218,9097,6681,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL877604,1,BAO_0000218,9098,4890,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,CHEMBL622924,1,BAO_0000218,9099,6410,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,In vivo,CHEMBL622925,1,BAO_0000218,9100,6410,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,In vivo,CHEMBL622926,1,BAO_0000218,9101,16366,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,In vivo,CHEMBL623625,1,BAO_0000218,9102,6227,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Expert,Plasma,,,50597,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,CHEMBL623626,1,BAO_0000218,9103,3598,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma drug concentration was determined,In vivo,CHEMBL623627,1,BAO_0000218,9104,1465,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,In vivo,CHEMBL623628,1,BAO_0000218,9105,4368,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Mean peak plasma concentration was observed after intravenous administration in rat,In vivo,CHEMBL623629,1,BAO_0000218,9106,15662,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Mean peak plasma concentration was observed after oral administration in rat,In vivo,CHEMBL623630,1,BAO_0000218,9107,15662,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,In vivo,CHEMBL623804,1,BAO_0000218,9108,5355,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,In vivo,CHEMBL623805,1,BAO_0000218,9109,5355,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Peak oral plasma concentration was determined in rats by oral administration,In vivo,CHEMBL623806,1,BAO_0000218,9110,1567,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration (Cmax) was determined,In vivo,CHEMBL623807,1,BAO_0000218,9111,4026,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,In vivo,CHEMBL623808,1,BAO_0000218,9112,6193,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration (Cmax) in rats,In vivo,CHEMBL623809,1,BAO_0000218,9113,4026,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration at 1 mg/kg peroral administration,In vivo,CHEMBL623810,1,BAO_0000218,9114,6485,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration in rat,In vivo,CHEMBL623811,1,BAO_0000218,9115,17655,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",In vivo,CHEMBL623812,1,BAO_0000218,9116,14941,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,In vivo,CHEMBL877605,1,BAO_0000218,9117,5394,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Cmax) in rat,In vivo,CHEMBL623813,1,BAO_0000218,9118,4408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,CHEMBL623814,1,BAO_0000218,9119,5983,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat after 3mg/kg oral dose,In vivo,CHEMBL623815,1,BAO_0000218,9120,4878,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,In vivo,CHEMBL623816,1,BAO_0000218,9121,5862,,10116.0,,,Sprague-Dawley,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rats after 20 mg/kg oral dose,In vivo,CHEMBL623145,1,BAO_0000218,9122,4517,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Cmax in rat plasma after 30mg/kg oral dose,In vivo,CHEMBL623146,1,BAO_0000218,9123,5932,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma concentration after oral administration of 100 mg/kg to rats,In vivo,CHEMBL623147,1,BAO_0000218,9124,5436,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,CHEMBL623042,1,BAO_0000218,9125,4910,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for the Cmax in rat at 10 mg/kg per orally,In vivo,CHEMBL623043,1,BAO_0000218,9126,4950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,CHEMBL623044,1,BAO_0000218,9127,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,CHEMBL623045,1,BAO_0000218,9128,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability as oral Cmax in rats at 30 mins,In vivo,CHEMBL623046,1,BAO_0000218,9129,3360,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability as oral Cmax in rats at 6hr,In vivo,CHEMBL623226,1,BAO_0000218,9130,3360,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The maximum concentration of compound was measured at the dose of 100 umol/kg,In vivo,CHEMBL623227,1,BAO_0000218,9131,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The maximum concentration of compound was measured at the dose of 300 umol/kg,In vivo,CHEMBL623228,1,BAO_0000218,9132,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The maximum concentration of compound was measured at the dose of 30 umol/kg,In vivo,CHEMBL623229,1,BAO_0000218,9133,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma levels for the compounds were determined by LC-MS.,In vivo,CHEMBL623230,1,BAO_0000218,9134,5160,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,mean peak plasma concentration was observed after intravenous administration in rat,In vivo,CHEMBL623231,1,BAO_0000218,9135,15662,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,mean peak plasma concentration was observed after oral administration in rat,In vivo,CHEMBL623232,1,BAO_0000218,9136,15662,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,CHEMBL623233,1,BAO_0000218,9137,4709,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,CHEMBL623234,1,BAO_0000218,9138,3535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in plasma (portal) following oral dose in rats at 1 hr,,CHEMBL623235,1,BAO_0000218,9139,3535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in plasma (portal) following oral dose in rats at 2 hr,,CHEMBL623236,1,BAO_0000218,9140,3535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,CHEMBL623237,1,BAO_0000218,9141,3535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,CHEMBL623238,1,BAO_0000218,9142,3535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,CHEMBL623239,1,BAO_0000218,9143,3535,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,Plasma,,,22224,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,In vivo,CHEMBL623240,0,BAO_0000218,9144,5005,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,CHEMBL623241,1,BAO_0000218,9145,6326,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,CHEMBL623242,1,BAO_0000218,9146,6326,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,CHEMBL874394,1,BAO_0000218,9147,6326,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,CHEMBL623243,1,BAO_0000218,9148,6326,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL623244,1,BAO_0000218,9149,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL623245,1,BAO_0000218,9150,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL623246,1,BAO_0000218,9151,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL623247,1,BAO_0000218,9152,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL623248,1,BAO_0000218,9153,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL623249,1,BAO_0000218,9154,16435,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL625072,1,BAO_0000218,9155,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL625073,1,BAO_0000218,9156,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL625074,1,BAO_0000218,9157,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL625075,1,BAO_0000218,9158,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL625076,1,BAO_0000218,9159,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL625077,1,BAO_0000218,9160,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL625078,1,BAO_0000218,9161,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL874395,1,BAO_0000218,9162,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL625079,1,BAO_0000218,9163,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL625080,1,BAO_0000218,9164,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL625081,1,BAO_0000218,9165,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL625082,1,BAO_0000218,9166,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL625083,1,BAO_0000218,9167,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL625084,1,BAO_0000218,9168,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL625085,1,BAO_0000218,9169,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL625086,1,BAO_0000218,9170,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL625087,1,BAO_0000218,9171,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL625088,1,BAO_0000218,9172,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL622205,1,BAO_0000218,9173,16434,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL622206,1,BAO_0000218,9174,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL622207,1,BAO_0000218,9175,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL622366,1,BAO_0000218,9176,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL622367,1,BAO_0000218,9177,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL875331,1,BAO_0000218,9178,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL622368,1,BAO_0000218,9179,16435,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL622369,1,BAO_0000218,9180,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL622370,1,BAO_0000218,9181,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL622371,1,BAO_0000218,9182,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL622372,1,BAO_0000218,9183,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL622373,1,BAO_0000218,9184,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL622374,1,BAO_0000218,9185,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL622375,1,BAO_0000218,9186,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL622376,1,BAO_0000218,9187,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL622377,1,BAO_0000218,9188,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL622378,1,BAO_0000218,9189,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL622379,1,BAO_0000218,9190,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL622380,1,BAO_0000218,9191,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL622381,1,BAO_0000218,9192,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL622382,1,BAO_0000218,9193,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,CHEMBL622383,1,BAO_0000218,9194,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,CHEMBL875332,1,BAO_0000218,9195,6175,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,CHEMBL622384,1,BAO_0000218,9196,6175,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,CHEMBL622385,1,BAO_0000218,9197,6175,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,CHEMBL622386,1,BAO_0000218,9198,6175,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for the plasma binding in rat,,CHEMBL622387,1,BAO_0000218,9199,10839,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,CHEMBL622388,1,BAO_0000218,9200,16459,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,CHEMBL622389,1,BAO_0000218,9201,16459,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,CHEMBL622390,1,BAO_0000218,9202,16459,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,CHEMBL622391,1,BAO_0000218,9203,16459,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,CHEMBL622392,1,BAO_0000218,9204,16459,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,CHEMBL622393,1,BAO_0000218,9205,16459,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma level at 2 hr after administration of the compound,,CHEMBL622394,1,BAO_0000218,9206,3278,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,plasma level at 2 hr after administration of the compound,,CHEMBL622395,1,BAO_0000218,9207,3278,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 1 min,,CHEMBL622396,1,BAO_0000218,9208,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 10 min,,CHEMBL624894,1,BAO_0000218,9209,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 10 mins,,CHEMBL624895,1,BAO_0000218,9210,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 2 hr,,CHEMBL624058,1,BAO_0000218,9211,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 3 min,,CHEMBL624059,1,BAO_0000218,9212,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 3 mins,,CHEMBL624060,1,BAO_0000218,9213,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 5 min,,CHEMBL624061,1,BAO_0000218,9214,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Stability in rat serum measured as % recovery at 5 mins,,CHEMBL624062,1,BAO_0000218,9215,4684,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,CHEMBL624063,1,BAO_0000218,9216,16456,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,CHEMBL624064,1,BAO_0000218,9217,16456,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,CHEMBL624065,1,BAO_0000218,9218,723,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,CHEMBL624066,1,BAO_0000218,9219,723,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life tested in mature male rat at a dose of 30 mg/kg,In vivo,CHEMBL877490,1,BAO_0000218,9220,5160,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after intravenous administration of 1 mg/kg in rat,In vivo,CHEMBL874442,1,BAO_0000218,9221,4709,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after administration (30 mg/kg) in rat,In vivo,CHEMBL626890,1,BAO_0000218,9222,5633,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat after 5 mg/Kg dose,In vivo,CHEMBL626891,1,BAO_0000218,9223,5302,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat after 5 mg/kg dose,In vivo,CHEMBL626892,1,BAO_0000218,9224,5302,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was determined,,CHEMBL626893,1,BAO_0000218,9225,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was evaluated in rat,,CHEMBL626894,1,BAO_0000218,9226,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was evaluated in rat; 0.5-1.0,,CHEMBL626895,1,BAO_0000218,9227,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was evaluated in rat; 5.9-7.5,,CHEMBL626896,1,BAO_0000218,9228,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in rat plasma,,CHEMBL626897,1,BAO_0000218,9229,14512,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life time in rat was determined,,CHEMBL626898,1,BAO_0000218,9230,6230,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Terminal half-life after iv administration to rats,In vivo,CHEMBL626899,1,BAO_0000218,9231,3364,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,In vivo,CHEMBL626900,1,BAO_0000218,9232,6874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,CHEMBL626901,1,BAO_0000218,9233,857,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),In vivo,CHEMBL626902,1,BAO_0000218,9234,858,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),In vivo,CHEMBL626903,1,BAO_0000218,9235,858,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,In vivo,CHEMBL874443,1,BAO_0000218,9236,5355,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,In vivo,CHEMBL626904,1,BAO_0000218,9237,5355,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats,,CHEMBL626905,1,BAO_0000218,9238,6305,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,CHEMBL873830,1,BAO_0000218,9239,13501,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,In vivo,CHEMBL626906,1,BAO_0000218,9240,17594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,CHEMBL631076,1,BAO_0000218,9241,4186,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biological half-life was measured in plasma of rats,,CHEMBL631077,1,BAO_0000218,9242,2932,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,CHEMBL631078,1,BAO_0000218,9243,17065,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,In vivo,CHEMBL631079,1,BAO_0000218,9244,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,In vivo,CHEMBL631080,1,BAO_0000218,9245,2713,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,CHEMBL631081,1,BAO_0000218,9246,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,CHEMBL631239,1,BAO_0000218,9247,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated for plasma half life in rat,,CHEMBL631240,1,BAO_0000218,9248,740,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC value at a dose of 5 mg/kg (p.o.) in rats,,CHEMBL631241,1,BAO_0000218,9249,6597,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC value after administration of 20 mg/Kg oral dose in rat,,CHEMBL631242,1,BAO_0000218,9250,2959,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,CHEMBL631243,1,BAO_0000218,9251,17594,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC0-96 after administration at 50 mg/kg,,CHEMBL874444,1,BAO_0000218,9252,17596,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,CHEMBL631244,1,BAO_0000218,9253,17594,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,CHEMBL631245,1,BAO_0000218,9254,3293,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,CHEMBL627162,1,BAO_0000218,9255,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,CHEMBL627163,1,BAO_0000218,9256,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,CHEMBL627164,1,BAO_0000218,9257,6757,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,CHEMBL627165,1,BAO_0000218,9258,5979,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,CHEMBL627166,1,BAO_0000218,9259,5979,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,CHEMBL627167,1,BAO_0000218,9260,5979,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (AUC) at a dose of 30 mg/kg in rats,,CHEMBL627822,1,BAO_0000218,9261,4026,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,CHEMBL627823,1,BAO_0000218,9262,5355,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,CHEMBL627824,1,BAO_0000218,9263,5355,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,CHEMBL627825,1,BAO_0000218,9264,5355,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,CHEMBL627826,1,BAO_0000218,9265,5633,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (Pharmacokinetic property) was determined,,CHEMBL627827,1,BAO_0000218,9266,1716,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (Pharmacokinetic property) of the compound; Not determined,,CHEMBL627828,1,BAO_0000218,9267,1716,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve after intravenous administration (1 mg/kg) in rat,,CHEMBL627829,1,BAO_0000218,9268,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,CHEMBL627830,1,BAO_0000218,9269,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,CHEMBL627831,1,BAO_0000218,9270,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in male SD rats was observed after oral administration in rat,,CHEMBL627832,1,BAO_0000218,9271,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,CHEMBL627833,1,BAO_0000218,9272,4413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,CHEMBL627834,1,BAO_0000218,9273,3598,,10116.0,,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,CHEMBL628004,1,BAO_0000218,9274,3598,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve at 5 mg/kg po was determined in rat,,CHEMBL628005,1,BAO_0000218,9275,5964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in Rat at a oral dose of 5 mg/kg,,CHEMBL628006,1,BAO_0000218,9276,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,CHEMBL628007,1,BAO_0000218,9277,4186,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined,,CHEMBL625676,1,BAO_0000218,9278,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,CHEMBL631309,1,BAO_0000218,9279,17858,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve after intravenous administration at 3 mg/kg,,CHEMBL631310,1,BAO_0000218,9280,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,CHEMBL631311,1,BAO_0000218,9281,6106,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve at 4 hr in rat,,CHEMBL631312,1,BAO_0000218,9282,5964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve at a dose of 30 mg/kg,,CHEMBL631313,1,BAO_0000218,9283,4026,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,CHEMBL631314,1,BAO_0000218,9284,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,CHEMBL631315,1,BAO_0000218,9285,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve for a 2-mpk po dose in SD rats,,CHEMBL631316,1,BAO_0000218,9286,5862,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in SD rats,,CHEMBL631317,1,BAO_0000218,9287,5862,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat after oral administration at 13 mg/kg dose,,CHEMBL874471,1,BAO_0000218,9288,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat by po administration at 0-24 hr,,CHEMBL631318,1,BAO_0000218,9289,5871,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under curve in rat plasma,,CHEMBL631319,1,BAO_0000218,9290,5919,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,CHEMBL631320,1,BAO_0000218,9291,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,CHEMBL631321,1,BAO_0000218,9292,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,CHEMBL631322,1,BAO_0000218,9293,10,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,CHEMBL631323,1,BAO_0000218,9294,11149,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve value in rat at a dose of 5 mg/kg,,CHEMBL631324,1,BAO_0000218,9295,5302,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined after oral administration in rats,,CHEMBL631325,1,BAO_0000218,9296,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,CHEMBL631326,1,BAO_0000218,9297,4890,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined after peroral administration in rat,,CHEMBL631327,1,BAO_0000218,9298,6011,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined at a dose 30 mpk administered orally.,,CHEMBL631328,1,BAO_0000218,9299,5375,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,CHEMBL631329,1,BAO_0000218,9300,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,CHEMBL627217,1,BAO_0000218,9301,4368,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in male rat,,CHEMBL626352,1,BAO_0000218,9302,5610,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in rat after PO administration,,CHEMBL626353,1,BAO_0000218,9303,5833,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in rat after a 3 mg/kg of oral dose,,CHEMBL626354,1,BAO_0000218,9304,4257,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,CHEMBL626355,1,BAO_0000218,9305,5937,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,CHEMBL626356,1,BAO_0000218,9306,5932,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,CHEMBL626357,1,BAO_0000218,9307,5932,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL626358,1,BAO_0000218,9308,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL626359,1,BAO_0000218,9309,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration in rat at a dose of 3 mg/kg,,CHEMBL626360,1,BAO_0000218,9310,17771,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration at 2 hr in rats was evaluated.,,CHEMBL626361,1,BAO_0000218,9311,1628,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration at 2 hr in rats was evaluated; Not available,,CHEMBL626362,1,BAO_0000218,9312,1628,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL626363,1,BAO_0000218,9313,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL626970,1,BAO_0000218,9314,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL626971,1,BAO_0000218,9315,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL626972,1,BAO_0000218,9316,4910,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL626973,1,BAO_0000218,9317,4910,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL626974,1,BAO_0000218,9318,4910,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL874592,1,BAO_0000218,9319,4910,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,CHEMBL626975,1,BAO_0000218,9320,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,CHEMBL626976,1,BAO_0000218,9321,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,CHEMBL626977,1,BAO_0000218,9322,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,CHEMBL626978,1,BAO_0000218,9323,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,PK study was carried to determine the relative absorption ranking in rat.,,CHEMBL626979,1,BAO_0000218,9324,16427,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,In vivo,CHEMBL626980,1,BAO_0000218,9325,4689,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,CHEMBL626981,1,BAO_0000218,9326,11450,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,CHEMBL626982,1,BAO_0000218,9327,11450,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,CHEMBL626983,1,BAO_0000218,9328,11450,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,CHEMBL622522,1,BAO_0000218,9329,11450,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,CHEMBL622523,1,BAO_0000218,9330,11450,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,CHEMBL622524,1,BAO_0000218,9331,11450,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,CHEMBL622525,1,BAO_0000218,9332,11450,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,CHEMBL622526,1,BAO_0000218,9333,11450,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,CHEMBL619849,1,BAO_0000218,9334,11450,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,CHEMBL619850,1,BAO_0000218,9335,11450,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,CHEMBL623864,1,BAO_0000218,9336,11450,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,CHEMBL623865,1,BAO_0000218,9337,11450,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,CHEMBL623866,1,BAO_0000218,9338,11450,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,CHEMBL623867,1,BAO_0000218,9339,11450,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,CHEMBL877615,1,BAO_0000218,9340,11450,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,CHEMBL623868,1,BAO_0000218,9341,11450,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,CHEMBL623869,1,BAO_0000218,9342,11450,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,CHEMBL623870,1,BAO_0000218,9343,11450,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,CHEMBL623871,1,BAO_0000218,9344,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL623872,1,BAO_0000218,9345,16434,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL622129,1,BAO_0000218,9346,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL622130,1,BAO_0000218,9347,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL622131,1,BAO_0000218,9348,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL622132,1,BAO_0000218,9349,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL622133,1,BAO_0000218,9350,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL622134,1,BAO_0000218,9351,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL622135,1,BAO_0000218,9352,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL622136,1,BAO_0000218,9353,16435,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL622137,1,BAO_0000218,9354,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL622138,1,BAO_0000218,9355,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL623017,1,BAO_0000218,9356,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL623018,1,BAO_0000218,9357,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL623019,1,BAO_0000218,9358,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL623020,1,BAO_0000218,9359,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL623021,1,BAO_0000218,9360,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL623022,1,BAO_0000218,9361,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL623023,1,BAO_0000218,9362,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL623024,1,BAO_0000218,9363,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL623025,1,BAO_0000218,9364,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL620545,1,BAO_0000218,9365,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL620546,1,BAO_0000218,9366,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL620547,1,BAO_0000218,9367,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL620548,1,BAO_0000218,9368,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL620549,1,BAO_0000218,9369,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL620550,1,BAO_0000218,9370,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,CHEMBL620551,1,BAO_0000218,9371,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL620552,1,BAO_0000218,9372,16434,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL620553,1,BAO_0000218,9373,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL620554,1,BAO_0000218,9374,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL875845,1,BAO_0000218,9375,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL620555,1,BAO_0000218,9376,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL620556,1,BAO_0000218,9377,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL620557,1,BAO_0000218,9378,16435,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL620558,1,BAO_0000218,9379,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL620559,1,BAO_0000218,9380,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL622939,1,BAO_0000218,9381,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL622940,1,BAO_0000218,9382,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL622941,1,BAO_0000218,9383,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL622942,1,BAO_0000218,9384,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL622943,1,BAO_0000218,9385,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL622944,1,BAO_0000218,9386,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL622945,1,BAO_0000218,9387,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL622946,1,BAO_0000218,9388,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for terminal half life in rat,,CHEMBL622947,1,BAO_0000218,9389,3341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,In vivo,CHEMBL622948,1,BAO_0000218,9390,3634,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,In vivo,CHEMBL622949,1,BAO_0000218,9391,3634,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for its half life in rat,,CHEMBL622950,1,BAO_0000218,9392,4839,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,Plasma,,,22224,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,In vivo,CHEMBL622951,0,BAO_0000218,9393,5005,,9544.0,1969.0,,,Macaca mulatta
A,1,,,U,Intermediate,Plasma,,,22224,Compound was tested for its plasma half life in Sprague Dawley rats,,CHEMBL622952,0,BAO_0000366,9394,5005,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Intermediate,Plasma,,,22224,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,CHEMBL622953,0,BAO_0000366,9395,5005,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma half-life period in rat,,CHEMBL873818,1,BAO_0000218,9396,1094,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Elimination half life after i.v. administration of compound in rats,In vivo,CHEMBL622954,1,BAO_0000218,9397,5031,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Elimination half-life after IV dosing at 0.5 mg/kg in rat,In vivo,CHEMBL622955,1,BAO_0000218,9398,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Elimination half-life after IV dosing at 1 mg/kg in rat,In vivo,CHEMBL875229,1,BAO_0000218,9399,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,In vivo,CHEMBL622956,1,BAO_0000218,9400,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,In vivo,CHEMBL622957,1,BAO_0000218,9401,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,In vivo,CHEMBL622958,1,BAO_0000218,9402,5408,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,In vivo,CHEMBL622959,1,BAO_0000218,9403,5408,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,In vivo,CHEMBL622960,1,BAO_0000218,9404,5408,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,In vivo,CHEMBL622961,1,BAO_0000218,9405,5408,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for the half life in rat (in vivo),In vivo,CHEMBL622962,1,BAO_0000218,9406,4687,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Hafl life in rat,,CHEMBL622963,1,BAO_0000218,9407,6640,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Hafl life rat,,CHEMBL622964,1,BAO_0000218,9408,6640,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Hafl life rat,,CHEMBL622965,1,BAO_0000218,9409,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Hafl life rat; Not determined,,CHEMBL622966,1,BAO_0000218,9410,6640,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Hafl life rat; Not determined,,CHEMBL622967,1,BAO_0000218,9411,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,CHEMBL622968,1,BAO_0000218,9412,17411,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,CHEMBL622969,1,BAO_0000218,9413,17411,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,CHEMBL875327,1,BAO_0000218,9414,17411,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat after 1 mg/kg i.v. administration,In vivo,CHEMBL628638,1,BAO_0000218,9415,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat after 2 mg/kg peroral administration,In vivo,CHEMBL628639,1,BAO_0000218,9416,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,CHEMBL625840,1,BAO_0000218,9417,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of 10 mg/kg oral dose determined in rats,In vivo,CHEMBL625841,1,BAO_0000218,9418,4722,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL625842,1,BAO_0000218,9419,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL625843,1,BAO_0000218,9420,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL625844,1,BAO_0000218,9421,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL873822,1,BAO_0000218,9422,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL625845,1,BAO_0000218,9423,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL627059,1,BAO_0000218,9424,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL627060,1,BAO_0000218,9425,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,CHEMBL627061,1,BAO_0000218,9426,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound at 5 mg/kg after po administration was determined in rat,In vivo,CHEMBL627709,1,BAO_0000218,9427,4762,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound determined after intravenous administration to rat,In vivo,CHEMBL627710,1,BAO_0000218,9428,5327,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life of compound was determined in rat,,CHEMBL627711,1,BAO_0000218,9429,4847,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL627712,1,BAO_0000218,9430,17720,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,CHEMBL627713,1,BAO_0000218,9431,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,CHEMBL627714,1,BAO_0000218,9432,4723,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,In vivo,CHEMBL627889,0,BAO_0000218,9433,4256,,9541.0,,,,Macaca fascicularis
A,1,,,U,Intermediate,,,,22224,Half life determined in rat by intravenous administration,In vivo,CHEMBL627890,0,BAO_0000218,9434,4256,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life determined in rats after iv administration,In vivo,CHEMBL627891,1,BAO_0000218,9435,4722,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,CHEMBL627892,1,BAO_0000218,9436,6535,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,CHEMBL627893,1,BAO_0000218,9437,6535,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat plasma was determined,,CHEMBL627894,1,BAO_0000218,9438,1435,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat plasma was determined; NA means not applicable,,CHEMBL627895,1,BAO_0000218,9439,1435,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat was tested,,CHEMBL627896,1,BAO_0000218,9440,5206,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life measured in rat plasma,,CHEMBL627897,1,BAO_0000218,9441,6080,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life recorded in rats,,CHEMBL627898,1,BAO_0000218,9442,4449,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was calculated,,CHEMBL627899,1,BAO_0000218,9443,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was calculated in rat,,CHEMBL873823,1,BAO_0000218,9444,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was determined,,CHEMBL627900,1,BAO_0000218,9445,3747,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after 10 mg/kg oral administration in rat,In vivo,CHEMBL627901,1,BAO_0000218,9446,17858,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,CHEMBL627902,1,BAO_0000218,9447,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after administering orally a dose of 30 mg/kg,In vivo,CHEMBL627903,1,BAO_0000218,9448,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,CHEMBL627904,1,BAO_0000218,9449,5031,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,CHEMBL627905,1,BAO_0000218,9450,4722,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,CHEMBL627906,1,BAO_0000218,9451,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,CHEMBL627907,1,BAO_0000218,9452,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,CHEMBL876783,1,BAO_0000218,9453,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,CHEMBL627908,1,BAO_0000218,9454,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,CHEMBL627909,1,BAO_0000218,9455,17065,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,CHEMBL627910,1,BAO_0000218,9456,1353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,CHEMBL627911,1,BAO_0000218,9457,1353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,CHEMBL627912,1,BAO_0000218,9458,1353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,CHEMBL627913,1,BAO_0000218,9459,1353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,CHEMBL627914,1,BAO_0000218,9460,1353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,CHEMBL627915,1,BAO_0000218,9461,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was evaluated after 20 uM/kg of peroral administration,,CHEMBL627916,1,BAO_0000218,9462,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,CHEMBL627917,1,BAO_0000218,9463,6062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,CHEMBL627918,1,BAO_0000218,9464,6056,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,CHEMBL627919,1,BAO_0000218,9465,5182,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,CHEMBL627920,1,BAO_0000218,9466,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve was evaluated at an oral dose of 30 mg/kg,,CHEMBL627921,1,BAO_0000218,9467,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,CHEMBL627922,1,BAO_0000218,9468,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,CHEMBL876784,1,BAO_0000218,9469,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,CHEMBL627923,1,BAO_0000218,9470,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,CHEMBL626208,1,BAO_0000218,9471,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,CHEMBL626209,1,BAO_0000218,9472,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,CHEMBL626210,1,BAO_0000218,9473,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,CHEMBL627994,1,BAO_0000218,9474,2463,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,CHEMBL627995,1,BAO_0000218,9475,4709,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,CHEMBL627996,1,BAO_0000218,9476,4075,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,CHEMBL627997,1,BAO_0000218,9477,5394,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,CHEMBL627998,1,BAO_0000218,9478,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,CHEMBL628640,1,BAO_0000218,9479,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,CHEMBL628641,1,BAO_0000218,9480,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,CHEMBL628642,1,BAO_0000218,9481,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for area under the curve expressed as (h*ug/ml),,CHEMBL628643,1,BAO_0000218,9482,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for area under curve in rat,,CHEMBL628644,1,BAO_0000218,9483,2591,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,CHEMBL628645,1,BAO_0000218,9484,6567,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,CHEMBL628646,1,BAO_0000218,9485,6211,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,CHEMBL628647,1,BAO_0000218,9486,5529,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,CHEMBL628648,1,BAO_0000218,9487,5408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,CHEMBL625358,1,BAO_0000218,9488,5408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,CHEMBL625359,1,BAO_0000218,9489,5408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,CHEMBL625360,1,BAO_0000218,9490,5408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,CHEMBL625361,1,BAO_0000218,9491,429,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,CHEMBL625362,1,BAO_0000218,9492,429,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,CHEMBL625363,1,BAO_0000218,9493,429,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,CHEMBL625364,1,BAO_0000218,9494,4796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,CHEMBL625365,1,BAO_0000218,9495,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,CHEMBL625366,1,BAO_0000218,9496,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,CHEMBL625367,1,BAO_0000218,9497,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,CHEMBL625368,1,BAO_0000218,9498,11450,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,CHEMBL625369,1,BAO_0000218,9499,11450,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,CHEMBL625370,1,BAO_0000218,9500,11450,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,CHEMBL625371,1,BAO_0000218,9501,11450,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,CHEMBL625372,1,BAO_0000218,9502,11450,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,CHEMBL625373,1,BAO_0000218,9503,11450,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,CHEMBL625374,1,BAO_0000218,9504,11450,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,CHEMBL877593,1,BAO_0000218,9505,11450,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,CHEMBL625375,1,BAO_0000218,9506,11450,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,CHEMBL625376,1,BAO_0000218,9507,11450,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,CHEMBL621973,1,BAO_0000218,9508,11450,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,CHEMBL621974,1,BAO_0000218,9509,11450,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,CHEMBL621975,1,BAO_0000218,9510,11450,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,CHEMBL622166,1,BAO_0000218,9511,11450,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,CHEMBL622167,1,BAO_0000218,9512,11450,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,CHEMBL622168,1,BAO_0000218,9513,11450,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,CHEMBL622169,1,BAO_0000218,9514,11450,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,CHEMBL622170,1,BAO_0000218,9515,11450,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,CHEMBL622171,1,BAO_0000218,9516,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,CHEMBL622172,1,BAO_0000218,9517,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,CHEMBL622173,1,BAO_0000218,9518,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,CHEMBL622174,1,BAO_0000218,9519,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,CHEMBL622175,1,BAO_0000218,9520,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,CHEMBL622176,1,BAO_0000218,9521,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,CHEMBL622177,1,BAO_0000218,9522,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,CHEMBL622178,1,BAO_0000218,9523,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,CHEMBL622179,1,BAO_0000218,9524,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,CHEMBL622180,1,BAO_0000218,9525,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL622181,1,BAO_0000218,9526,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL622182,1,BAO_0000218,9527,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL622183,1,BAO_0000218,9528,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL622184,1,BAO_0000218,9529,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL622185,1,BAO_0000218,9530,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL622186,1,BAO_0000218,9531,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL622187,1,BAO_0000218,9532,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,CHEMBL625002,1,BAO_0000218,9533,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,CHEMBL622090,1,BAO_0000218,9534,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL622091,1,BAO_0000218,9535,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL622092,1,BAO_0000218,9536,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL622093,1,BAO_0000218,9537,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL622094,1,BAO_0000218,9538,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL622095,1,BAO_0000218,9539,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL622264,1,BAO_0000218,9540,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL622265,1,BAO_0000218,9541,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL622266,1,BAO_0000218,9542,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL622267,1,BAO_0000218,9543,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL622268,1,BAO_0000218,9544,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL622269,1,BAO_0000218,9545,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL625071,1,BAO_0000218,9546,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL621621,1,BAO_0000218,9547,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL621622,1,BAO_0000218,9548,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL621623,1,BAO_0000218,9549,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL621624,1,BAO_0000218,9550,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL621625,1,BAO_0000218,9551,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL621626,1,BAO_0000218,9552,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL621627,1,BAO_0000218,9553,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL621628,1,BAO_0000218,9554,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL875328,1,BAO_0000218,9555,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL621629,1,BAO_0000218,9556,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL621630,1,BAO_0000218,9557,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL621631,1,BAO_0000218,9558,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL621632,1,BAO_0000218,9559,16434,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL621633,1,BAO_0000218,9560,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL621634,1,BAO_0000218,9561,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL621635,1,BAO_0000218,9562,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL621636,1,BAO_0000218,9563,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL621637,1,BAO_0000218,9564,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL621638,1,BAO_0000218,9565,16435,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL618883,1,BAO_0000218,9566,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,CHEMBL618884,1,BAO_0000218,9567,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL628627,1,BAO_0000218,9568,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL628628,1,BAO_0000218,9569,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,CHEMBL628629,1,BAO_0000218,9570,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after administering orally a dose of 3 mg/kg,In vivo,CHEMBL628630,1,BAO_0000218,9571,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,CHEMBL628631,1,BAO_0000218,9572,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after administering intravenously a dose of 1 mg/kg,In vivo,CHEMBL628632,1,BAO_0000218,9573,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after oral dosing in rats,In vivo,CHEMBL628633,1,BAO_0000218,9574,526,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,In vivo,CHEMBL628634,1,BAO_0000218,9575,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life by intravenous administration of 3.4 mg/kg in rat,In vivo,CHEMBL627789,1,BAO_0000218,9576,4368,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat,,CHEMBL627790,1,BAO_0000218,9577,3371,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat,,CHEMBL627791,1,BAO_0000218,9578,6448,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat,,CHEMBL627792,1,BAO_0000218,9579,6453,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat after intravenous administration of the compound,In vivo,CHEMBL627793,1,BAO_0000218,9580,4353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,CHEMBL627794,1,BAO_0000218,9581,4353,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat after po administration of the compound,In vivo,CHEMBL627795,1,BAO_0000218,9582,4353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat after po administration of the compound; ND means Not determined,In vivo,CHEMBL627796,1,BAO_0000218,9583,4353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,In vivo,CHEMBL875335,1,BAO_0000218,9584,4353,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,CHEMBL627797,1,BAO_0000218,9585,4353,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat i.v.,In vivo,CHEMBL627798,1,BAO_0000218,9586,5789,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat i.v. at 2 mg/kg concentration,In vivo,CHEMBL627799,1,BAO_0000218,9587,17686,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats,,CHEMBL627800,1,BAO_0000218,9588,6495,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats after intravenous administration,In vivo,CHEMBL627801,1,BAO_0000218,9589,484,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rats at the dose of 1.0 mpk by i.v. administration,In vivo,CHEMBL627802,1,BAO_0000218,9590,6467,,10116.0,,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Half life in rat,,CHEMBL627803,1,BAO_0000218,9591,6642,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was evaluated after intravenous administration to rats,In vivo,CHEMBL873820,1,BAO_0000218,9592,16367,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,CHEMBL627804,1,BAO_0000218,9593,1369,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was evaluated in rat,,CHEMBL627805,1,BAO_0000218,9594,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was evaluated in rat,,CHEMBL627806,1,BAO_0000218,9595,6049,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was evaluated in rat; Not tested,,CHEMBL627107,1,BAO_0000218,9596,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,In vivo,CHEMBL627108,1,BAO_0000218,9597,16366,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,In vivo,CHEMBL627109,1,BAO_0000218,9598,11149,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,In vivo,CHEMBL627110,1,BAO_0000218,9599,11149,,10116.0,178.0,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,CHEMBL627111,0,BAO_0000218,9600,2891,,9443.0,,,,Primates
A,1,,,U,Intermediate,,,,22224,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,CHEMBL627112,0,BAO_0000218,9601,2891,,9443.0,,,,Primates
A,1,,,U,Intermediate,,,,22224,Half life was measured in rat at dose of 30 mg/kg by iv administration,In vivo,CHEMBL627113,0,BAO_0000218,9602,2891,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Half life was measured in rat at dose of 30 mg/kg by po administration,In vivo,CHEMBL627114,0,BAO_0000218,9603,2891,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life (t1/2) was determined,,CHEMBL627115,1,BAO_0000218,9604,4026,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period at a dose of 10 uM/kg in rat was determined,,CHEMBL627116,1,BAO_0000218,9605,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,In vivo,CHEMBL627117,1,BAO_0000218,9606,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was determined,,CHEMBL627118,1,BAO_0000218,9607,5503,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after intravenous administration at 20 mpk in rats,In vivo,CHEMBL627119,1,BAO_0000218,9608,4426,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after intravenous administration at 20 mpk in rats; Not performed.,In vivo,CHEMBL627120,1,BAO_0000218,9609,4426,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after intravenous administration in rat,In vivo,CHEMBL626922,1,BAO_0000218,9610,6109,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,CHEMBL626923,1,BAO_0000218,9611,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,CHEMBL626924,1,BAO_0000218,9612,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in 80% rat plasma at 37 degree Centigrade,,CHEMBL626925,1,BAO_0000218,9613,4755,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in SD rats,,CHEMBL626926,1,BAO_0000218,9614,5862,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,CHEMBL626927,1,BAO_0000218,9615,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,CHEMBL626928,1,BAO_0000218,9616,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,CHEMBL626929,1,BAO_0000218,9617,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,CHEMBL626930,1,BAO_0000218,9618,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat,,CHEMBL626931,1,BAO_0000218,9619,5960,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat,,CHEMBL626932,1,BAO_0000218,9620,6103,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat,,CHEMBL626933,1,BAO_0000218,9621,6317,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat after oral administration at 10.5 mg/kg dose,In vivo,CHEMBL873826,1,BAO_0000218,9622,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat after oral administration at 11.2 mg/kg dose,In vivo,CHEMBL626934,1,BAO_0000218,9623,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat after oral administration at 13 mg/kg dose,In vivo,CHEMBL626935,1,BAO_0000218,9624,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat after oral administration at 9.7 mg/kg dose,In vivo,CHEMBL626936,1,BAO_0000218,9625,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,CHEMBL626937,1,BAO_0000218,9626,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,CHEMBL625906,1,BAO_0000218,9627,6295,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,CHEMBL625907,1,BAO_0000218,9628,6296,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,PK study was carried to determine AUC (area under curve) value in rat,,CHEMBL625908,1,BAO_0000218,9629,16427,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC after intravenous administration to rats,,CHEMBL625909,1,BAO_0000218,9630,16367,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC after oral administration to rats,,CHEMBL625910,1,BAO_0000218,9631,16367,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,CHEMBL625911,1,BAO_0000218,9632,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,CHEMBL625912,1,BAO_0000218,9633,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,CHEMBL626538,1,BAO_0000218,9634,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,CHEMBL876794,1,BAO_0000218,9635,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,CHEMBL626539,1,BAO_0000218,9636,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,CHEMBL626540,1,BAO_0000218,9637,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,CHEMBL626541,1,BAO_0000218,9638,5394,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,CHEMBL626542,1,BAO_0000218,9639,5394,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,CHEMBL626543,1,BAO_0000218,9640,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,CHEMBL626544,1,BAO_0000218,9641,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,CHEMBL626545,1,BAO_0000218,9642,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,CHEMBL626546,1,BAO_0000218,9643,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter area under curve was reported,,CHEMBL626547,1,BAO_0000218,9644,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (AUC) in rat,,CHEMBL626548,1,BAO_0000218,9645,4408,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,CHEMBL626549,1,BAO_0000218,9646,5983,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,CHEMBL626550,1,BAO_0000218,9647,4397,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,CHEMBL626551,1,BAO_0000218,9648,4397,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property was determined,,CHEMBL623777,1,BAO_0000218,9649,5491,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,CHEMBL623778,1,BAO_0000218,9650,5491,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,CHEMBL623779,1,BAO_0000218,9651,5491,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,CHEMBL623780,1,BAO_0000218,9652,4199,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,CHEMBL622015,1,BAO_0000218,9653,4199,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,CHEMBL622016,1,BAO_0000218,9654,4199,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,CHEMBL622017,1,BAO_0000218,9655,5173,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,CHEMBL622018,1,BAO_0000218,9656,5173,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,CHEMBL622019,1,BAO_0000218,9657,5173,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,CHEMBL622020,1,BAO_0000218,9658,5173,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,CHEMBL622021,1,BAO_0000218,9659,16366,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,CHEMBL622022,1,BAO_0000218,9660,16366,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,CHEMBL622023,1,BAO_0000218,9661,5327,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,CHEMBL622024,1,BAO_0000218,9662,6681,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,CHEMBL622693,1,BAO_0000218,9663,12873,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,CHEMBL622694,1,BAO_0000218,9664,12873,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,CHEMBL622695,1,BAO_0000218,9665,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,CHEMBL622696,1,BAO_0000218,9666,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,CHEMBL622697,1,BAO_0000218,9667,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,CHEMBL622874,1,BAO_0000218,9668,6619,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,CHEMBL622875,1,BAO_0000218,9669,6619,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,CHEMBL622876,1,BAO_0000218,9670,10363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,CHEMBL622877,1,BAO_0000218,9671,4796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,CHEMBL622878,1,BAO_0000218,9672,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,CHEMBL622879,1,BAO_0000218,9673,4910,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,CHEMBL877602,1,BAO_0000218,9674,4839,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,CHEMBL622880,1,BAO_0000218,9675,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,CHEMBL622881,1,BAO_0000218,9676,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,CHEMBL622882,1,BAO_0000218,9677,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,CHEMBL622883,1,BAO_0000218,9678,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,CHEMBL622884,1,BAO_0000218,9679,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,CHEMBL622885,1,BAO_0000218,9680,11450,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,CHEMBL622886,1,BAO_0000218,9681,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,CHEMBL622887,1,BAO_0000218,9682,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,CHEMBL622888,1,BAO_0000218,9683,8151,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622889,1,BAO_0000218,9684,8677,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622890,1,BAO_0000218,9685,8677,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622891,1,BAO_0000218,9686,8677,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL877603,1,BAO_0000218,9687,8677,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622892,1,BAO_0000218,9688,8677,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622893,1,BAO_0000218,9689,8677,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622894,1,BAO_0000218,9690,8677,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622895,1,BAO_0000218,9691,8677,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,In vivo,CHEMBL622896,1,BAO_0000218,9692,8677,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622897,1,BAO_0000218,9693,8677,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622898,1,BAO_0000218,9694,8677,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622899,1,BAO_0000218,9695,8677,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622900,1,BAO_0000218,9696,8677,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624114,1,BAO_0000218,9697,8677,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624115,1,BAO_0000218,9698,8677,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624116,1,BAO_0000218,9699,8677,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624117,1,BAO_0000218,9700,8677,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624118,1,BAO_0000218,9701,8677,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624119,1,BAO_0000218,9702,8677,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624120,1,BAO_0000218,9703,8677,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624121,1,BAO_0000218,9704,8677,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624122,1,BAO_0000218,9705,8677,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624123,1,BAO_0000218,9706,8677,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624124,1,BAO_0000218,9707,8677,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624125,1,BAO_0000218,9708,8677,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624126,1,BAO_0000218,9709,8677,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624127,1,BAO_0000218,9710,8677,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624128,1,BAO_0000218,9711,8677,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL624129,1,BAO_0000218,9712,8677,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL624130,1,BAO_0000218,9713,8677,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622340,1,BAO_0000218,9714,8677,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622341,1,BAO_0000218,9715,8677,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622342,1,BAO_0000218,9716,8677,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622343,1,BAO_0000218,9717,8677,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622344,1,BAO_0000218,9718,8677,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622345,1,BAO_0000218,9719,8677,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622346,1,BAO_0000218,9720,8677,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622347,1,BAO_0000218,9721,8677,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622348,1,BAO_0000218,9722,8677,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622349,1,BAO_0000218,9723,8677,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,CHEMBL622350,1,BAO_0000218,9724,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,CHEMBL622351,1,BAO_0000218,9725,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,CHEMBL622352,1,BAO_0000218,9726,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,CHEMBL622353,1,BAO_0000218,9727,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,CHEMBL622354,1,BAO_0000218,9728,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,CHEMBL622355,1,BAO_0000218,9729,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,CHEMBL622356,1,BAO_0000218,9730,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,CHEMBL622357,1,BAO_0000218,9731,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,CHEMBL622358,1,BAO_0000218,9732,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,CHEMBL622359,1,BAO_0000218,9733,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,CHEMBL874393,1,BAO_0000218,9734,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL622872,1,BAO_0000218,9735,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL622873,1,BAO_0000218,9736,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL623047,1,BAO_0000218,9737,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL623048,1,BAO_0000218,9738,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL623049,1,BAO_0000218,9739,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL623050,1,BAO_0000218,9740,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL623051,1,BAO_0000218,9741,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL623052,1,BAO_0000218,9742,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL626343,1,BAO_0000218,9743,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,CHEMBL626344,1,BAO_0000218,9744,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,CHEMBL626345,1,BAO_0000218,9745,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,CHEMBL626346,1,BAO_0000218,9746,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,CHEMBL626347,1,BAO_0000218,9747,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,CHEMBL626348,1,BAO_0000218,9748,16434,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,CHEMBL626349,1,BAO_0000218,9749,16434,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,CHEMBL626350,1,BAO_0000218,9750,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,CHEMBL626351,1,BAO_0000218,9751,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,CHEMBL627650,1,BAO_0000218,9752,16435,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,CHEMBL627651,1,BAO_0000218,9753,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,CHEMBL627652,1,BAO_0000218,9754,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,CHEMBL627653,1,BAO_0000218,9755,16435,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,CHEMBL627654,1,BAO_0000218,9756,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,CHEMBL627835,1,BAO_0000218,9757,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,CHEMBL627836,1,BAO_0000218,9758,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,CHEMBL627837,1,BAO_0000218,9759,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,CHEMBL627838,1,BAO_0000218,9760,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,CHEMBL875338,1,BAO_0000218,9761,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,CHEMBL627839,1,BAO_0000218,9762,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,CHEMBL627840,1,BAO_0000218,9763,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,CHEMBL627841,1,BAO_0000218,9764,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,CHEMBL627842,1,BAO_0000218,9765,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,CHEMBL627843,1,BAO_0000218,9766,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,CHEMBL627844,1,BAO_0000218,9767,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,CHEMBL627845,1,BAO_0000218,9768,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period in rat by iv administration at a dose of 3 mg/kg,In vivo,CHEMBL627846,1,BAO_0000218,9769,5874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,CHEMBL627847,1,BAO_0000218,9770,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,CHEMBL873821,1,BAO_0000218,9771,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,CHEMBL626079,1,BAO_0000218,9772,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,CHEMBL626080,1,BAO_0000218,9773,1515,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period was evaluated in rat plasma,,CHEMBL626081,1,BAO_0000218,9774,5491,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life period was evaluated in rat plasma; Not tested,,CHEMBL875344,1,BAO_0000218,9775,5491,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was evaluated in rats,,CHEMBL626082,1,BAO_0000218,9776,1918,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Half life period was evaluated in rats, iv",In vivo,CHEMBL626250,1,BAO_0000218,9777,1918,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period after intravenous administration at 5 mg/kg in rat,In vivo,CHEMBL626251,1,BAO_0000218,9778,6113,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,CHEMBL626252,1,BAO_0000218,9779,5546,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,In vivo,CHEMBL626253,1,BAO_0000218,9780,5553,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half life stability of compound was evaluated in rat plasma,,CHEMBL626254,1,BAO_0000218,9781,4188,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,CHEMBL626255,1,BAO_0000218,9782,6215,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,CHEMBL626256,1,BAO_0000218,9783,6141,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,CHEMBL626257,1,BAO_0000218,9784,5182,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,In vivo,CHEMBL626258,1,BAO_0000218,9785,5182,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,In vivo,CHEMBL626259,1,BAO_0000218,9786,5710,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half in rat i.v.,In vivo,CHEMBL626260,1,BAO_0000218,9787,5789,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half period in rat after intravenous administration,In vivo,CHEMBL875345,1,BAO_0000218,9788,6011,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life after repeated oral dose of compound at 1 mg/kg in rats,In vivo,CHEMBL626261,1,BAO_0000218,9789,17594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Half-life measured in in vitro Cathepsin B assay in rat liver,In vitro,CHEMBL626262,1,BAO_0000218,9790,12357,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life of compound was determined in rats,,CHEMBL626263,1,BAO_0000218,9791,5210,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life at 10 mg/kg in rat upon intravenous administration,In vivo,CHEMBL625270,1,BAO_0000218,9792,17596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life determined in rat,,CHEMBL625271,1,BAO_0000218,9793,6672,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life determined in rat,,CHEMBL625272,1,BAO_0000218,9794,6673,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,CHEMBL625273,1,BAO_0000218,9795,4910,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,CHEMBL625274,1,BAO_0000218,9796,3741,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,CHEMBL625275,1,BAO_0000218,9797,17671,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,In vivo,CHEMBL625276,1,BAO_0000218,9798,4910,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in rat plasma,,CHEMBL625277,1,BAO_0000218,9799,17537,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in rat plasma was determined,,CHEMBL625278,1,BAO_0000218,9800,4965,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in rat plasma; Not tested,,CHEMBL625279,1,BAO_0000218,9801,17537,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Half-life in rat serum,,CHEMBL625280,1,BAO_0000218,9802,6124,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50597,Half-life in rat serum; na is not available,,CHEMBL876797,1,BAO_0000218,9803,6124,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was calculated in rat,,CHEMBL625281,1,BAO_0000218,9804,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life was calculated in rat plasma,,CHEMBL873827,1,BAO_0000218,9805,17668,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was determined,,CHEMBL625282,1,BAO_0000218,9806,3185,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was determined,,CHEMBL625283,1,BAO_0000218,9807,4883,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life after administration of 20 mg/Kg oral dose in rat,In vivo,CHEMBL625284,1,BAO_0000218,9808,2959,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life after administration of 3.2 mg/kg intravenously in male rat,In vivo,CHEMBL625285,1,BAO_0000218,9809,4029,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life after intravenous administration in female rat,In vivo,CHEMBL625286,1,BAO_0000218,9810,4029,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life after intravenous administration in male rat,In vivo,CHEMBL625287,1,BAO_0000218,9811,4029,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life after intravenous dose in rat,In vivo,CHEMBL625288,1,BAO_0000218,9812,6180,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Half-life in a rat liver homogenate preparation,,CHEMBL625289,1,BAO_0000218,9813,1557,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in plasma of rat,,CHEMBL625290,1,BAO_0000218,9814,12500,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in plasma of rat at dose of 3-10 mgkg,,CHEMBL876798,1,BAO_0000218,9815,12500,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat,,CHEMBL625291,1,BAO_0000218,9816,5064,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat,,CHEMBL625292,1,BAO_0000218,9817,5145,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat,,CHEMBL625293,1,BAO_0000218,9818,5147,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat,,CHEMBL622832,1,BAO_0000218,9819,5833,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat,,CHEMBL622833,1,BAO_0000218,9820,6596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat,,CHEMBL622834,1,BAO_0000218,9821,17655,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat after oral administration at 10 mg/kg,In vivo,CHEMBL622835,1,BAO_0000218,9822,6495,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat after po administration at a dose of 10 mg/kg,In vivo,CHEMBL622836,1,BAO_0000218,9823,17538,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,CHEMBL622837,1,BAO_0000218,9824,17538,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat at 3 mg/kg dose administered intravenously,In vivo,CHEMBL622838,1,BAO_0000218,9825,10,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Half-life in rat brain homogenate,,CHEMBL622839,1,BAO_0000218,9826,17669,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in rat plasma,,CHEMBL622840,1,BAO_0000218,9827,17065,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rats,,CHEMBL622841,1,BAO_0000218,9828,4333,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in Dawley rats,,CHEMBL622842,1,BAO_0000218,9829,6827,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in vitro in rat plasma,In vitro,CHEMBL622843,1,BAO_0000218,9830,889,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,In vitro,CHEMBL622844,1,BAO_0000218,9831,889,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,CHEMBL622845,1,BAO_0000218,9832,3747,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The area under the curve of compound was measured at the dose of 100 umol/kg,,CHEMBL622846,1,BAO_0000218,9833,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The area under the curve of compound was measured at the dose of 300 umol/kg,,CHEMBL622847,1,BAO_0000218,9834,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The area under the curve of compound was measured at the dose of 30 umol/kg,,CHEMBL622848,1,BAO_0000218,9835,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability as oral AUC in rats,In vivo,CHEMBL622849,1,BAO_0000218,9836,3360,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The plasma concentration versus time curve (AUC) was determined,,CHEMBL622850,1,BAO_0000218,9837,5334,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL876807,1,BAO_0000218,9838,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL622851,1,BAO_0000218,9839,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL622852,1,BAO_0000218,9840,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,CHEMBL622853,1,BAO_0000218,9841,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,CHEMBL622854,1,BAO_0000218,9842,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,CHEMBL622855,1,BAO_0000218,9843,17411,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,CHEMBL622856,1,BAO_0000218,9844,14941,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,CHEMBL622857,1,BAO_0000218,9845,14941,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat after po administration at a dose of 10 mg/kg,,CHEMBL622858,1,BAO_0000218,9846,17538,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,CHEMBL622859,1,BAO_0000218,9847,17752,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,CHEMBL622860,1,BAO_0000218,9848,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,CHEMBL622861,1,BAO_0000218,9849,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,CHEMBL622862,1,BAO_0000218,9850,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,CHEMBL622863,1,BAO_0000218,9851,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve value 6 hr after po administration in rat,,CHEMBL623817,1,BAO_0000218,9852,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,CHEMBL623818,1,BAO_0000218,9853,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,CHEMBL623819,1,BAO_0000218,9854,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,CHEMBL623820,1,BAO_0000218,9855,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,CHEMBL623821,1,BAO_0000218,9856,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC normalized for dose (AUCN) in rat,,CHEMBL623822,1,BAO_0000218,9857,6642,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat after p.o. administration,,CHEMBL623823,1,BAO_0000218,9858,6640,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat after p.o. administration,,CHEMBL623824,1,BAO_0000218,9859,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat after p.o. administration; Not determined,,CHEMBL623825,1,BAO_0000218,9860,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in rat after peroral administration,,CHEMBL622070,1,BAO_0000218,9861,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (carotid artery) value of the compound,,CHEMBL622071,1,BAO_0000218,9862,3603,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability expressed as the area under curve of rat carotid artery,,CHEMBL622072,1,BAO_0000218,9863,3550,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve in male SD rats was observed after intravenous administration in rat,,CHEMBL622073,1,BAO_0000218,9864,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve of the compound was determined,,CHEMBL622074,1,BAO_0000218,9865,17720,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,CHEMBL622075,1,BAO_0000218,9866,5407,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,CHEMBL622076,1,BAO_0000218,9867,17752,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,CHEMBL622077,1,BAO_0000218,9868,17752,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve (portal vein) value of the compound,,CHEMBL622078,1,BAO_0000218,9869,3603,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability expressed as the area under curve of rat portal vein,,CHEMBL622079,1,BAO_0000218,9870,3550,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Area Under plasma concentration time curve in rat upon peroral administration,,CHEMBL622080,1,BAO_0000218,9871,17655,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,CHEMBL877612,1,BAO_0000218,9872,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,CHEMBL622081,1,BAO_0000218,9873,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for oral bioavailability in rats,,CHEMBL622082,1,BAO_0000218,9874,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for oral bioavailability in rats after iv administration,,CHEMBL622083,1,BAO_0000218,9875,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for oral bioavailability in rats; 30-80,,CHEMBL622084,1,BAO_0000218,9876,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for oral bioavailability in rats; 50-60,,CHEMBL622085,1,BAO_0000218,9877,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for oral bioavailability in rats; no data,,CHEMBL622086,1,BAO_0000218,9878,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for oral bioavailability in rats; peptide,,CHEMBL622087,1,BAO_0000218,9879,17791,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,CHEMBL622088,1,BAO_0000218,9880,7768,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,CHEMBL622089,1,BAO_0000218,9881,7768,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,CHEMBL623685,1,BAO_0000218,9882,7768,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,CHEMBL623686,1,BAO_0000218,9883,7768,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL623687,1,BAO_0000218,9884,8677,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL623688,1,BAO_0000218,9885,8677,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL623689,1,BAO_0000218,9886,8677,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Stomach,,,50597,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622485,1,BAO_0000218,9887,8677,,10116.0,945.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622486,1,BAO_0000218,9888,8677,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL877613,1,BAO_0000218,9889,8677,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,CHEMBL622487,1,BAO_0000218,9890,8677,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622488,1,BAO_0000218,9891,8677,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,CHEMBL622489,1,BAO_0000218,9892,8677,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,CHEMBL622490,1,BAO_0000218,9893,6899,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,CHEMBL622491,1,BAO_0000218,9894,6899,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,CHEMBL622492,1,BAO_0000218,9895,6899,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,CHEMBL622493,1,BAO_0000218,9896,6899,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,CHEMBL622494,1,BAO_0000218,9897,6899,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,CHEMBL622495,1,BAO_0000218,9898,8677,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,CHEMBL622496,1,BAO_0000218,9899,6899,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,CHEMBL622497,1,BAO_0000218,9900,6899,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,CHEMBL622498,1,BAO_0000218,9901,2189,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,CHEMBL624918,1,BAO_0000218,9902,2189,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,CHEMBL624919,1,BAO_0000218,9903,2189,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of compound in rat blood after 5 min of administration,In vivo,CHEMBL624920,1,BAO_0000218,9904,10839,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of compound in rat blood after 5 min of administration.,In vivo,CHEMBL624921,1,BAO_0000218,9905,10839,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of compound in rat brain after 5 min of administration,In vivo,CHEMBL624922,1,BAO_0000218,9906,10839,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of compound in rat heart after 5 min of administration,In vivo,CHEMBL624923,1,BAO_0000218,9907,10839,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of compound in rat heart after 5 min of administration.,In vivo,CHEMBL624924,1,BAO_0000218,9908,10839,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of compound in rat kidney after 5 min of administration,In vivo,CHEMBL624925,1,BAO_0000218,9909,10839,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of compound in rat kidney after 5 min of administration.,In vivo,CHEMBL624926,1,BAO_0000218,9910,10839,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of compound in rat liver after 5 min of administration,In vivo,CHEMBL624927,1,BAO_0000218,9911,10839,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of compound in rat liver after 5 min of administration.,In vivo,CHEMBL874402,1,BAO_0000218,9912,10839,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of compound in rat lung after 5 min of administration,In vivo,CHEMBL624928,1,BAO_0000218,9913,10839,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of compound in rat lung after 5 min of administration.,In vivo,CHEMBL624929,1,BAO_0000218,9914,10839,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,CHEMBL624930,1,BAO_0000218,9915,10839,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,CHEMBL624931,1,BAO_0000218,9916,10839,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624932,1,BAO_0000218,9917,4043,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624933,1,BAO_0000218,9918,4043,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624934,1,BAO_0000218,9919,4043,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624935,1,BAO_0000218,9920,4043,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624936,1,BAO_0000218,9921,4043,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624937,1,BAO_0000218,9922,4043,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624938,1,BAO_0000218,9923,4043,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624939,1,BAO_0000218,9924,4043,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL624940,1,BAO_0000218,9925,4043,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,CHEMBL874403,1,BAO_0000218,9926,4043,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,CHEMBL624941,1,BAO_0000218,9927,1446,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,CHEMBL624942,1,BAO_0000218,9928,9971,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,CHEMBL624943,1,BAO_0000218,9929,9971,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,% Bioavailability after 1 day of the drug administration in rats,In vivo,CHEMBL624944,1,BAO_0000218,9930,5765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,% Bioavailability after 4 day of the drug administration in rats,In vivo,CHEMBL624945,1,BAO_0000218,9931,5765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Absolute bioavailability was evaluated in rat,In vivo,CHEMBL624946,1,BAO_0000218,9932,4257,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,CHEMBL624947,1,BAO_0000218,9933,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,CHEMBL624948,1,BAO_0000218,9934,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,CHEMBL624949,1,BAO_0000218,9935,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,CHEMBL622025,1,BAO_0000218,9936,13091,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,CHEMBL622026,1,BAO_0000218,9937,13091,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,CHEMBL622027,1,BAO_0000218,9938,13091,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,CHEMBL622028,1,BAO_0000218,9939,13091,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,CHEMBL622029,1,BAO_0000218,9940,13091,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,CHEMBL622208,1,BAO_0000218,9941,13091,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,CHEMBL622209,1,BAO_0000218,9942,13091,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,CHEMBL622210,1,BAO_0000218,9943,13091,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,CHEMBL622211,1,BAO_0000218,9944,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,CHEMBL622212,1,BAO_0000218,9945,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,CHEMBL622213,1,BAO_0000218,9946,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,CHEMBL874404,1,BAO_0000218,9947,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,CHEMBL620452,1,BAO_0000218,9948,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,CHEMBL620453,1,BAO_0000218,9949,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,CHEMBL620454,1,BAO_0000218,9950,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,CHEMBL624067,1,BAO_0000218,9951,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,CHEMBL624068,1,BAO_0000218,9952,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,CHEMBL624069,1,BAO_0000218,9953,13091,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,CHEMBL624070,1,BAO_0000218,9954,13091,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,CHEMBL624071,1,BAO_0000218,9955,13091,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,CHEMBL624072,1,BAO_0000218,9956,13091,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,CHEMBL624073,1,BAO_0000218,9957,13091,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,CHEMBL624788,1,BAO_0000218,9958,13091,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,CHEMBL624789,1,BAO_0000218,9959,13091,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,CHEMBL624790,1,BAO_0000218,9960,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,CHEMBL624791,1,BAO_0000218,9961,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,CHEMBL624792,1,BAO_0000218,9962,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,CHEMBL624793,1,BAO_0000218,9963,13091,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,CHEMBL877491,1,BAO_0000218,9964,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,CHEMBL624957,1,BAO_0000218,9965,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,CHEMBL624958,1,BAO_0000218,9966,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,CHEMBL624959,1,BAO_0000218,9967,13091,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Dissociation constant was determined,,CHEMBL624960,1,BAO_0000218,9968,11977,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,CHEMBL624961,1,BAO_0000218,9969,14941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,CHEMBL624962,1,BAO_0000218,9970,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,CHEMBL624963,1,BAO_0000218,9971,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,CHEMBL624964,1,BAO_0000218,9972,4755,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,LogP value was evaluated in the in situ rat gut perfusion assay,,CHEMBL624965,1,BAO_0000218,9973,589,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,CHEMBL624966,1,BAO_0000218,9974,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,In vivo,CHEMBL624967,1,BAO_0000218,9975,5031,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,In vivo,CHEMBL624968,1,BAO_0000218,9976,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,CHEMBL624969,1,BAO_0000218,9977,17720,,10116.0,,,,Rattus norvegicus
F,1,,,N,Expert,,,,50597,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,CHEMBL624970,1,BAO_0000218,9978,2862,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was evaluated after 10 uM/kg of intra arterial administration,,CHEMBL624971,1,BAO_0000218,9979,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was evaluated after 20 uM/kg of peroral administration,In vivo,CHEMBL624972,1,BAO_0000218,9980,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,CHEMBL624973,1,BAO_0000218,9981,6005,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life was evaluated in plasma of rat,,CHEMBL624974,1,BAO_0000218,9982,2938,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,CHEMBL624975,1,BAO_0000218,9983,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was evaluated in rats at an oral dose of 30 mg/kg,In vivo,CHEMBL877492,1,BAO_0000218,9984,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was measured in rat after an iv dose of 1 mg/kg,In vivo,CHEMBL624976,1,BAO_0000218,9985,6062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period of compound in rats after peroral administration,In vivo,CHEMBL624977,1,BAO_0000218,9986,6571,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life period of compound was measured in rat plasma.,,CHEMBL626848,1,BAO_0000218,9987,3136,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life period of compound was measured in rat plasma; ND is not determined,,CHEMBL626849,1,BAO_0000218,9988,3136,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Half-life period of compound was measured in rat plasma; not determined,,CHEMBL626850,1,BAO_0000218,9989,3136,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,CHEMBL626851,1,BAO_0000218,9990,4521,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period in rat by iv administration,In vivo,CHEMBL626852,1,BAO_0000218,9991,5871,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period in rats following intravenous administration at 2 mg/kg,In vivo,CHEMBL626853,1,BAO_0000218,9992,6077,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,CHEMBL626854,1,BAO_0000218,9993,6679,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period was determined for the compound in rat,,CHEMBL627486,1,BAO_0000218,9994,5144,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,CHEMBL627487,1,BAO_0000218,9995,4498,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",In vivo,CHEMBL627488,1,BAO_0000218,9996,4498,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life value after IV dose at a dose of 5 mg/kg in rats.,In vivo,CHEMBL627489,1,BAO_0000218,9997,1908,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,CHEMBL627490,1,BAO_0000218,9998,6211,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was determined in rat after intravenous administration (0.5 mg/kg),In vivo,CHEMBL873829,1,BAO_0000218,9999,5529,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was determined in rat at a dose of 1 mpk i.v.,In vivo,CHEMBL627655,1,BAO_0000218,10000,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,CHEMBL625994,1,BAO_0000218,10001,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,CHEMBL625995,1,BAO_0000218,10002,6444,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life in rat,,CHEMBL625996,1,BAO_0000218,10003,5207,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,In vitro half life in rat plasma,In vitro,CHEMBL625850,1,BAO_0000218,10004,530,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",In vitro,CHEMBL625851,1,BAO_0000218,10005,1116,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro half life in rat,In vitro,CHEMBL625852,1,BAO_0000218,10006,3219,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo half life period after intravenous administration in rat,In vivo,CHEMBL625853,1,BAO_0000218,10007,6109,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,CHEMBL625854,1,BAO_0000218,10008,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,CHEMBL874450,1,BAO_0000218,10009,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL625855,1,BAO_0000218,10010,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL625856,1,BAO_0000218,10011,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL625857,1,BAO_0000218,10012,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL873831,1,BAO_0000218,10013,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Longer half-life in rat (i.v.) at 0.5 mpk,In vivo,CHEMBL625858,1,BAO_0000218,10014,17853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Longer half-life in rat (p.o.) at 2.0 mpk,In vivo,CHEMBL625859,1,BAO_0000218,10015,17853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (half life) in rat,,CHEMBL625860,1,BAO_0000218,10016,3457,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,In vivo,CHEMBL625861,1,BAO_0000218,10017,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,In vivo,CHEMBL625862,1,BAO_0000218,10018,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,In vivo,CHEMBL625863,1,BAO_0000218,10019,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,In vivo,CHEMBL625864,1,BAO_0000218,10020,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,In vivo,CHEMBL625865,1,BAO_0000218,10021,5739,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic half time was determined intravenously in rats.,In vivo,CHEMBL625866,1,BAO_0000218,10022,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,In vivo,CHEMBL625867,1,BAO_0000218,10023,6567,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half life of hydrolysis of the compound,,CHEMBL625868,1,BAO_0000218,10024,2448,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,In vivo,CHEMBL625869,1,BAO_0000218,10025,5423,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half life period was calculated in rat,,CHEMBL874451,1,BAO_0000218,10026,4853,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life in Sprague-Dawley rats,,CHEMBL625870,1,BAO_0000218,10027,4514,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life in Sprague-Dawley rats; Not determined,,CHEMBL625871,1,BAO_0000218,10028,4514,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life in rats,,CHEMBL625872,1,BAO_0000218,10029,1500,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life in rats; <MQL,,CHEMBL625873,1,BAO_0000218,10030,1500,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life period (0-8 h) was determined,,CHEMBL625874,1,BAO_0000218,10031,5334,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,CHEMBL625875,1,BAO_0000218,10032,5334,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,CHEMBL625876,1,BAO_0000218,10033,5334,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,CHEMBL631258,1,BAO_0000218,10034,5334,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,CHEMBL631259,1,BAO_0000218,10035,4956,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,CHEMBL631260,1,BAO_0000218,10036,4956,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,CHEMBL631261,1,BAO_0000218,10037,7768,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,CHEMBL631262,1,BAO_0000218,10038,7768,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,CHEMBL631263,1,BAO_0000218,10039,7768,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,CHEMBL631264,1,BAO_0000218,10040,7768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,CHEMBL631265,1,BAO_0000218,10041,7768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,CHEMBL631266,1,BAO_0000218,10042,7768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,CHEMBL631267,1,BAO_0000218,10043,7768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,CHEMBL631268,1,BAO_0000218,10044,7768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,CHEMBL631269,1,BAO_0000218,10045,7768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,CHEMBL631270,1,BAO_0000218,10046,7768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,CHEMBL631271,1,BAO_0000218,10047,7768,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,CHEMBL631272,1,BAO_0000218,10048,7768,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,CHEMBL631273,1,BAO_0000218,10049,7768,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,CHEMBL631274,1,BAO_0000218,10050,7768,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,CHEMBL631275,1,BAO_0000218,10051,7768,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,CHEMBL626984,1,BAO_0000218,10052,7768,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,CHEMBL626985,1,BAO_0000218,10053,7768,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,CHEMBL626986,1,BAO_0000218,10054,7768,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,CHEMBL626987,1,BAO_0000218,10055,7768,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,CHEMBL626988,1,BAO_0000218,10056,7768,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,CHEMBL626989,1,BAO_0000218,10057,7768,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,CHEMBL626990,1,BAO_0000218,10058,7768,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,CHEMBL626991,1,BAO_0000218,10059,7768,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,CHEMBL626992,1,BAO_0000218,10060,7768,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,CHEMBL626993,1,BAO_0000218,10061,7768,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,CHEMBL874593,1,BAO_0000218,10062,7768,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,CHEMBL626994,1,BAO_0000218,10063,7768,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,CHEMBL626995,1,BAO_0000218,10064,7768,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,CHEMBL626190,1,BAO_0000218,10065,7768,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,CHEMBL626191,1,BAO_0000218,10066,7768,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,CHEMBL626364,1,BAO_0000218,10067,7768,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,CHEMBL626365,1,BAO_0000218,10068,7768,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,CHEMBL626366,1,BAO_0000218,10069,7768,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,CHEMBL626367,1,BAO_0000218,10070,7768,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,CHEMBL626368,1,BAO_0000218,10071,7768,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,CHEMBL626369,1,BAO_0000218,10072,7768,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,CHEMBL626370,1,BAO_0000218,10073,7768,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,CHEMBL626371,1,BAO_0000218,10074,4498,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",In vivo,CHEMBL626372,1,BAO_0000218,10075,4498,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after a dose of 10 mg/kg p.o.,In vivo,CHEMBL626373,1,BAO_0000218,10076,3603,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after peroral administration (10 mg/kg) was determined in rat,In vivo,CHEMBL626374,1,BAO_0000218,10077,6215,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,In vivo,CHEMBL626375,1,BAO_0000218,10078,5710,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),In vivo,CHEMBL626376,1,BAO_0000218,10079,5710,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat po was determined,In vivo,CHEMBL626377,1,BAO_0000218,10080,5676,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability of compound at 10 mg/kg in rat after oral administration,In vivo,CHEMBL626378,1,BAO_0000218,10081,17667,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,In vivo,CHEMBL626379,1,BAO_0000218,10082,17667,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,CHEMBL626380,1,BAO_0000218,10083,6848,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,CHEMBL626381,1,BAO_0000218,10084,6848,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL626382,1,BAO_0000218,10085,17267,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (Sprague-Dawley) (female),In vivo,CHEMBL626383,1,BAO_0000218,10086,6362,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,CHEMBL874652,1,BAO_0000218,10087,17671,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),In vivo,CHEMBL626384,1,BAO_0000218,10088,17671,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,In vivo,CHEMBL626385,1,BAO_0000218,10089,4333,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat at an oral dose of 2 mg/kg,In vivo,CHEMBL626386,1,BAO_0000218,10090,6077,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL626387,1,BAO_0000218,10091,3278,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL626388,1,BAO_0000218,10092,5964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL626389,1,BAO_0000218,10093,4884,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL626390,1,BAO_0000218,10094,4905,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,In vivo,CHEMBL626391,1,BAO_0000218,10095,4884,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL626392,1,BAO_0000218,10096,6850,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL626393,1,BAO_0000218,10097,2864,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was determined in rat,In vivo,CHEMBL623026,1,BAO_0000218,10098,5780,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability,In vivo,CHEMBL623027,1,BAO_0000218,10099,1465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability,In vivo,CHEMBL623028,1,BAO_0000218,10100,5199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat after 1 day dosing,In vivo,CHEMBL623029,1,BAO_0000218,10101,5765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat after 4 day dosing,In vivo,CHEMBL623030,1,BAO_0000218,10102,5765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,In vivo,CHEMBL623031,1,BAO_0000218,10103,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after IV dosing at 1 mg/kg in rat; no data,In vivo,CHEMBL623032,1,BAO_0000218,10104,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after oral administration at a dose of 2 mg/kg in rat,In vivo,CHEMBL623033,1,BAO_0000218,10105,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after oral administration at a dose of 4 mg/kg in rat,In vivo,CHEMBL623034,1,BAO_0000218,10106,6518,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,CHEMBL623035,1,BAO_0000218,10107,2083,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,CHEMBL623036,1,BAO_0000218,10108,17260,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,CHEMBL623037,1,BAO_0000218,10109,4956,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability by intravenous administration of 3.4 mg/kg in rat,In vivo,CHEMBL623038,1,BAO_0000218,10110,4368,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,In vivo,CHEMBL874385,1,BAO_0000218,10111,17752,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (Fisher) (fasted),In vivo,CHEMBL623039,1,BAO_0000218,10112,1446,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Bioavailability in monkey after po administration of 10 mg/kg dose,In vivo,CHEMBL623040,0,BAO_0000218,10113,2891,,9443.0,,,,Primates
A,1,,,U,Intermediate,,,,22224,Oral bioavailability in monkey (dose 10 mg/kg),In vivo,CHEMBL623041,0,BAO_0000218,10114,2891,,9443.0,,,,Primates
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL623741,1,BAO_0000218,10115,6672,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL623742,1,BAO_0000218,10116,6673,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL623743,1,BAO_0000218,10117,17655,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL623744,1,BAO_0000218,10118,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 2.0 mg/kg p.o.),In vivo,CHEMBL623745,1,BAO_0000218,10119,17853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),In vivo,CHEMBL623746,1,BAO_0000218,10120,4521,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 5 mg/kg p.o.),In vivo,CHEMBL623747,1,BAO_0000218,10121,4940,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,CHEMBL623748,0,BAO_0000218,10122,2891,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,CHEMBL623916,0,BAO_0000218,10123,2891,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,CHEMBL623917,1,BAO_0000218,10124,4521,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 2 mg/kg i.v.),In vivo,CHEMBL623918,1,BAO_0000218,10125,17686,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL874386,1,BAO_0000218,10126,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Bioavailability in rat; Only traces detected in rat plasma,In vivo,CHEMBL623919,1,BAO_0000218,10127,17796,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL623920,1,BAO_0000218,10128,5064,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability upon oral administration of compound,In vivo,CHEMBL623148,1,BAO_0000218,10129,5147,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),In vivo,CHEMBL623149,1,BAO_0000218,10130,1916,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL623150,1,BAO_0000218,10131,6049,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",In vivo,CHEMBL623151,1,BAO_0000218,10132,1445,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",In vivo,CHEMBL623152,1,BAO_0000218,10133,1445,,10116.0,,,,Rattus norvegicus
F,1,,,N,Expert,,,,50597,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,CHEMBL623153,1,BAO_0000218,10134,2862,,10116.0,,,,Rattus norvegicus
F,1,,,N,Expert,,,,50597,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,CHEMBL623154,1,BAO_0000218,10135,2862,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro and metabolic stability was determined,,CHEMBL623155,1,BAO_0000218,10136,4194,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro metabolic stability in rat hepatocytes,,CHEMBL623156,1,BAO_0000218,10137,4194,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,CHEMBL623157,1,BAO_0000218,10138,5486,,10116.0,,,,Rattus norvegicus
A,1,,401.0,N,Intermediate,Liver,Hepatocyte,,50597,Metabolic rate for compound was observed in rat hepatocytes,In vitro,CHEMBL623158,1,BAO_0000218,10139,17582,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,CHEMBL623159,1,BAO_0000218,10140,5600,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,CHEMBL874390,1,BAO_0000218,10141,14294,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,CHEMBL623160,1,BAO_0000218,10142,14294,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Metabolism of compound in rat S9 microsomes; Trace,,CHEMBL623161,1,BAO_0000218,10143,14294,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,CHEMBL623162,1,BAO_0000218,10144,17847,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,CHEMBL623163,1,BAO_0000218,10145,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,CHEMBL623164,1,BAO_0000218,10146,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,CHEMBL623165,1,BAO_0000218,10147,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,CHEMBL623166,1,BAO_0000218,10148,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,CHEMBL624983,1,BAO_0000218,10149,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,CHEMBL624984,1,BAO_0000218,10150,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,CHEMBL624985,1,BAO_0000218,10151,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,CHEMBL622970,1,BAO_0000218,10152,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,CHEMBL622971,1,BAO_0000218,10153,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,CHEMBL622972,1,BAO_0000218,10154,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,CHEMBL622973,1,BAO_0000218,10155,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,CHEMBL622974,1,BAO_0000218,10156,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,CHEMBL622975,1,BAO_0000218,10157,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,CHEMBL622976,1,BAO_0000218,10158,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,CHEMBL622977,1,BAO_0000218,10159,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,CHEMBL624351,1,BAO_0000218,10160,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,CHEMBL624352,1,BAO_0000218,10161,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,CHEMBL624353,1,BAO_0000218,10162,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,CHEMBL622397,1,BAO_0000218,10163,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,CHEMBL622398,1,BAO_0000218,10164,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,CHEMBL622399,1,BAO_0000218,10165,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,CHEMBL622400,1,BAO_0000218,10166,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,CHEMBL628428,1,BAO_0000218,10167,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,CHEMBL628590,1,BAO_0000218,10168,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,CHEMBL628591,1,BAO_0000218,10169,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,CHEMBL628592,1,BAO_0000218,10170,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,CHEMBL628593,1,BAO_0000218,10171,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,CHEMBL875333,1,BAO_0000218,10172,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,CHEMBL628594,1,BAO_0000218,10173,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,CHEMBL628595,1,BAO_0000218,10174,4969,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Stability in rat plasma was determined,,CHEMBL628596,1,BAO_0000218,10175,6737,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Stability in rat plasma was determined; ND= no data,,CHEMBL628597,1,BAO_0000218,10176,6737,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tested for plasma half life period in rat (0-8 hr),,CHEMBL628598,1,BAO_0000218,10177,5089,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tested for plasma half life period in rat (0-8 hr); Not determined,,CHEMBL628599,1,BAO_0000218,10178,5089,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,CHEMBL628600,1,BAO_0000218,10179,1466,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,CHEMBL628601,1,BAO_0000218,10180,1466,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for the half life in rat,,CHEMBL628602,1,BAO_0000218,10181,4950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,In vitro,CHEMBL628603,1,BAO_0000218,10182,2412,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,In vitro,CHEMBL628604,1,BAO_0000218,10183,2412,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,In vitro,CHEMBL628605,1,BAO_0000218,10184,2412,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,In vitro,CHEMBL628606,1,BAO_0000218,10185,2412,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,In vitro,CHEMBL628607,1,BAO_0000218,10186,2412,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The biological half life the compound was measured at the dose of 100 umol/kg,,CHEMBL628608,1,BAO_0000218,10187,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The biological half life the compound was measured at the dose of 30 umol/kg,,CHEMBL628609,1,BAO_0000218,10188,15022,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The compound was evaluated for plasma half life period in rat,,CHEMBL628610,1,BAO_0000218,10189,406,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,CHEMBL873819,1,BAO_0000218,10190,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,CHEMBL628611,1,BAO_0000218,10191,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The pharmacokinetic parameter half-life period in vivo in rats,In vivo,CHEMBL628612,1,BAO_0000218,10192,5247,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The pharmacokinetic property, Half-life was determined",In vivo,CHEMBL628613,1,BAO_0000218,10193,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The pharmacokinetic property, Half-life in rat in vivo",In vivo,CHEMBL628614,1,BAO_0000218,10194,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The pharmacokinetic property, Half-life was determined; ND denotes no data",In vivo,CHEMBL628615,1,BAO_0000218,10195,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",In vivo,CHEMBL628616,1,BAO_0000218,10196,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The plasma half life period in rats,,CHEMBL627924,1,BAO_0000218,10197,3918,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,CHEMBL627925,1,BAO_0000218,10198,2906,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,CHEMBL627926,1,BAO_0000218,10199,6467,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,t1/2 (apparent elimination)of the compound was determined,,CHEMBL627927,1,BAO_0000218,10200,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,t1/2 value in rat,,CHEMBL627928,1,BAO_0000218,10201,3788,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half life in rat,,CHEMBL627539,1,BAO_0000218,10202,17796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,CHEMBL876790,1,BAO_0000218,10203,12873,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,CHEMBL858186,1,BAO_0000218,10204,5983,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Half-life period in fasted rats,,CHEMBL627540,1,BAO_0000218,10205,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,CHEMBL627541,1,BAO_0000218,10206,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,CHEMBL627715,1,BAO_0000218,10207,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,CHEMBL627716,1,BAO_0000218,10208,429,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum time required to achieve Cmax was determined in rat,,CHEMBL627717,1,BAO_0000218,10209,17655,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,CHEMBL627718,1,BAO_0000218,10210,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,CHEMBL627719,1,BAO_0000218,10211,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,In vivo,CHEMBL627720,1,BAO_0000218,10212,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,In vivo,CHEMBL627721,1,BAO_0000218,10213,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,In vivo,CHEMBL627722,1,BAO_0000218,10214,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL627723,1,BAO_0000218,10215,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL626058,1,BAO_0000218,10216,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL626059,1,BAO_0000218,10217,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL626060,1,BAO_0000218,10218,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL626061,1,BAO_0000218,10219,17720,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,CHEMBL876791,1,BAO_0000218,10220,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,CHEMBL626062,1,BAO_0000218,10221,4723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,CHEMBL626063,1,BAO_0000218,10222,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,CHEMBL626064,1,BAO_0000218,10223,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL626065,1,BAO_0000218,10224,17720,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,CHEMBL626066,1,BAO_0000218,10225,17720,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,tmax upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,CHEMBL626067,1,BAO_0000218,10226,1466,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,CHEMBL626068,1,BAO_0000218,10227,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,CHEMBL626069,1,BAO_0000218,10228,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of 3-methoxyacetaminophen glucuronide,,CHEMBL626070,1,BAO_0000218,10229,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of N-methoxyacetaminophen glucuronide,,CHEMBL626071,1,BAO_0000218,10230,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of N-methoxyacetaminophen sulfate,,CHEMBL626072,1,BAO_0000218,10231,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of acetaminophen,,CHEMBL626073,1,BAO_0000218,10232,7449,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,CHEMBL626741,1,BAO_0000218,10233,7768,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,CHEMBL626742,1,BAO_0000218,10234,17655,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,CHEMBL626743,1,BAO_0000218,10235,17735,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,CHEMBL876792,1,BAO_0000218,10236,5960,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,CHEMBL626744,1,BAO_0000218,10237,17735,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for antidiuretic activity in rats,,CHEMBL626745,1,BAO_0000218,10238,7116,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rat after 3mg/kg oral dose,In vivo,CHEMBL626746,1,BAO_0000218,10239,4878,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,CHEMBL626747,1,BAO_0000218,10240,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,CHEMBL626748,1,BAO_0000218,10241,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability administered orally at a dose of 10 mg/kg to rats,,CHEMBL626749,1,BAO_0000218,10242,16367,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral Bioavailability was determined,,CHEMBL626750,1,BAO_0000218,10243,16366,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,,CHEMBL626751,1,BAO_0000218,10244,4426,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat; Not performed.,,CHEMBL626913,1,BAO_0000218,10245,4426,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability,,CHEMBL626914,1,BAO_0000218,10246,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was determined; ND denotes no data,,CHEMBL626915,1,BAO_0000218,10247,5041,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,CHEMBL626916,1,BAO_0000218,10248,1500,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,CHEMBL626917,1,BAO_0000218,10249,1500,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Binding towards rat plasma protein at 10 uM,,CHEMBL626918,1,BAO_0000218,10250,17409,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Binding towards rat plasma protein at 100 uM,,CHEMBL626919,1,BAO_0000218,10251,17409,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,CHEMBL626920,1,BAO_0000218,10252,2959,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,CHEMBL621976,1,BAO_0000218,10253,13501,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat after 5 mg/kg oral gavage,In vivo,CHEMBL877599,1,BAO_0000218,10254,6567,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL621977,1,BAO_0000218,10255,6571,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 1 mg/kg i.v.),In vivo,CHEMBL621978,1,BAO_0000218,10256,6715,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 3 mg/kg p.o.),In vivo,CHEMBL621979,1,BAO_0000218,10257,6715,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL621980,1,BAO_0000218,10258,2932,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability of the compound in rats after administration of 30 mg/kg,In vivo,CHEMBL621981,1,BAO_0000218,10259,4171,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after administration of 10 mg/kg in rats,In vivo,CHEMBL621982,1,BAO_0000218,10260,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability after administration of 2 mg/kg in rats,In vivo,CHEMBL882953,1,BAO_0000218,10261,17509,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,CHEMBL621983,1,BAO_0000218,10262,4527,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in dogs was determined; high,In vivo,CHEMBL621984,1,BAO_0000218,10263,4026,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in monkey after intravenous administration at 1 mpk,In vivo,CHEMBL621985,1,BAO_0000218,10264,6659,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in monkey after peroral administration at 10 mpk,In vivo,CHEMBL621986,1,BAO_0000218,10265,6659,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat after intravenous administration at 1 mpk,In vivo,CHEMBL621987,1,BAO_0000218,10266,6659,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Bioavailability in rat after intravenous administration at 2 mpk,In vivo,CHEMBL877600,1,BAO_0000218,10267,6659,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat after peroral administration at 30 mpk,In vivo,CHEMBL621988,1,BAO_0000218,10268,6659,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Bioavailability in rat after peroral administration at at 100 mpk,In vivo,CHEMBL621989,1,BAO_0000218,10269,6659,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rats was evaluated,In vivo,CHEMBL621990,1,BAO_0000218,10270,6597,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,In vivo,CHEMBL621991,1,BAO_0000218,10271,1202,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,In vivo,CHEMBL621992,1,BAO_0000218,10272,1202,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,In vivo,CHEMBL621993,1,BAO_0000218,10273,1202,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,In vivo,CHEMBL621994,1,BAO_0000218,10274,1202,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL621995,1,BAO_0000218,10275,5207,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL621996,1,BAO_0000218,10276,5970,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 10 mg/kg),In vivo,CHEMBL621997,1,BAO_0000218,10277,17538,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,CHEMBL621998,1,BAO_0000218,10278,17538,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,CHEMBL621999,1,BAO_0000218,10279,1466,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622000,1,BAO_0000218,10280,2879,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was measured in rat after oral administration; 2-4,In vivo,CHEMBL622001,1,BAO_0000218,10281,2879,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was measured in rat after oral administration; 3-7,In vivo,CHEMBL622002,1,BAO_0000218,10282,2879,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (intraduodenal administration),In vivo,CHEMBL622003,1,BAO_0000218,10283,3777,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (intraduodenal administration),In vivo,CHEMBL877601,1,BAO_0000218,10284,3777,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL624871,1,BAO_0000218,10285,3777,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622004,1,BAO_0000218,10286,3777,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),In vivo,CHEMBL882954,1,BAO_0000218,10287,5423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,In vivo,CHEMBL622005,1,BAO_0000218,10288,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,In vivo,CHEMBL622006,1,BAO_0000218,10289,16365,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was measured in rat,In vivo,CHEMBL622007,1,BAO_0000218,10290,4239,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was reported,In vivo,CHEMBL622008,1,BAO_0000218,10291,5438,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,CHEMBL622009,1,BAO_0000218,10292,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,CHEMBL622010,1,BAO_0000218,10293,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,In vivo,CHEMBL622011,1,BAO_0000218,10294,4199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),In vivo,CHEMBL622012,1,BAO_0000218,10295,4199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),In vivo,CHEMBL622013,1,BAO_0000218,10296,4199,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,CHEMBL622014,1,BAO_0000218,10297,4890,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was determined at 3 mg/kg po dose in rats,In vivo,CHEMBL624749,1,BAO_0000218,10298,2792,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 2 mg/kg),In vivo,CHEMBL624750,1,BAO_0000218,10299,5529,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",In vivo,CHEMBL624751,1,BAO_0000218,10300,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,CHEMBL624752,1,BAO_0000218,10301,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,CHEMBL624753,1,BAO_0000218,10302,6685,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,In vivo,CHEMBL624754,1,BAO_0000218,10303,6005,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,CHEMBL624755,1,BAO_0000218,10304,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,CHEMBL624756,1,BAO_0000218,10305,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL624757,1,BAO_0000218,10306,6103,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,CHEMBL624758,1,BAO_0000218,10307,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,CHEMBL622270,1,BAO_0000218,10308,6410,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (Sprague-Dawley),In vivo,CHEMBL622271,1,BAO_0000218,10309,5353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat at the dose of 2 mg/kg,In vivo,CHEMBL622272,1,BAO_0000218,10310,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622273,1,BAO_0000218,10311,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (cannulated) (dose 2 mg/kg),In vivo,CHEMBL622274,1,BAO_0000218,10312,5809,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability value of compound in rats was determined after peroral administration,In vivo,CHEMBL622275,1,BAO_0000218,10313,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 20 mg/kg),In vivo,CHEMBL622276,1,BAO_0000218,10314,3634,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622277,1,BAO_0000218,10315,3341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 5 mg/kg),In vivo,CHEMBL622278,1,BAO_0000218,10316,2690,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622279,1,BAO_0000218,10317,3184,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622280,1,BAO_0000218,10318,740,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for oral bioavailability in rats; 15-27 %,In vivo,CHEMBL624083,1,BAO_0000218,10319,1806,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,In vivo,CHEMBL624084,1,BAO_0000218,10320,4891,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),In vivo,CHEMBL624085,1,BAO_0000218,10321,3634,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for bioavailability in rats,In vivo,CHEMBL624086,1,BAO_0000218,10322,64,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL624087,1,BAO_0000218,10323,4839,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL624088,1,BAO_0000218,10324,1094,,10116.0,,,,Rattus norvegicus
A,1,,,U,Intermediate,,,,22224,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,In vivo,CHEMBL624089,0,BAO_0000218,10325,5005,,9544.0,,,,Macaca mulatta
A,1,,,U,Intermediate,,,,22224,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,CHEMBL624090,0,BAO_0000218,10326,5005,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Evaluated for the bioavailability in rat (in vivo),In vivo,CHEMBL624091,1,BAO_0000218,10327,4687,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,F value of compound in rats was determined after peroral administration,In vivo,CHEMBL624092,1,BAO_0000218,10328,17804,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL624093,1,BAO_0000218,10329,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL624094,1,BAO_0000218,10330,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL624095,1,BAO_0000218,10331,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,CHEMBL624096,1,BAO_0000218,10332,5974,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",In vivo,CHEMBL624097,1,BAO_0000218,10333,1088,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum fall in carotid flow in rat,In vivo,CHEMBL624098,1,BAO_0000218,10334,1742,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,In vivo,CHEMBL874392,1,BAO_0000218,10335,4689,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 5 mg/kg),In vivo,CHEMBL624099,1,BAO_0000218,10336,2463,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,CHEMBL624100,1,BAO_0000218,10337,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,CHEMBL624101,1,BAO_0000218,10338,5654,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (male Wistar),In vivo,CHEMBL624102,1,BAO_0000218,10339,6874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability after administration (30 mg/kg) in rat; good,In vivo,CHEMBL624103,1,BAO_0000218,10340,5633,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability at the dose of 2 mg/kg in rat,In vivo,CHEMBL624104,1,BAO_0000218,10341,5496,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability determined in rats,In vivo,CHEMBL624105,1,BAO_0000218,10342,2358,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),In vivo,CHEMBL624106,1,BAO_0000218,10343,16456,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,CHEMBL624107,1,BAO_0000218,10344,5302,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,CHEMBL623943,1,BAO_0000218,10345,5302,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 5 mg/kg,In vivo,CHEMBL623944,1,BAO_0000218,10346,5302,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,CHEMBL623945,1,BAO_0000218,10347,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,CHEMBL623946,1,BAO_0000218,10348,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,CHEMBL623947,1,BAO_0000218,10349,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,CHEMBL623948,1,BAO_0000218,10350,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,CHEMBL623949,1,BAO_0000218,10351,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,CHEMBL623950,1,BAO_0000218,10352,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,CHEMBL874398,1,BAO_0000218,10353,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,CHEMBL623951,1,BAO_0000218,10354,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,CHEMBL623952,1,BAO_0000218,10355,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,CHEMBL623953,1,BAO_0000218,10356,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,CHEMBL623954,1,BAO_0000218,10357,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,CHEMBL623955,1,BAO_0000218,10358,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,CHEMBL623956,1,BAO_0000218,10359,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,CHEMBL627807,1,BAO_0000218,10360,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,CHEMBL627808,1,BAO_0000218,10361,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,CHEMBL627809,1,BAO_0000218,10362,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,CHEMBL627810,1,BAO_0000218,10363,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,CHEMBL627811,1,BAO_0000218,10364,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,CHEMBL627812,1,BAO_0000218,10365,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,CHEMBL627813,1,BAO_0000218,10366,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,CHEMBL627814,1,BAO_0000218,10367,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,CHEMBL875336,1,BAO_0000218,10368,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,CHEMBL627815,1,BAO_0000218,10369,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,CHEMBL627816,1,BAO_0000218,10370,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,CHEMBL627817,1,BAO_0000218,10371,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,CHEMBL627818,1,BAO_0000218,10372,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,CHEMBL627819,1,BAO_0000218,10373,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,CHEMBL627820,1,BAO_0000218,10374,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,CHEMBL627821,1,BAO_0000218,10375,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,CHEMBL628464,1,BAO_0000218,10376,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,CHEMBL626239,1,BAO_0000218,10377,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,CHEMBL626240,1,BAO_0000218,10378,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,CHEMBL626241,1,BAO_0000218,10379,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,CHEMBL626242,1,BAO_0000218,10380,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,CHEMBL626243,1,BAO_0000218,10381,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,CHEMBL626244,1,BAO_0000218,10382,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,CHEMBL626907,1,BAO_0000218,10383,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,CHEMBL626908,1,BAO_0000218,10384,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,CHEMBL626909,1,BAO_0000218,10385,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,CHEMBL626910,1,BAO_0000218,10386,11020,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of acetaminophen cysteine conjugate,,CHEMBL875342,1,BAO_0000218,10387,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of acetaminophen glucuronide,,CHEMBL626911,1,BAO_0000218,10388,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of acetaminophen sulfate,,CHEMBL626912,1,BAO_0000218,10389,7449,,10116.0,,,,Rattus norvegicus
F,1,,,N,Intermediate,,,,50597,Percent total excretion of acetaminophen-mercapturic acid,,CHEMBL627065,1,BAO_0000218,10390,7449,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,CHEMBL627066,1,BAO_0000218,10391,3172,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,CHEMBL627067,1,BAO_0000218,10392,16456,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Muscle tissue,,,22224,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,CHEMBL627068,0,BAO_0000218,10393,10839,,8656.0,2385.0,,,ratrat
A,1,,,U,Autocuration,Muscle tissue,,,22224,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,CHEMBL627069,0,BAO_0000218,10394,10839,,8656.0,2385.0,,,ratrat
A,1,,,U,Autocuration,,,,22224,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,CHEMBL627070,0,BAO_0000218,10395,5334,,9940.0,,,,Ovis aries
A,1,,,U,Autocuration,,,,22224,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,CHEMBL627071,0,BAO_0000218,10396,5334,,9940.0,,,,Ovis aries
A,1,,,U,Autocuration,,,,22224,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,CHEMBL627072,0,BAO_0000218,10397,5334,,9940.0,,,,Ovis aries
A,1,,,U,Autocuration,,,,22224,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,CHEMBL627073,0,BAO_0000218,10398,5334,,9940.0,,,,Ovis aries
A,1,,,U,Autocuration,,,,22224,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,CHEMBL625387,0,BAO_0000218,10399,5334,,9940.0,,,,Ovis aries
A,1,,,U,Autocuration,,,,22224,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,CHEMBL625388,0,BAO_0000218,10400,5334,,9940.0,,,,Ovis aries
A,1,,,U,Autocuration,Plasma,,,22224,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,CHEMBL625389,0,BAO_0000218,10401,5334,,9940.0,1969.0,,,Ovis aries
A,1,,,U,Autocuration,Plasma,,,22224,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,CHEMBL875343,0,BAO_0000218,10402,5334,,9940.0,1969.0,,,Ovis aries
A,1,,,N,Intermediate,,,,50497,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,CHEMBL876795,1,BAO_0000218,10403,1735,,8570.0,,,,Serpentes
A,1,,,N,Intermediate,,,,50497,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,CHEMBL626552,1,BAO_0000218,10404,1469,,8570.0,,,,Serpentes
A,1,,,N,Intermediate,,,,50497,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,CHEMBL626553,1,BAO_0000218,10405,1336,,8570.0,,,,Serpentes
A,1,,,U,Autocuration,Plasma,,,22224,The human biological plasma half life of the compound,,CHEMBL626554,0,BAO_0000366,10406,12403,,9606.0,1969.0,,,Homo sapiens
A,1,,,N,Intermediate,Urine,,,50597,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,CHEMBL626555,1,BAO_0000218,10407,8151,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,CHEMBL626556,1,BAO_0000218,10408,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,CHEMBL626557,1,BAO_0000218,10409,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,CHEMBL626558,1,BAO_0000218,10410,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,CHEMBL626559,1,BAO_0000218,10411,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,CHEMBL626560,1,BAO_0000218,10412,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,CHEMBL876803,1,BAO_0000218,10413,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,CHEMBL627964,1,BAO_0000218,10414,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,CHEMBL627965,1,BAO_0000218,10415,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,CHEMBL627966,1,BAO_0000218,10416,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,CHEMBL627967,1,BAO_0000218,10417,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,CHEMBL627968,1,BAO_0000218,10418,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,CHEMBL627969,1,BAO_0000218,10419,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,CHEMBL627970,1,BAO_0000218,10420,8004,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,CHEMBL627971,1,BAO_0000218,10421,8004,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,CHEMBL627972,1,BAO_0000218,10422,8004,,10116.0,178.0,,,Rattus norvegicus
B,1,,,D,Expert,,,,180,Dissociation constant against binding to human cyclophilin A,,CHEMBL856029,9,BAO_0000357,10423,15917,,9606.0,,,,Homo sapiens
B,1,,,H,Expert,,,,11591,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,CHEMBL627973,8,BAO_0000019,10424,12396,,9913.0,,,,Bos taurus
A,1,,,U,Autocuration,,,,22224,-Log C was determined by performing the electroshock minimum test,,CHEMBL627974,0,BAO_0000019,10425,7065,,,,,,
A,1,,,U,Autocuration,,,,22224,-Log C was determined by performing the foot shock test,,CHEMBL627975,0,BAO_0000019,10426,7065,,,,,,
A,1,,,U,Autocuration,,,,22224,-Log C was determined by performing the incl screen test,,CHEMBL627976,0,BAO_0000019,10427,7065,,,,,,
A,1,,,U,Autocuration,,,,22224,-Log C was determined by performing the maximum electroshock test,,CHEMBL627977,0,BAO_0000019,10428,7065,,,,,,
A,1,,,U,Autocuration,,,,22224,-Log C was determined by performing the pentylenetetrazole test,,CHEMBL627978,0,BAO_0000019,10429,7065,,,,,,
A,1,,,U,Autocuration,,,,22224,Tested for experimental arotinoid inhibitory dose,,CHEMBL627979,0,BAO_0000019,10430,12415,,,,,,
A,1,,,U,Autocuration,,,,22224,Negative log transformed activity,,CHEMBL876804,0,BAO_0000019,10431,10256,,,,,,
A,1,,,U,Autocuration,,,,22224,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,CHEMBL627980,0,BAO_0000019,10432,7991,,,,,,
A,1,,,N,Intermediate,,,,50512,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,CHEMBL627981,1,BAO_0000218,10433,14342,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50512,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,CHEMBL627982,1,BAO_0000218,10434,14342,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50512,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,CHEMBL627983,1,BAO_0000218,10435,14342,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,Ileum,,,50512,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,CHEMBL627984,1,BAO_0000218,10436,14342,,10141.0,2116.0,,,Cavia porcellus
P,1,,,U,Autocuration,,,,22229,Solubility in water was determined; values expressed as -log,,CHEMBL627985,0,BAO_0000100,10437,6047,,,,,,
A,1,,,U,Autocuration,,,,22224,Ratio of Kcat to that of Km was determined,,CHEMBL627986,0,BAO_0000019,10438,17269,,,,,,
A,1,,,U,Autocuration,,,,22224,Observed first order rate constant,,CHEMBL627987,0,BAO_0000019,10439,10026,,,,,,
A,1,,,U,Autocuration,,,,22224,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,CHEMBL627988,0,BAO_0000019,10440,14583,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,CHEMBL627989,1,BAO_0000218,10441,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,CHEMBL627990,1,BAO_0000218,10442,2661,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral Bioavailability after administration of 10 mg/kg in male rat,In vivo,CHEMBL876805,1,BAO_0000218,10443,4029,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),In vivo,CHEMBL627991,1,BAO_0000218,10444,17735,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL627992,1,BAO_0000218,10445,4576,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,CHEMBL627993,1,BAO_0000218,10446,17582,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability at 1 mg/kg was determined in rat,In vivo,CHEMBL622817,1,BAO_0000218,10447,17651,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability at 10 mg/kg was determined in rat,In vivo,CHEMBL622818,1,BAO_0000218,10448,17651,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",In vivo,CHEMBL622819,1,BAO_0000218,10449,17670,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL872267,1,BAO_0000218,10450,5045,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622820,1,BAO_0000218,10451,1696,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability after intravenous administration in rats at 24 uM/kg,In vivo,CHEMBL622821,1,BAO_0000218,10452,17764,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622822,1,BAO_0000218,10453,6448,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622823,1,BAO_0000218,10454,6596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622824,1,BAO_0000218,10455,17547,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat at a dose of 3 mg/kg,In vivo,CHEMBL622825,1,BAO_0000218,10456,17771,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after oral administration at 10 mg/kg,In vivo,CHEMBL622901,1,BAO_0000218,10457,6495,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622902,1,BAO_0000218,10458,4558,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL621844,1,BAO_0000218,10459,17596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in Dawley rats,In vivo,CHEMBL621845,1,BAO_0000218,10460,6827,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL621846,1,BAO_0000218,10461,4026,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 30 mg/kg),In vivo,CHEMBL621847,1,BAO_0000218,10462,10,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,CHEMBL877609,1,BAO_0000218,10463,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,CHEMBL621848,1,BAO_0000218,10464,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,CHEMBL621849,1,BAO_0000218,10465,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,CHEMBL622030,1,BAO_0000218,10466,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percent oral bioavailability determined in rats,In vivo,CHEMBL622031,1,BAO_0000218,10467,4796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,CHEMBL622032,1,BAO_0000218,10468,4883,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was evaluated for bioavailability in rats; 32-51,In vivo,CHEMBL622033,1,BAO_0000218,10469,2137,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,CHEMBL622034,1,BAO_0000218,10470,2959,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622035,1,BAO_0000218,10471,1361,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability percent in rat at the dose of 2 mg/kg,In vivo,CHEMBL882966,1,BAO_0000218,10472,4727,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated after 20 uM/kg of peroral administration,In vivo,CHEMBL622036,1,BAO_0000218,10473,16423,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622037,1,BAO_0000218,10474,5206,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622038,1,BAO_0000218,10475,6448,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rats,In vivo,CHEMBL622039,1,BAO_0000218,10476,17723,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,In vivo,CHEMBL622040,1,BAO_0000218,10477,17738,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL622041,1,BAO_0000218,10478,17738,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL622042,1,BAO_0000218,10479,17738,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL622043,1,BAO_0000218,10480,17738,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL622044,1,BAO_0000218,10481,17738,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL622045,1,BAO_0000218,10482,17738,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL622046,1,BAO_0000218,10483,17738,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL622047,1,BAO_0000218,10484,17738,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL877610,1,BAO_0000218,10485,17738,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL622048,1,BAO_0000218,10486,17738,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL622049,1,BAO_0000218,10487,17738,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL622050,1,BAO_0000218,10488,17738,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL622051,1,BAO_0000218,10489,17738,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL622052,1,BAO_0000218,10490,17738,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL622053,1,BAO_0000218,10491,17738,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL622054,1,BAO_0000218,10492,17738,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL622055,1,BAO_0000218,10493,17738,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rats was determined; High,In vivo,CHEMBL622056,1,BAO_0000218,10494,5237,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in the rat was determined,In vivo,CHEMBL622057,1,BAO_0000218,10495,5503,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,In vivo,CHEMBL628008,1,BAO_0000218,10496,15765,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),In vivo,CHEMBL622058,1,BAO_0000218,10497,15660,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL622059,1,BAO_0000218,10498,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL622060,1,BAO_0000218,10499,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL622061,1,BAO_0000218,10500,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,CHEMBL622062,1,BAO_0000218,10501,5978,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,In vivo,CHEMBL622063,1,BAO_0000218,10502,5656,,10116.0,,,,Rattus norvegicus
A,1,,,N,Expert,,,,50597,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,CHEMBL877611,1,BAO_0000218,10503,3598,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound in Sprague Dawley rats,In vivo,CHEMBL622064,1,BAO_0000218,10504,4216,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound in rat,In vivo,CHEMBL622065,1,BAO_0000218,10505,17839,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 2 mg/kg),In vivo,CHEMBL622066,1,BAO_0000218,10506,6570,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound in rat was determined,In vivo,CHEMBL622067,1,BAO_0000218,10507,5334,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound in rats,In vivo,CHEMBL622068,1,BAO_0000218,10508,6886,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound was determined in rats,In vivo,CHEMBL622069,1,BAO_0000218,10509,5210,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability at a dose of 30 mg/kg in rats,In vivo,CHEMBL624796,1,BAO_0000218,10510,4170,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 10 mg/kg),In vivo,CHEMBL624797,1,BAO_0000218,10511,6028,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 10 mg/kg),In vivo,CHEMBL623053,1,BAO_0000218,10512,6028,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability evaluated in rat,In vivo,CHEMBL623054,1,BAO_0000218,10513,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in fasted rat,In vivo,CHEMBL623055,1,BAO_0000218,10514,6168,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in fed rat,In vivo,CHEMBL623056,1,BAO_0000218,10515,6168,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (mature male) (dose 30 mg/kg),In vivo,CHEMBL623057,1,BAO_0000218,10516,5160,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623058,1,BAO_0000218,10517,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,CHEMBL623059,1,BAO_0000218,10518,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after administration of 10 mg/kg po,In vivo,CHEMBL623060,1,BAO_0000218,10519,6535,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623061,1,BAO_0000218,10520,4194,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623062,1,BAO_0000218,10521,6230,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623063,1,BAO_0000218,10522,6619,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623064,1,BAO_0000218,10523,17607,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in ratrs,In vivo,CHEMBL623065,1,BAO_0000218,10524,4942,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623066,1,BAO_0000218,10525,4942,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623067,1,BAO_0000218,10526,6646,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rats was determined; High,In vivo,CHEMBL623068,1,BAO_0000218,10527,5237,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623069,1,BAO_0000218,10528,6646,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623070,1,BAO_0000218,10529,4449,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was calculated in rat,In vivo,CHEMBL623071,1,BAO_0000218,10530,6057,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL623072,1,BAO_0000218,10531,2552,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL623073,1,BAO_0000218,10532,5496,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL623074,1,BAO_0000218,10533,6484,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL623075,1,BAO_0000218,10534,6485,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability after i.v. administration,In vivo,CHEMBL623076,1,BAO_0000218,10535,6616,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,CHEMBL623077,1,BAO_0000218,10536,4969,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley),In vivo,CHEMBL623078,1,BAO_0000218,10537,5862,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in Sprague-Dawley rats,In vivo,CHEMBL623079,1,BAO_0000218,10538,4514,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,CHEMBL623080,1,BAO_0000218,10539,4514,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,CHEMBL623081,1,BAO_0000218,10540,4514,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,In vivo,CHEMBL623082,1,BAO_0000218,10541,5546,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in fasted rat,In vivo,CHEMBL874400,1,BAO_0000218,10542,6168,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in fed rat,In vivo,CHEMBL623083,1,BAO_0000218,10543,6168,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623084,1,BAO_0000218,10544,3624,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623085,1,BAO_0000218,10545,5213,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623086,1,BAO_0000218,10546,5496,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623087,1,BAO_0000218,10547,5553,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623088,1,BAO_0000218,10548,5833,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623089,1,BAO_0000218,10549,5836,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623090,1,BAO_0000218,10550,5865,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623091,1,BAO_0000218,10551,5960,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623092,1,BAO_0000218,10552,6249,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623093,1,BAO_0000218,10553,6448,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL874401,1,BAO_0000218,10554,6453,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623094,1,BAO_0000218,10555,6640,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL623095,1,BAO_0000218,10556,17607,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after peroral administration at 10 mg/kg,In vivo,CHEMBL623096,1,BAO_0000218,10557,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after peroral administration at 5 mg/kg,In vivo,CHEMBL624913,1,BAO_0000218,10558,5939,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),In vivo,CHEMBL624914,1,BAO_0000218,10559,6281,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,In vivo,CHEMBL624915,1,BAO_0000218,10560,5874,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat; Not measured,In vivo,CHEMBL624916,1,BAO_0000218,10561,5213,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL624917,1,BAO_0000218,10562,4964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,CHEMBL625157,1,BAO_0000218,10563,11020,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vitro metabolic potential in rat liver microsomes,,CHEMBL625158,1,BAO_0000218,10564,6251,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",In vivo,CHEMBL625159,1,BAO_0000218,10565,1568,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",In vivo,CHEMBL625160,1,BAO_0000218,10566,3032,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,In vivo,CHEMBL625161,1,BAO_0000218,10567,3748,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL625162,1,BAO_0000218,10568,401,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL625163,1,BAO_0000218,10569,6512,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rats at 10 mg/kg,In vivo,CHEMBL625164,1,BAO_0000218,10570,17617,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,CHEMBL625165,1,BAO_0000218,10571,6679,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL625166,1,BAO_0000218,10572,6742,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,CHEMBL625167,1,BAO_0000218,10573,589,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,CHEMBL625168,1,BAO_0000218,10574,589,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance of the compound,In vivo,CHEMBL625169,1,BAO_0000218,10575,3185,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance at 10 mg/kg in rat upon intravenous administration,In vivo,CHEMBL626264,1,BAO_0000218,10576,17596,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,In vivo,CHEMBL626265,1,BAO_0000218,10577,2713,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The compound was tested for plasma clearance in rat,In vivo,CHEMBL626266,1,BAO_0000218,10578,12500,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,In vivo,CHEMBL626267,1,BAO_0000218,10579,12500,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration upon oral administration of 1 mg/Kg in rats,,CHEMBL626268,1,BAO_0000218,10580,2713,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,CHEMBL626269,1,BAO_0000218,10581,1446,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,CHEMBL626270,1,BAO_0000218,10582,6227,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,CHEMBL626271,1,BAO_0000218,10583,4709,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,CHEMBL626272,1,BAO_0000218,10584,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,CHEMBL626273,1,BAO_0000218,10585,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,CHEMBL875346,1,BAO_0000218,10586,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,CHEMBL626274,1,BAO_0000218,10587,5510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for protein binding in rat plasma,,CHEMBL626275,1,BAO_0000218,10588,4514,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,CHEMBL624646,1,BAO_0000218,10589,2713,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,CHEMBL624647,1,BAO_0000218,10590,2713,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,CHEMBL624648,1,BAO_0000218,10591,5340,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve ratio was determined (po/iv) in rat,,CHEMBL624649,1,BAO_0000218,10592,12058,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,CHEMBL624650,1,BAO_0000218,10593,11195,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,CHEMBL624651,1,BAO_0000218,10594,11195,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,CHEMBL624652,1,BAO_0000218,10595,11195,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,CHEMBL624653,1,BAO_0000218,10596,6495,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Ratio of AUCbrain to AUCplasma,,CHEMBL624654,1,BAO_0000218,10597,6078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Ratio of brain to plasma,,CHEMBL624655,1,BAO_0000218,10598,5656,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,CHEMBL624656,1,BAO_0000218,10599,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,CHEMBL624657,1,BAO_0000218,10600,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,CHEMBL624658,1,BAO_0000218,10601,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,CHEMBL624659,1,BAO_0000218,10602,10130,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,CHEMBL624660,1,BAO_0000218,10603,10130,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,CHEMBL624661,1,BAO_0000218,10604,10130,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Steady state brain :blood ratio was determined,,CHEMBL624662,1,BAO_0000218,10605,5213,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL625199,1,BAO_0000218,10606,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,CHEMBL625200,1,BAO_0000218,10607,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,CHEMBL625201,1,BAO_0000218,10608,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,CHEMBL625202,1,BAO_0000218,10609,4910,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percentage recovery after 3h incubation with rat hapatocytes was determined,,CHEMBL625203,1,BAO_0000218,10610,2083,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,CHEMBL625204,1,BAO_0000218,10611,2082,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,CHEMBL625205,1,BAO_0000218,10612,2082,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,CHEMBL625206,1,BAO_0000218,10613,6351,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,CHEMBL625207,0,BAO_0000019,10614,14583,,,,,,
A,1,,,U,Autocuration,,,,22224,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,CHEMBL625208,0,BAO_0000019,10615,14583,,,,,,
A,1,,495.0,N,Intermediate,,Caco-2,,50587,In vivo absorption in Caco-2 cell line monolayers was determined,,CHEMBL625209,1,BAO_0000218,10616,4608,,9606.0,,,,Homo sapiens
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625210,0,BAO_0000100,10617,13668,,,,,,
A,1,,,N,Intermediate,,,,50597,Area under curve was determine after peroral administration at 10 mpk in Rat,,CHEMBL625211,1,BAO_0000218,10618,5669,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50797,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,CHEMBL625212,1,BAO_0000218,10619,5669,,9544.0,,,,Macaca mulatta
A,1,,,N,Intermediate,,,,50597,Area under curve was determine after peroral administration at 160 mpk in Rat,,CHEMBL625213,1,BAO_0000218,10620,5669,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determine after peroral administration at 20 mpk in Rat,,CHEMBL625214,1,BAO_0000218,10621,5669,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Area under curve was determine after peroral administration at 50 mpk in Rat,,CHEMBL874542,1,BAO_0000218,10622,5669,,10116.0,,,,Rattus norvegicus
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (AlogP),,CHEMBL625215,0,BAO_0000100,10623,6472,,,,,,
A,1,,,U,Autocuration,,,,22224,Activated partial thromboplastin time measured,,CHEMBL625216,0,BAO_0000019,10624,15106,,,,,,
P,1,,,U,Autocuration,,,,22224,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,CHEMBL625217,0,BAO_0000100,10625,15207,,,,,,
P,1,,,U,Autocuration,,,,22224,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,CHEMBL625218,0,BAO_0000100,10626,15207,,,,,,
A,1,,,N,Intermediate,Plasma,,,50588,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,CHEMBL622864,1,BAO_0000218,10627,13941,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,CHEMBL622865,1,BAO_0000218,10628,13941,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,CHEMBL622866,1,BAO_0000218,10629,13941,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,CHEMBL622867,1,BAO_0000218,10630,13941,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50512,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,CHEMBL876808,1,BAO_0000218,10631,15240,,10141.0,1969.0,,,Cavia porcellus
A,1,,,U,Autocuration,Brain,,,22224,AUC in brain,,CHEMBL627725,0,BAO_0000019,10632,10655,,,955.0,,,
A,1,,,U,Autocuration,Serum,,,22224,AUC in serum,,CHEMBL627726,0,BAO_0000019,10633,10655,,,1977.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,AUC was determined,,CHEMBL627727,0,BAO_0000019,10634,6504,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,AUC of the compound.,,CHEMBL627728,0,BAO_0000019,10635,10615,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,AUC value (0-4 hr),,CHEMBL627729,0,BAO_0000019,10636,10353,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,CHEMBL627730,0,BAO_0000019,10637,14907,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,CHEMBL627731,0,BAO_0000019,10638,14907,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,CHEMBL627732,0,BAO_0000019,10639,14907,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,CHEMBL627733,0,BAO_0000019,10640,14907,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,AUC(area under curve) was determined after intravenous administration in rats,,CHEMBL627734,1,BAO_0000218,10641,16359,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,AUC(area under curve) was determined after oral administration in rats,,CHEMBL627735,1,BAO_0000218,10642,16359,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50512,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,CHEMBL627736,1,BAO_0000218,10643,15240,,10141.0,1969.0,,,Cavia porcellus
A,1,,,N,Intermediate,Plasma,,,50597,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,CHEMBL876809,1,BAO_0000218,10644,15240,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area Under Curve after oral dosing of 100 uM/Kg,,CHEMBL627737,0,BAO_0000019,10645,15469,,,,,,
A,1,,,U,Autocuration,,,,22224,Area Under Curve after oral dosing of 30 uM/Kg,,CHEMBL627738,0,BAO_0000019,10646,15469,,,,,,
A,1,,,U,Autocuration,,,,22224,Area Under Curve was measured by ploting the graph between concentration verses time,,CHEMBL627739,0,BAO_0000019,10647,13520,,,,,,
A,1,,,N,Intermediate,,,,50588,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,CHEMBL626143,1,BAO_0000218,10648,17025,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,CHEMBL626144,0,BAO_0000218,10649,17025,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50592,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,CHEMBL626145,1,BAO_0000218,10650,17025,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50597,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,CHEMBL626146,1,BAO_0000218,10651,17025,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,CHEMBL626147,1,BAO_0000218,10652,12032,,10116.0,178.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under curve (AUC) was determined,,CHEMBL626148,0,BAO_0000019,10653,10291,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve (AUC) following ip administration at 1 mg/kg,,CHEMBL626149,0,BAO_0000218,10654,5767,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve (AUC) was determined; ND is Not determined,,CHEMBL626150,0,BAO_0000019,10655,1434,,,,,,
A,1,,,N,Intermediate,,,,50588,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,CHEMBL626151,1,BAO_0000218,10656,14925,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,CHEMBL626152,1,BAO_0000218,10657,14925,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,CHEMBL626153,1,BAO_0000218,10658,14925,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Area under curve (AUR) was determined,,CHEMBL626154,0,BAO_0000019,10659,1434,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve at 1 uM/dg administered intravenously,,CHEMBL626155,0,BAO_0000019,10660,11883,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve at 10 uM/dg administered perorally,,CHEMBL626156,0,BAO_0000019,10661,11883,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve at 2 uM/dg administered intravenously,,CHEMBL626157,0,BAO_0000019,10662,11883,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve at 20 uM/dg administered perorally,,CHEMBL626158,0,BAO_0000019,10663,11883,,,,,,
A,1,,,N,Intermediate,,,,50588,Area under curve at a peroral dose of 3 mg/kg in dog,,CHEMBL626159,1,BAO_0000218,10664,15233,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Area under curve at a peroral dose of 3 mg/kg in rat,,CHEMBL626160,1,BAO_0000218,10665,15233,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Area under curve at an iv dose of 1 mg/kg in dog,,CHEMBL626161,1,BAO_0000218,10666,15233,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Area under curve at an iv dose of 1 mg/kg in rat,,CHEMBL626162,1,BAO_0000218,10667,15233,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,CHEMBL626163,0,BAO_0000019,10668,12978,,,,,,
A,1,,,U,Autocuration,,,,22224,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,CHEMBL626164,0,BAO_0000019,10669,12978,,,,,,
A,1,,,N,Intermediate,,,,50594,Area under curve measured as conc vs time after intravenous administration to mice.,,CHEMBL626165,1,BAO_0000218,10670,11355,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Area under curve measured as conc vs time after peroral administration to mice.,,CHEMBL626166,1,BAO_0000218,10671,11355,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,CHEMBL626167,1,BAO_0000218,10672,12923,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,CHEMBL626168,1,BAO_0000218,10673,12923,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,CHEMBL877463,1,BAO_0000218,10674,12923,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,CHEMBL626169,1,BAO_0000218,10675,12923,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL626170,1,BAO_0000218,10676,17738,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL626171,1,BAO_0000218,10677,17738,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL626172,1,BAO_0000218,10678,17738,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL626173,1,BAO_0000218,10679,17738,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,In vivo,CHEMBL626174,1,BAO_0000218,10680,17738,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL626175,1,BAO_0000218,10681,17738,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL626176,1,BAO_0000218,10682,17738,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL626177,1,BAO_0000218,10683,17738,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL622499,1,BAO_0000218,10684,17738,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,In vivo,CHEMBL622500,1,BAO_0000218,10685,17738,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL622501,1,BAO_0000218,10686,17738,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL622502,1,BAO_0000218,10687,17738,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL622503,1,BAO_0000218,10688,17738,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL877614,1,BAO_0000218,10689,17738,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL624839,1,BAO_0000218,10690,17738,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL624840,1,BAO_0000218,10691,17738,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL624841,1,BAO_0000218,10692,17738,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL624842,1,BAO_0000218,10693,17738,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,In vivo,CHEMBL624843,1,BAO_0000218,10694,17738,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,In vivo,CHEMBL624844,1,BAO_0000218,10695,17738,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,In vivo,CHEMBL624845,1,BAO_0000218,10696,17738,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,In vivo,CHEMBL621904,1,BAO_0000218,10697,17738,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,In vivo,CHEMBL621905,1,BAO_0000218,10698,11195,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,In vivo,CHEMBL874382,1,BAO_0000218,10699,11195,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,In vivo,CHEMBL621906,1,BAO_0000218,10700,11195,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,In vivo,CHEMBL621907,1,BAO_0000218,10701,11195,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,In vivo,CHEMBL622096,1,BAO_0000218,10702,11195,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,In vivo,CHEMBL622097,1,BAO_0000218,10703,11195,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,In vivo,CHEMBL622098,1,BAO_0000218,10704,11195,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,In vivo,CHEMBL622099,1,BAO_0000218,10705,11195,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,In vivo,CHEMBL622100,1,BAO_0000218,10706,11195,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,In vivo,CHEMBL622101,1,BAO_0000218,10707,11195,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,In vivo,CHEMBL622102,1,BAO_0000218,10708,11195,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,In vivo,CHEMBL622103,1,BAO_0000218,10709,11195,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,In vivo,CHEMBL622104,1,BAO_0000218,10710,11195,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,In vivo,CHEMBL622105,1,BAO_0000218,10711,11195,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,In vivo,CHEMBL622106,1,BAO_0000218,10712,11195,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,In vivo,CHEMBL622107,1,BAO_0000218,10713,11195,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,In vivo,CHEMBL622108,1,BAO_0000218,10714,11195,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,In vivo,CHEMBL622109,1,BAO_0000218,10715,11195,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,In vivo,CHEMBL622110,1,BAO_0000218,10716,11195,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,In vivo,CHEMBL622111,1,BAO_0000218,10717,11195,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,In vivo,CHEMBL874383,1,BAO_0000218,10718,11195,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,In vivo,CHEMBL622112,1,BAO_0000218,10719,11195,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,In vivo,CHEMBL622113,1,BAO_0000218,10720,11195,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,In vivo,CHEMBL622114,1,BAO_0000218,10721,11195,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,In vivo,CHEMBL622115,1,BAO_0000218,10722,11195,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,In vivo,CHEMBL622116,1,BAO_0000218,10723,11195,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622117,1,BAO_0000218,10724,6193,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622118,1,BAO_0000218,10725,6803,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rats at 6 mg/kg,In vivo,CHEMBL622119,1,BAO_0000218,10726,6647,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 6 mg/kg),In vivo,CHEMBL622120,1,BAO_0000218,10727,6647,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rats at 6 mg/kg dose; Not tested,In vivo,CHEMBL622121,1,BAO_0000218,10728,6647,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622122,1,BAO_0000218,10729,6640,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622123,1,BAO_0000218,10730,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL622124,1,BAO_0000218,10731,6641,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL622125,1,BAO_0000218,10732,6642,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL622126,1,BAO_0000218,10733,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,CHEMBL620455,1,BAO_0000218,10734,6141,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL620456,1,BAO_0000218,10735,4390,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL620457,1,BAO_0000218,10736,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was evaluated; Not tested,In vivo,CHEMBL620458,1,BAO_0000218,10737,5472,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL620459,1,BAO_0000218,10738,5438,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat by oral dosing,In vivo,CHEMBL620460,1,BAO_0000218,10739,4883,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,CHEMBL620461,1,BAO_0000218,10740,1908,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley),In vivo,CHEMBL620462,1,BAO_0000218,10741,4853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,CHEMBL620463,1,BAO_0000218,10742,4853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,CHEMBL620464,1,BAO_0000218,10743,4853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,CHEMBL620465,1,BAO_0000218,10744,4853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),In vivo,CHEMBL620466,1,BAO_0000218,10745,4853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,In vivo,CHEMBL620467,1,BAO_0000218,10746,4853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,In vivo,CHEMBL620468,1,BAO_0000218,10747,4853,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,In vivo,CHEMBL620469,1,BAO_0000218,10748,12873,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,In vivo,CHEMBL620470,1,BAO_0000218,10749,12873,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL620471,1,BAO_0000218,10750,3169,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL620472,1,BAO_0000218,10751,6305,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,In vivo,CHEMBL620473,1,BAO_0000218,10752,4762,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL620474,1,BAO_0000218,10753,17847,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),In vivo,CHEMBL620475,1,BAO_0000218,10754,6211,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL620476,1,BAO_0000218,10755,6011,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL620477,1,BAO_0000218,10756,6317,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,In vivo,CHEMBL620478,1,BAO_0000218,10757,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,In vivo,CHEMBL618768,1,BAO_0000218,10758,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after oral administration at 13 mg/kg dose,In vivo,CHEMBL618769,1,BAO_0000218,10759,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,In vivo,CHEMBL618770,1,BAO_0000218,10760,6644,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability (dose 20 mg/kg p.o.),In vivo,CHEMBL618771,1,BAO_0000218,10761,6113,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,In vivo,CHEMBL618772,1,BAO_0000218,10762,5937,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat at 10 mg/kg of the compound,In vivo,CHEMBL618773,1,BAO_0000218,10763,5711,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,CHEMBL875842,1,BAO_0000218,10764,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,CHEMBL618774,1,BAO_0000218,10765,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,CHEMBL618775,1,BAO_0000218,10766,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,CHEMBL618776,1,BAO_0000218,10767,17717,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percent bioavailability (F) in rats after iv administration,In vivo,CHEMBL618777,1,BAO_0000218,10768,4722,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,In vivo,CHEMBL618778,1,BAO_0000218,10769,4722,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 5 uM/kg p.o.),In vivo,CHEMBL618779,1,BAO_0000218,10770,4353,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability,In vivo,CHEMBL618780,1,BAO_0000218,10771,15662,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat (dose 2 mg/kg p.o.),In vivo,CHEMBL618781,1,BAO_0000218,10772,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,In vivo,CHEMBL618782,1,BAO_0000218,10773,4756,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 20 mg/kg),In vivo,CHEMBL618783,1,BAO_0000218,10774,3436,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL618784,1,BAO_0000218,10775,17800,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percent oral bioavailability evaluated in rat,In vivo,CHEMBL618785,1,BAO_0000218,10776,15762,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL618786,1,BAO_0000218,10777,5089,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Percent oral bioavailability in rat; Not determined,In vivo,CHEMBL618787,1,BAO_0000218,10778,5089,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat,In vivo,CHEMBL618788,1,BAO_0000218,10779,3185,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability in rat,In vivo,CHEMBL618789,1,BAO_0000218,10780,5145,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),In vivo,CHEMBL618790,1,BAO_0000218,10781,3457,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),In vivo,CHEMBL618791,1,BAO_0000218,10782,3457,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,In vivo,CHEMBL875843,1,BAO_0000218,10783,5983,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat (dose 20 mg/kg p.o.),In vivo,CHEMBL618792,1,BAO_0000218,10784,5739,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax at a dose of 30 mg/kg in rat,In vivo,CHEMBL623395,1,BAO_0000218,10785,3579,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Cmax in monkeys at a dose of 1 mg/kg,In vivo,CHEMBL623396,0,BAO_0000218,10786,17788,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Cmax in rat,In vivo,CHEMBL623397,1,BAO_0000218,10787,14956,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rats at a dose of 1 mg/kg,In vivo,CHEMBL623398,1,BAO_0000218,10788,17788,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Cmax was measured in mice after an oral dose of 50 mg/kg.,In vivo,CHEMBL623399,1,BAO_0000218,10789,9750,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,"Cmax value at a dose of 12.7 uM/kg, po",In vivo,CHEMBL623400,0,BAO_0000218,10790,12767,,,,,,
A,1,,,U,Autocuration,,,,22224,"Cmax value at a dose of 6.3 uM/kg, iv",In vivo,CHEMBL623401,0,BAO_0000218,10791,12767,,,,,,
A,1,,,U,Autocuration,,,,22224,"Cmax value at a dose of 7.1 uM/kg, iv",In vivo,CHEMBL623402,0,BAO_0000218,10792,12767,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value of compound was determined after 1 hr,In vivo,CHEMBL623403,0,BAO_0000218,10793,12703,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value of the compound,In vivo,CHEMBL623404,0,BAO_0000218,10794,15778,,,,,,
A,1,,,N,Intermediate,,,,50597,Cmax value administered intraintestinal in rats.,In vivo,CHEMBL625997,1,BAO_0000218,10795,12818,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax value administered perorally was determined in rat; Not determined,In vivo,CHEMBL625998,1,BAO_0000218,10796,14964,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Cmax value at the dose of 2.3 mg/kg,In vivo,CHEMBL625999,0,BAO_0000218,10797,15808,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value at the dose of 5 mg/kg,In vivo,CHEMBL626000,0,BAO_0000218,10798,15808,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value in the period of 8 hr after dosing. ,In vivo,CHEMBL626001,0,BAO_0000218,10799,15778,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value at a oral dose of 20 mg/kg; Not tested,In vivo,CHEMBL626002,0,BAO_0000218,10800,3715,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value at a oral dose of 20 mg/kg,In vivo,CHEMBL626003,0,BAO_0000218,10801,3715,,,,,,
A,1,,,N,Intermediate,,,,50597,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,CHEMBL626004,1,BAO_0000218,10802,1446,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50512,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,In vivo,CHEMBL626005,1,BAO_0000218,10803,15240,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50597,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,In vivo,CHEMBL626006,1,BAO_0000218,10804,15240,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,In vivo,CHEMBL626007,1,BAO_0000218,10805,14810,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50594,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,In vivo,CHEMBL626008,1,BAO_0000218,10806,14239,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50588,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,In vivo,CHEMBL626009,1,BAO_0000218,10807,12555,,9615.0,2107.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,In vivo,CHEMBL626010,1,BAO_0000218,10808,10754,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Blood,,,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,In vivo,CHEMBL626011,1,BAO_0000218,10809,10754,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,In vivo,CHEMBL626012,1,BAO_0000218,10810,10754,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,In vivo,CHEMBL626013,1,BAO_0000218,10811,10754,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,In vivo,CHEMBL626014,1,BAO_0000218,10812,10754,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,In vivo,CHEMBL877496,1,BAO_0000218,10813,10754,,10090.0,178.0,,,Mus musculus
F,1,,,N,Intermediate,,,,50588,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,In vivo,CHEMBL626015,1,BAO_0000218,10814,14600,,9615.0,,,,Canis lupus familiaris
F,1,,,N,Intermediate,,,,50588,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,In vivo,CHEMBL626016,1,BAO_0000218,10815,14600,,9615.0,,,,Canis lupus familiaris
F,1,,,N,Intermediate,,,,50588,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,In vivo,CHEMBL626017,1,BAO_0000218,10816,14600,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Bioavailability as maximal plasma concentration in dogs,In vivo,CHEMBL626018,1,BAO_0000218,10817,13543,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Bioavailability as maximal plasma concentration in dogs,In vivo,CHEMBL626692,1,BAO_0000218,10818,13543,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Bioavailability as maximal plasma concentration in rats,In vivo,CHEMBL626693,1,BAO_0000218,10819,13543,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Bioavailability as maximal plasma concentration in rats,In vivo,CHEMBL626694,0,BAO_0000218,10820,13543,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50588,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,CHEMBL626695,1,BAO_0000218,10821,14600,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Blood,,,50588,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,CHEMBL626696,1,BAO_0000218,10822,14600,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Blood,,,50588,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,CHEMBL626697,1,BAO_0000218,10823,14600,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Blood,,,50588,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,In vivo,CHEMBL626859,1,BAO_0000218,10824,14600,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Blood,,,50588,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,CHEMBL626860,1,BAO_0000218,10825,14600,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Blood,,,50588,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,CHEMBL626861,1,BAO_0000218,10826,14600,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,In vivo,CHEMBL626296,1,BAO_0000218,10827,14681,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,In vivo,CHEMBL626297,0,BAO_0000218,10828,15905,,,,,,
A,1,,,U,Autocuration,Plasma,,,22224,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,In vivo,CHEMBL626298,0,BAO_0000218,10829,15905,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",In vivo,CHEMBL626299,1,BAO_0000218,10830,13304,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,In vivo,CHEMBL626300,1,BAO_0000218,10831,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,In vivo,CHEMBL626301,1,BAO_0000218,10832,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,In vivo,CHEMBL626962,1,BAO_0000218,10833,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,In vivo,CHEMBL626963,1,BAO_0000218,10834,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,In vivo,CHEMBL626964,1,BAO_0000218,10835,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,100710,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,In vivo,CHEMBL626965,1,BAO_0000218,10836,14839,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,CHEMBL626966,1,BAO_0000218,10837,14839,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,CHEMBL626967,1,BAO_0000218,10838,14839,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,100710,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,In vivo,CHEMBL626968,1,BAO_0000218,10839,14839,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,CHEMBL626969,1,BAO_0000218,10840,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,CHEMBL627126,1,BAO_0000218,10841,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,CHEMBL631276,1,BAO_0000218,10842,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,CHEMBL631277,1,BAO_0000218,10843,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,CHEMBL631278,1,BAO_0000218,10844,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,CHEMBL874457,1,BAO_0000218,10845,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,CHEMBL631279,1,BAO_0000218,10846,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,CHEMBL631280,1,BAO_0000218,10847,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,CHEMBL631281,1,BAO_0000218,10848,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,CHEMBL631968,1,BAO_0000218,10849,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,CHEMBL631969,1,BAO_0000218,10850,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,CHEMBL631970,1,BAO_0000218,10851,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,CHEMBL631971,1,BAO_0000218,10852,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,CHEMBL631972,1,BAO_0000218,10853,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,CHEMBL630435,1,BAO_0000218,10854,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,CHEMBL630436,1,BAO_0000218,10855,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,CHEMBL630437,1,BAO_0000218,10856,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,CHEMBL630438,1,BAO_0000218,10857,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,CHEMBL630439,1,BAO_0000218,10858,8418,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,CHEMBL630440,1,BAO_0000218,10859,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,CHEMBL630441,1,BAO_0000218,10860,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,CHEMBL630442,1,BAO_0000218,10861,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,CHEMBL625234,1,BAO_0000218,10862,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,CHEMBL625235,1,BAO_0000218,10863,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,CHEMBL625236,1,BAO_0000218,10864,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,CHEMBL625237,1,BAO_0000218,10865,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,CHEMBL626125,1,BAO_0000218,10866,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,CHEMBL626126,1,BAO_0000218,10867,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,CHEMBL626127,1,BAO_0000218,10868,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,CHEMBL626128,1,BAO_0000218,10869,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,CHEMBL626129,1,BAO_0000218,10870,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,CHEMBL626130,1,BAO_0000218,10871,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,CHEMBL626131,1,BAO_0000218,10872,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,CHEMBL626132,1,BAO_0000218,10873,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,CHEMBL626752,1,BAO_0000218,10874,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,CHEMBL626753,1,BAO_0000218,10875,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,CHEMBL626754,1,BAO_0000218,10876,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,CHEMBL626755,1,BAO_0000218,10877,8418,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,CHEMBL626756,1,BAO_0000218,10878,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,CHEMBL626757,1,BAO_0000218,10879,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,CHEMBL626758,1,BAO_0000218,10880,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,CHEMBL626759,1,BAO_0000218,10881,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,CHEMBL626760,1,BAO_0000218,10882,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,CHEMBL626394,1,BAO_0000218,10883,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,CHEMBL626395,1,BAO_0000218,10884,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,CHEMBL626396,1,BAO_0000218,10885,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL626397,1,BAO_0000218,10886,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,CHEMBL626398,1,BAO_0000218,10887,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,CHEMBL626399,1,BAO_0000218,10888,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,CHEMBL874653,1,BAO_0000218,10889,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,CHEMBL626400,1,BAO_0000218,10890,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,CHEMBL626401,1,BAO_0000218,10891,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL626402,1,BAO_0000218,10892,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,CHEMBL626403,1,BAO_0000218,10893,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,CHEMBL626404,1,BAO_0000218,10894,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,CHEMBL626405,1,BAO_0000218,10895,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,CHEMBL625529,1,BAO_0000218,10896,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,CHEMBL625530,1,BAO_0000218,10897,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL625531,1,BAO_0000218,10898,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,CHEMBL625532,1,BAO_0000218,10899,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,CHEMBL625533,1,BAO_0000218,10900,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,CHEMBL875474,1,BAO_0000218,10901,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,CHEMBL625534,1,BAO_0000218,10902,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,CHEMBL625535,1,BAO_0000218,10903,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL625536,1,BAO_0000218,10904,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,CHEMBL625537,1,BAO_0000218,10905,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,CHEMBL625538,1,BAO_0000218,10906,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,CHEMBL625539,1,BAO_0000218,10907,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,CHEMBL625540,1,BAO_0000218,10908,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,CHEMBL625541,1,BAO_0000218,10909,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL625542,1,BAO_0000218,10910,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,CHEMBL625543,1,BAO_0000218,10911,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,CHEMBL625544,1,BAO_0000218,10912,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,CHEMBL625545,1,BAO_0000218,10913,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,CHEMBL625546,1,BAO_0000218,10914,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,CHEMBL625547,1,BAO_0000218,10915,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,CHEMBL625548,1,BAO_0000218,10916,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,CHEMBL625549,1,BAO_0000218,10917,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,CHEMBL625550,1,BAO_0000218,10918,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,CHEMBL625551,1,BAO_0000218,10919,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,CHEMBL875475,1,BAO_0000218,10920,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,CHEMBL625552,1,BAO_0000218,10921,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,CHEMBL625553,1,BAO_0000218,10922,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL625554,1,BAO_0000218,10923,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,CHEMBL625555,1,BAO_0000218,10924,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,CHEMBL625556,1,BAO_0000218,10925,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,CHEMBL624986,1,BAO_0000218,10926,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,CHEMBL624987,1,BAO_0000218,10927,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL624988,1,BAO_0000218,10928,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,In vivo,CHEMBL624989,1,BAO_0000218,10929,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,In vivo,CHEMBL624990,1,BAO_0000218,10930,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,In vivo,CHEMBL874391,1,BAO_0000218,10931,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,In vivo,CHEMBL624991,1,BAO_0000218,10932,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,In vivo,CHEMBL624992,1,BAO_0000218,10933,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,In vivo,CHEMBL624993,1,BAO_0000218,10934,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,In vivo,CHEMBL624994,1,BAO_0000218,10935,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,In vivo,CHEMBL624995,1,BAO_0000218,10936,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,In vivo,CHEMBL624996,1,BAO_0000218,10937,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,In vivo,CHEMBL624997,1,BAO_0000218,10938,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,In vivo,CHEMBL624998,1,BAO_0000218,10939,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,In vivo,CHEMBL624999,1,BAO_0000218,10940,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,In vivo,CHEMBL882955,1,BAO_0000218,10941,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,In vivo,CHEMBL625000,1,BAO_0000218,10942,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,In vivo,CHEMBL625001,1,BAO_0000218,10943,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,In vivo,CHEMBL625089,1,BAO_0000218,10944,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,In vivo,CHEMBL625090,1,BAO_0000218,10945,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,In vivo,CHEMBL625091,1,BAO_0000218,10946,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,In vivo,CHEMBL625092,1,BAO_0000218,10947,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,In vivo,CHEMBL625093,1,BAO_0000218,10948,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,In vivo,CHEMBL625094,1,BAO_0000218,10949,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,In vivo,CHEMBL625095,1,BAO_0000218,10950,9025,,9615.0,1637.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for its bioavailability in the dogs,In vivo,CHEMBL625096,1,BAO_0000218,10951,2249,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for its bioavailability in the rats,In vivo,CHEMBL625097,1,BAO_0000218,10952,2249,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for oral bioavailability,In vivo,CHEMBL882956,0,BAO_0000218,10953,17515,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for percentage of Oral bioavailability in rats,In vivo,CHEMBL625098,1,BAO_0000218,10954,14541,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in guinea pig,In vivo,CHEMBL625099,0,BAO_0000218,10955,12797,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the oral bioavailability in rat,In vivo,CHEMBL625100,1,BAO_0000218,10956,12797,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for the oral bioavailability in dog,In vivo,CHEMBL625101,1,BAO_0000218,10957,12797,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the oral bioavailability in rat,In vivo,CHEMBL874396,1,BAO_0000218,10958,12797,,10116.0,,,,Rattus norvegicus
F,1,,,U,Autocuration,,,,22224,Bioavailability in dog (dosed i.v.),In vivo,CHEMBL625102,0,BAO_0000218,10959,11727,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was tested for in vivo bioavailability in dog,In vivo,CHEMBL625103,1,BAO_0000218,10960,13249,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,100712,Compound was tested for in vivo bioavailability in hamsters,In vivo,CHEMBL625104,1,BAO_0000218,10961,13249,,10026.0,,,,Cricetinae
A,1,,,U,Autocuration,,,,22224,Compound was tested for in vivo bioavailability in monkey,In vivo,CHEMBL625105,0,BAO_0000218,10962,13249,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Compound was tested for in vivo bioavailability in rat,In vivo,CHEMBL625106,1,BAO_0000218,10963,13249,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in mouse,In vivo,CHEMBL625107,0,BAO_0000218,10964,9552,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Compound was tested for percent of oral bioavailability in mice; 56-74,In vivo,CHEMBL625108,1,BAO_0000218,10965,9552,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),In vivo,CHEMBL625109,0,BAO_0000218,10966,14839,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),In vivo,CHEMBL625110,0,BAO_0000218,10967,14839,,9541.0,,,,Macaca fascicularis
A,1,,,U,Autocuration,,,,22224,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),In vivo,CHEMBL625111,0,BAO_0000218,10968,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50594,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),In vivo,CHEMBL625112,1,BAO_0000218,10969,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Oral bioavailability in nude mice,In vivo,CHEMBL875334,1,BAO_0000218,10970,14839,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Bioavailability in monkey (i.d. dosing),In vivo,CHEMBL628617,0,BAO_0000218,10971,11219,,9443.0,,,,Primates
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat,In vivo,CHEMBL628618,0,BAO_0000218,10972,9552,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,In vivo,CHEMBL628619,0,BAO_0000218,10973,11732,,,,,,
A,1,,,U,Autocuration,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,In vivo,CHEMBL628620,0,BAO_0000218,10974,11732,,,,,,
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,CHEMBL628621,1,BAO_0000218,10975,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,CHEMBL628622,1,BAO_0000218,10976,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,CHEMBL628623,1,BAO_0000218,10977,14839,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,100710,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,In vivo,CHEMBL628624,1,BAO_0000218,10978,14839,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,CHEMBL628625,1,BAO_0000218,10979,14839,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,100710,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,In vivo,CHEMBL628626,1,BAO_0000218,10980,14839,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,CHEMBL627041,1,BAO_0000218,10981,14839,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,CHEMBL627042,1,BAO_0000218,10982,14839,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,CHEMBL627043,1,BAO_0000218,10983,14839,,10090.0,1969.0,,,Mus musculus
A,1,,,U,Autocuration,Plasma,,,22224,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,In vivo,CHEMBL627044,0,BAO_0000218,10984,13932,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50594,Cmax in mouse plasma,In vivo,CHEMBL627045,1,BAO_0000218,10985,11637,,10090.0,1969.0,,,Mus musculus
A,1,,,U,Autocuration,Plasma,,,22224,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,In vivo,CHEMBL627046,0,BAO_0000218,10986,11637,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,Maximal plasma concentration in rat,In vivo,CHEMBL627047,1,BAO_0000218,10987,13960,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,In vivo,CHEMBL627048,1,BAO_0000218,10988,15905,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,In vivo,CHEMBL627049,1,BAO_0000218,10989,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,In vivo,CHEMBL627050,1,BAO_0000218,10990,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,In vivo,CHEMBL627051,1,BAO_0000218,10991,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,In vivo,CHEMBL627052,1,BAO_0000218,10992,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,In vivo,CHEMBL627053,1,BAO_0000218,10993,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,In vivo,CHEMBL627054,1,BAO_0000218,10994,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,CHEMBL627055,1,BAO_0000218,10995,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,CHEMBL627056,1,BAO_0000218,10996,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,CHEMBL627057,1,BAO_0000218,10997,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,CHEMBL627058,1,BAO_0000218,10998,15011,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,CHEMBL626211,1,BAO_0000218,10999,15011,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Maximum Concentration of the compound.,In vivo,CHEMBL626212,0,BAO_0000218,11000,10291,,,,,,
A,1,,,N,Intermediate,,,,50588,Maximum Concentration was measured after iv administration into Beagle dog,In vivo,CHEMBL626213,1,BAO_0000218,11001,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Maximum Concentration was measured after iv administration into Beagle dog.,In vivo,CHEMBL626214,1,BAO_0000218,11002,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Maximum Concentration was measured after po administration into Beagle dog,In vivo,CHEMBL626215,1,BAO_0000218,11003,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Maximum Concentration was measured after po administration into Beagle dog.,In vivo,CHEMBL626216,1,BAO_0000218,11004,14599,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,Blood,,,22224,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,In vivo,CHEMBL626217,0,BAO_0000218,11005,12767,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Maximum blood level reached after an iv dose of 12.2 uM/kg,In vivo,CHEMBL626218,0,BAO_0000218,11006,12767,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,In vivo,CHEMBL626219,0,BAO_0000218,11007,12767,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,In vivo,CHEMBL626220,0,BAO_0000218,11008,12767,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Maximum blood level reached after an oral dose of 5.0 mg/kg,In vivo,CHEMBL626221,0,BAO_0000218,11009,12767,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Maximum blood level reached at dose of 10.6 uM/kg orally,In vivo,CHEMBL626222,0,BAO_0000218,11010,12767,,,178.0,,,
A,1,,,N,Intermediate,,,,50512,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,In vivo,CHEMBL626223,1,BAO_0000218,11011,14706,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50512,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,In vivo,CHEMBL626224,1,BAO_0000218,11012,14706,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,Brain,,,50597,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,In vivo,CHEMBL626225,1,BAO_0000218,11013,14793,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,In vivo,CHEMBL626226,1,BAO_0000218,11014,14793,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,In vivo,CHEMBL626227,1,BAO_0000218,11015,14793,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,In vivo,CHEMBL626228,1,BAO_0000218,11016,14793,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,CHEMBL626229,1,BAO_0000218,11017,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,CHEMBL626921,1,BAO_0000218,11018,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,In vivo,CHEMBL876793,1,BAO_0000218,11019,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,In vivo,CHEMBL625309,1,BAO_0000218,11020,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50278,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),In vivo,CHEMBL625310,1,BAO_0000218,11021,10524,,1423.0,,,,Bacillus subtilis
A,1,,,U,Autocuration,,,,22224,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,In vivo,CHEMBL625311,0,BAO_0000218,11022,11871,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,In vivo,CHEMBL625312,1,BAO_0000218,11023,11871,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,In vivo,CHEMBL625313,0,BAO_0000218,11024,3437,,,,,,
A,1,,,N,Intermediate,,,,50594,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,In vivo,CHEMBL625314,1,BAO_0000218,11025,12038,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Maximum concentration in male rats after iv administration of 20 mg/kg,In vivo,CHEMBL625315,1,BAO_0000218,11026,12038,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,CHEMBL625316,1,BAO_0000218,11027,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,CHEMBL625317,1,BAO_0000218,11028,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,CHEMBL625318,1,BAO_0000218,11029,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,CHEMBL625319,1,BAO_0000218,11030,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,CHEMBL625320,1,BAO_0000218,11031,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,CHEMBL625321,1,BAO_0000218,11032,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,CHEMBL625322,1,BAO_0000218,11033,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,CHEMBL876801,1,BAO_0000218,11034,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,CHEMBL625323,1,BAO_0000218,11035,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,CHEMBL625324,1,BAO_0000218,11036,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,CHEMBL625325,1,BAO_0000218,11037,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,CHEMBL625326,1,BAO_0000218,11038,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,CHEMBL625327,1,BAO_0000218,11039,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,CHEMBL625328,1,BAO_0000218,11040,8418,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,CHEMBL625329,1,BAO_0000218,11041,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,CHEMBL625330,1,BAO_0000218,11042,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,CHEMBL627774,1,BAO_0000218,11043,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,CHEMBL627775,1,BAO_0000218,11044,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,CHEMBL627949,1,BAO_0000218,11045,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,CHEMBL627950,1,BAO_0000218,11046,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,CHEMBL627951,1,BAO_0000218,11047,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,CHEMBL627952,1,BAO_0000218,11048,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,CHEMBL627953,1,BAO_0000218,11049,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,CHEMBL627954,1,BAO_0000218,11050,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,CHEMBL627955,1,BAO_0000218,11051,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,CHEMBL627956,1,BAO_0000218,11052,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,CHEMBL876802,1,BAO_0000218,11053,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,CHEMBL627957,1,BAO_0000218,11054,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,CHEMBL627958,1,BAO_0000218,11055,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,CHEMBL627959,1,BAO_0000218,11056,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,CHEMBL627960,1,BAO_0000218,11057,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,CHEMBL627961,1,BAO_0000218,11058,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,CHEMBL627962,1,BAO_0000218,11059,8418,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,CHEMBL627963,1,BAO_0000218,11060,9796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL624759,1,BAO_0000218,11061,9796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,CHEMBL624760,1,BAO_0000218,11062,9796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL624761,1,BAO_0000218,11063,9796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL877607,1,BAO_0000218,11064,9796,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,CHEMBL624762,1,BAO_0000218,11065,9796,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL624763,1,BAO_0000218,11066,9796,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,CHEMBL624764,1,BAO_0000218,11067,9796,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL624765,1,BAO_0000218,11068,9796,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL624766,1,BAO_0000218,11069,9796,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,CHEMBL624767,1,BAO_0000218,11070,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,CHEMBL624768,1,BAO_0000218,11071,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,CHEMBL624769,1,BAO_0000218,11072,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL624770,1,BAO_0000218,11073,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,CHEMBL624771,1,BAO_0000218,11074,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,CHEMBL624772,1,BAO_0000218,11075,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,CHEMBL624773,1,BAO_0000218,11076,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,CHEMBL624774,1,BAO_0000218,11077,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,CHEMBL624775,1,BAO_0000218,11078,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL624776,1,BAO_0000218,11079,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,CHEMBL624777,1,BAO_0000218,11080,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,CHEMBL624778,1,BAO_0000218,11081,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,CHEMBL624779,1,BAO_0000218,11082,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL624780,1,BAO_0000218,11083,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,CHEMBL624781,1,BAO_0000218,11084,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,CHEMBL877608,1,BAO_0000218,11085,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,CHEMBL624782,1,BAO_0000218,11086,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,CHEMBL624783,1,BAO_0000218,11087,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,CHEMBL624784,1,BAO_0000218,11088,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,CHEMBL624785,1,BAO_0000218,11089,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,CHEMBL624786,1,BAO_0000218,11090,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,CHEMBL624787,1,BAO_0000218,11091,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,CHEMBL628676,1,BAO_0000218,11092,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,CHEMBL621842,1,BAO_0000218,11093,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,CHEMBL621843,1,BAO_0000218,11094,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,CHEMBL623873,1,BAO_0000218,11095,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL623874,1,BAO_0000218,11096,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,CHEMBL623875,1,BAO_0000218,11097,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,CHEMBL623876,1,BAO_0000218,11098,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,CHEMBL623877,1,BAO_0000218,11099,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,CHEMBL623878,1,BAO_0000218,11100,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,CHEMBL623879,1,BAO_0000218,11101,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,CHEMBL623880,1,BAO_0000218,11102,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,CHEMBL623881,1,BAO_0000218,11103,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,CHEMBL623957,1,BAO_0000218,11104,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,CHEMBL623958,1,BAO_0000218,11105,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,CHEMBL623959,1,BAO_0000218,11106,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,CHEMBL623960,1,BAO_0000218,11107,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,CHEMBL623961,1,BAO_0000218,11108,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL623962,1,BAO_0000218,11109,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,CHEMBL624676,1,BAO_0000218,11110,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,CHEMBL624677,1,BAO_0000218,11111,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,CHEMBL624678,1,BAO_0000218,11112,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,CHEMBL624679,1,BAO_0000218,11113,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL624680,1,BAO_0000218,11114,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,In vivo,CHEMBL624849,0,BAO_0000218,11115,11732,,,,,,
A,1,,,U,Autocuration,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,In vivo,CHEMBL624850,0,BAO_0000218,11116,11732,,,,,,
A,1,,,U,Autocuration,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,In vivo,CHEMBL874399,0,BAO_0000218,11117,11732,,,,,,
A,1,,,U,Autocuration,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,In vivo,CHEMBL624851,0,BAO_0000218,11118,11732,,,,,,
A,1,,,U,Autocuration,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,In vivo,CHEMBL624852,0,BAO_0000218,11119,11732,,,,,,
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rat (dose 10 mg/kg),In vivo,CHEMBL624853,0,BAO_0000218,11120,13359,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rat (Sprague-Dawley),In vivo,CHEMBL624854,0,BAO_0000218,11121,16618,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rat,In vivo,CHEMBL624855,0,BAO_0000218,11122,13960,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rats was determined in vivo,In vivo,CHEMBL624856,0,BAO_0000218,11123,13917,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in dog,In vivo,CHEMBL882957,0,BAO_0000218,11124,14266,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Oral bioavailability of compound in monkey,In vivo,CHEMBL624857,0,BAO_0000218,11125,12359,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound in rat,In vivo,CHEMBL622202,1,BAO_0000218,11126,12359,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat of PMEA prodrug,In vivo,CHEMBL622203,0,BAO_0000218,11127,12359,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,In vivo,CHEMBL625522,1,BAO_0000218,11128,12359,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Serum conc at 3 hours following 25 mg/kg dose,In vivo,CHEMBL622868,0,BAO_0000218,11129,10791,,9544.0,,,,Macaca mulatta
A,1,,,U,Autocuration,Urine,,,22224,Urine conc 0-5 hours following 25 mg/kg dose,In vivo,CHEMBL622869,0,BAO_0000218,11130,10791,,9544.0,1088.0,,,Macaca mulatta
A,1,,,U,Autocuration,Urine,,,22224,Urine conc 0-24 hours following 25 mg/kg dose,In vivo,CHEMBL622870,0,BAO_0000218,11131,10791,,9544.0,1088.0,,,Macaca mulatta
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in African green monkeys; 20-25,In vivo,CHEMBL622871,0,BAO_0000218,11132,138,,9534.0,,,,Chlorocebus aethiops
A,1,,,N,Intermediate,,,,100710,Oral bioavailability in cynomolgus monkey.,In vivo,CHEMBL620560,1,BAO_0000218,11133,14521,,9541.0,,,,Macaca fascicularis
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in dog,In vivo,CHEMBL620561,0,BAO_0000218,11134,13953,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral bioavailability in dog at 10 mg/kg oral dose,In vivo,CHEMBL620562,1,BAO_0000218,11135,12836,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,100712,Oral bioavailability in hamster at 10 mg/kg oral dose,In vivo,CHEMBL620563,1,BAO_0000218,11136,12836,,10026.0,,,,Cricetinae
A,1,,,N,Intermediate,,,,50597,Oral bioavailability in rat at 10 mg/kg oral dose,In vivo,CHEMBL620564,1,BAO_0000218,11137,12836,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rat,In vivo,CHEMBL872265,0,BAO_0000218,11138,14521,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rat,In vivo,CHEMBL620565,0,BAO_0000218,11139,13953,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability,In vivo,CHEMBL620566,0,BAO_0000218,11140,6799,,9347.0,,,,Eutheria
A,1,,,U,Autocuration,,,,22224,Oral bioavailability was determined; range 49-102%,In vivo,CHEMBL620567,0,BAO_0000218,11141,11311,,,,,,
A,1,,,N,Intermediate,,,,50588,Oral bioavailability was determined in dogs,In vivo,CHEMBL620568,1,BAO_0000218,11142,4013,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rat,In vivo,CHEMBL620569,0,BAO_0000218,11143,4013,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability,In vivo,CHEMBL620570,0,BAO_0000218,11144,17591,,9347.0,,,,Eutheria
A,1,,,U,Autocuration,,,,22224,Oral bioavailability was determined; Not orally available,In vivo,CHEMBL620571,0,BAO_0000218,11145,17591,,,,,,
A,1,,,N,Intermediate,,,,50594,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,CHEMBL620572,1,BAO_0000218,11146,15011,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),In vivo,CHEMBL620573,0,BAO_0000218,11147,15011,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,In vivo,CHEMBL620574,0,BAO_0000218,11148,15011,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in Rhesus monkey,In vivo,CHEMBL620575,0,BAO_0000218,11149,9552,,9544.0,,,,Macaca mulatta
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in dog (female mongrel),In vivo,CHEMBL620576,0,BAO_0000218,11150,9552,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,In vivo,CHEMBL875846,0,BAO_0000218,11151,3639,,,,,,
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in dog,In vivo,CHEMBL620577,0,BAO_0000218,11152,13397,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Percentage Bioavailability was evaluated.,In vivo,CHEMBL620578,0,BAO_0000218,11153,3031,,,,,,
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat administered i.d.,In vivo,CHEMBL620579,0,BAO_0000218,11154,12818,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability,In vivo,CHEMBL621248,0,BAO_0000218,11155,4847,,9347.0,,,,Eutheria
A,1,,,U,Autocuration,,,,22224,Bioavailability in dog (male Beagle) i.v. administration,In vivo,CHEMBL625390,0,BAO_0000218,11156,12421,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",In vivo,CHEMBL625391,0,BAO_0000218,11157,11966,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),In vivo,CHEMBL872266,0,BAO_0000218,11158,11218,,9443.0,,,,Primates
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in rat (Sprague-Dawley) (male),In vivo,CHEMBL625392,0,BAO_0000218,11159,13129,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The oral bioavailability was measured on rats after oral administration,In vivo,CHEMBL625393,1,BAO_0000218,11160,12350,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,CHEMBL625394,1,BAO_0000218,11161,2231,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50797,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,CHEMBL625395,1,BAO_0000218,11162,2231,,9544.0,,,,Macaca mulatta
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,CHEMBL625396,0,BAO_0000218,11163,12187,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in dog (male Beagle) i.v. administration,In vivo,CHEMBL625397,0,BAO_0000218,11164,12421,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625398,1,BAO_0000218,11165,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625399,1,BAO_0000218,11166,13256,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Cerebellum,,,50594,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL626074,1,BAO_0000218,11167,13256,,10090.0,2037.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL626075,1,BAO_0000218,11168,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,CHEMBL626076,1,BAO_0000218,11169,2231,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50797,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,CHEMBL626077,1,BAO_0000218,11170,2231,,9544.0,1969.0,,,Macaca mulatta
A,1,,,N,Intermediate,Blood,,,50597,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,CHEMBL626078,1,BAO_0000218,11171,12178,,10116.0,178.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Blood,,,22224,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,CHEMBL625846,0,BAO_0000218,11172,12178,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),In vivo,CHEMBL625847,0,BAO_0000218,11173,12178,,,178.0,,,
A,1,,,N,Expert,,,,50597,Maximum concentration observed in rats at an oral dose of 50 mg/kg,In vivo,CHEMBL625848,1,BAO_0000218,11174,15633,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of compound in plasma administered orally to rats,In vivo,CHEMBL625849,1,BAO_0000218,11175,14258,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",In vivo,CHEMBL626023,1,BAO_0000218,11176,14224,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",In vivo,CHEMBL626024,1,BAO_0000218,11177,14224,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",In vivo,CHEMBL626025,1,BAO_0000218,11178,14224,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Maximum concentration after 10 mg/kg by oral administration,In vivo,CHEMBL626026,0,BAO_0000218,11179,5566,,,,,,
A,1,,,U,Autocuration,,,,22224,Maximum concentration at a dose of 1.5 mg/kg,In vivo,CHEMBL626027,0,BAO_0000218,11180,16935,,,,,,
A,1,,,U,Autocuration,,,,22224,Maximum concentration at a dose of 2.0 mg/kg,In vivo,CHEMBL626028,0,BAO_0000218,11181,16935,,,,,,
A,1,,,N,Intermediate,Plasma,,,50588,Maximum concentration in dog plasma,In vivo,CHEMBL626029,1,BAO_0000218,11182,14224,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,In vivo,CHEMBL626030,0,BAO_0000218,11183,12536,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,In vivo,CHEMBL626031,0,BAO_0000218,11184,12536,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,In vivo,CHEMBL626032,0,BAO_0000218,11185,12536,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,In vivo,CHEMBL626033,0,BAO_0000218,11186,12536,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,In vivo,CHEMBL626034,0,BAO_0000218,11187,12536,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50588,Maximum concentration in plasma after oral administration in dog (25 mg/kg),In vivo,CHEMBL626035,1,BAO_0000218,11188,9994,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma at Tmax,In vivo,CHEMBL626036,0,BAO_0000218,11189,1434,,,1969.0,,,
A,1,,,N,Expert,Plasma,,,50588,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,In vivo,CHEMBL626037,1,BAO_0000218,11190,12836,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,100712,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,In vivo,CHEMBL626038,1,BAO_0000218,11191,12836,,10026.0,1969.0,,,Cricetinae
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,In vivo,CHEMBL626039,1,BAO_0000218,11192,12836,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,In vivo,CHEMBL626040,1,BAO_0000218,11193,12545,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50592,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,In vivo,CHEMBL626041,1,BAO_0000218,11194,13856,,9986.0,1969.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Maximum concentration was calculated,In vivo,CHEMBL626042,0,BAO_0000218,11195,3550,,,,,,
A,1,,,U,Autocuration,,,,22224,Maximum concentration was calculated.,In vivo,CHEMBL626043,0,BAO_0000218,11196,2632,,,,,,
A,1,,,U,Autocuration,,,,22224,Maximum concentration at a peroral dose of 10 mg/kg,In vivo,CHEMBL626044,0,BAO_0000218,11197,5566,,,,,,
A,1,,,U,Autocuration,,,,22224,Maximum concentration of the drug at 10 uM/dg administered perorally,In vivo,CHEMBL626045,0,BAO_0000218,11198,11883,,,,,,
A,1,,,U,Autocuration,,,,22224,Maximum concentration of the drug at 2 uM/dg administered intravenously,In vivo,CHEMBL626046,0,BAO_0000218,11199,11883,,,,,,
A,1,,,N,Intermediate,Plasma,,,50588,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",In vivo,CHEMBL626047,1,BAO_0000218,11200,14122,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,100712,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",In vivo,CHEMBL626048,1,BAO_0000218,11201,14122,,10026.0,1969.0,,,Cricetinae
A,1,,,N,Intermediate,Plasma,,,50597,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",In vivo,CHEMBL626049,1,BAO_0000218,11202,14122,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,In vivo,CHEMBL626050,1,BAO_0000218,11203,12542,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,In vivo,CHEMBL874541,1,BAO_0000218,11204,12542,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,100712,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,In vivo,CHEMBL622826,1,BAO_0000218,11205,12542,,10026.0,1969.0,,,Cricetinae
A,1,,,N,Intermediate,Plasma,,,100712,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,In vivo,CHEMBL622827,1,BAO_0000218,11206,12542,,10026.0,1969.0,,,Cricetinae
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,In vivo,CHEMBL622828,1,BAO_0000218,11207,12542,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,In vivo,CHEMBL622829,1,BAO_0000218,11208,14080,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration reached following intravenous administration in male rat,In vivo,CHEMBL876806,1,BAO_0000218,11209,11911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,In vivo,CHEMBL622830,1,BAO_0000218,11210,13204,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,In vivo,CHEMBL622831,1,BAO_0000218,11211,13204,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,In vivo,CHEMBL626794,1,BAO_0000218,11212,14346,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,In vivo,CHEMBL626795,1,BAO_0000218,11213,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,CHEMBL626796,1,BAO_0000218,11214,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,In vivo,CHEMBL626797,1,BAO_0000218,11215,14346,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum drug concentration is determined after oral dosing in rats.,In vivo,CHEMBL626798,1,BAO_0000218,11216,14127,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Maximum observed concentration in oral (5 mg/kg) fasted dogs,In vivo,CHEMBL626799,1,BAO_0000218,11217,14339,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Maximum observed concentration in oral (5 mg/kg) fed dogs,In vivo,CHEMBL626800,1,BAO_0000218,11218,14339,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration,In vivo,CHEMBL626801,0,BAO_0000218,11219,13494,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,In vivo,CHEMBL876816,1,BAO_0000218,11220,14925,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,In vivo,CHEMBL626802,1,BAO_0000218,11221,14474,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,In vivo,CHEMBL626803,1,BAO_0000218,11222,14474,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration following oral administration of 30 umol/kg,In vivo,CHEMBL626804,0,BAO_0000218,11223,13917,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,CHEMBL626805,1,BAO_0000218,11224,9796,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,CHEMBL626309,1,BAO_0000218,11225,9796,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,CHEMBL626310,1,BAO_0000218,11226,9796,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL626311,1,BAO_0000218,11227,9796,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL626312,1,BAO_0000218,11228,9796,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL626313,1,BAO_0000218,11229,9796,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,CHEMBL626314,1,BAO_0000218,11230,9796,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,CHEMBL626315,1,BAO_0000218,11231,9796,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL626316,1,BAO_0000218,11232,9796,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,CHEMBL626317,1,BAO_0000218,11233,9796,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,CHEMBL626318,1,BAO_0000218,11234,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,CHEMBL626319,1,BAO_0000218,11235,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,CHEMBL626320,1,BAO_0000218,11236,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,CHEMBL875053,1,BAO_0000218,11237,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,CHEMBL626321,1,BAO_0000218,11238,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,CHEMBL626322,1,BAO_0000218,11239,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,CHEMBL626323,1,BAO_0000218,11240,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,CHEMBL626324,1,BAO_0000218,11241,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,CHEMBL626325,1,BAO_0000218,11242,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,CHEMBL626326,1,BAO_0000218,11243,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,CHEMBL626327,1,BAO_0000218,11244,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,CHEMBL626328,1,BAO_0000218,11245,8363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,CHEMBL626329,1,BAO_0000218,11246,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,CHEMBL626330,1,BAO_0000218,11247,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,CHEMBL626331,1,BAO_0000218,11248,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,CHEMBL626332,1,BAO_0000218,11249,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,CHEMBL626333,1,BAO_0000218,11250,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,CHEMBL626334,1,BAO_0000218,11251,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,CHEMBL626335,1,BAO_0000218,11252,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,CHEMBL624798,1,BAO_0000218,11253,8684,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,CHEMBL624799,1,BAO_0000218,11254,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,CHEMBL624800,1,BAO_0000218,11255,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,CHEMBL624801,1,BAO_0000218,11256,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,CHEMBL624802,1,BAO_0000218,11257,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,CHEMBL624803,1,BAO_0000218,11258,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,CHEMBL624804,1,BAO_0000218,11259,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,CHEMBL624805,1,BAO_0000218,11260,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,CHEMBL624806,1,BAO_0000218,11261,8684,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,CHEMBL624807,1,BAO_0000218,11262,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,CHEMBL624808,1,BAO_0000218,11263,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,CHEMBL624809,1,BAO_0000218,11264,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,CHEMBL624810,1,BAO_0000218,11265,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,CHEMBL877618,1,BAO_0000218,11266,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,CHEMBL624811,1,BAO_0000218,11267,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,CHEMBL624812,1,BAO_0000218,11268,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,CHEMBL624813,1,BAO_0000218,11269,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,CHEMBL624814,1,BAO_0000218,11270,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,CHEMBL624815,1,BAO_0000218,11271,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,CHEMBL624816,1,BAO_0000218,11272,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,CHEMBL624817,1,BAO_0000218,11273,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,CHEMBL624818,1,BAO_0000218,11274,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,CHEMBL624819,1,BAO_0000218,11275,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,CHEMBL624820,1,BAO_0000218,11276,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL624821,1,BAO_0000218,11277,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,CHEMBL624822,1,BAO_0000218,11278,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,CHEMBL624823,1,BAO_0000218,11279,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50212,Observed diffusion coefficient in organic solvent for Escherichia coli,,CHEMBL624824,1,BAO_0000218,11280,15599,,562.0,,,,Escherichia coli
A,1,,,N,Intermediate,Blood,,,50597,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,CHEMBL624825,1,BAO_0000218,11281,9614,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,CHEMBL624826,1,BAO_0000218,11282,9614,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cardiac atrium,,,50597,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,CHEMBL876817,1,BAO_0000218,11283,9614,,10116.0,2081.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cardiac atrium,,,50597,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,CHEMBL624827,1,BAO_0000218,11284,9614,,10116.0,2081.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,CHEMBL624828,1,BAO_0000218,11285,9614,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,CHEMBL624829,1,BAO_0000218,11286,9614,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,CHEMBL624830,1,BAO_0000218,11287,9614,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,CHEMBL624831,1,BAO_0000218,11288,9614,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cardiac atrium,,,50597,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,CHEMBL624832,1,BAO_0000218,11289,9614,,10116.0,2081.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cardiac atrium,,,50597,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,CHEMBL624833,1,BAO_0000218,11290,9614,,10116.0,2081.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,CHEMBL624834,1,BAO_0000218,11291,9614,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,CHEMBL624835,1,BAO_0000218,11292,9614,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,CHEMBL624836,1,BAO_0000218,11293,9614,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,CHEMBL624837,1,BAO_0000218,11294,9614,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,CHEMBL624838,1,BAO_0000218,11295,9071,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,CHEMBL622188,1,BAO_0000218,11296,9071,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,CHEMBL622189,1,BAO_0000218,11297,9071,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,CHEMBL622190,1,BAO_0000218,11298,9071,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,CHEMBL625170,1,BAO_0000218,11299,9071,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,CHEMBL625171,1,BAO_0000218,11300,9071,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,CHEMBL625172,1,BAO_0000218,11301,9071,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,CHEMBL625173,1,BAO_0000218,11302,9071,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,CHEMBL625174,1,BAO_0000218,11303,9071,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,CHEMBL625175,1,BAO_0000218,11304,9071,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,CHEMBL625176,1,BAO_0000218,11305,9071,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,CHEMBL625177,1,BAO_0000218,11306,9071,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,CHEMBL625178,1,BAO_0000218,11307,9071,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,CHEMBL625179,1,BAO_0000218,11308,9071,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,CHEMBL625180,1,BAO_0000218,11309,9071,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,CHEMBL625181,0,BAO_0000218,11310,10677,,,,,,
A,1,,,N,Intermediate,Urine,,,50594,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,CHEMBL625182,1,BAO_0000218,11311,9750,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,CHEMBL625183,1,BAO_0000218,11312,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,CHEMBL875848,1,BAO_0000218,11313,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,CHEMBL622260,1,BAO_0000218,11314,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,CHEMBL622261,1,BAO_0000218,11315,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,CHEMBL622262,1,BAO_0000218,11316,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,CHEMBL622263,1,BAO_0000218,11317,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,CHEMBL622418,1,BAO_0000218,11318,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,CHEMBL622419,1,BAO_0000218,11319,8319,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL623388,1,BAO_0000218,11320,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL623389,1,BAO_0000218,11321,13256,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL623390,1,BAO_0000218,11322,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL623391,1,BAO_0000218,11323,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL623392,1,BAO_0000218,11324,13256,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Cerebellum,,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL623393,1,BAO_0000218,11325,13256,,10090.0,2037.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL623394,1,BAO_0000218,11326,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL618885,1,BAO_0000218,11327,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL618886,1,BAO_0000218,11328,13256,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL618887,1,BAO_0000218,11329,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL619535,1,BAO_0000218,11330,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL619536,1,BAO_0000218,11331,13256,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Cerebellum,,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL619537,1,BAO_0000218,11332,13256,,10090.0,2037.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL619705,1,BAO_0000218,11333,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL619706,1,BAO_0000218,11334,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL619707,1,BAO_0000218,11335,13256,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL619708,1,BAO_0000218,11336,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625219,1,BAO_0000218,11337,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625220,1,BAO_0000218,11338,13256,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Cerebellum,,,50594,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625221,1,BAO_0000218,11339,13256,,10090.0,2037.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625222,1,BAO_0000218,11340,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625223,1,BAO_0000218,11341,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625224,1,BAO_0000218,11342,13256,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,CHEMBL625225,1,BAO_0000218,11343,13256,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in Rat blood after 24 hours of iv administration,In vivo,CHEMBL625226,1,BAO_0000218,11344,8829,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,In vivo,CHEMBL625227,1,BAO_0000218,11345,8829,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in Rat blood after 30 minutes of iv administration,In vivo,CHEMBL625228,1,BAO_0000218,11346,8829,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,In vivo,CHEMBL875354,1,BAO_0000218,11347,8829,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in Rat blood after 5 minutes of iv administration,In vivo,CHEMBL625229,1,BAO_0000218,11348,8829,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,In vivo,CHEMBL625230,1,BAO_0000218,11349,8829,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in Rat heart after 24 hours of iv administration,In vivo,CHEMBL625231,1,BAO_0000218,11350,8829,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,In vivo,CHEMBL625900,1,BAO_0000218,11351,8829,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in Rat heart after 30 minutes of iv administration,In vivo,CHEMBL625901,1,BAO_0000218,11352,8829,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,In vivo,CHEMBL625902,1,BAO_0000218,11353,8829,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in Rat heart after 5 minutes of iv administration,In vivo,CHEMBL625903,1,BAO_0000218,11354,8829,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,In vivo,CHEMBL625904,1,BAO_0000218,11355,8829,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 24 hours of iv administration,In vivo,CHEMBL625905,1,BAO_0000218,11356,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,In vivo,CHEMBL627861,1,BAO_0000218,11357,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,CHEMBL627862,1,BAO_0000218,11358,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,CHEMBL627863,1,BAO_0000218,11359,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,CHEMBL627769,1,BAO_0000218,11360,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,In vivo,CHEMBL627770,1,BAO_0000218,11361,13249,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,100710,Cmax in cynomolgus monkey (PO dose),In vivo,CHEMBL627771,1,BAO_0000218,11362,13622,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50597,Cmax in rat (PO dose),In vivo,CHEMBL627772,1,BAO_0000218,11363,13622,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax in rat (PO dose),In vivo,CHEMBL627773,1,BAO_0000218,11364,13622,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,In vivo,CHEMBL621922,1,BAO_0000218,11365,13494,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Cmax in rat plasma after oral dose (10 mg/kg),In vivo,CHEMBL621923,1,BAO_0000218,11366,12170,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Cmax in plasma after oral dose (10 mg/kg),In vivo,CHEMBL621924,0,BAO_0000218,11367,12170,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50588,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,In vivo,CHEMBL621925,1,BAO_0000218,11368,17025,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,In vivo,CHEMBL621926,0,BAO_0000218,11369,17025,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50592,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,In vivo,CHEMBL621927,1,BAO_0000218,11370,17025,,9986.0,1969.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,In vivo,CHEMBL621928,1,BAO_0000218,11371,17025,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,In vivo,CHEMBL621929,1,BAO_0000218,11372,14187,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50594,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,In vivo,CHEMBL621930,1,BAO_0000218,11373,14816,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration after oral dosing in rat,In vivo,CHEMBL621931,1,BAO_0000218,11374,17820,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,In vivo,CHEMBL621932,0,BAO_0000218,11375,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,CHEMBL621933,0,BAO_0000218,11376,14380,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50588,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,In vivo,CHEMBL621934,1,BAO_0000218,11377,14691,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,In vivo,CHEMBL621935,1,BAO_0000218,11378,14691,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,In vivo,CHEMBL621936,1,BAO_0000218,11379,13375,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was determined,In vivo,CHEMBL621937,0,BAO_0000218,11380,6236,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,CHEMBL621938,0,BAO_0000218,11381,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,CHEMBL621939,0,BAO_0000218,11382,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,In vivo,CHEMBL621940,0,BAO_0000218,11383,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,In vivo,CHEMBL621941,0,BAO_0000218,11384,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,In vivo,CHEMBL621942,0,BAO_0000218,11385,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,CHEMBL626178,0,BAO_0000218,11386,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,In vivo,CHEMBL626179,0,BAO_0000218,11387,14380,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,In vivo,CHEMBL626180,0,BAO_0000218,11388,14380,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,Plasma Cmax in rat (PO dose),In vivo,CHEMBL626181,1,BAO_0000218,11389,13622,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum serum concentration after po dose of 5.22 mg/kg in rats,In vivo,CHEMBL626182,1,BAO_0000218,11390,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum serum concentration after po dose of 5.46 mg/kg in rats,In vivo,CHEMBL626183,1,BAO_0000218,11391,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,In vivo,CHEMBL626184,1,BAO_0000218,11392,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,In vivo,CHEMBL626185,1,BAO_0000218,11393,15372,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,In vivo,CHEMBL626186,1,BAO_0000218,11394,14925,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,In vivo,CHEMBL877589,1,BAO_0000218,11395,14925,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Maximum concentration of the drug at 1 uM/dg administered intravenously,In vivo,CHEMBL626187,0,BAO_0000218,11396,11883,,,,,,
A,1,,,U,Autocuration,,,,22224,Maximum concentration of the drug at 20 uM/dg administered perorally,In vivo,CHEMBL626188,0,BAO_0000218,11397,11883,,,,,,
A,1,,,U,Autocuration,,,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,In vivo,CHEMBL626189,0,BAO_0000218,11398,13391,,,,,,
A,1,,,U,Autocuration,Blood,,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,CHEMBL626855,0,BAO_0000218,11399,13391,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,In vivo,CHEMBL623781,0,BAO_0000218,11400,13391,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,CHEMBL623782,0,BAO_0000218,11401,13391,,,178.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,In vivo,CHEMBL623783,1,BAO_0000218,11402,16360,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Cmax in dog plasma after 1mg/kg oral dose,In vivo,CHEMBL623784,1,BAO_0000218,11403,3673,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,In vivo,CHEMBL623785,1,BAO_0000218,11404,14431,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,In vivo,CHEMBL623786,1,BAO_0000218,11405,14431,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral maximum concentration in rat,In vivo,CHEMBL623787,1,BAO_0000218,11406,14964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral maximum concentration in rat,In vivo,CHEMBL623788,1,BAO_0000218,11407,14964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50594,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,In vivo,CHEMBL623789,1,BAO_0000218,11408,14209,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Peak concentration in blood after intravenous administration to mice,In vivo,CHEMBL623790,1,BAO_0000218,11409,11355,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Peak concentration in blood after peroral administration to mice,In vivo,CHEMBL623791,1,BAO_0000218,11410,11355,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50597,Peak concentration in rat plasma was determined,In vivo,CHEMBL623792,1,BAO_0000218,11411,11966,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,CHEMBL623793,0,BAO_0000218,11412,8918,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50594,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,CHEMBL623794,1,BAO_0000218,11413,8918,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,CHEMBL623795,1,BAO_0000218,11414,8918,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,CHEMBL623796,1,BAO_0000218,11415,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,CHEMBL623797,1,BAO_0000218,11416,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,CHEMBL623798,1,BAO_0000218,11417,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,CHEMBL623799,1,BAO_0000218,11418,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,CHEMBL624490,1,BAO_0000218,11419,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,CHEMBL624491,1,BAO_0000218,11420,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,CHEMBL624492,1,BAO_0000218,11421,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,CHEMBL624493,1,BAO_0000218,11422,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,CHEMBL877595,1,BAO_0000218,11423,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,CHEMBL624494,1,BAO_0000218,11424,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,CHEMBL624495,1,BAO_0000218,11425,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,CHEMBL624681,1,BAO_0000218,11426,8684,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,CHEMBL624682,1,BAO_0000218,11427,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,CHEMBL624683,1,BAO_0000218,11428,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,CHEMBL624684,1,BAO_0000218,11429,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,CHEMBL624685,1,BAO_0000218,11430,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,CHEMBL624686,1,BAO_0000218,11431,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,CHEMBL624687,1,BAO_0000218,11432,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,CHEMBL624688,1,BAO_0000218,11433,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,CHEMBL627161,1,BAO_0000218,11434,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,CHEMBL622127,1,BAO_0000218,11435,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,CHEMBL622128,1,BAO_0000218,11436,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,CHEMBL874384,1,BAO_0000218,11437,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,CHEMBL624898,1,BAO_0000218,11438,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,CHEMBL624899,1,BAO_0000218,11439,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,CHEMBL624900,1,BAO_0000218,11440,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,CHEMBL624901,1,BAO_0000218,11441,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,CHEMBL624902,1,BAO_0000218,11442,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,CHEMBL624903,1,BAO_0000218,11443,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,CHEMBL624904,1,BAO_0000218,11444,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,CHEMBL624905,1,BAO_0000218,11445,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,CHEMBL624906,1,BAO_0000218,11446,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,CHEMBL624907,1,BAO_0000218,11447,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,CHEMBL624908,1,BAO_0000218,11448,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,CHEMBL624909,1,BAO_0000218,11449,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,CHEMBL624910,1,BAO_0000218,11450,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,CHEMBL624911,1,BAO_0000218,11451,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,CHEMBL874388,1,BAO_0000218,11452,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,CHEMBL624912,1,BAO_0000218,11453,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,CHEMBL622930,1,BAO_0000218,11454,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,CHEMBL623121,1,BAO_0000218,11455,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,CHEMBL623122,1,BAO_0000218,11456,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,CHEMBL623123,1,BAO_0000218,11457,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,CHEMBL623124,1,BAO_0000218,11458,8684,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,CHEMBL623125,1,BAO_0000218,11459,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,CHEMBL623126,1,BAO_0000218,11460,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,CHEMBL623127,1,BAO_0000218,11461,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,CHEMBL623128,1,BAO_0000218,11462,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,CHEMBL623129,1,BAO_0000218,11463,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,CHEMBL623130,1,BAO_0000218,11464,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,CHEMBL623131,1,BAO_0000218,11465,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,CHEMBL623132,1,BAO_0000218,11466,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,CHEMBL623133,1,BAO_0000218,11467,8319,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,CHEMBL623134,1,BAO_0000218,11468,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,CHEMBL874389,1,BAO_0000218,11469,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,CHEMBL623135,1,BAO_0000218,11470,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,CHEMBL623136,1,BAO_0000218,11471,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,CHEMBL623137,1,BAO_0000218,11472,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,CHEMBL623138,1,BAO_0000218,11473,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,CHEMBL623139,1,BAO_0000218,11474,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,CHEMBL623140,1,BAO_0000218,11475,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,CHEMBL623141,1,BAO_0000218,11476,8319,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,CHEMBL623142,1,BAO_0000218,11477,8319,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,CHEMBL623143,1,BAO_0000218,11478,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50594,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,CHEMBL623144,1,BAO_0000218,11479,14571,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50597,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,CHEMBL623405,1,BAO_0000218,11480,14571,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,CHEMBL624074,1,BAO_0000218,11481,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,CHEMBL624075,1,BAO_0000218,11482,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,CHEMBL624076,1,BAO_0000218,11483,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,CHEMBL624077,1,BAO_0000218,11484,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,CHEMBL624078,1,BAO_0000218,11485,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,CHEMBL624079,1,BAO_0000218,11486,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,CHEMBL624261,1,BAO_0000218,11487,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,CHEMBL624262,1,BAO_0000218,11488,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,CHEMBL624263,1,BAO_0000218,11489,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,CHEMBL624264,1,BAO_0000218,11490,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,CHEMBL624265,1,BAO_0000218,11491,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,CHEMBL624266,1,BAO_0000218,11492,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,CHEMBL624267,1,BAO_0000218,11493,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,CHEMBL624268,1,BAO_0000218,11494,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,CHEMBL875227,1,BAO_0000218,11495,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,CHEMBL624269,1,BAO_0000218,11496,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,CHEMBL624270,1,BAO_0000218,11497,8319,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,CHEMBL624271,1,BAO_0000218,11498,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,CHEMBL624272,1,BAO_0000218,11499,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,CHEMBL624273,1,BAO_0000218,11500,8319,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,CHEMBL624274,1,BAO_0000218,11501,12064,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,CHEMBL624275,1,BAO_0000218,11502,12064,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,CHEMBL624276,1,BAO_0000218,11503,12064,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,CHEMBL624277,1,BAO_0000218,11504,12038,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,% dose converted to 2-amino-5-chlorophenyl sulfate,,CHEMBL624278,0,BAO_0000019,11505,14314,,,,,,
A,1,,,U,Autocuration,,,,22224,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,CHEMBL624279,0,BAO_0000019,11506,14314,,,,,,
A,1,,,N,Intermediate,Feces,,,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,CHEMBL624280,1,BAO_0000218,11507,11488,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,CHEMBL624281,1,BAO_0000218,11508,11488,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,CHEMBL622933,1,BAO_0000218,11509,11488,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,CHEMBL622934,1,BAO_0000218,11510,11488,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,CHEMBL622935,1,BAO_0000218,11511,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 5 minutes of iv administration,In vivo,CHEMBL622936,1,BAO_0000218,11512,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,In vivo,CHEMBL875228,1,BAO_0000218,11513,8829,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in Rat lung after 24 hours of iv administration,In vivo,CHEMBL622937,1,BAO_0000218,11514,8829,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,In vivo,CHEMBL622938,1,BAO_0000218,11515,8829,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in Rat lung after 30 minutes of iv administration,In vivo,CHEMBL619736,1,BAO_0000218,11516,8829,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,In vivo,CHEMBL625117,1,BAO_0000218,11517,8829,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in Rat lung after 5 minutes of iv administration,In vivo,CHEMBL625118,1,BAO_0000218,11518,8829,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,In vivo,CHEMBL625119,1,BAO_0000218,11519,8829,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",In vivo,CHEMBL625120,1,BAO_0000218,11520,14972,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",In vivo,CHEMBL625121,1,BAO_0000218,11521,14972,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Thalamus,,,50597,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",In vivo,CHEMBL625122,1,BAO_0000218,11522,14972,,10116.0,10000006.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL622204,1,BAO_0000218,11523,14608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL877503,1,BAO_0000218,11524,14608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL627127,1,BAO_0000218,11525,14608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Hippocampus,,,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL627128,0,BAO_0000218,11526,14608,,,10000000.0,,,
A,1,,,U,Autocuration,Hippocampus,,,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL627129,0,BAO_0000218,11527,14608,,,10000000.0,,,
A,1,,,U,Autocuration,Hippocampus,,,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL627130,0,BAO_0000218,11528,14608,,,10000000.0,,,
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL627131,1,BAO_0000218,11529,14608,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL627132,1,BAO_0000218,11530,14608,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL627133,1,BAO_0000218,11531,14608,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL627134,1,BAO_0000218,11532,14608,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL627135,1,BAO_0000218,11533,14608,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL627136,1,BAO_0000218,11534,14608,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL628435,1,BAO_0000218,11535,14608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL628436,1,BAO_0000218,11536,14608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL628437,1,BAO_0000218,11537,14608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL628438,1,BAO_0000218,11538,14608,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL628439,1,BAO_0000218,11539,14608,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL628440,1,BAO_0000218,11540,14608,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL628441,1,BAO_0000218,11541,14608,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL628442,1,BAO_0000218,11542,14608,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL628443,1,BAO_0000218,11543,14608,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL628444,1,BAO_0000218,11544,14608,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL628445,1,BAO_0000218,11545,14608,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL877504,1,BAO_0000218,11546,14608,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL628446,1,BAO_0000218,11547,14608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL626874,1,BAO_0000218,11548,14608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL626875,1,BAO_0000218,11549,14608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL626876,1,BAO_0000218,11550,14608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL626877,1,BAO_0000218,11551,14608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL626878,1,BAO_0000218,11552,14608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL626879,1,BAO_0000218,11553,14608,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,CHEMBL626880,0,BAO_0000218,11554,8918,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50594,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,CHEMBL626881,1,BAO_0000218,11555,8918,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50597,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,CHEMBL626882,1,BAO_0000218,11556,8918,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Peak plasma concentration was measured in dogs,In vivo,CHEMBL626883,1,BAO_0000218,11557,14470,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,CHEMBL626884,1,BAO_0000218,11558,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,CHEMBL626885,1,BAO_0000218,11559,14886,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,CHEMBL626886,1,BAO_0000218,11560,14886,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,CHEMBL626887,1,BAO_0000218,11561,14886,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,CHEMBL626888,1,BAO_0000218,11562,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,In vivo,CHEMBL626889,1,BAO_0000218,11563,13465,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,In vivo,CHEMBL626761,0,BAO_0000218,11564,13465,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,In vivo,CHEMBL626762,1,BAO_0000218,11565,13465,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,In vivo,CHEMBL626763,1,BAO_0000218,11566,13465,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,In vivo,CHEMBL626764,1,BAO_0000218,11567,13465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,In vivo,CHEMBL626765,1,BAO_0000218,11568,13465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,In vivo,CHEMBL626766,1,BAO_0000218,11569,13465,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,In vivo,CHEMBL626767,1,BAO_0000218,11570,13465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,In vivo,CHEMBL626768,1,BAO_0000218,11571,13465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,In vivo,CHEMBL626769,1,BAO_0000218,11572,13465,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,In vivo,CHEMBL874463,1,BAO_0000218,11573,13465,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,In vivo,CHEMBL626770,0,BAO_0000218,11574,13465,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,In vivo,CHEMBL626771,0,BAO_0000218,11575,13465,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,In vivo,CHEMBL626772,1,BAO_0000218,11576,13465,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,In vivo,CHEMBL626773,1,BAO_0000218,11577,14731,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,In vivo,CHEMBL626774,1,BAO_0000218,11578,14731,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,In vivo,CHEMBL626775,1,BAO_0000218,11579,13376,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,In vivo,CHEMBL626776,1,BAO_0000218,11580,13376,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Maximum concentration (Cmax) in rat when administered orally,In vivo,CHEMBL626777,1,BAO_0000218,11581,14443,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Maximal concentration in monkey plasma after 25 mg/kg oral dose,In vivo,CHEMBL626778,0,BAO_0000218,11582,13465,,314293.0,1969.0,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",In vivo,CHEMBL626779,0,BAO_0000218,11583,16359,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",In vivo,CHEMBL626780,0,BAO_0000218,11584,16359,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,In vivo,CHEMBL626781,0,BAO_0000218,11585,15618,,,1969.0,,,
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic profile Cmax was evaluated in rats,In vivo,CHEMBL632164,1,BAO_0000218,11586,14554,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),In vivo,CHEMBL632165,1,BAO_0000218,11587,11537,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),In vivo,CHEMBL632166,1,BAO_0000218,11588,11537,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),In vivo,CHEMBL632167,1,BAO_0000218,11589,11537,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),In vivo,CHEMBL632168,1,BAO_0000218,11590,11537,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,Plasma,,,22224,Cmax in rat plasma,In vivo,CHEMBL632169,0,BAO_0000218,11591,2021,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Cmax in dog plasma after 30mg/kg oral dose,In vivo,CHEMBL632170,1,BAO_0000218,11592,5932,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Cmax in rat plasma after 30mg/kg oral dose,In vivo,CHEMBL632171,1,BAO_0000218,11593,5932,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma level in rats at 30 mg/kg,In vivo,CHEMBL632172,1,BAO_0000218,11594,17320,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50594,Tested for maximum plasma concentration in mice,In vivo,CHEMBL632173,1,BAO_0000218,11595,15831,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,CHEMBL632174,1,BAO_0000218,11596,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The Cmax values in female wistar rats.,In vivo,CHEMBL632175,1,BAO_0000218,11597,14941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,In vivo,CHEMBL632176,1,BAO_0000218,11598,15343,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,In vivo,CHEMBL632177,1,BAO_0000218,11599,15343,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,In vivo,CHEMBL632178,1,BAO_0000218,11600,14856,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,CHEMBL632179,1,BAO_0000218,11601,13129,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,In vivo,CHEMBL632180,1,BAO_0000218,11602,13098,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,In vivo,CHEMBL632181,1,BAO_0000218,11603,13098,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,In vivo,CHEMBL632182,1,BAO_0000218,11604,13098,,10116.0,178.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Blood,,,22224,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,In vivo,CHEMBL632183,0,BAO_0000218,11605,15478,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,In vivo,CHEMBL632184,1,BAO_0000218,11606,15341,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,In vivo,CHEMBL874470,1,BAO_0000218,11607,15341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,CHEMBL631302,1,BAO_0000218,11608,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,CHEMBL631303,1,BAO_0000218,11609,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,CHEMBL631304,1,BAO_0000218,11610,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,CHEMBL631305,1,BAO_0000218,11611,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,CHEMBL631306,1,BAO_0000218,11612,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,CHEMBL631307,1,BAO_0000218,11613,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,CHEMBL631308,1,BAO_0000218,11614,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,CHEMBL625557,1,BAO_0000218,11615,8684,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,CHEMBL625558,1,BAO_0000218,11616,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,CHEMBL625559,1,BAO_0000218,11617,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,CHEMBL625560,1,BAO_0000218,11618,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,CHEMBL625561,1,BAO_0000218,11619,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,CHEMBL625562,1,BAO_0000218,11620,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,CHEMBL875320,1,BAO_0000218,11621,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,CHEMBL625563,1,BAO_0000218,11622,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,CHEMBL625564,1,BAO_0000218,11623,8684,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,CHEMBL625565,1,BAO_0000218,11624,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,CHEMBL625566,1,BAO_0000218,11625,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,CHEMBL625567,1,BAO_0000218,11626,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,CHEMBL625568,1,BAO_0000218,11627,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,CHEMBL628217,1,BAO_0000218,11628,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,CHEMBL628218,1,BAO_0000218,11629,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,CHEMBL628219,1,BAO_0000218,11630,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,CHEMBL628220,1,BAO_0000218,11631,8684,,10116.0,995.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Distribution in the blood after 120 min of intravenous administration,,CHEMBL628221,0,BAO_0000019,11632,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the blood after 15 min of intravenous administration,,CHEMBL628222,0,BAO_0000019,11633,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the blood after 30 min of intravenous administration,,CHEMBL628223,0,BAO_0000019,11634,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the blood after 5 min of intravenous administration,,CHEMBL628224,0,BAO_0000019,11635,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the blood after 60 min of intravenous administration,,CHEMBL628225,0,BAO_0000019,11636,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the blood after 90 min of intravenous administration,,CHEMBL628226,0,BAO_0000019,11637,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the bone after 120 min of intravenous administration,,CHEMBL628227,0,BAO_0000019,11638,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the bone after 15 min of intravenous administration,,CHEMBL875481,0,BAO_0000019,11639,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the bone after 30 min of intravenous administration,,CHEMBL628228,0,BAO_0000019,11640,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the bone after 5 min of intravenous administration,,CHEMBL628229,0,BAO_0000019,11641,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the bone after 60 min of intravenous administration,,CHEMBL628230,0,BAO_0000019,11642,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the bone after 90 min of intravenous administration,,CHEMBL628231,0,BAO_0000019,11643,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the heart after 120 min of intravenous administration,,CHEMBL628232,0,BAO_0000019,11644,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the heart after 15 min of intravenous administration,,CHEMBL628233,0,BAO_0000019,11645,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the heart after 30 min of intravenous administration,,CHEMBL628234,0,BAO_0000019,11646,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the heart after 5 min of intravenous administration,,CHEMBL628235,0,BAO_0000019,11647,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the heart after 60 min of intravenous administration,,CHEMBL628236,0,BAO_0000019,11648,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the heart after 90 min of intravenous administration,,CHEMBL628237,0,BAO_0000019,11649,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the kidneys after 120 min of intravenous administration,,CHEMBL628238,0,BAO_0000019,11650,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the kidneys after 15 min of intravenous administration,,CHEMBL628239,0,BAO_0000019,11651,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the kidneys after 30 min of intravenous administration,,CHEMBL628240,0,BAO_0000019,11652,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the kidneys after 5 min of intravenous administration,,CHEMBL628241,0,BAO_0000019,11653,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the kidneys after 60 min of intravenous administration,,CHEMBL628242,0,BAO_0000019,11654,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the kidneys after 90 min of intravenous administration,,CHEMBL875482,0,BAO_0000019,11655,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the liver after 120 min of intravenous administration,,CHEMBL628243,0,BAO_0000019,11656,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the liver after 15 min of intravenous administration,,CHEMBL628244,0,BAO_0000019,11657,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the liver after 30 min of intravenous administration,,CHEMBL628245,0,BAO_0000019,11658,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the liver after 5 min of intravenous administration,,CHEMBL628246,0,BAO_0000019,11659,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the liver after 60 min of intravenous administration,,CHEMBL628247,0,BAO_0000019,11660,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the liver after 90 min of intravenous administration,,CHEMBL628248,0,BAO_0000019,11661,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the lung after 120 min of intravenous administration,,CHEMBL628249,0,BAO_0000019,11662,8926,,,,,,
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,CHEMBL625452,1,BAO_0000218,11663,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,CHEMBL625453,1,BAO_0000218,11664,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,CHEMBL625454,1,BAO_0000218,11665,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,CHEMBL623844,1,BAO_0000218,11666,14839,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,CHEMBL623845,1,BAO_0000218,11667,12178,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,CHEMBL623846,1,BAO_0000218,11668,12178,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,CHEMBL623847,0,BAO_0000218,11669,12178,,,,,,
A,1,,,N,Intermediate,,,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,CHEMBL623848,1,BAO_0000218,11670,12186,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,CHEMBL623849,1,BAO_0000218,11671,12186,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,CHEMBL623850,1,BAO_0000218,11672,12186,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,CHEMBL623851,1,BAO_0000218,11673,12186,,9541.0,,,,Macaca fascicularis
A,1,,,U,Autocuration,,,,22224,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,CHEMBL623852,0,BAO_0000218,11674,12187,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50506,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,CHEMBL624551,1,BAO_0000218,11675,12187,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,CHEMBL624552,1,BAO_0000218,11676,12187,,9669.0,,,,Mustela putorius furo
A,1,,,U,Autocuration,,,,22224,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,CHEMBL624553,0,BAO_0000218,11677,12187,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,CHEMBL624554,0,BAO_0000218,11678,12187,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,CHEMBL624555,1,BAO_0000218,11679,12187,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,CHEMBL624741,1,BAO_0000218,11680,12187,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,CHEMBL624742,1,BAO_0000218,11681,14122,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,100712,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,CHEMBL624743,1,BAO_0000218,11682,14122,,10026.0,,,,Cricetinae
A,1,,,N,Intermediate,,,,50597,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,CHEMBL877606,1,BAO_0000218,11683,14122,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,CHEMBL624744,0,BAO_0000218,11684,13391,,,,,,
A,1,,,U,Autocuration,Blood,,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL624745,0,BAO_0000218,11685,13391,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL624746,0,BAO_0000218,11686,13391,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL624747,0,BAO_0000218,11687,13391,,,178.0,,,
A,1,,,U,Autocuration,,,,22224,Oral absorption expressed as Area under curve was determined,,CHEMBL624748,0,BAO_0000019,11688,16360,,,,,,
A,1,,,N,Intermediate,,,,50588,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,CHEMBL622504,1,BAO_0000218,11689,3673,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,CHEMBL622505,1,BAO_0000218,11690,14122,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,100712,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,CHEMBL622506,1,BAO_0000218,11691,14122,,10026.0,,,,Cricetinae
A,1,,,N,Intermediate,,,,100712,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,CHEMBL622507,1,BAO_0000218,11692,14122,,10026.0,,,,Cricetinae
A,1,,,N,Intermediate,,,,50597,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,CHEMBL622508,1,BAO_0000218,11693,14122,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,CHEMBL622509,0,BAO_0000019,11694,13889,,,,,,
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,CHEMBL622510,1,BAO_0000218,11695,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,CHEMBL622511,1,BAO_0000218,11696,17279,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,CHEMBL622512,1,BAO_0000218,11697,14548,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,CHEMBL622513,1,BAO_0000218,11698,14548,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,CHEMBL622514,1,BAO_0000218,11699,14548,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,CHEMBL622515,1,BAO_0000218,11700,14548,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,CHEMBL622516,1,BAO_0000218,11701,14548,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,CHEMBL622517,1,BAO_0000218,11702,14548,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,CHEMBL622518,1,BAO_0000218,11703,14548,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,CHEMBL622519,1,BAO_0000218,11704,14548,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL622520,1,BAO_0000218,11705,14608,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL622521,1,BAO_0000218,11706,14608,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50594,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL625113,1,BAO_0000218,11707,14608,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL625114,1,BAO_0000218,11708,14608,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL874397,1,BAO_0000218,11709,14608,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL625115,1,BAO_0000218,11710,14608,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL625116,1,BAO_0000218,11711,14608,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL623932,1,BAO_0000218,11712,14608,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL623933,1,BAO_0000218,11713,14608,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL623934,1,BAO_0000218,11714,14608,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL623935,1,BAO_0000218,11715,14608,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,CHEMBL623936,1,BAO_0000218,11716,14608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,CHEMBL623937,1,BAO_0000218,11717,14608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,CHEMBL623938,1,BAO_0000218,11718,14608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL623939,1,BAO_0000218,11719,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,CHEMBL623940,1,BAO_0000218,11720,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,CHEMBL623941,1,BAO_0000218,11721,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL627216,1,BAO_0000218,11722,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL623942,1,BAO_0000218,11723,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL618793,1,BAO_0000218,11724,15383,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL618794,1,BAO_0000218,11725,15383,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL618795,1,BAO_0000218,11726,15383,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL618796,1,BAO_0000218,11727,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL618797,1,BAO_0000218,11728,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,CHEMBL618798,1,BAO_0000218,11729,15383,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL618799,1,BAO_0000218,11730,15383,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,CHEMBL618800,1,BAO_0000218,11731,15383,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,CHEMBL618801,1,BAO_0000218,11732,15383,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL618802,1,BAO_0000218,11733,15383,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL618803,1,BAO_0000218,11734,15383,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,CHEMBL618804,1,BAO_0000218,11735,15383,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL618805,1,BAO_0000218,11736,15383,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,CHEMBL618806,1,BAO_0000218,11737,15383,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,CHEMBL618807,1,BAO_0000218,11738,15383,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL618808,1,BAO_0000218,11739,15383,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL618809,1,BAO_0000218,11740,15383,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL618810,1,BAO_0000218,11741,15383,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,CHEMBL618811,1,BAO_0000218,11742,15383,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,CHEMBL875844,1,BAO_0000218,11743,15383,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL618812,1,BAO_0000218,11744,15383,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,Muscle tissue,,,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL618813,1,BAO_0000218,11745,15383,,10090.0,2385.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL618814,1,BAO_0000218,11746,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL618815,1,BAO_0000218,11747,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL618816,1,BAO_0000218,11748,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL618817,1,BAO_0000218,11749,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL620544,1,BAO_0000218,11750,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,In vivo,CHEMBL626230,1,BAO_0000218,11751,15341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,CHEMBL626231,1,BAO_0000218,11752,15341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,In vivo,CHEMBL626232,1,BAO_0000218,11753,15341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,In vivo,CHEMBL626233,1,BAO_0000218,11754,14906,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,In vivo,CHEMBL626234,1,BAO_0000218,11755,14906,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,In vivo,CHEMBL875341,1,BAO_0000218,11756,14906,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50587,The maximum plasma concentration (100 mg/kg) administered orally in human,In vivo,CHEMBL626235,1,BAO_0000218,11757,14215,,9606.0,1969.0,,,Homo sapiens
A,1,,,U,Autocuration,Plasma,,,22224,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,In vivo,CHEMBL626236,0,BAO_0000218,11758,14215,,9481.0,1969.0,,,Callithrix
A,1,,,U,Autocuration,Plasma,,,22224,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,In vivo,CHEMBL626237,0,BAO_0000218,11759,14215,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50588,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,In vivo,CHEMBL626238,1,BAO_0000218,11760,14215,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50587,The maximum plasma concentration (200 mg/kg) administered orally in human,In vivo,CHEMBL622412,1,BAO_0000218,11761,14215,,9606.0,1969.0,,,Homo sapiens
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,In vivo,CHEMBL623114,1,BAO_0000218,11762,14215,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,In vivo,CHEMBL623115,0,BAO_0000218,11763,14215,,9481.0,1969.0,,,Callithrix
A,1,,,U,Autocuration,Plasma,,,22224,The maximum plasma concentration (25 mg/kg) administered orally in monkey,In vivo,CHEMBL623116,0,BAO_0000218,11764,14215,,314293.0,1969.0,,,Simiiformes
A,1,,,U,Autocuration,Plasma,,,22224,The maximum plasma concentration (30 mg/kg) administered orally in dog,In vivo,CHEMBL623117,0,BAO_0000218,11765,14215,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50587,The maximum plasma concentration (400 mg/kg) administered orally in human,In vivo,CHEMBL623118,1,BAO_0000218,11766,14215,,9606.0,1969.0,,,Homo sapiens
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,In vivo,CHEMBL623119,1,BAO_0000218,11767,14215,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma concentration (50 mg/kg) administered orally in rat,In vivo,CHEMBL623120,1,BAO_0000218,11768,14215,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50587,The maximum plasma concentration (800 mg/kg) administered orally in human,In vivo,CHEMBL623286,1,BAO_0000218,11769,14215,,9606.0,1969.0,,,Homo sapiens
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma concentration was measured on rats,In vivo,CHEMBL623287,1,BAO_0000218,11770,14067,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The maximum plasma concentration was measured on rats after oral administration,In vivo,CHEMBL623288,1,BAO_0000218,11771,12350,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Plasma drug Cmax in rat (PO dose),In vivo,CHEMBL623289,1,BAO_0000218,11772,14813,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,In vivo,CHEMBL623290,0,BAO_0000218,11773,12536,,,,,,
A,1,,,N,Intermediate,Plasma,,,50588,maximum Plasma concentration in Dog was determined after Peroral administration,In vivo,CHEMBL623291,1,BAO_0000218,11774,14169,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,maximum Plasma concentration in Rats was determined after Peroral administration,In vivo,CHEMBL623292,1,BAO_0000218,11775,14169,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,In vivo,CHEMBL623293,1,BAO_0000218,11776,15604,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,In vivo,CHEMBL623294,0,BAO_0000218,11777,15604,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50597,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,In vivo,CHEMBL623295,1,BAO_0000218,11778,15604,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,maximum concentration was measured when administered through oral route in mice,In vivo,CHEMBL623296,1,BAO_0000218,11779,14387,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,CHEMBL875349,1,BAO_0000218,11780,15115,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,CHEMBL623297,0,BAO_0000019,11781,15115,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,CHEMBL623298,0,BAO_0000019,11782,15115,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,CHEMBL623299,0,BAO_0000019,11783,15115,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter was evaluated in rats,,CHEMBL623300,1,BAO_0000218,11784,16359,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,CHEMBL623301,1,BAO_0000218,11785,12829,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,CHEMBL623302,1,BAO_0000218,11786,12829,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,CHEMBL623303,1,BAO_0000218,11787,12829,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,CHEMBL623304,1,BAO_0000218,11788,12829,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,CHEMBL623305,1,BAO_0000218,11789,12829,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,CHEMBL623306,1,BAO_0000218,11790,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,CHEMBL623307,1,BAO_0000218,11791,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,CHEMBL623308,1,BAO_0000218,11792,15137,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50594,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,CHEMBL623309,1,BAO_0000218,11793,15137,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Plasma Concentration after 120 min of oral administration to mice,,CHEMBL623310,1,BAO_0000218,11794,13509,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Plasma Concentration after 30 min of oral administration to mice,,CHEMBL623311,1,BAO_0000218,11795,13509,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,100710,Plasma Concentration after 60 min of oral administration to mice,,CHEMBL623312,1,BAO_0000218,11796,13509,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50594,Plasma Concentration after 60 min of oral administration to mice; Not determined,,CHEMBL875350,1,BAO_0000218,11797,13509,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Plasma Concentration after 90 min of oral administration to mice,,CHEMBL628635,1,BAO_0000218,11798,13509,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,CHEMBL628636,1,BAO_0000218,11799,12064,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,CHEMBL628637,1,BAO_0000218,11800,12064,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,CHEMBL628058,1,BAO_0000218,11801,12064,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,CHEMBL628059,1,BAO_0000218,11802,10677,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,CHEMBL628060,1,BAO_0000218,11803,10677,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Distribution in the lung after 15 min of intravenous administration,,CHEMBL628061,0,BAO_0000019,11804,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the lung after 30 min of intravenous administration,,CHEMBL628062,0,BAO_0000019,11805,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the lung after 5 min of intravenous administration,,CHEMBL628063,0,BAO_0000019,11806,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the lung after 60 min of intravenous administration,,CHEMBL628064,0,BAO_0000019,11807,8926,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution in the lung after 90 min of intravenous administration,,CHEMBL628065,0,BAO_0000019,11808,8926,,,,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,Distribution in the muscle after 120 min of intravenous administration,,CHEMBL628066,0,BAO_0000019,11809,8926,,,2385.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,Distribution in the muscle after 15 min of intravenous administration,,CHEMBL628067,0,BAO_0000019,11810,8926,,,2385.0,,,
A,1,,,N,Intermediate,Muscle tissue,,,50594,Distribution in the muscle after 30 min of intravenous administration,,CHEMBL874646,1,BAO_0000218,11811,8926,,10090.0,2385.0,,,Mus musculus
A,1,,,U,Autocuration,Muscle tissue,,,22224,Distribution in the muscle after 5 min of intravenous administration,,CHEMBL628068,0,BAO_0000019,11812,8926,,,2385.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,Distribution in the muscle after 60 min of intravenous administration,,CHEMBL628069,0,BAO_0000019,11813,8926,,,2385.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,Distribution in the muscle after 90 min of intravenous administration,,CHEMBL628070,0,BAO_0000019,11814,8926,,,2385.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,Distribution in the spleen after 120 min of intravenous administration,,CHEMBL628071,0,BAO_0000019,11815,8926,,,2106.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,Distribution in the spleen after 15 min of intravenous administration,,CHEMBL628072,0,BAO_0000019,11816,8926,,,2106.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,Distribution in the spleen after 30 min of intravenous administration,,CHEMBL628073,0,BAO_0000019,11817,8926,,,2106.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,Distribution in the spleen after 5 min of intravenous administration,,CHEMBL628074,0,BAO_0000019,11818,8926,,,2106.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,Distribution in the spleen after 60 min of intravenous administration,,CHEMBL628075,0,BAO_0000019,11819,8926,,,2106.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,Distribution in the spleen after 90 min of intravenous administration,,CHEMBL628076,0,BAO_0000019,11820,8926,,,2106.0,,,
A,1,,,N,Intermediate,Adrenal cortex,,,50597,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,CHEMBL628077,1,BAO_0000218,11821,7570,,10116.0,1235.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,CHEMBL628078,1,BAO_0000218,11822,7570,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,CHEMBL628079,1,BAO_0000218,11823,7570,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,CHEMBL628080,1,BAO_0000218,11824,7570,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,CHEMBL628081,1,BAO_0000218,11825,7570,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Adrenal cortex,,,50597,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,CHEMBL628082,1,BAO_0000218,11826,7570,,10116.0,1235.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,CHEMBL874647,1,BAO_0000218,11827,7570,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,CHEMBL626406,1,BAO_0000218,11828,7570,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,CHEMBL626407,1,BAO_0000218,11829,7570,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,CHEMBL626408,1,BAO_0000218,11830,7570,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,CHEMBL626409,1,BAO_0000218,11831,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,CHEMBL626410,1,BAO_0000218,11832,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,CHEMBL626411,1,BAO_0000218,11833,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,CHEMBL626412,1,BAO_0000218,11834,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,CHEMBL626413,1,BAO_0000218,11835,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,CHEMBL626414,1,BAO_0000218,11836,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,CHEMBL626415,1,BAO_0000218,11837,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,CHEMBL626416,1,BAO_0000218,11838,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,CHEMBL627062,1,BAO_0000218,11839,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,CHEMBL627063,1,BAO_0000218,11840,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,CHEMBL627064,1,BAO_0000218,11841,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,CHEMBL627227,1,BAO_0000218,11842,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,CHEMBL627228,1,BAO_0000218,11843,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,CHEMBL627229,1,BAO_0000218,11844,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,CHEMBL625792,1,BAO_0000218,11845,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,CHEMBL625793,1,BAO_0000218,11846,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,CHEMBL625794,1,BAO_0000218,11847,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,CHEMBL625795,1,BAO_0000218,11848,8608,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,CHEMBL625796,1,BAO_0000218,11849,13792,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,CHEMBL625797,1,BAO_0000218,11850,13376,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,CHEMBL625798,1,BAO_0000218,11851,13376,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,CHEMBL875613,0,BAO_0000218,11852,14380,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,CHEMBL625799,0,BAO_0000218,11853,14380,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,CHEMBL625800,0,BAO_0000218,11854,14380,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,CHEMBL625801,0,BAO_0000218,11855,14380,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,CHEMBL625802,0,BAO_0000218,11856,14380,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,CHEMBL625803,0,BAO_0000218,11857,14380,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,CHEMBL625804,0,BAO_0000019,11858,14380,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,CHEMBL622530,0,BAO_0000218,11859,14380,,,,,,
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,CHEMBL622531,1,BAO_0000218,11860,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,CHEMBL622532,1,BAO_0000218,11861,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,CHEMBL623176,1,BAO_0000218,11862,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,CHEMBL623177,1,BAO_0000218,11863,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,CHEMBL623178,1,BAO_0000218,11864,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,CHEMBL623179,1,BAO_0000218,11865,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,CHEMBL623180,1,BAO_0000218,11866,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,CHEMBL623181,1,BAO_0000218,11867,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,CHEMBL624131,1,BAO_0000218,11868,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,CHEMBL624132,1,BAO_0000218,11869,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,CHEMBL624133,1,BAO_0000218,11870,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,CHEMBL624846,1,BAO_0000218,11871,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,CHEMBL624847,1,BAO_0000218,11872,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,CHEMBL624848,1,BAO_0000218,11873,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,CHEMBL625012,1,BAO_0000218,11874,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,CHEMBL625013,1,BAO_0000218,11875,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,CHEMBL625014,1,BAO_0000218,11876,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,CHEMBL625015,1,BAO_0000218,11877,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,CHEMBL625016,1,BAO_0000218,11878,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,CHEMBL625017,1,BAO_0000218,11879,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,CHEMBL625018,1,BAO_0000218,11880,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,CHEMBL625019,1,BAO_0000218,11881,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,CHEMBL625020,1,BAO_0000218,11882,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,CHEMBL625021,1,BAO_0000218,11883,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,CHEMBL625022,1,BAO_0000218,11884,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,CHEMBL625023,1,BAO_0000218,11885,14731,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,CHEMBL625024,1,BAO_0000218,11886,14731,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,CHEMBL627626,1,BAO_0000218,11887,14731,,9541.0,,,,Macaca fascicularis
A,1,,,U,Autocuration,Brain,,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,CHEMBL627627,0,BAO_0000218,11888,13758,,,955.0,,,
A,1,,,U,Autocuration,Serum,,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,CHEMBL627628,0,BAO_0000218,11889,13758,,,1977.0,,,
A,1,,,U,Autocuration,Brain,,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,CHEMBL627629,0,BAO_0000218,11890,13758,,,955.0,,,
A,1,,,U,Autocuration,Serum,,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,CHEMBL627630,0,BAO_0000218,11891,13758,,,1977.0,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,CHEMBL627631,0,BAO_0000019,11892,16359,,,,,,
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,CHEMBL629515,0,BAO_0000218,11893,16359,,,,,,
A,1,,,N,Intermediate,Spleen,,,50594,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL629516,1,BAO_0000218,11894,15383,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL629517,1,BAO_0000218,11895,15383,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL629518,1,BAO_0000218,11896,15383,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,CHEMBL877499,1,BAO_0000218,11897,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,CHEMBL629519,1,BAO_0000218,11898,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,CHEMBL629520,1,BAO_0000218,11899,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,CHEMBL629521,1,BAO_0000218,11900,15383,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,CHEMBL629522,1,BAO_0000218,11901,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,CHEMBL629523,1,BAO_0000218,11902,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,CHEMBL629524,1,BAO_0000218,11903,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,CHEMBL629525,1,BAO_0000218,11904,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,CHEMBL629526,1,BAO_0000218,11905,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,CHEMBL629527,1,BAO_0000218,11906,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,CHEMBL629528,1,BAO_0000218,11907,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,CHEMBL629529,1,BAO_0000218,11908,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,CHEMBL629530,1,BAO_0000218,11909,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,CHEMBL629531,1,BAO_0000218,11910,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,CHEMBL628656,1,BAO_0000218,11911,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,CHEMBL628657,1,BAO_0000218,11912,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL628658,1,BAO_0000218,11913,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL628659,1,BAO_0000218,11914,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL877500,1,BAO_0000218,11915,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL628660,1,BAO_0000218,11916,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL628661,1,BAO_0000218,11917,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL628662,1,BAO_0000218,11918,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL628663,1,BAO_0000218,11919,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL628664,1,BAO_0000218,11920,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL628665,1,BAO_0000218,11921,13751,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL628666,1,BAO_0000218,11922,13751,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL628667,1,BAO_0000218,11923,13751,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL628668,1,BAO_0000218,11924,13751,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL628669,1,BAO_0000218,11925,13751,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL628670,1,BAO_0000218,11926,13751,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL628671,1,BAO_0000218,11927,13751,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL628672,1,BAO_0000218,11928,13751,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL630300,1,BAO_0000218,11929,13751,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL629787,1,BAO_0000218,11930,13751,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL629788,1,BAO_0000218,11931,13751,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL629789,1,BAO_0000218,11932,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL629790,1,BAO_0000218,11933,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL629791,1,BAO_0000218,11934,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL629792,1,BAO_0000218,11935,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL629793,1,BAO_0000218,11936,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL629794,1,BAO_0000218,11937,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,CHEMBL874459,1,BAO_0000218,11938,10677,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,CHEMBL629795,1,BAO_0000218,11939,10677,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,CHEMBL629796,1,BAO_0000218,11940,10677,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,CHEMBL629797,1,BAO_0000218,11941,10677,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,CHEMBL629798,1,BAO_0000218,11942,10677,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Adrenal gland,,,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL629799,1,BAO_0000218,11943,10911,,10116.0,2369.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Adrenal gland,,,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629800,1,BAO_0000218,11944,10911,,10116.0,2369.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Adrenal gland,,,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629801,1,BAO_0000218,11945,10911,,10116.0,2369.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Adrenal gland,,,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,In vivo,CHEMBL629802,1,BAO_0000218,11946,10911,,10116.0,2369.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Adrenal gland,,,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629803,1,BAO_0000218,11947,10911,,10116.0,2369.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL629804,1,BAO_0000218,11948,10911,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629805,1,BAO_0000218,11949,10911,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,CHEMBL629806,1,BAO_0000218,11950,10911,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629807,1,BAO_0000218,11951,10911,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629808,1,BAO_0000218,11952,10911,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL629809,1,BAO_0000218,11953,10911,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629810,1,BAO_0000218,11954,10911,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,CHEMBL629811,1,BAO_0000218,11955,10911,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629812,1,BAO_0000218,11956,10911,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,In vivo,CHEMBL629813,1,BAO_0000218,11957,10911,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL874460,1,BAO_0000218,11958,10911,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL629814,1,BAO_0000218,11959,10911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629815,1,BAO_0000218,11960,10911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629816,1,BAO_0000218,11961,10911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL629817,1,BAO_0000218,11962,10911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL626643,1,BAO_0000218,11963,10911,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL626644,1,BAO_0000218,11964,10911,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL626806,1,BAO_0000218,11965,10911,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL626807,1,BAO_0000218,11966,10911,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627261,1,BAO_0000218,11967,10911,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627262,1,BAO_0000218,11968,10911,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627263,1,BAO_0000218,11969,10911,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627264,1,BAO_0000218,11970,10911,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627265,1,BAO_0000218,11971,10911,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627266,1,BAO_0000218,11972,10911,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627267,1,BAO_0000218,11973,10911,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627268,1,BAO_0000218,11974,10911,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627269,1,BAO_0000218,11975,10911,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627270,1,BAO_0000218,11976,10911,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,CHEMBL627271,1,BAO_0000218,11977,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,CHEMBL627946,1,BAO_0000218,11978,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,CHEMBL875472,1,BAO_0000218,11979,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,CHEMBL627947,1,BAO_0000218,11980,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,CHEMBL627948,1,BAO_0000218,11981,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,CHEMBL628113,1,BAO_0000218,11982,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,CHEMBL628114,1,BAO_0000218,11983,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,CHEMBL628115,1,BAO_0000218,11984,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,CHEMBL628116,1,BAO_0000218,11985,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,CHEMBL628117,1,BAO_0000218,11986,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,CHEMBL628118,1,BAO_0000218,11987,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,CHEMBL628119,1,BAO_0000218,11988,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,CHEMBL628120,1,BAO_0000218,11989,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,CHEMBL628121,1,BAO_0000218,11990,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,CHEMBL628122,1,BAO_0000218,11991,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,CHEMBL627297,1,BAO_0000218,11992,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,CHEMBL627298,1,BAO_0000218,11993,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,CHEMBL627299,1,BAO_0000218,11994,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,CHEMBL627300,1,BAO_0000218,11995,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,CHEMBL627301,1,BAO_0000218,11996,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,CHEMBL627302,1,BAO_0000218,11997,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,CHEMBL627303,1,BAO_0000218,11998,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,CHEMBL627304,1,BAO_0000218,11999,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,CHEMBL627305,1,BAO_0000218,12000,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,CHEMBL627306,1,BAO_0000218,12001,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,CHEMBL623982,1,BAO_0000218,12002,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,CHEMBL623983,1,BAO_0000218,12003,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,CHEMBL623984,1,BAO_0000218,12004,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,CHEMBL623985,1,BAO_0000218,12005,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,CHEMBL623986,1,BAO_0000218,12006,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,CHEMBL623987,1,BAO_0000218,12007,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,CHEMBL623988,1,BAO_0000218,12008,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,CHEMBL623989,1,BAO_0000218,12009,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,CHEMBL622215,1,BAO_0000218,12010,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,CHEMBL622216,1,BAO_0000218,12011,8608,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,CHEMBL877481,1,BAO_0000218,12012,8608,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,CHEMBL622217,0,BAO_0000218,12013,16359,,,,,,
A,1,,,N,Intermediate,,,,50594,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,CHEMBL622218,1,BAO_0000218,12014,13701,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic profile AUC was evaluated in rats,,CHEMBL622219,1,BAO_0000218,12015,14554,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic property (Area under curve),,CHEMBL622220,0,BAO_0000019,12016,6241,,,,,,
A,1,,,N,Intermediate,,,,50588,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,CHEMBL622221,1,BAO_0000218,12017,11537,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,CHEMBL622222,1,BAO_0000218,12018,11537,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,CHEMBL622223,1,BAO_0000218,12019,11537,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,CHEMBL622224,1,BAO_0000218,12020,11537,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Plasma concentration (AUC) was determined,,CHEMBL622225,0,BAO_0000019,12021,13118,,,,,,
A,1,,,U,Autocuration,,,,22224,Plasma concentration (AUC) was determined; Not detectable,,CHEMBL622226,0,BAO_0000019,12022,13118,,,,,,
A,1,,,N,Intermediate,,,,50512,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,CHEMBL624154,1,BAO_0000218,12023,9562,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,CHEMBL624155,1,BAO_0000218,12024,10363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,CHEMBL624156,1,BAO_0000218,12025,10363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,CHEMBL624157,1,BAO_0000218,12026,10363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,CHEMBL624158,1,BAO_0000218,12027,10363,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,CHEMBL624159,1,BAO_0000218,12028,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,CHEMBL624160,1,BAO_0000218,12029,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,CHEMBL624161,1,BAO_0000218,12030,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,CHEMBL624162,1,BAO_0000218,12031,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,CHEMBL624163,1,BAO_0000218,12032,13317,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,CHEMBL624164,1,BAO_0000218,12033,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The AUC(0-infinity) values in female wistar rats.,,CHEMBL624165,1,BAO_0000218,12034,14941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,CHEMBL624166,1,BAO_0000218,12035,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,CHEMBL624167,1,BAO_0000218,12036,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The AUC(0-t)values in female wistar rats.,,CHEMBL624168,1,BAO_0000218,12037,14941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The Area under the concentration time curve of compound was measured on rats,,CHEMBL624169,1,BAO_0000218,12038,14067,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50587,The area under curve (100 mg/kg) administered orally in humans,,CHEMBL624170,1,BAO_0000218,12039,14215,,9606.0,,,,Homo sapiens
A,1,,,U,Autocuration,,,,22224,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,CHEMBL624171,0,BAO_0000218,12040,14215,,9481.0,,,,Callithrix
A,1,,,U,Autocuration,,,,22224,The area under curve (12.5 mg/kg) administered intravenously in monkey,,CHEMBL624172,0,BAO_0000218,12041,14215,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50588,The area under curve (15 mg/kg) administered intravenously in dog,,CHEMBL624173,1,BAO_0000218,12042,14215,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50587,The area under curve (200 mg/kg) administered orally in humans,,CHEMBL877488,1,BAO_0000218,12043,14215,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50597,The area under curve (25 mg/kg) administered intravenously in rat,,CHEMBL624174,1,BAO_0000218,12044,14215,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,The area under curve (25 mg/kg) administered orally in marmoset,,CHEMBL624175,0,BAO_0000218,12045,14215,,9481.0,,,,Callithrix
A,1,,,U,Autocuration,,,,22224,The area under curve (25 mg/kg) administered orally in monkey,,CHEMBL624176,0,BAO_0000218,12046,14215,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50588,The area under curve (30 mg/kg) administered orally in dog,,CHEMBL624177,1,BAO_0000218,12047,14215,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50587,The area under curve (400 mg/kg) administered orally in humans,,CHEMBL624178,1,BAO_0000218,12048,14215,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50597,The area under curve (50 mg/kg) administered orally in fasted rat,,CHEMBL624179,1,BAO_0000218,12049,14215,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The area under curve (50 mg/kg) administered orally in rat,,CHEMBL627689,1,BAO_0000218,12050,14215,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50587,The area under curve (800 mg/kg) administered orally in humans,,CHEMBL627690,1,BAO_0000218,12051,14215,,9606.0,,,,Homo sapiens
A,1,,,U,Autocuration,,,,22224,The compound was evaluated for area under the curve,,CHEMBL627691,0,BAO_0000019,12052,11324,,,,,,
A,1,,,U,Autocuration,,,,22224,The compound was evaluated for area under the curve in marmosets,,CHEMBL627692,0,BAO_0000019,12053,11324,,9481.0,,,,Callithrix
A,1,,,U,Autocuration,,,,22224,The compound was evaluated for area under the curve in marmosets,,CHEMBL627693,0,BAO_0000019,12054,11324,,9481.0,,,,Callithrix
A,1,,,N,Intermediate,,,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,CHEMBL627694,1,BAO_0000218,12055,13875,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,CHEMBL627695,1,BAO_0000218,12056,13875,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,CHEMBL627696,0,BAO_0000218,12057,13875,,,,,,
A,1,,,N,Intermediate,,,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,CHEMBL627697,1,BAO_0000218,12058,13875,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,CHEMBL627698,1,BAO_0000218,12059,13875,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,CHEMBL627699,1,BAO_0000218,12060,13875,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,CHEMBL627700,1,BAO_0000218,12061,13807,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total drug exposure is determined after oral dosing in rats.,,CHEMBL627701,1,BAO_0000218,12062,14127,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Total drug exposure (5 mg/kg) when administered intravenously,,CHEMBL627702,0,BAO_0000218,12063,15116,,,,,,
A,1,,,U,Autocuration,,,,22224,Total drug exposure (5 mg/kg) when administered orally,,CHEMBL627703,0,BAO_0000218,12064,15116,,,,,,
A,1,,,U,Autocuration,,,,22224,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,CHEMBL626873,0,BAO_0000218,12065,15604,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,CHEMBL629583,1,BAO_0000218,12066,15604,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,CHEMBL629584,1,BAO_0000218,12067,15604,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,CHEMBL629585,1,BAO_0000218,12068,15604,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL629586,1,BAO_0000218,12069,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL629587,1,BAO_0000218,12070,13751,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL629588,1,BAO_0000218,12071,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL629589,1,BAO_0000218,12072,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL629590,1,BAO_0000218,12073,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL629591,1,BAO_0000218,12074,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL629592,1,BAO_0000218,12075,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL629593,1,BAO_0000218,12076,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL629594,1,BAO_0000218,12077,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL629595,1,BAO_0000218,12078,13751,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL630290,1,BAO_0000218,12079,13751,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL627137,1,BAO_0000218,12080,13751,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL627138,1,BAO_0000218,12081,13751,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL627139,1,BAO_0000218,12082,13751,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL627140,1,BAO_0000218,12083,13751,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL627141,1,BAO_0000218,12084,13751,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL627142,1,BAO_0000218,12085,13751,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL627143,1,BAO_0000218,12086,13751,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL874449,1,BAO_0000218,12087,13751,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL627144,1,BAO_0000218,12088,13751,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL627145,1,BAO_0000218,12089,13751,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL627146,1,BAO_0000218,12090,13751,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL627147,1,BAO_0000218,12091,13751,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL627148,1,BAO_0000218,12092,13751,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL627149,1,BAO_0000218,12093,13751,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL632160,1,BAO_0000218,12094,13751,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL632161,1,BAO_0000218,12095,13751,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL632162,1,BAO_0000218,12096,13751,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL632163,1,BAO_0000218,12097,13751,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL874469,1,BAO_0000218,12098,13751,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL627182,1,BAO_0000218,12099,13751,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,CHEMBL627183,1,BAO_0000218,12100,13751,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL627184,1,BAO_0000218,12101,13751,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL627185,1,BAO_0000218,12102,13751,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL627186,1,BAO_0000218,12103,13751,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL627187,1,BAO_0000218,12104,13751,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL627188,1,BAO_0000218,12105,13751,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL627189,1,BAO_0000218,12106,13751,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL627190,1,BAO_0000218,12107,13751,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,CHEMBL627191,1,BAO_0000218,12108,13751,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,CHEMBL627192,1,BAO_0000218,12109,13751,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,CHEMBL627193,1,BAO_0000218,12110,13751,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,CHEMBL874590,1,BAO_0000218,12111,10911,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627194,1,BAO_0000218,12112,10911,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627195,1,BAO_0000218,12113,10911,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627196,1,BAO_0000218,12114,10911,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627197,1,BAO_0000218,12115,10911,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627198,1,BAO_0000218,12116,10911,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,In vivo,CHEMBL627199,1,BAO_0000218,12117,10911,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Female gonad,,,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627200,1,BAO_0000218,12118,10911,,10116.0,992.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627201,1,BAO_0000218,12119,10911,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627202,1,BAO_0000218,12120,10911,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627203,1,BAO_0000218,12121,10911,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627204,1,BAO_0000218,12122,10911,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627205,1,BAO_0000218,12123,10911,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627206,1,BAO_0000218,12124,10911,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627207,1,BAO_0000218,12125,10911,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627208,1,BAO_0000218,12126,10911,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627209,1,BAO_0000218,12127,10911,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627210,1,BAO_0000218,12128,10911,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627211,1,BAO_0000218,12129,10911,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL627212,1,BAO_0000218,12130,10911,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,CHEMBL627213,1,BAO_0000218,12131,10911,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL626599,1,BAO_0000218,12132,10911,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL626600,1,BAO_0000218,12133,10911,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,CHEMBL626601,1,BAO_0000218,12134,10911,,10116.0,995.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,CHEMBL627484,0,BAO_0000019,12135,8081,,,,,,
A,1,,,N,Intermediate,Plasma,,,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,CHEMBL627485,1,BAO_0000218,12136,17248,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,CHEMBL628147,1,BAO_0000218,12137,17248,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,CHEMBL628148,1,BAO_0000218,12138,17248,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,CHEMBL628149,1,BAO_0000218,12139,17248,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,CHEMBL628150,1,BAO_0000218,12140,17248,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,CHEMBL628318,1,BAO_0000218,12141,17248,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,CHEMBL628319,1,BAO_0000218,12142,17248,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,CHEMBL875609,1,BAO_0000218,12143,15592,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,CHEMBL628320,0,BAO_0000019,12144,7040,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,CHEMBL628321,0,BAO_0000019,12145,7040,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,CHEMBL628322,0,BAO_0000019,12146,7040,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,CHEMBL628323,0,BAO_0000019,12147,7040,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,CHEMBL628324,0,BAO_0000019,12148,7040,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,CHEMBL628325,0,BAO_0000019,12149,7040,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,CHEMBL628326,0,BAO_0000019,12150,7040,,,,,,
A,1,,,N,Intermediate,Adrenal medulla,,,50588,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,CHEMBL628327,1,BAO_0000218,12151,9614,,9615.0,1236.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Adrenal medulla,,,50588,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,CHEMBL628328,1,BAO_0000218,12152,9614,,9615.0,1236.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Blood,,,50588,"Concentration of compound in blood of dog 1, after administering intravenously",,CHEMBL628329,1,BAO_0000218,12153,9614,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,CHEMBL628330,1,BAO_0000218,12154,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,CHEMBL628331,1,BAO_0000218,12155,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,CHEMBL628332,1,BAO_0000218,12156,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,CHEMBL628333,1,BAO_0000218,12157,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,CHEMBL628334,1,BAO_0000218,12158,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,CHEMBL628335,1,BAO_0000218,12159,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,CHEMBL628336,1,BAO_0000218,12160,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,CHEMBL628337,1,BAO_0000218,12161,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,CHEMBL628338,1,BAO_0000218,12162,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,CHEMBL875610,1,BAO_0000218,12163,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,CHEMBL628339,1,BAO_0000218,12164,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,CHEMBL628340,1,BAO_0000218,12165,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,CHEMBL628341,1,BAO_0000218,12166,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,CHEMBL622214,1,BAO_0000218,12167,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,CHEMBL623167,1,BAO_0000218,12168,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,CHEMBL623168,1,BAO_0000218,12169,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,CHEMBL623169,1,BAO_0000218,12170,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,CHEMBL623170,1,BAO_0000218,12171,8608,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,CHEMBL627224,1,BAO_0000218,12172,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,CHEMBL875634,1,BAO_0000218,12173,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,CHEMBL627225,1,BAO_0000218,12174,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,CHEMBL627226,1,BAO_0000218,12175,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,CHEMBL626083,1,BAO_0000218,12176,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,CHEMBL626084,1,BAO_0000218,12177,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,CHEMBL626085,1,BAO_0000218,12178,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,CHEMBL626086,1,BAO_0000218,12179,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,CHEMBL626087,1,BAO_0000218,12180,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,CHEMBL626088,1,BAO_0000218,12181,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,CHEMBL626089,1,BAO_0000218,12182,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,CHEMBL626090,1,BAO_0000218,12183,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,CHEMBL626091,1,BAO_0000218,12184,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,CHEMBL626092,1,BAO_0000218,12185,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,CHEMBL626093,1,BAO_0000218,12186,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,CHEMBL626094,1,BAO_0000218,12187,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,CHEMBL626095,1,BAO_0000218,12188,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,CHEMBL626096,1,BAO_0000218,12189,8608,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,CHEMBL626097,0,BAO_0000218,12190,15604,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,CHEMBL626098,1,BAO_0000218,12191,15604,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,CHEMBL626099,0,BAO_0000218,12192,1806,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,CHEMBL626100,0,BAO_0000218,12193,1806,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50588,AUC 0-inf in dog,,CHEMBL626101,1,BAO_0000218,12194,17237,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50512,AUC 0-inf in guinea pig,,CHEMBL626102,1,BAO_0000218,12195,17237,,10141.0,1969.0,,,Cavia porcellus
A,1,,,N,Intermediate,Plasma,,,50588,AUC 0-t in dog,,CHEMBL626103,1,BAO_0000218,12196,17237,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50512,AUC 0-t in guinea pig,,CHEMBL628391,1,BAO_0000218,12197,17237,,10141.0,1969.0,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50597,The compound was tested for brain to plasma partition in rat,,CHEMBL628392,1,BAO_0000218,12198,15194,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for brain to plasma partition in rat.,,CHEMBL628393,1,BAO_0000218,12199,15194,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Blood,,,22224,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,CHEMBL628394,0,BAO_0000019,12200,8787,,,178.0,,,
A,1,,,N,Intermediate,,,,50588,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,CHEMBL628395,1,BAO_0000218,12201,17025,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,CHEMBL628396,0,BAO_0000218,12202,17025,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50592,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,CHEMBL628397,1,BAO_0000218,12203,17025,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50597,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,CHEMBL628398,1,BAO_0000218,12204,17025,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50797,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,CHEMBL628399,1,BAO_0000218,12205,4236,,9544.0,,,,Macaca mulatta
A,1,,,N,Intermediate,,,,50588,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,CHEMBL628400,1,BAO_0000218,12206,15343,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,CHEMBL874907,1,BAO_0000218,12207,15343,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under curve of the compound was determined,,CHEMBL628401,0,BAO_0000019,12208,17720,,,,,,
A,1,,,U,Autocuration,Plasma,,,22224,AUC in monkeys at a dose of 1 mg/kg,,CHEMBL628402,0,BAO_0000218,12209,17788,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50597,AUC in rats at a dose of 1 mg/kg,,CHEMBL628403,1,BAO_0000218,12210,17788,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for the overall absorbance loss at pH of 2,,CHEMBL628404,0,BAO_0000019,12211,8778,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for the overall absorbance loss at pH of 4,,CHEMBL628405,0,BAO_0000019,12212,8778,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for the overall absorbance loss at pH of 7,,CHEMBL628406,0,BAO_0000019,12213,8778,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for its absorption in the rats,,CHEMBL628407,1,BAO_0000218,12214,2249,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,CHEMBL628408,1,BAO_0000218,12215,8881,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,CHEMBL629171,1,BAO_0000218,12216,8881,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,CHEMBL629172,1,BAO_0000218,12217,8881,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,CHEMBL629173,1,BAO_0000218,12218,8881,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum,,CHEMBL629174,1,BAO_0000218,12219,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 10-17,,CHEMBL629175,1,BAO_0000218,12220,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 10-18,,CHEMBL629176,1,BAO_0000218,12221,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 10-19,,CHEMBL629177,1,BAO_0000218,12222,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 12-15,,CHEMBL629178,1,BAO_0000218,12223,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 13-19,,CHEMBL631869,1,BAO_0000218,12224,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 14-17,,CHEMBL631870,1,BAO_0000218,12225,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 15-18,,CHEMBL631871,1,BAO_0000218,12226,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 2-5,,CHEMBL631872,1,BAO_0000218,12227,15286,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Ileum,,,22224,In vitro percent permeability into rat ileum; Range is 23-42,,CHEMBL875775,0,BAO_0000221,12228,15286,,,2116.0,,,
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 28-36,,CHEMBL631873,1,BAO_0000218,12229,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 29-35,,CHEMBL631874,1,BAO_0000218,12230,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 46-66,,CHEMBL631875,1,BAO_0000218,12231,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 50-68,,CHEMBL631876,1,BAO_0000218,12232,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; Range is 78-81,,CHEMBL631877,1,BAO_0000218,12233,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,CHEMBL631878,1,BAO_0000218,12234,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; nd indicates not detected,,CHEMBL631879,1,BAO_0000218,12235,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; nt indicates not detected,,CHEMBL631880,1,BAO_0000218,12236,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro percent permeability into rat ileum; nt indicates not tested,,CHEMBL631881,1,BAO_0000218,12237,15286,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for oral absorption in bile-duct cannulated rats,,CHEMBL631882,1,BAO_0000218,12238,13770,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for oral absorption in bile-duct cannulated rats.,,CHEMBL630749,1,BAO_0000218,12239,13770,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50587,Oral absorption using Caco-2 cell monolayers.,,CHEMBL630750,1,BAO_0000218,12240,5202,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,Percent of the drug absorbed after administration to humans was determined,,CHEMBL630253,1,BAO_0000218,12241,14920,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,CHEMBL630254,1,BAO_0000218,12242,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,CHEMBL630255,1,BAO_0000218,12243,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,CHEMBL630256,1,BAO_0000218,12244,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,CHEMBL875781,1,BAO_0000218,12245,13751,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,CHEMBL630257,1,BAO_0000218,12246,13751,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,CHEMBL630258,1,BAO_0000218,12247,13751,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,CHEMBL630259,1,BAO_0000218,12248,15807,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,CHEMBL630260,1,BAO_0000218,12249,15807,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,CHEMBL630261,1,BAO_0000218,12250,15807,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,CHEMBL630262,1,BAO_0000218,12251,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,CHEMBL630263,1,BAO_0000218,12252,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,CHEMBL630264,1,BAO_0000218,12253,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,CHEMBL630265,1,BAO_0000218,12254,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,CHEMBL630266,1,BAO_0000218,12255,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,CHEMBL630267,1,BAO_0000218,12256,14950,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,CHEMBL630268,1,BAO_0000218,12257,14950,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,CHEMBL630269,1,BAO_0000218,12258,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,CHEMBL630270,1,BAO_0000218,12259,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,CHEMBL630141,1,BAO_0000218,12260,14950,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,CHEMBL630142,1,BAO_0000218,12261,14950,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,CHEMBL630143,1,BAO_0000218,12262,14950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,CHEMBL630144,1,BAO_0000218,12263,14950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Prostate gland,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,CHEMBL630145,1,BAO_0000218,12264,14950,,10116.0,2367.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Prostate gland,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,CHEMBL630146,1,BAO_0000218,12265,14950,,10116.0,2367.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,CHEMBL630147,1,BAO_0000218,12266,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,CHEMBL630148,1,BAO_0000218,12267,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,CHEMBL630149,1,BAO_0000218,12268,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,CHEMBL630150,1,BAO_0000218,12269,14950,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,CHEMBL630151,1,BAO_0000218,12270,14950,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,CHEMBL632031,1,BAO_0000218,12271,14950,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,CHEMBL632032,1,BAO_0000218,12272,14950,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,CHEMBL632033,1,BAO_0000218,12273,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,CHEMBL632034,1,BAO_0000218,12274,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,CHEMBL632035,1,BAO_0000218,12275,14950,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,CHEMBL632036,1,BAO_0000218,12276,14950,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,CHEMBL632037,1,BAO_0000218,12277,14950,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,CHEMBL632038,1,BAO_0000218,12278,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,CHEMBL632039,1,BAO_0000218,12279,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,CHEMBL632040,1,BAO_0000218,12280,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,CHEMBL632041,1,BAO_0000218,12281,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50588,"Concentration of compound in blood of dog 2, after administering intravenously",,CHEMBL632042,1,BAO_0000218,12282,9614,,9615.0,178.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,CHEMBL632043,1,BAO_0000218,12283,9614,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,CHEMBL632044,1,BAO_0000218,12284,9614,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Liver,,,50588,"Concentration of compound in liver of dog 1, after administering intravenously",,CHEMBL632045,1,BAO_0000218,12285,9614,,9615.0,2107.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Liver,,,50588,"Concentration of compound in liver of dog 2, after administering intravenously",,CHEMBL632046,1,BAO_0000218,12286,9614,,9615.0,2107.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Lung,,,50588,"Concentration of compound in lung of dog 1, after administering intravenously",,CHEMBL632047,1,BAO_0000218,12287,9614,,9615.0,2048.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Lung,,,50588,"Concentration of compound in lung of dog 2, after administering intravenously",,CHEMBL632048,1,BAO_0000218,12288,9614,,9615.0,2048.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Muscle tissue,,,50588,"Concentration of compound in muscle of dog 1, after administering intravenously",,CHEMBL632049,1,BAO_0000218,12289,9614,,9615.0,2385.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Muscle tissue,,,50588,"Concentration of compound in muscle of dog 2, after administering intravenously",,CHEMBL876418,1,BAO_0000218,12290,9614,,9615.0,2385.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Spleen,,,50588,"Concentration of compound in spleen of dog 1,after administering intravenously",,CHEMBL632050,1,BAO_0000218,12291,9614,,9615.0,2106.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Spleen,,,50588,"Concentration of compound in spleen of dog 2, after administering intravenously",,CHEMBL632051,1,BAO_0000218,12292,9614,,9615.0,2106.0,,,Canis lupus familiaris
F,1,,,U,Autocuration,,,,22224,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,CHEMBL632052,0,BAO_0000218,12293,10353,,,,,,
F,1,,,U,Autocuration,,,,22224,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,CHEMBL632053,0,BAO_0000218,12294,10353,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,CHEMBL632054,0,BAO_0000218,12295,10353,,,,,,
F,1,,,U,Autocuration,,,,22224,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,CHEMBL632055,0,BAO_0000218,12296,10353,,,,,,
F,1,,,U,Autocuration,,,,22224,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,CHEMBL631181,0,BAO_0000218,12297,10353,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,CHEMBL631182,0,BAO_0000218,12298,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,CHEMBL631183,0,BAO_0000218,12299,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL631184,0,BAO_0000218,12300,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL629774,0,BAO_0000218,12301,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL629775,0,BAO_0000218,12302,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL876549,0,BAO_0000218,12303,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL628172,0,BAO_0000218,12304,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,CHEMBL628173,0,BAO_0000218,12305,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,CHEMBL628174,0,BAO_0000218,12306,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,CHEMBL628175,0,BAO_0000218,12307,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,CHEMBL628176,0,BAO_0000218,12308,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628177,0,BAO_0000218,12309,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL628178,0,BAO_0000218,12310,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,CHEMBL628179,0,BAO_0000218,12311,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,CHEMBL628180,0,BAO_0000218,12312,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,CHEMBL628181,0,BAO_0000218,12313,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL628182,0,BAO_0000218,12314,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL628183,0,BAO_0000218,12315,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,CHEMBL628184,0,BAO_0000218,12316,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628185,0,BAO_0000218,12317,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL875617,0,BAO_0000218,12318,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,CHEMBL628186,0,BAO_0000218,12319,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL628187,0,BAO_0000218,12320,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,CHEMBL628188,0,BAO_0000218,12321,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,CHEMBL628189,0,BAO_0000218,12322,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,CHEMBL628190,0,BAO_0000218,12323,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628191,0,BAO_0000218,12324,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,CHEMBL626513,0,BAO_0000218,12325,9196,,,,,,
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,CHEMBL626514,1,BAO_0000218,12326,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,CHEMBL626515,1,BAO_0000218,12327,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,CHEMBL626516,1,BAO_0000218,12328,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,CHEMBL626517,1,BAO_0000218,12329,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,CHEMBL626518,1,BAO_0000218,12330,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,CHEMBL626519,1,BAO_0000218,12331,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,CHEMBL626520,1,BAO_0000218,12332,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,CHEMBL626521,1,BAO_0000218,12333,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,CHEMBL626522,1,BAO_0000218,12334,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,CHEMBL626523,1,BAO_0000218,12335,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,CHEMBL626524,1,BAO_0000218,12336,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,CHEMBL626688,1,BAO_0000218,12337,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,CHEMBL626689,1,BAO_0000218,12338,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,CHEMBL626690,1,BAO_0000218,12339,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,CHEMBL626691,1,BAO_0000218,12340,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,CHEMBL627319,1,BAO_0000218,12341,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,CHEMBL624052,1,BAO_0000218,12342,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,CHEMBL624053,1,BAO_0000218,12343,8608,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL624054,1,BAO_0000218,12344,8085,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL624055,1,BAO_0000218,12345,8085,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL624056,1,BAO_0000218,12346,8085,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL624057,1,BAO_0000218,12347,8085,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL622281,1,BAO_0000218,12348,8085,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL622282,1,BAO_0000218,12349,8085,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL622283,1,BAO_0000218,12350,8085,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL622284,1,BAO_0000218,12351,8085,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL622285,1,BAO_0000218,12352,8085,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,CHEMBL622286,1,BAO_0000218,12353,8085,,10116.0,995.0,,,Rattus norvegicus
P,1,,,U,Autocuration,,,,22224,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,CHEMBL622287,0,BAO_0000100,12354,7657,,,,,,
A,1,,,N,Intermediate,,,,50594,Partition coefficient (logD7.4),,CHEMBL622288,1,BAO_0000218,12355,8935,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,CHEMBL622289,1,BAO_0000218,12356,13792,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,CHEMBL622290,1,BAO_0000218,12357,13792,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,CHEMBL622291,1,BAO_0000218,12358,13792,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,CHEMBL622292,1,BAO_0000218,12359,13792,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,CHEMBL622293,1,BAO_0000218,12360,13792,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,CHEMBL622294,1,BAO_0000218,12361,13792,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,CHEMBL622295,1,BAO_0000218,12362,13792,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50597,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,CHEMBL622296,1,BAO_0000218,12363,13792,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,CHEMBL874409,1,BAO_0000218,12364,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,CHEMBL622297,1,BAO_0000218,12365,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,CHEMBL622298,1,BAO_0000218,12366,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,CHEMBL622299,1,BAO_0000218,12367,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,CHEMBL622300,1,BAO_0000218,12368,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,CHEMBL622301,1,BAO_0000218,12369,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,CHEMBL622302,1,BAO_0000218,12370,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,CHEMBL622303,1,BAO_0000218,12371,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,CHEMBL622304,1,BAO_0000218,12372,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,CHEMBL622305,1,BAO_0000218,12373,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,CHEMBL622306,1,BAO_0000218,12374,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,CHEMBL626864,1,BAO_0000218,12375,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,CHEMBL626865,1,BAO_0000218,12376,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,CHEMBL626866,1,BAO_0000218,12377,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,CHEMBL626867,1,BAO_0000218,12378,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,CHEMBL626868,1,BAO_0000218,12379,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,CHEMBL626869,1,BAO_0000218,12380,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,CHEMBL626870,1,BAO_0000218,12381,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,CHEMBL626871,1,BAO_0000218,12382,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,CHEMBL626872,1,BAO_0000218,12383,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,CHEMBL632185,1,BAO_0000218,12384,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,CHEMBL632186,1,BAO_0000218,12385,14103,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Amount of acetic acid produced by the compound,,CHEMBL629310,0,BAO_0000019,12386,12904,,,,,,
A,1,,,U,Autocuration,,,,22224,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,CHEMBL629311,0,BAO_0000019,12387,12904,,,,,,
A,1,,,N,Intermediate,,,,50597,Log of (Cbrain/Cblood) in rats,,CHEMBL629312,1,BAO_0000218,12388,9663,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,CHEMBL629313,0,BAO_0000221,12389,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,CHEMBL629314,0,BAO_0000221,12390,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,CHEMBL629315,0,BAO_0000221,12391,7652,,,,,,
B,1,,,U,Autocuration,,,,22224,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,CHEMBL629316,0,BAO_0000219,12392,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,CHEMBL629317,0,BAO_0000221,12393,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,CHEMBL629318,0,BAO_0000019,12394,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,CHEMBL877497,0,BAO_0000019,12395,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,CHEMBL629319,0,BAO_0000019,12396,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,CHEMBL629320,0,BAO_0000019,12397,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,CHEMBL629496,0,BAO_0000019,12398,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,CHEMBL629497,0,BAO_0000019,12399,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,CHEMBL629498,0,BAO_0000019,12400,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,CHEMBL629499,0,BAO_0000019,12401,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,CHEMBL629500,0,BAO_0000019,12402,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,CHEMBL629501,0,BAO_0000019,12403,7652,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,CHEMBL629502,0,BAO_0000019,12404,7652,,,,,,
F,1,,,U,Autocuration,,,,22224,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,In vivo,CHEMBL629503,0,BAO_0000218,12405,8267,,,,,,
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,CHEMBL629504,1,BAO_0000218,12406,8267,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,CHEMBL629505,0,BAO_0000019,12407,14479,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for total body clearance,,CHEMBL629506,0,BAO_0000019,12408,17515,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for volume of distribution at steady state,,CHEMBL629507,0,BAO_0000019,12409,17515,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,CHEMBL877498,0,BAO_0000019,12410,8142,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of the diamine which is monoprotonated at pH 7.4,,CHEMBL629508,0,BAO_0000019,12411,14849,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,CHEMBL629509,0,BAO_0000019,12412,7653,,,,,,
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,CHEMBL629510,1,BAO_0000218,12413,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,CHEMBL629511,1,BAO_0000218,12414,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,CHEMBL629512,1,BAO_0000218,12415,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,CHEMBL629513,1,BAO_0000218,12416,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,CHEMBL629514,1,BAO_0000218,12417,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,CHEMBL628447,1,BAO_0000218,12418,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,CHEMBL628448,1,BAO_0000218,12419,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,CHEMBL628449,1,BAO_0000218,12420,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,CHEMBL631119,1,BAO_0000218,12421,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,CHEMBL631120,1,BAO_0000218,12422,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,CHEMBL631121,1,BAO_0000218,12423,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,CHEMBL874458,1,BAO_0000218,12424,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,CHEMBL631122,1,BAO_0000218,12425,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,CHEMBL631123,1,BAO_0000218,12426,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,CHEMBL631124,1,BAO_0000218,12427,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,CHEMBL631125,1,BAO_0000218,12428,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,CHEMBL631290,1,BAO_0000218,12429,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,CHEMBL631291,1,BAO_0000218,12430,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,CHEMBL631292,1,BAO_0000218,12431,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,CHEMBL631293,1,BAO_0000218,12432,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,CHEMBL631294,1,BAO_0000218,12433,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,CHEMBL631295,1,BAO_0000218,12434,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,CHEMBL631296,1,BAO_0000218,12435,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,CHEMBL631297,1,BAO_0000218,12436,8631,,10116.0,178.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Maximum biodistribution (Bmax) was determined.,,CHEMBL631298,0,BAO_0000218,12437,10263,,,,,,
A,1,,,N,Intermediate,,,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,CHEMBL631299,1,BAO_0000218,12438,12364,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,CHEMBL631300,1,BAO_0000218,12439,12364,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,CHEMBL631301,1,BAO_0000218,12440,12364,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,CHEMBL630291,1,BAO_0000218,12441,12364,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL630292,0,BAO_0000218,12442,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,CHEMBL630293,0,BAO_0000218,12443,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,CHEMBL630294,0,BAO_0000218,12444,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL630295,0,BAO_0000218,12445,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL630296,0,BAO_0000218,12446,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626782,0,BAO_0000218,12447,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL626783,0,BAO_0000218,12448,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL626784,0,BAO_0000218,12449,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL626785,0,BAO_0000218,12450,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626786,0,BAO_0000218,12451,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL626787,0,BAO_0000218,12452,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,CHEMBL626788,0,BAO_0000218,12453,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,CHEMBL625927,0,BAO_0000218,12454,9196,,,,,,
A,1,,,N,Intermediate,Blood,,,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL625928,1,BAO_0000218,12455,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,CHEMBL625929,1,BAO_0000218,12456,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,CHEMBL625930,1,BAO_0000218,12457,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,CHEMBL625931,1,BAO_0000218,12458,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,CHEMBL627230,1,BAO_0000218,12459,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627231,1,BAO_0000218,12460,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,CHEMBL627232,1,BAO_0000218,12461,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,CHEMBL627233,1,BAO_0000218,12462,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL875470,1,BAO_0000218,12463,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627234,1,BAO_0000218,12464,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627235,1,BAO_0000218,12465,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627236,1,BAO_0000218,12466,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627237,1,BAO_0000218,12467,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627238,1,BAO_0000218,12468,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627239,1,BAO_0000218,12469,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627240,1,BAO_0000218,12470,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627241,1,BAO_0000218,12471,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627242,1,BAO_0000218,12472,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,CHEMBL627243,1,BAO_0000218,12473,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,CHEMBL627244,1,BAO_0000218,12474,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627245,1,BAO_0000218,12475,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627246,1,BAO_0000218,12476,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627247,1,BAO_0000218,12477,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627248,1,BAO_0000218,12478,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627249,1,BAO_0000218,12479,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL625569,1,BAO_0000218,12480,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL625570,1,BAO_0000218,12481,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL625571,1,BAO_0000218,12482,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,CHEMBL625572,1,BAO_0000218,12483,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,CHEMBL625573,1,BAO_0000218,12484,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,CHEMBL625574,1,BAO_0000218,12485,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,CHEMBL626245,1,BAO_0000218,12486,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL626246,1,BAO_0000218,12487,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL626247,0,BAO_0000218,12488,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL626248,0,BAO_0000218,12489,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,CHEMBL626249,0,BAO_0000218,12490,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL626420,0,BAO_0000218,12491,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,CHEMBL626421,0,BAO_0000218,12492,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,CHEMBL626422,0,BAO_0000218,12493,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL626423,0,BAO_0000218,12494,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL626424,0,BAO_0000218,12495,9196,,,,,,
A,1,,,N,Intermediate,,,,50588,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,CHEMBL626425,1,BAO_0000218,12496,12023,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,CHEMBL875476,1,BAO_0000218,12497,12023,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,100710,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,CHEMBL626426,1,BAO_0000218,12498,12023,,9541.0,,,,Macaca fascicularis
P,1,,,U,Autocuration,,,,22224,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,CHEMBL626427,0,BAO_0000100,12499,10580,,,,,,
P,1,,,U,Autocuration,,,,22224,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,CHEMBL626428,0,BAO_0000100,12500,10580,,,,,,
A,1,,,U,Autocuration,,,,22224,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,CHEMBL626429,0,BAO_0000019,12501,16032,,,,,,
A,1,,,U,Autocuration,Urine,,,22224,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,CHEMBL625025,0,BAO_0000019,12502,16032,,,1088.0,,,
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,CHEMBL625026,1,BAO_0000218,12503,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,CHEMBL625027,1,BAO_0000218,12504,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,CHEMBL874410,1,BAO_0000218,12505,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,CHEMBL625028,1,BAO_0000218,12506,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,CHEMBL625029,1,BAO_0000218,12507,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,CHEMBL625030,1,BAO_0000218,12508,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL625031,1,BAO_0000218,12509,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,CHEMBL625032,1,BAO_0000218,12510,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,CHEMBL625033,1,BAO_0000218,12511,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,CHEMBL625034,1,BAO_0000218,12512,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,CHEMBL624872,1,BAO_0000218,12513,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,CHEMBL624873,1,BAO_0000218,12514,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,CHEMBL624874,1,BAO_0000218,12515,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,CHEMBL624875,1,BAO_0000218,12516,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,CHEMBL624876,1,BAO_0000218,12517,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,CHEMBL624877,1,BAO_0000218,12518,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,CHEMBL624878,1,BAO_0000218,12519,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,CHEMBL624879,1,BAO_0000218,12520,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL624880,1,BAO_0000218,12521,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,CHEMBL624881,1,BAO_0000218,12522,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,CHEMBL624882,1,BAO_0000218,12523,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,CHEMBL624883,1,BAO_0000218,12524,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,CHEMBL624884,1,BAO_0000218,12525,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,CHEMBL624885,1,BAO_0000218,12526,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,CHEMBL624886,1,BAO_0000218,12527,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,CHEMBL624887,1,BAO_0000218,12528,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,CHEMBL624888,1,BAO_0000218,12529,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,CHEMBL624889,1,BAO_0000218,12530,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,CHEMBL624890,1,BAO_0000218,12531,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL621964,1,BAO_0000218,12532,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,CHEMBL621965,1,BAO_0000218,12533,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,CHEMBL621966,1,BAO_0000218,12534,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,CHEMBL621967,1,BAO_0000218,12535,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,CHEMBL622164,1,BAO_0000218,12536,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,CHEMBL623097,0,BAO_0000019,12537,7653,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,CHEMBL623098,0,BAO_0000019,12538,7653,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,CHEMBL623099,0,BAO_0000019,12539,7653,,,,,,
A,1,,,U,Autocuration,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,CHEMBL623100,0,BAO_0000019,12540,7653,,,,,,
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,CHEMBL628673,1,BAO_0000218,12541,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,CHEMBL628674,1,BAO_0000218,12542,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,CHEMBL628675,1,BAO_0000218,12543,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,CHEMBL627644,1,BAO_0000218,12544,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,CHEMBL627645,1,BAO_0000218,12545,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,CHEMBL627646,1,BAO_0000218,12546,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,CHEMBL627647,1,BAO_0000218,12547,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,CHEMBL627648,1,BAO_0000218,12548,9104,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Free level in rat plasma,,CHEMBL627649,1,BAO_0000218,12549,12902,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Level reaching in blood plasma of rat or human was determined,,CHEMBL628313,0,BAO_0000019,12550,6614,,,,,,
A,1,,,N,Intermediate,,,,50597,Log (Cbrain/Cblood) in rats,,CHEMBL628314,1,BAO_0000218,12551,9663,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,CHEMBL628315,0,BAO_0000019,12552,17658,,,,,,
A,1,,,U,Autocuration,,,,22224,Mean percentage of compound transport through membrane; expressed as membrane transport,,CHEMBL628316,0,BAO_0000019,12553,17658,,,,,,
A,1,,,U,Autocuration,,,,22224,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,CHEMBL628317,0,BAO_0000218,12554,14314,,,,,,
A,1,,,U,Autocuration,,,,22224,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,CHEMBL628473,0,BAO_0000019,12555,7385,,,,,,
A,1,,,U,Autocuration,,,,22224,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,CHEMBL628474,0,BAO_0000019,12556,7385,,,,,,
A,1,,,U,Autocuration,,,,22224,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,CHEMBL628475,0,BAO_0000019,12557,7385,,,,,,
A,1,,,U,Autocuration,,,,22224,Net water uptake by a carrier mediated transport (%cm) mechanism,,CHEMBL628476,0,BAO_0000019,12558,1329,,,,,,
A,1,,,U,Autocuration,,,,22224,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,CHEMBL628477,0,BAO_0000218,12559,12187,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50506,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,CHEMBL628478,1,BAO_0000218,12560,12187,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,CHEMBL628479,1,BAO_0000218,12561,12187,,9669.0,,,,Mustela putorius furo
A,1,,,U,Autocuration,,,,22224,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,CHEMBL628480,0,BAO_0000218,12562,12187,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,CHEMBL628481,0,BAO_0000218,12563,12187,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50597,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,CHEMBL628482,1,BAO_0000218,12564,12187,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,CHEMBL628483,1,BAO_0000218,12565,12187,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,CHEMBL628484,1,BAO_0000218,12566,9278,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,CHEMBL628485,1,BAO_0000218,12567,9278,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,100710,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,CHEMBL628486,1,BAO_0000218,12568,9278,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,50587,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,CHEMBL628487,1,BAO_0000218,12569,9278,,9606.0,1969.0,,,Homo sapiens
A,1,,,N,Intermediate,Plasma,,,50597,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,CHEMBL628488,1,BAO_0000218,12570,9278,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,CHEMBL628489,1,BAO_0000218,12571,9278,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,CHEMBL628490,1,BAO_0000218,12572,9278,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,100710,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,CHEMBL628491,1,BAO_0000218,12573,12186,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,CHEMBL877507,1,BAO_0000218,12574,12186,,9541.0,,,,Macaca fascicularis
A,1,,,U,Autocuration,,,,22224,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,CHEMBL628492,0,BAO_0000218,12575,12186,,,,,,
A,1,,,U,Autocuration,,,,22224,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,CHEMBL628493,0,BAO_0000019,12576,12041,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,CHEMBL628494,0,BAO_0000019,12577,12041,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,CHEMBL628495,0,BAO_0000019,12578,12041,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50587,Permeability in Caco-2 assay at 10E-6,,CHEMBL628496,1,BAO_0000218,12579,6737,,9606.0,,,,Homo sapiens
A,1,,,U,Autocuration,Brain,,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,CHEMBL628497,0,BAO_0000218,12580,13758,,,955.0,,,
A,1,,,U,Autocuration,Brain,,,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,CHEMBL628498,0,BAO_0000218,12581,13758,,,955.0,,,
A,1,,,U,Autocuration,,,,22224,Plasma protein binding was determined,,CHEMBL628499,0,BAO_0000019,12582,5676,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL627656,0,BAO_0000218,12583,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL627657,0,BAO_0000218,12584,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL626808,0,BAO_0000218,12585,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626809,0,BAO_0000218,12586,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL626810,0,BAO_0000218,12587,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL626811,0,BAO_0000218,12588,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL874465,0,BAO_0000218,12589,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626812,0,BAO_0000218,12590,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL626813,0,BAO_0000218,12591,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626814,0,BAO_0000218,12592,14793,,,,,,
A,1,,,U,Autocuration,,,,22224,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,CHEMBL626815,0,BAO_0000019,12593,14000,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL628566,0,BAO_0000019,12594,5948,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,CHEMBL628567,0,BAO_0000100,12595,13824,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL628568,0,BAO_0000100,12596,10778,,,,,,
A,1,,,N,Intermediate,,,,50588,C max in dog,In vivo,CHEMBL628569,1,BAO_0000218,12597,17237,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50512,C max in guinea pig,In vivo,CHEMBL628570,1,BAO_0000218,12598,17237,,10141.0,,,,Cavia porcellus
A,1,,,U,Autocuration,,,,22224,C max value was evaluated,In vivo,CHEMBL628571,0,BAO_0000218,12599,2809,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value after oral dose of 0.1 mg//kg,In vivo,CHEMBL628572,0,BAO_0000218,12600,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value after oral dose of 0.3 mg/kg,In vivo,CHEMBL628573,0,BAO_0000218,12601,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value after oral dose of 1 mg/kg,In vivo,CHEMBL628574,0,BAO_0000218,12602,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value after oral dose of 10 mg/kg,In vivo,CHEMBL628575,0,BAO_0000218,12603,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value after oral dose of 23.4 mg/kg,In vivo,CHEMBL628576,0,BAO_0000218,12604,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value after oral dose of 3 mg/kg,In vivo,CHEMBL628577,0,BAO_0000218,12605,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax value after oral dose of 3.87 mg/kg,In vivo,CHEMBL628578,0,BAO_0000218,12606,11954,,,,,,
A,1,,,N,Intermediate,,,,50588,Cmax value in female Beagle dogs,In vivo,CHEMBL874466,1,BAO_0000218,12607,12768,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Cmax value in male rats,In vivo,CHEMBL628579,1,BAO_0000218,12608,12768,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Cmax value in rat plasma when administered 20 mg/kg perorally,In vivo,CHEMBL628580,1,BAO_0000218,12609,12780,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,CHEMBL628581,1,BAO_0000218,12610,15592,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,CHEMBL628582,1,BAO_0000218,12611,15592,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,CHEMBL628583,1,BAO_0000218,12612,17025,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,CHEMBL625782,0,BAO_0000218,12613,17025,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50592,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,CHEMBL625783,1,BAO_0000218,12614,17025,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50597,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,CHEMBL625784,1,BAO_0000218,12615,17025,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50797,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,CHEMBL625785,1,BAO_0000218,12616,4236,,9544.0,1969.0,,,Macaca mulatta
A,1,,,N,Intermediate,,,,50597,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,CHEMBL625786,1,BAO_0000218,12617,15791,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,CHEMBL874467,0,BAO_0000019,12618,11149,,,,,,
A,1,,,N,Intermediate,,,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,CHEMBL625787,1,BAO_0000218,12619,15592,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50677,cytotoxicity against HIV protease enzyme.,,CHEMBL625964,1,BAO_0000218,12620,15778,,12721.0,,,,Human immunodeficiency virus
A,1,,,N,Intermediate,,,,50594,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,CHEMBL625965,1,BAO_0000218,12621,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,CHEMBL625966,1,BAO_0000218,12622,12745,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50588,The plasma clearance in dog.,In vivo,CHEMBL625967,1,BAO_0000218,12623,13941,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,The plasma clearance in rat.,In vivo,CHEMBL625968,1,BAO_0000218,12624,13941,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Clearance from plasma in male Sprague-Dawley rats,In vivo,CHEMBL625969,1,BAO_0000218,12625,16449,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,100710,Clearance from plasma in male cynomolgus monkeys,In vivo,CHEMBL625970,1,BAO_0000218,12626,16449,,9541.0,1969.0,,,Macaca fascicularis
A,1,,,N,Intermediate,Plasma,,,50588,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",In vivo,CHEMBL625971,1,BAO_0000218,12627,14224,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Clearance of compound in dog plasma,In vivo,CHEMBL625972,1,BAO_0000218,12628,14224,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50587,Clearance of compound in human plasma,In vivo,CHEMBL625973,1,BAO_0000218,12629,14224,,9606.0,1969.0,,,Homo sapiens
A,1,,,N,Intermediate,,,,50588,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,In vivo,CHEMBL625974,1,BAO_0000218,12630,14317,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Clearance of compound when administered intravenously as an individual dose to a single dog.,In vivo,CHEMBL625975,1,BAO_0000218,12631,14317,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,"Clearance (10 mg/kg, intravenously) in dog plasma",In vivo,CHEMBL625976,1,BAO_0000218,12632,14224,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Clearance value in dog,In vivo,CHEMBL625977,1,BAO_0000218,12633,17237,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50512,Clearance value in guinea pig,In vivo,CHEMBL625978,1,BAO_0000218,12634,17237,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50597,Clearance values in rats after iv administration.,In vivo,CHEMBL874468,1,BAO_0000218,12635,14187,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,In vivo,CHEMBL625421,0,BAO_0000218,12636,4806,,,1969.0,,,
A,1,,,N,Intermediate,,,,50592,In vivo clearance (5 mg/kg) was determined in rabbits,In vivo,CHEMBL625422,1,BAO_0000218,12637,15025,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50597,Plasma Clearance rate was determined for the compound in rats,In vivo,CHEMBL625423,1,BAO_0000218,12638,13197,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Plasma Clearance rate was determined for the compound in squirrel monkeys,In vivo,CHEMBL625424,0,BAO_0000218,12639,13197,,9520.0,,,,Saimiri
A,1,,,N,Intermediate,,,,50597,Plasma clearance in rat,In vivo,CHEMBL625425,1,BAO_0000218,12640,13960,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Plasma clearance of the compound,In vivo,CHEMBL625426,0,BAO_0000218,12641,17820,,,,,,
A,1,,,N,Intermediate,,,,50512,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,In vivo,CHEMBL625427,1,BAO_0000218,12642,14706,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50512,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,In vivo,CHEMBL625428,1,BAO_0000218,12643,14706,,10141.0,,,,Cavia porcellus
A,1,,,U,Autocuration,,,,22224,Plasma clearance was determined,In vivo,CHEMBL625429,0,BAO_0000218,12644,6504,,,,,,
A,1,,,N,Intermediate,,,,50588,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,In vivo,CHEMBL625430,1,BAO_0000218,12645,14925,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Plasma clearance rate was determined for the compound in rats,In vivo,CHEMBL625431,1,BAO_0000218,12646,13197,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Plasma clearance rate was determined for the compound in squirrel monkeys,In vivo,CHEMBL627307,0,BAO_0000218,12647,13197,,9520.0,,,,Saimiri
A,1,,,U,Autocuration,,,,22224,Slow clearance (CL) was determined,In vivo,CHEMBL627308,0,BAO_0000218,12648,3437,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,CHEMBL627309,0,BAO_0000218,12649,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,CHEMBL627310,0,BAO_0000218,12650,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,CHEMBL627311,0,BAO_0000218,12651,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,CHEMBL627312,0,BAO_0000218,12652,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,CHEMBL627313,0,BAO_0000218,12653,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,CHEMBL627314,0,BAO_0000218,12654,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,CHEMBL627315,0,BAO_0000218,12655,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL627316,0,BAO_0000218,12656,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL627317,0,BAO_0000218,12657,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL627318,0,BAO_0000218,12658,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,CHEMBL627999,0,BAO_0000218,12659,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628000,0,BAO_0000218,12660,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,CHEMBL628001,0,BAO_0000218,12661,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL628002,0,BAO_0000218,12662,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,CHEMBL625610,0,BAO_0000218,12663,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL625611,0,BAO_0000218,12664,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,CHEMBL625612,0,BAO_0000218,12665,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,CHEMBL625613,0,BAO_0000218,12666,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL875479,0,BAO_0000218,12667,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,CHEMBL625614,0,BAO_0000218,12668,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,CHEMBL625615,0,BAO_0000218,12669,9196,,,,,,
A,1,,,U,Autocuration,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,CHEMBL626302,0,BAO_0000218,12670,9196,,,,,,
A,1,,,N,Intermediate,Blood,,,50597,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL626303,1,BAO_0000218,12671,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,CHEMBL627420,1,BAO_0000218,12672,8374,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,CHEMBL627421,1,BAO_0000218,12673,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,CHEMBL625695,1,BAO_0000218,12674,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,CHEMBL625696,1,BAO_0000218,12675,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of compound in mice brain was measured after 1 hr,,CHEMBL875606,1,BAO_0000218,12676,10009,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of compound in mice brain was measured after 24 hr r,,CHEMBL625697,1,BAO_0000218,12677,10009,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of compound in mice brain was measured after 2 hr,,CHEMBL625698,1,BAO_0000218,12678,10009,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of compound in mice brain was measured after 3 hr,,CHEMBL625699,1,BAO_0000218,12679,10009,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of compound in mice brain was measured after 6 hr,,CHEMBL625700,1,BAO_0000218,12680,10009,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Distribution of compound in mice liver was measured after 1 hr,,CHEMBL625701,1,BAO_0000218,12681,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,CHEMBL625702,1,BAO_0000218,12682,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Distribution of compound in mice liver was measured after 2 hr,,CHEMBL625703,1,BAO_0000218,12683,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Distribution of compound in mice liver was measured after 3 hr,,CHEMBL625704,1,BAO_0000218,12684,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Distribution of compound in mice liver was measured after 6 hr,,CHEMBL625705,1,BAO_0000218,12685,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Adrenal medulla,,,50588,Distribution in dog adrenal medulla 30 min after administration.,,CHEMBL625706,1,BAO_0000218,12686,8170,,9615.0,1236.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Adrenal medulla,,,50588,Distribution in dog adrenal medulla 72 hours after administration.,,CHEMBL625707,1,BAO_0000218,12687,8170,,9615.0,1236.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog Ovary 24 hours after administration.,,CHEMBL625708,1,BAO_0000218,12688,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog Ovary 72 hours after administration.,,CHEMBL625709,1,BAO_0000218,12689,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog adipose 24 hours after administration.,,CHEMBL624180,1,BAO_0000218,12690,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog adipose 72 hours after administration.,,CHEMBL624181,1,BAO_0000218,12691,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Adrenal cortex,,,50588,Distribution in female dog adrenal cortex 72 hours after administration.,,CHEMBL624182,1,BAO_0000218,12692,8170,,9615.0,1235.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Adrenal cortex,,,50588,Distribution in female dog adrenal cortex 72 hours after administration.,,CHEMBL624183,1,BAO_0000218,12693,8170,,9615.0,1235.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,CHEMBL624184,1,BAO_0000218,12694,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,CHEMBL877489,1,BAO_0000218,12695,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL624185,1,BAO_0000218,12696,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,CHEMBL624186,1,BAO_0000218,12697,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,CHEMBL624187,1,BAO_0000218,12698,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,CHEMBL624188,1,BAO_0000218,12699,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,CHEMBL624189,1,BAO_0000218,12700,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,CHEMBL624190,1,BAO_0000218,12701,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,CHEMBL624191,1,BAO_0000218,12702,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,CHEMBL624192,1,BAO_0000218,12703,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,CHEMBL624193,1,BAO_0000218,12704,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,CHEMBL624194,1,BAO_0000218,12705,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,CHEMBL624891,1,BAO_0000218,12706,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,CHEMBL624892,1,BAO_0000218,12707,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,CHEMBL624893,1,BAO_0000218,12708,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL627632,1,BAO_0000218,12709,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,CHEMBL627633,1,BAO_0000218,12710,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,CHEMBL627634,1,BAO_0000218,12711,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,CHEMBL627635,1,BAO_0000218,12712,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,CHEMBL627636,1,BAO_0000218,12713,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,CHEMBL626816,1,BAO_0000218,12714,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,CHEMBL626817,1,BAO_0000218,12715,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,CHEMBL626818,1,BAO_0000218,12716,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,CHEMBL626819,1,BAO_0000218,12717,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,CHEMBL626820,1,BAO_0000218,12718,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL626821,1,BAO_0000218,12719,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,CHEMBL626822,1,BAO_0000218,12720,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,CHEMBL626823,1,BAO_0000218,12721,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,CHEMBL626824,1,BAO_0000218,12722,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,CHEMBL626825,1,BAO_0000218,12723,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,CHEMBL626826,1,BAO_0000218,12724,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,CHEMBL626827,1,BAO_0000218,12725,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,CHEMBL626828,1,BAO_0000218,12726,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,CHEMBL626829,1,BAO_0000218,12727,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL626830,1,BAO_0000218,12728,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,CHEMBL627150,1,BAO_0000218,12729,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL627151,1,BAO_0000218,12730,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,CHEMBL627152,1,BAO_0000218,12731,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,CHEMBL627153,1,BAO_0000218,12732,8594,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Rate of acetate production by the compound was determined,,CHEMBL627154,0,BAO_0000019,12733,12904,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate of acetate production by the compound was determined; Not determined,,CHEMBL627155,0,BAO_0000019,12734,12904,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,CHEMBL627156,0,BAO_0000019,12735,3730,,,,,,
A,1,,,U,Autocuration,,,,22224,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,CHEMBL627157,0,BAO_0000019,12736,3627,,,,,,
A,1,,,N,Intermediate,,,,50592,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,CHEMBL627158,1,BAO_0000218,12737,13799,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Plasma,,,50592,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,CHEMBL627159,1,BAO_0000218,12738,13799,,9986.0,1969.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50594,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,CHEMBL627160,1,BAO_0000218,12739,13799,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,CHEMBL628540,1,BAO_0000218,12740,13799,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,CHEMBL628541,1,BAO_0000218,12741,13799,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,CHEMBL628542,1,BAO_0000218,12742,13799,,10116.0,1969.0,,,Rattus norvegicus
P,1,,,U,Autocuration,,,,22229,Solubility after at a pH 1.2,,CHEMBL628543,0,BAO_0000100,12743,6629,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility after at pH 1.2,,CHEMBL628544,0,BAO_0000100,12744,6629,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility after injection of water,,CHEMBL628545,0,BAO_0000100,12745,6629,,,,,,
A,1,,,U,Autocuration,,,,22224,Statistical significance of IC 50 values; Expressed as R value,,CHEMBL628546,0,BAO_0000019,12746,14000,,,,,,
A,1,,,U,Autocuration,,,,22224,Systemic availability with respect to methyldopa was determined,,CHEMBL874455,0,BAO_0000019,12747,8267,,,,,,
A,1,,,N,Intermediate,,,,50597,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,CHEMBL628547,1,BAO_0000218,12748,13799,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,CHEMBL628548,1,BAO_0000218,12749,13799,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,CHEMBL628549,1,BAO_0000218,12750,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,CHEMBL628550,1,BAO_0000218,12751,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,CHEMBL628551,1,BAO_0000218,12752,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,CHEMBL628552,1,BAO_0000218,12753,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,CHEMBL628553,1,BAO_0000218,12754,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,CHEMBL628554,1,BAO_0000218,12755,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,CHEMBL628555,1,BAO_0000218,12756,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,CHEMBL628556,1,BAO_0000218,12757,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Kidney,,,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,CHEMBL628557,1,BAO_0000218,12758,7132,,9986.0,2113.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,CHEMBL628558,1,BAO_0000218,12759,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,CHEMBL628559,1,BAO_0000218,12760,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,CHEMBL628560,1,BAO_0000218,12761,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,CHEMBL874456,1,BAO_0000218,12762,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,CHEMBL628561,1,BAO_0000218,12763,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,CHEMBL628562,1,BAO_0000218,12764,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,CHEMBL628563,1,BAO_0000218,12765,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,CHEMBL628564,1,BAO_0000218,12766,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,CHEMBL628565,1,BAO_0000218,12767,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,CHEMBL631248,1,BAO_0000218,12768,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,CHEMBL631249,1,BAO_0000218,12769,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Kidney,,,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,CHEMBL627214,1,BAO_0000218,12770,7132,,9986.0,2113.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,CHEMBL874591,1,BAO_0000218,12771,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,CHEMBL627215,1,BAO_0000218,12772,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,CHEMBL625471,1,BAO_0000218,12773,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,CHEMBL625472,1,BAO_0000218,12774,7132,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,CHEMBL625473,1,BAO_0000218,12775,7132,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50588,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,In vivo,CHEMBL625474,1,BAO_0000218,12776,13317,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,In vivo,CHEMBL625475,1,BAO_0000218,12777,15341,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,In vivo,CHEMBL625476,1,BAO_0000218,12778,15341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,In vivo,CHEMBL625477,1,BAO_0000218,12779,15341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,CHEMBL625478,1,BAO_0000218,12780,15341,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,esophageal tunica muscularis mucosae,,,50597,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,In vitro,CHEMBL625479,1,BAO_0000218,12781,12801,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,esophageal tunica muscularis mucosae,,,50597,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,In vitro,CHEMBL625480,1,BAO_0000218,12782,12801,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,In vivo,CHEMBL625481,1,BAO_0000218,12783,14856,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,In vivo,CHEMBL625482,1,BAO_0000218,12784,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,In vivo,CHEMBL625483,1,BAO_0000218,12785,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,In vivo,CHEMBL625484,1,BAO_0000218,12786,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,In vivo,CHEMBL625485,1,BAO_0000218,12787,14062,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,In vivo,CHEMBL625486,1,BAO_0000218,12788,14346,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,In vivo,CHEMBL625487,1,BAO_0000218,12789,14346,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,In vivo,CHEMBL625488,1,BAO_0000218,12790,14346,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,In vivo,CHEMBL625489,1,BAO_0000218,12791,14346,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,In vivo,CHEMBL625490,1,BAO_0000218,12792,14346,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,In vivo,CHEMBL625491,1,BAO_0000218,12793,14346,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,CHEMBL625492,1,BAO_0000218,12794,14346,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50587,plasma clearance in human,In vivo,CHEMBL625493,1,BAO_0000218,12795,15711,,9606.0,1969.0,,,Homo sapiens
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,CHEMBL625494,1,BAO_0000218,12796,14886,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,CHEMBL625495,1,BAO_0000218,12797,14886,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,CHEMBL625496,1,BAO_0000218,12798,14886,,10116.0,,,,Rattus norvegicus
P,1,,,U,Autocuration,,,,22229,1-Octanol/water partition coefficient measured at 7.4,,CHEMBL625497,0,BAO_0000100,12799,4115,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625498,0,BAO_0000100,12800,13733,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL625499,0,BAO_0000019,12801,12102,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625500,0,BAO_0000100,12802,12676,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625501,0,BAO_0000100,12803,13733,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625502,0,BAO_0000100,12804,13740,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (relative to BAY K 8644),,CHEMBL625503,0,BAO_0000100,12805,12766,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625504,0,BAO_0000100,12806,2764,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625505,0,BAO_0000100,12807,12355,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient of the compound,,CHEMBL625506,0,BAO_0000100,12808,11314,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL625507,0,BAO_0000019,12809,12706,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625508,0,BAO_0000100,12810,12645,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625509,0,BAO_0000100,12811,13668,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625510,0,BAO_0000100,12812,12819,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL883125,0,BAO_0000100,12813,13668,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625511,0,BAO_0000100,12814,13017,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient of the compound,,CHEMBL874650,0,BAO_0000019,12815,2448,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient of the compound,,CHEMBL625512,0,BAO_0000019,12816,11526,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient of compound was determined,,CHEMBL625513,0,BAO_0000019,12817,12426,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient was determined,,CHEMBL625514,0,BAO_0000019,12818,2448,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625515,0,BAO_0000100,12819,12001,,,,,,
P,1,,,U,Autocuration,,,,22229,partition coefficient of compound was determined,,CHEMBL625516,0,BAO_0000100,12820,12426,,,,,,
A,1,,,N,Intermediate,,,,50588,The total body administered intravenously in dog,In vivo,CHEMBL625517,1,BAO_0000218,12821,13204,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,The total body administered intravenously in rats,In vivo,CHEMBL625518,1,BAO_0000218,12822,13204,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Time taken for the administration to female NIH mice weighing 25-30 g.,,CHEMBL625519,1,BAO_0000218,12823,13889,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Time taken for the administration,,CHEMBL625520,0,BAO_0000019,12824,13889,,,,,,
A,1,,,N,Intermediate,,,,50588,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,In vivo,CHEMBL874651,1,BAO_0000218,12825,17025,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,In vivo,CHEMBL625521,0,BAO_0000218,12826,17025,,314293.0,,,,Simiiformes
A,1,,,N,Intermediate,,,,50592,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,In vivo,CHEMBL623171,1,BAO_0000218,12827,17025,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50597,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,In vivo,CHEMBL623853,1,BAO_0000218,12828,17025,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Plasma clearance for the compound was determined.,,CHEMBL623854,0,BAO_0000019,12829,15067,,,,,,
P,1,,,U,Autocuration,,,,22224,CLog P value of the compound,,CHEMBL874405,0,BAO_0000100,12830,3091,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL623855,0,BAO_0000100,12831,15592,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL623856,0,BAO_0000100,12832,14738,,,,,,
P,1,,,U,Autocuration,,,,22224,ClogP value of the compound; nd ='no data',,CHEMBL623857,0,BAO_0000100,12833,14738,,,,,,
P,1,,,U,Autocuration,,,,22224,ClogP value of the compound; nd ='not determined',,CHEMBL623858,0,BAO_0000100,12834,14738,,,,,,
P,1,,,U,Autocuration,,,,22224,CLog P was determined,,CHEMBL623859,0,BAO_0000100,12835,6076,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL839829,0,BAO_0000100,12836,17840,,,,,,
A,1,,,U,Autocuration,,,,22224,CLogP was calculated,,CHEMBL623860,0,BAO_0000019,12837,13589,,,,,,
A,1,,,U,Autocuration,,,,22224,CLogP value was determined,,CHEMBL623861,0,BAO_0000019,12838,17655,,,,,,
A,1,,,U,Autocuration,,,,22224,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,CHEMBL623862,0,BAO_0000019,12839,5867,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL874406,0,BAO_0000100,12840,5867,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL623863,0,BAO_0000100,12841,10783,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624021,0,BAO_0000100,12842,14849,,,,,,
A,1,,,N,Intermediate,Adrenal medulla,,,50588,Distribution in female dog adrenal medulla 24 hours after administration.,,CHEMBL624022,1,BAO_0000218,12843,8170,,9615.0,1236.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Adrenal medulla,,,50588,Distribution in female dog adrenal medulla 72 hours after administration.,,CHEMBL624023,1,BAO_0000218,12844,8170,,9615.0,1236.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog bile 24 hours after administration.,,CHEMBL624024,1,BAO_0000218,12845,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog bile 72 hr after administration.,,CHEMBL624025,1,BAO_0000218,12846,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog blood 24 hours after administration.,,CHEMBL624026,1,BAO_0000218,12847,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog blood 72 hours after administration.,,CHEMBL624027,1,BAO_0000218,12848,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog heart 24 hours after administration.,,CHEMBL624028,1,BAO_0000218,12849,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog heart 72 hours after administration.,,CHEMBL624029,1,BAO_0000218,12850,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog kidney 24 hours after administration.,,CHEMBL624030,1,BAO_0000218,12851,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog kidney 72 hours after administration.,,CHEMBL624031,1,BAO_0000218,12852,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Intestine,,,50588,Distribution in female dog large intestine 24 hours after administration.,,CHEMBL624032,1,BAO_0000218,12853,8170,,9615.0,160.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Intestine,,,50588,Distribution in female dog large intestine 72 hours after administration.,,CHEMBL874407,1,BAO_0000218,12854,8170,,9615.0,160.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog liver 24 hours after administration.,,CHEMBL624033,1,BAO_0000218,12855,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog liver 72 hours after administration.,,CHEMBL624034,1,BAO_0000218,12856,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog lung 24 hours after administration.,,CHEMBL624035,1,BAO_0000218,12857,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog lung 72 hours after administration.,,CHEMBL624036,1,BAO_0000218,12858,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Muscle tissue,,,50588,Distribution in female dog muscle 24 hours after administration.,,CHEMBL624037,1,BAO_0000218,12859,8170,,9615.0,2385.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Muscle tissue,,,50588,Distribution in female dog muscle 72 hours after administration.,,CHEMBL624038,1,BAO_0000218,12860,8170,,9615.0,2385.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog pancreas 24 hours after administration.,,CHEMBL624039,1,BAO_0000218,12861,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Distribution in female dog pancreas 72 hours after administration.,,CHEMBL624040,1,BAO_0000218,12862,8170,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Intestine,,,50588,Distribution in female dog small intestine 24 hours after administration.,,CHEMBL624041,1,BAO_0000218,12863,8170,,9615.0,160.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Intestine,,,50588,Distribution in female dog small intestine 72 hours after administration.,,CHEMBL624042,1,BAO_0000218,12864,8170,,9615.0,160.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Spleen,,,50588,Distribution in female dog spleen 24 hours after administration.,,CHEMBL624043,1,BAO_0000218,12865,8170,,9615.0,2106.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Spleen,,,50588,Distribution in female dog spleen 72 hours after administration.,,CHEMBL624044,1,BAO_0000218,12866,8170,,9615.0,2106.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Stomach,,,50588,Distribution in female dog stomach 24 hours after administration.,,CHEMBL624045,1,BAO_0000218,12867,8170,,9615.0,945.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Stomach,,,50588,Distribution in female dog stomach 72 hours after administration.,,CHEMBL624046,1,BAO_0000218,12868,8170,,9615.0,945.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Thyroid gland,,,50588,Distribution in female dog thyroid 24 hours after administration.,,CHEMBL624047,1,BAO_0000218,12869,8170,,9615.0,2046.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Thyroid gland,,,50588,Distribution in female dog thyroid 72 hours after administration.,,CHEMBL624048,1,BAO_0000218,12870,8170,,9615.0,2046.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Distribution in female dog urine 24 hours after administration.,,CHEMBL874408,1,BAO_0000218,12871,8170,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Distribution in female dog urine 72 hr after administration.,,CHEMBL624049,1,BAO_0000218,12872,8170,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,CHEMBL624050,0,BAO_0000218,12873,14283,,,1969.0,,,
A,1,,,U,Autocuration,,,,22224,Plasma concentration at 7 hr after intravenous dosing,,CHEMBL624051,0,BAO_0000019,12874,5623,,,,,,
A,1,,,N,Intermediate,,,,50597,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,CHEMBL623278,1,BAO_0000218,12875,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,CHEMBL623279,1,BAO_0000218,12876,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,CHEMBL623280,1,BAO_0000218,12877,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,CHEMBL623963,1,BAO_0000218,12878,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,CHEMBL623964,1,BAO_0000218,12879,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,CHEMBL623965,1,BAO_0000218,12880,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,CHEMBL623966,1,BAO_0000218,12881,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,CHEMBL874415,1,BAO_0000218,12882,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,CHEMBL623967,1,BAO_0000218,12883,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,CHEMBL623968,1,BAO_0000218,12884,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,CHEMBL623969,1,BAO_0000218,12885,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,CHEMBL628409,1,BAO_0000218,12886,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,CHEMBL628410,1,BAO_0000218,12887,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,CHEMBL628411,1,BAO_0000218,12888,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,CHEMBL628412,1,BAO_0000218,12889,13477,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,CHEMBL628413,0,BAO_0000019,12890,12553,,,,,,
A,1,,,U,Autocuration,Plasma,,,22224,The concentration in plasmat; Not determined,,CHEMBL628414,0,BAO_0000019,12891,14548,,,1969.0,,,
A,1,,,N,Intermediate,,,,50597,Tissue level at 10 mg/kg/po in wistar rats in blood,,CHEMBL628415,1,BAO_0000218,12892,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,CHEMBL628416,1,BAO_0000218,12893,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue level at 10 mg/kg/po in wistar rats in heart,,CHEMBL628417,1,BAO_0000218,12894,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Tissue level at 10 mg/kg/po in wistar rats in liver,,CHEMBL874908,1,BAO_0000218,12895,14393,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue level at 10 mg/kg/po in wistar rats in plasma,,CHEMBL628418,1,BAO_0000218,12896,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,CHEMBL628419,1,BAO_0000218,12897,14393,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,CHEMBL628420,1,BAO_0000218,12898,14393,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Water solubility at 37 degree C.,,CHEMBL628421,0,BAO_0000019,12899,1629,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,CHEMBL626726,0,BAO_0000100,12900,8194,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,CHEMBL626727,0,BAO_0000100,12901,8194,,,,,,
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,CHEMBL626728,1,BAO_0000218,12902,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,CHEMBL626729,1,BAO_0000218,12903,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,CHEMBL626730,1,BAO_0000218,12904,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,CHEMBL626731,1,BAO_0000218,12905,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,CHEMBL626732,1,BAO_0000218,12906,8594,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,CHEMBL626733,1,BAO_0000218,12907,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,CHEMBL626734,1,BAO_0000218,12908,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,CHEMBL626735,1,BAO_0000218,12909,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,CHEMBL874909,1,BAO_0000218,12910,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,CHEMBL626736,1,BAO_0000218,12911,8594,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,CHEMBL626737,1,BAO_0000218,12912,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,CHEMBL630999,1,BAO_0000218,12913,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,CHEMBL631000,1,BAO_0000218,12914,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,CHEMBL631001,1,BAO_0000218,12915,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,CHEMBL631002,1,BAO_0000218,12916,8594,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,CHEMBL631003,1,BAO_0000218,12917,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,CHEMBL631004,1,BAO_0000218,12918,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,CHEMBL631005,1,BAO_0000218,12919,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,CHEMBL631006,1,BAO_0000218,12920,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,CHEMBL631007,1,BAO_0000218,12921,8594,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,CHEMBL631008,1,BAO_0000218,12922,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,CHEMBL631009,1,BAO_0000218,12923,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,CHEMBL631010,1,BAO_0000218,12924,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,CHEMBL631011,1,BAO_0000218,12925,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,CHEMBL631012,1,BAO_0000218,12926,8594,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,CHEMBL630271,1,BAO_0000218,12927,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,CHEMBL630272,1,BAO_0000218,12928,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,CHEMBL630273,1,BAO_0000218,12929,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,CHEMBL630274,1,BAO_0000218,12930,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,CHEMBL630275,1,BAO_0000218,12931,8594,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,CHEMBL875782,1,BAO_0000218,12932,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,CHEMBL630276,1,BAO_0000218,12933,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,CHEMBL630277,1,BAO_0000218,12934,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,CHEMBL630278,1,BAO_0000218,12935,8594,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,CHEMBL630279,1,BAO_0000218,12936,8594,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,CHEMBL630280,0,BAO_0000019,12937,8151,,,,,,
A,1,,,U,Autocuration,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,CHEMBL630281,0,BAO_0000019,12938,8151,,,,,,
A,1,,,N,Intermediate,,,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,CHEMBL630282,1,BAO_0000218,12939,7132,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,CHEMBL630283,1,BAO_0000218,12940,7132,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,CHEMBL630284,0,BAO_0000019,12941,5797,,,,,,
A,1,,,U,Autocuration,,,,22224,Alkylating activity was determined,,CHEMBL630285,0,BAO_0000019,12942,7849,,,,,,
A,1,,,U,Autocuration,,,,22224,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,CHEMBL630286,0,BAO_0000251,12943,14220,Microsomes,,,,,
A,1,,,N,Intermediate,,,,50592,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,CHEMBL630069,1,BAO_0000218,12944,8650,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,CHEMBL630070,1,BAO_0000218,12945,8650,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,CHEMBL630071,1,BAO_0000218,12946,8650,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,CHEMBL630072,1,BAO_0000218,12947,8650,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,CHEMBL875110,1,BAO_0000218,12948,8650,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50597,Compound was tested for antidiuretic activity in rats,,CHEMBL630073,1,BAO_0000218,12949,7116,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was tested for inactivation kinetic values,,CHEMBL630074,0,BAO_0000019,12950,14131,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,In vivo,CHEMBL630075,0,BAO_0000218,12951,7415,,,,,,
A,1,,,U,Autocuration,,,,22224,Dissociation rate calculated from the first-order equation using the t1/2 value,,CHEMBL630076,0,BAO_0000019,12952,13178,,,,,,
P,1,,,U,Autocuration,,,,22229,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,CHEMBL630077,0,BAO_0000100,12953,8815,,,,,,
P,1,,,U,Autocuration,,,,22229,Aqueous solubility was measured,,CHEMBL630078,0,BAO_0000100,12954,1450,,,,,,
P,1,,,U,Autocuration,,,,22229,Aqueous solubility was measured at a pH 4,,CHEMBL630079,0,BAO_0000100,12955,1450,,,,,,
P,1,,,U,Autocuration,,,,22229,Aqueous solubility (pH 7),,CHEMBL630080,0,BAO_0000100,12956,1450,,,,,,
P,1,,,U,Autocuration,,,,22229,Aqueous solubility was measured at a pH 9,,CHEMBL630081,0,BAO_0000100,12957,1450,,,,,,
A,1,,,U,Autocuration,,,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,CHEMBL630082,0,BAO_0000019,12958,12711,,,,,,
A,1,,,U,Autocuration,,,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,CHEMBL630083,0,BAO_0000019,12959,12711,,,,,,
A,1,,,U,Autocuration,,,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,CHEMBL630084,0,BAO_0000019,12960,12711,,,,,,
P,1,,,U,Autocuration,,,,22229,Aqueous solubility of the compound,,CHEMBL629198,0,BAO_0000100,12961,15032,,,,,,
P,1,,,U,Autocuration,,,,22229,Aqueous solubility at 37 degree Celsius at pH 7.38,,CHEMBL629199,0,BAO_0000100,12962,9964,,,,,,
P,1,,,U,Autocuration,,,,22229,Aqueous solubility in pH 7.4 phosphate buffer,,CHEMBL629200,0,BAO_0000100,12963,14962,,,,,,
A,1,,,N,Intermediate,,,,50588,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,CHEMBL629201,1,BAO_0000218,12964,12487,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,CHEMBL629202,1,BAO_0000218,12965,12487,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50587,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,CHEMBL875111,1,BAO_0000218,12966,10026,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,CHEMBL629203,1,BAO_0000218,12967,10026,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,CHEMBL629204,1,BAO_0000218,12968,10026,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,CHEMBL629205,1,BAO_0000218,12969,10026,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,CHEMBL629206,1,BAO_0000218,12970,10026,,9606.0,,,,Homo sapiens
A,1,,,U,Autocuration,,,,22224,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,CHEMBL631185,0,BAO_0000019,12971,10026,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the average bile flow rat in rats,,CHEMBL631186,1,BAO_0000218,12972,7415,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50592,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,CHEMBL631187,1,BAO_0000218,12973,17025,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50592,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,CHEMBL631188,1,BAO_0000218,12974,17025,,9986.0,,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Average half life period was determined,,CHEMBL876419,0,BAO_0000019,12975,10184,,,,,,
A,1,,,U,Autocuration,,,,22224,Average half life period was determined,,CHEMBL631189,0,BAO_0000019,12976,10184,,,,,,
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,CHEMBL631190,1,BAO_0000218,12977,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,CHEMBL631191,1,BAO_0000218,12978,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,CHEMBL631192,1,BAO_0000218,12979,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,CHEMBL632400,1,BAO_0000218,12980,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,CHEMBL630564,1,BAO_0000218,12981,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,CHEMBL630565,1,BAO_0000218,12982,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,CHEMBL630566,1,BAO_0000218,12983,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,CHEMBL631229,1,BAO_0000218,12984,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,CHEMBL631230,1,BAO_0000218,12985,8613,,10298.0,,,,Human herpesvirus 1
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL876428,0,BAO_0000100,12986,6030,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631231,0,BAO_0000100,12987,6147,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (MacLogP),,CHEMBL631232,0,BAO_0000100,12988,14556,,,,,,
A,1,,,U,Autocuration,,,,22224,Hydrophilicity was determined,,CHEMBL631233,0,BAO_0000019,12989,768,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631234,0,BAO_0000100,12990,14452,,,,,,
A,1,,,U,Autocuration,,,,22224,Increased absorption was determined,,CHEMBL883126,0,BAO_0000019,12991,5237,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity value was evaluated,,CHEMBL631235,0,BAO_0000100,12992,14378,,,,,,
P,1,,,U,Autocuration,,,,22224,Log P value of the compound.,,CHEMBL631236,0,BAO_0000100,12993,14418,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient of compound was determined,,CHEMBL631237,0,BAO_0000019,12994,5249,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631238,0,BAO_0000100,12995,14621,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL876429,0,BAO_0000100,12996,12542,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient was measured by medchem software; Not calculated,,CHEMBL631414,0,BAO_0000019,12997,12542,,,,,,
P,1,,,U,Autocuration,,,,22224,Partition coefficient was measured by octanol-water using standard shake-flask method,,CHEMBL631415,0,BAO_0000100,12998,12542,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631416,0,BAO_0000100,12999,15462,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL631417,0,BAO_0000019,13000,14884,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631418,0,BAO_0000100,13001,16526,,,,,,
P,1,,,U,Autocuration,,,,22229,The Octanol/Water partition coefficient CLogP,,CHEMBL631419,0,BAO_0000100,13002,13693,,,,,,
A,1,,,U,Autocuration,,,,22224,The pharmacokinetic parameter C Log p was reported,,CHEMBL631420,0,BAO_0000019,13003,13693,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631421,0,BAO_0000100,13004,13779,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631422,0,BAO_0000100,13005,14772,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631423,0,BAO_0000100,13006,14393,,,,,,
A,1,,,N,Intermediate,Plasma,,,50597,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,CHEMBL876430,1,BAO_0000218,13007,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,CHEMBL631424,1,BAO_0000218,13008,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,Compound was administered intravenously in dog to evaluate plasma clearance values,In vivo,CHEMBL631425,1,BAO_0000218,13009,13744,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Plasma,,,22224,Compound was administered intravenously in monkey to evaluate plasma clearance values,In vivo,CHEMBL631426,0,BAO_0000218,13010,13744,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50594,Compound was administered intravenously in mouse to evaluate plasma clearance values,In vivo,CHEMBL631427,1,BAO_0000218,13011,13744,,10090.0,1969.0,,,Mus musculus
A,1,,,N,Intermediate,Plasma,,,50588,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,In vivo,CHEMBL631428,1,BAO_0000218,13012,13207,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Liver,,,50797,Intrinsic clearance in Rhesus liver microsome,In vitro,CHEMBL631429,1,BAO_0000218,13013,5669,Microsomes,9544.0,2107.0,,,Macaca mulatta
A,1,,,N,Intermediate,Liver,,,50588,Intrinsic clearance in dog liver microsome,In vitro,CHEMBL631430,1,BAO_0000218,13014,5669,Microsomes,9615.0,2107.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Liver,,,50597,Intrinsic clearance in rat liver microsome,In vitro,CHEMBL631431,1,BAO_0000218,13015,5669,Microsomes,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50797,Low plasma clearance was calculated in rhesus monkey,In vivo,CHEMBL631432,1,BAO_0000218,13016,4853,,9544.0,1969.0,,,Macaca mulatta
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,In vivo,CHEMBL631433,1,BAO_0000218,13017,16452,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Plasma clearance after intravenous dose of 0.3 mg/kg,In vivo,CHEMBL631434,0,BAO_0000218,13018,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Plasma clearance after intravenous dose of 1 mg/kg,In vivo,CHEMBL631435,0,BAO_0000218,13019,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Plasma clearance after intravenous dose of 3 mg/kg,In vivo,CHEMBL631436,0,BAO_0000218,13020,11954,,,,,,
A,1,,,U,Autocuration,,,,22224,Plasma clearance after intravenous dose of 3.87 mg/kg,In vivo,CHEMBL631437,0,BAO_0000218,13021,11954,,,,,,
A,1,,,N,Intermediate,,,,50597,Plasma clearance after peroral administration at 10 mpk in Rat,In vivo,CHEMBL631438,1,BAO_0000218,13022,5669,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50797,Plasma clearance after peroral administration at 10 mpk in Rhesus,In vivo,CHEMBL876431,1,BAO_0000218,13023,5669,,9544.0,,,,Macaca mulatta
A,1,,,N,Intermediate,,,,50588,Plasma clearance after peroral administration at 10 mpk in dog,In vivo,CHEMBL631439,1,BAO_0000218,13024,5669,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,In vivo,CHEMBL631440,1,BAO_0000218,13025,13662,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,CHEMBL631441,0,BAO_0000019,13026,8272,,,,,,
A,1,,,U,Autocuration,,,,22224,Critical Micellar concentration was determined,,CHEMBL631442,0,BAO_0000019,13027,13410,,,,,,
A,1,,,U,Autocuration,,,,22224,Critical Micellar concentration of the compound. was determined,,CHEMBL626525,0,BAO_0000019,13028,13410,,,,,,
A,1,,,U,Autocuration,,,,22224,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,CHEMBL627168,0,BAO_0000019,13029,12628,,,,,,
A,1,,,U,Autocuration,,,,22224,Critical micellar concentration was measured in water by the dye solubilization method,,CHEMBL875618,0,BAO_0000019,13030,9675,,,,,,
B,1,,,U,Autocuration,,,,22224,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,CHEMBL626612,0,BAO_0000019,13031,12628,,,,,,
A,1,,,U,Autocuration,,,,22224,CMR value (relative to BAY K 8644),,CHEMBL626613,0,BAO_0000019,13032,12766,,,,,,
A,1,,,U,Autocuration,,,,22224,Carbamoylating activity was determined,,CHEMBL626614,0,BAO_0000019,13033,7849,,,,,,
A,1,,,U,Autocuration,,,,22224,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,CHEMBL626615,0,BAO_0000218,13034,12187,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,CHEMBL626616,0,BAO_0000019,13035,2040,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,CHEMBL626617,0,BAO_0000019,13036,2040,,,,,,
A,1,,,N,Intermediate,Plasma,,,50588,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,In vivo,CHEMBL626618,1,BAO_0000218,13037,14180,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,In vivo,CHEMBL626619,1,BAO_0000218,13038,14180,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,"Clearance rate at 0.46 mg/kg, iv, in dogs",In vivo,CHEMBL626620,1,BAO_0000218,13039,14474,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,"Clearance rate at 5.5 mg/kg, iv, in rat",In vivo,CHEMBL626621,1,BAO_0000218,13040,14474,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,In vivo,CHEMBL626622,1,BAO_0000218,13041,14548,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,100710,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,In vivo,CHEMBL626623,1,BAO_0000218,13042,14548,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,In vivo,CHEMBL626624,1,BAO_0000218,13043,14548,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,In vivo,CHEMBL626625,1,BAO_0000218,13044,14548,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,CHEMBL626626,1,BAO_0000218,13045,6125,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Tested for the total clearance of the compound,In vivo,CHEMBL626627,0,BAO_0000218,13046,6874,,,,,,
A,1,,,N,Intermediate,,,,50588,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,In vivo,CHEMBL626628,1,BAO_0000218,13047,15343,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Total body clearance was determined,In vivo,CHEMBL626629,0,BAO_0000218,13048,6236,,,,,,
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,CHEMBL626630,1,BAO_0000218,13049,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,CHEMBL626631,1,BAO_0000218,13050,11510,,10116.0,,,,Rattus norvegicus
P,1,,,U,Autocuration,,,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,CHEMBL626632,0,BAO_0000100,13051,8194,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,CHEMBL626633,0,BAO_0000100,13052,8194,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,CHEMBL626634,0,BAO_0000100,13053,8194,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,CHEMBL626635,0,BAO_0000100,13054,8194,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,CHEMBL626636,0,BAO_0000100,13055,8194,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,CHEMBL626637,0,BAO_0000100,13056,8194,,,,,,
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,CHEMBL626638,1,BAO_0000218,13057,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,CHEMBL626639,1,BAO_0000218,13058,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,CHEMBL626640,1,BAO_0000218,13059,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,CHEMBL626641,1,BAO_0000218,13060,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,CHEMBL627272,1,BAO_0000218,13061,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,CHEMBL627273,1,BAO_0000218,13062,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,CHEMBL627441,1,BAO_0000218,13063,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,CHEMBL628355,1,BAO_0000218,13064,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,CHEMBL628356,1,BAO_0000218,13065,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,CHEMBL628357,1,BAO_0000218,13066,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,CHEMBL628358,1,BAO_0000218,13067,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,N,Intermediate,,,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,CHEMBL622307,1,BAO_0000218,13068,13273,,4754.0,,,,Pneumocystis carinii
A,1,,,U,Autocuration,,,,22224,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,CHEMBL622527,0,BAO_0000019,13069,13118,,,,,,
A,1,,,U,Autocuration,,,,22224,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,CHEMBL622528,0,BAO_0000019,13070,13118,,,,,,
A,1,,,U,Autocuration,,,,22224,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,CHEMBL622529,0,BAO_0000019,13071,13118,,,,,,
A,1,,,U,Autocuration,,,,22224,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,CHEMBL622992,0,BAO_0000019,13072,13118,,,,,,
A,1,,,U,Autocuration,,,,22224,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,CHEMBL622993,0,BAO_0000019,13073,13118,,,,,,
A,1,,,U,Autocuration,,,,22224,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,CHEMBL622994,0,BAO_0000019,13074,13118,,,,,,
A,1,,,N,Intermediate,,,,50597,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,CHEMBL622995,1,BAO_0000218,13075,10633,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,CHEMBL622996,1,BAO_0000218,13076,10633,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,CHEMBL622997,1,BAO_0000218,13077,10633,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,CHEMBL622998,1,BAO_0000218,13078,10633,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Cp max following ip administration at 1 mg/kg,,CHEMBL622999,0,BAO_0000218,13079,5767,,,,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma was reported at 0.5 hour,In vivo,CHEMBL623000,0,BAO_0000218,13080,3302,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,Maximum concentration in plasma was reported at 2 hour,In vivo,CHEMBL623001,0,BAO_0000218,13081,3302,,,1969.0,,,
A,1,,,N,Intermediate,,,,50594,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,CHEMBL623002,1,BAO_0000218,13082,12467,,10090.0,,,,Mus musculus
P,1,,,U,Autocuration,,,,22229,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,CHEMBL623003,0,BAO_0000100,13083,11778,,,,,,
A,1,,,U,Autocuration,,,,22224,Steady state concentration was evaluated,,CHEMBL623004,0,BAO_0000019,13084,4321,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL623005,0,BAO_0000019,13085,14884,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logD7.4),,CHEMBL623006,0,BAO_0000019,13086,15234,,,,,,
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,CHEMBL623007,1,BAO_0000218,13087,14198,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,CHEMBL623008,1,BAO_0000218,13088,14198,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,CHEMBL876654,1,BAO_0000218,13089,14198,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,CHEMBL623009,1,BAO_0000218,13090,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,CHEMBL623010,1,BAO_0000218,13091,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,CHEMBL623011,1,BAO_0000218,13092,14198,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,CHEMBL623012,1,BAO_0000218,13093,14198,,10116.0,160.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,CHEMBL623013,0,BAO_0000019,13094,8151,,,,,,
A,1,,,U,Autocuration,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,CHEMBL623014,0,BAO_0000019,13095,8151,,,,,,
A,1,,,U,Autocuration,Urine,,,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,CHEMBL623015,0,BAO_0000019,13096,8151,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,CHEMBL623016,0,BAO_0000019,13097,8151,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,CHEMBL624858,0,BAO_0000019,13098,8151,,,1088.0,,,
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,CHEMBL624859,1,BAO_0000218,13099,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,CHEMBL624860,1,BAO_0000218,13100,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,CHEMBL624861,1,BAO_0000218,13101,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,CHEMBL624862,1,BAO_0000218,13102,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,CHEMBL624863,1,BAO_0000218,13103,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,CHEMBL876655,1,BAO_0000218,13104,8151,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,CHEMBL624864,1,BAO_0000218,13105,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,CHEMBL624865,1,BAO_0000218,13106,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,CHEMBL624866,1,BAO_0000218,13107,6996,,9615.0,,,,Canis lupus familiaris
F,1,,,N,Expert,,,,50588,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,CHEMBL624867,1,BAO_0000218,13108,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,CHEMBL624868,1,BAO_0000218,13109,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,CHEMBL628450,1,BAO_0000218,13110,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,CHEMBL628451,1,BAO_0000218,13111,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,CHEMBL628452,1,BAO_0000218,13112,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,CHEMBL628453,1,BAO_0000218,13113,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,CHEMBL628454,1,BAO_0000218,13114,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,CHEMBL628455,1,BAO_0000218,13115,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,CHEMBL628456,1,BAO_0000218,13116,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,CHEMBL628457,1,BAO_0000218,13117,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,CHEMBL877505,1,BAO_0000218,13118,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,CHEMBL628458,1,BAO_0000218,13119,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,CHEMBL628459,1,BAO_0000218,13120,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,CHEMBL628460,1,BAO_0000218,13121,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,CHEMBL628461,1,BAO_0000218,13122,6996,,9615.0,,,,Canis lupus familiaris
B,1,,,U,Autocuration,,,,22224,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,CHEMBL628462,0,BAO_0000218,13123,6996,,,,,,
A,1,,,N,Intermediate,,,,50588,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,CHEMBL628463,1,BAO_0000218,13124,6996,,9615.0,,,,Canis lupus familiaris
F,1,,,N,Expert,,,,50597,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,CHEMBL625666,1,BAO_0000218,13125,6996,,10116.0,,,,Rattus norvegicus
B,1,,,U,Autocuration,,,,22224,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,CHEMBL625667,0,BAO_0000218,13126,6996,,,,,,
A,1,,,N,Expert,,,,50597,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,CHEMBL625668,1,BAO_0000218,13127,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,CHEMBL625669,1,BAO_0000218,13128,6996,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,CHEMBL625670,0,BAO_0000019,13129,7114,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,CHEMBL625671,1,BAO_0000218,13130,7114,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,CHEMBL625672,1,BAO_0000218,13131,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,CHEMBL625673,1,BAO_0000218,13132,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,CHEMBL625674,1,BAO_0000218,13133,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,CHEMBL625675,1,BAO_0000218,13134,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,CHEMBL627637,1,BAO_0000218,13135,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,CHEMBL627638,1,BAO_0000218,13136,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,CHEMBL627639,1,BAO_0000218,13137,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,CHEMBL627640,1,BAO_0000218,13138,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,CHEMBL627641,1,BAO_0000218,13139,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,CHEMBL627642,1,BAO_0000218,13140,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,CHEMBL877506,1,BAO_0000218,13141,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50594,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,CHEMBL627275,1,BAO_0000218,13142,8613,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50506,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,CHEMBL627643,1,BAO_0000218,13143,11219,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,CHEMBL631246,1,BAO_0000218,13144,11219,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,CHEMBL631247,1,BAO_0000218,13145,11219,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,CHEMBL629532,1,BAO_0000218,13146,11219,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,CHEMBL629533,1,BAO_0000218,13147,11219,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,CHEMBL629534,1,BAO_0000218,13148,11219,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,50506,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,CHEMBL629535,1,BAO_0000218,13149,11219,,9669.0,,,,Mustela putorius furo
A,1,,,U,Autocuration,,,,22224,Pharmacokinetic parameter :drug bound to plasma was reported,,CHEMBL625932,0,BAO_0000019,13150,14837,,,,,,
A,1,,,U,Autocuration,,,,22224,compound was evaluated for drug bound in plasma,,CHEMBL625933,0,BAO_0000019,13151,14837,,,,,,
A,1,,,N,Intermediate,,,,50597,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,CHEMBL625934,1,BAO_0000218,13152,15343,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability,,CHEMBL625935,0,BAO_0000218,13153,13761,,9347.0,,,,Eutheria
A,1,,,N,Intermediate,,,,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,CHEMBL625936,1,BAO_0000218,13154,14810,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,CHEMBL625937,1,BAO_0000218,13155,14810,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,CHEMBL625938,1,BAO_0000218,13156,13249,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Bile,,,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,CHEMBL625939,1,BAO_0000218,13157,9267,,10116.0,1970.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bile,,,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,CHEMBL625940,1,BAO_0000218,13158,9267,,10116.0,1970.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bile,,,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,CHEMBL874464,1,BAO_0000218,13159,9267,,10116.0,1970.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bile,,,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,CHEMBL625941,1,BAO_0000218,13160,9267,,10116.0,1970.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bile,,,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,CHEMBL625942,1,BAO_0000218,13161,9267,,10116.0,1970.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bile,,,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,CHEMBL625943,1,BAO_0000218,13162,9267,,10116.0,1970.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Serum,,,50587,In vitro protein binding in human serum at 5 ug/ml,,CHEMBL625944,1,BAO_0000218,13163,15549,,9606.0,1977.0,,,Homo sapiens
A,1,,,U,Autocuration,,,,22224,Serum protein binding ability was measured,,CHEMBL625945,0,BAO_0000019,13164,10929,,,,,,
A,1,,,U,Autocuration,,,,22224,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,CHEMBL625946,0,BAO_0000019,13165,15444,,,,,,
A,1,,,U,Autocuration,,,,22224,Oral bioavailability in dog,In vivo,CHEMBL625947,0,BAO_0000218,13166,12860,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,CHEMBL625948,1,BAO_0000218,13167,12170,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Absolute oral bioavailability at an iv dose of 14 mg/kg,In vivo,CHEMBL625949,0,BAO_0000218,13168,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,In vivo,CHEMBL625950,0,BAO_0000218,13169,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,Oral bioavailability (dose 15 mg/kg i.v.),In vivo,CHEMBL625951,0,BAO_0000218,13170,15173,,9347.0,,,,Eutheria
A,1,,,U,Autocuration,,,,22224,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,In vivo,CHEMBL625952,0,BAO_0000218,13171,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,In vivo,CHEMBL625953,0,BAO_0000218,13172,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,In vivo,CHEMBL625954,0,BAO_0000218,13173,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,In vivo,CHEMBL882959,0,BAO_0000218,13174,15173,,,,,,
A,1,,,N,Intermediate,,,,50588,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,In vivo,CHEMBL625955,1,BAO_0000218,13175,11767,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Bioavailability in ferret,In vivo,CHEMBL625956,0,BAO_0000218,13176,11219,,9669.0,,,,Mustela putorius furo
A,1,,,N,Intermediate,,,,100710,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,In vivo,CHEMBL625957,1,BAO_0000218,13177,12186,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,CHEMBL625958,1,BAO_0000218,13178,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,CHEMBL625959,1,BAO_0000218,13179,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,CHEMBL626642,1,BAO_0000218,13180,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,CHEMBL631330,1,BAO_0000218,13181,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,CHEMBL631331,1,BAO_0000218,13182,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,CHEMBL631332,1,BAO_0000218,13183,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,CHEMBL631333,1,BAO_0000218,13184,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,CHEMBL632018,1,BAO_0000218,13185,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,CHEMBL632019,1,BAO_0000218,13186,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,CHEMBL632020,1,BAO_0000218,13187,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,CHEMBL632021,1,BAO_0000218,13188,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,CHEMBL632022,1,BAO_0000218,13189,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,CHEMBL632023,1,BAO_0000218,13190,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,CHEMBL632024,1,BAO_0000218,13191,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,CHEMBL874472,1,BAO_0000218,13192,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,CHEMBL632025,1,BAO_0000218,13193,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,CHEMBL632026,1,BAO_0000218,13194,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,CHEMBL632027,1,BAO_0000218,13195,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,CHEMBL632028,1,BAO_0000218,13196,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,CHEMBL626430,1,BAO_0000218,13197,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,CHEMBL626431,1,BAO_0000218,13198,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,CHEMBL626432,1,BAO_0000218,13199,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,CHEMBL626433,1,BAO_0000218,13200,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,CHEMBL626434,1,BAO_0000218,13201,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,CHEMBL627280,1,BAO_0000218,13202,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,CHEMBL627281,1,BAO_0000218,13203,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,CHEMBL627282,1,BAO_0000218,13204,11510,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Total body clearance was measured at given dose,,CHEMBL627283,0,BAO_0000019,13205,7199,,,,,,
A,1,,,U,Autocuration,,,,22224,Total body clearance was measured at given dose.,,CHEMBL627284,0,BAO_0000218,13206,7199,,,,,,
A,1,,,N,Intermediate,,,,50597,Metabolic clearance from the body in rat,,CHEMBL627285,1,BAO_0000218,13207,7095,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Renal clearance from the body,In vivo,CHEMBL627286,0,BAO_0000218,13208,7095,,,,,,
A,1,,,N,Intermediate,,,,50597,Renal clearance from the body in rat,In vivo,CHEMBL875477,1,BAO_0000218,13209,7095,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,In vivo,CHEMBL627287,1,BAO_0000218,13210,12528,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,In vivo,CHEMBL627288,1,BAO_0000218,13211,12528,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Total clearance from the body in rat,,CHEMBL627289,1,BAO_0000218,13212,7095,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Clearance into cortex from rat plasma or PBS,In vivo,CHEMBL627290,1,BAO_0000218,13213,14223,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,In vivo,CHEMBL627291,0,BAO_0000218,13214,13569,,,,,,
A,1,,,U,Autocuration,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,In vivo,CHEMBL627292,0,BAO_0000218,13215,13569,,,,,,
A,1,,,U,Autocuration,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,In vivo,CHEMBL627293,0,BAO_0000218,13216,13569,,,,,,
A,1,,,U,Autocuration,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,CHEMBL627294,0,BAO_0000218,13217,13569,,,,,,
A,1,,,U,Autocuration,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,In vivo,CHEMBL875478,0,BAO_0000218,13218,13569,,,,,,
A,1,,,U,Autocuration,,,,22224,Clearance was determined,In vivo,CHEMBL627295,0,BAO_0000218,13219,13979,,,,,,
A,1,,,N,Intermediate,,,,50594,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,In vivo,CHEMBL627296,1,BAO_0000218,13220,14315,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50592,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,In vivo,CHEMBL626119,1,BAO_0000218,13221,14315,,9986.0,,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,,,,50597,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,In vivo,CHEMBL626120,1,BAO_0000218,13222,14315,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance in rat after iv dose (100 ug/kg),In vivo,CHEMBL626121,1,BAO_0000218,13223,12174,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Clearance in guinea pig,In vivo,CHEMBL626122,0,BAO_0000218,13224,12797,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for clearance in rat,In vivo,CHEMBL626123,1,BAO_0000218,13225,12797,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for the clearance in dog,In vivo,CHEMBL623456,1,BAO_0000218,13226,12797,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the clearance in rat,In vivo,CHEMBL623457,1,BAO_0000218,13227,12797,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested in vivo for clearance after iv administration in the rat,In vivo,CHEMBL623458,1,BAO_0000218,13228,11500,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,IV clearance determined at an iv dose of 14 mg/kg,In vivo,CHEMBL623459,0,BAO_0000218,13229,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,IV clearance determined at an iv dose of 15.2 mg/kg,In vivo,CHEMBL875484,0,BAO_0000218,13230,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,IV clearance determined at an iv dose of 15 mg/kg,In vivo,CHEMBL623460,0,BAO_0000218,13231,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,IV clearance determined at an peroral dose of 30 mg/kg.,In vivo,CHEMBL623461,0,BAO_0000218,13232,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,IV clearance determined at an peroral dose of 30.2 mg/kg.,In vivo,CHEMBL623462,0,BAO_0000218,13233,15173,,,,,,
A,1,,,U,Autocuration,,,,22224,IV clearance determined at an peroral dose of 30.3 mg/kg.,In vivo,CHEMBL627386,0,BAO_0000218,13234,15173,,,,,,
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,CHEMBL627387,1,BAO_0000218,13235,14198,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,CHEMBL627388,1,BAO_0000218,13236,14198,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,CHEMBL627389,1,BAO_0000218,13237,14198,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,CHEMBL627390,1,BAO_0000218,13238,14198,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,CHEMBL627391,1,BAO_0000218,13239,14198,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,CHEMBL627392,1,BAO_0000218,13240,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,CHEMBL627393,1,BAO_0000218,13241,14198,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Trachea,,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,CHEMBL627394,1,BAO_0000218,13242,14198,,10116.0,3126.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,CHEMBL627395,1,BAO_0000218,13243,14198,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,CHEMBL875485,1,BAO_0000218,13244,14198,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,CHEMBL627396,1,BAO_0000218,13245,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,CHEMBL627397,1,BAO_0000218,13246,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,CHEMBL627398,1,BAO_0000218,13247,14198,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,In vivo,CHEMBL627399,1,BAO_0000218,13248,14198,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,CHEMBL627400,1,BAO_0000218,13249,14198,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,CHEMBL627401,1,BAO_0000218,13250,14198,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,CHEMBL627402,1,BAO_0000218,13251,14198,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,CHEMBL627403,1,BAO_0000218,13252,14198,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,CHEMBL627404,1,BAO_0000218,13253,14198,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,CHEMBL623101,1,BAO_0000218,13254,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,CHEMBL877480,1,BAO_0000218,13255,14198,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Trachea,,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,CHEMBL623102,1,BAO_0000218,13256,14198,,10116.0,3126.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,CHEMBL623103,1,BAO_0000218,13257,14198,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,CHEMBL623104,1,BAO_0000218,13258,14198,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,CHEMBL623105,1,BAO_0000218,13259,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,CHEMBL623106,1,BAO_0000218,13260,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,CHEMBL623107,1,BAO_0000218,13261,14198,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,CHEMBL623108,1,BAO_0000218,13262,14198,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,CHEMBL623109,1,BAO_0000218,13263,14198,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,CHEMBL623110,1,BAO_0000218,13264,14198,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,CHEMBL623111,1,BAO_0000218,13265,14198,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,CHEMBL625060,1,BAO_0000218,13266,14198,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,CHEMBL625061,1,BAO_0000218,13267,14198,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,CHEMBL625062,1,BAO_0000218,13268,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,CHEMBL625063,1,BAO_0000218,13269,14198,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Trachea,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,CHEMBL625064,1,BAO_0000218,13270,14198,,10116.0,3126.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Bone,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,CHEMBL625065,1,BAO_0000218,13271,14198,,10116.0,10000001.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,CHEMBL625066,1,BAO_0000218,13272,14198,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,CHEMBL625067,1,BAO_0000218,13273,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,CHEMBL625068,1,BAO_0000218,13274,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,CHEMBL622159,1,BAO_0000218,13275,14198,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Intestine,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,In vivo,CHEMBL622160,1,BAO_0000218,13276,14198,,10116.0,160.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,CHEMBL622161,1,BAO_0000218,13277,14198,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,CHEMBL622162,1,BAO_0000218,13278,14198,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,CHEMBL622163,1,BAO_0000218,13279,14198,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,CHEMBL622313,1,BAO_0000218,13280,14198,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,CHEMBL622314,1,BAO_0000218,13281,14198,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,CHEMBL622315,1,BAO_0000218,13282,14198,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Trachea,,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,CHEMBL622316,1,BAO_0000218,13283,14198,,10116.0,3126.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50212,Normal diffusion coefficient in water for Escherichia coli,,CHEMBL877486,1,BAO_0000218,13284,15599,,562.0,,,,Escherichia coli
A,1,,,U,Autocuration,,,,22224,Average max percent decrease in RVR (renal vascular resistance) was determined,,CHEMBL622317,0,BAO_0000019,13285,8204,,,,,,
A,1,,,U,Autocuration,,,,22224,Average max percent decrease in RVR (renal vascular resistance) was determined.,,CHEMBL622318,0,BAO_0000019,13286,8204,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,CHEMBL622319,0,BAO_0000019,13287,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,CHEMBL622320,0,BAO_0000019,13288,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,CHEMBL622321,0,BAO_0000019,13289,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,CHEMBL622322,0,BAO_0000019,13290,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,CHEMBL622323,0,BAO_0000019,13291,7114,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,CHEMBL622324,1,BAO_0000218,13292,7114,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,CHEMBL622325,1,BAO_0000218,13293,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,CHEMBL622326,1,BAO_0000218,13294,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,CHEMBL877487,1,BAO_0000218,13295,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,CHEMBL622327,1,BAO_0000218,13296,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,CHEMBL622328,1,BAO_0000218,13297,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,CHEMBL622329,1,BAO_0000218,13298,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,CHEMBL622330,1,BAO_0000218,13299,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,CHEMBL622331,1,BAO_0000218,13300,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,CHEMBL622332,1,BAO_0000218,13301,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,CHEMBL622333,1,BAO_0000218,13302,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,CHEMBL627658,0,BAO_0000218,13303,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,CHEMBL630428,0,BAO_0000218,13304,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,CHEMBL630429,0,BAO_0000218,13305,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,CHEMBL630430,0,BAO_0000218,13306,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,CHEMBL630431,0,BAO_0000218,13307,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,CHEMBL630432,1,BAO_0000218,13308,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,CHEMBL630433,1,BAO_0000218,13309,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,CHEMBL630434,1,BAO_0000218,13310,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,CHEMBL629372,1,BAO_0000218,13311,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,CHEMBL629553,1,BAO_0000218,13312,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,CHEMBL629554,1,BAO_0000218,13313,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,CHEMBL874447,1,BAO_0000218,13314,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,CHEMBL629555,1,BAO_0000218,13315,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,CHEMBL629556,1,BAO_0000218,13316,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,CHEMBL629557,1,BAO_0000218,13317,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,CHEMBL629558,1,BAO_0000218,13318,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,CHEMBL629559,1,BAO_0000218,13319,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,CHEMBL629560,1,BAO_0000218,13320,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,CHEMBL629561,1,BAO_0000218,13321,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,CHEMBL629562,1,BAO_0000218,13322,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,CHEMBL629563,1,BAO_0000218,13323,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,CHEMBL629564,1,BAO_0000218,13324,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,CHEMBL629565,1,BAO_0000218,13325,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,CHEMBL629566,1,BAO_0000218,13326,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,CHEMBL629567,1,BAO_0000218,13327,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,CHEMBL629568,1,BAO_0000218,13328,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,CHEMBL629569,1,BAO_0000218,13329,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,CHEMBL629570,1,BAO_0000218,13330,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,CHEMBL629571,0,BAO_0000218,13331,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,CHEMBL629572,0,BAO_0000218,13332,12170,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,CHEMBL629573,0,BAO_0000218,13333,12170,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability (dose 20 mg/kg),In vivo,CHEMBL629574,0,BAO_0000218,13334,4985,,9347.0,,,,Eutheria
A,1,,,U,Autocuration,,,,22224,Bioavailability in dog,In vivo,CHEMBL629575,0,BAO_0000218,13335,15145,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat (Sprague-Dawley) (male),In vivo,CHEMBL874448,0,BAO_0000218,13336,14080,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in monkey (dose 10 mg/kg i.d.),In vivo,CHEMBL629576,0,BAO_0000218,13337,11219,,9443.0,,,,Primates
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat,In vivo,CHEMBL629577,0,BAO_0000218,13338,15145,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat,In vivo,CHEMBL629578,0,BAO_0000218,13339,15145,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in dog (dose 3.0 mg/kg p.o.),In vivo,CHEMBL629579,0,BAO_0000218,13340,1202,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,In vivo,CHEMBL882958,0,BAO_0000218,13341,1202,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50505,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,In vivo,CHEMBL629580,1,BAO_0000218,13342,1202,,9598.0,,,,Pan troglodytes
A,1,,,U,Autocuration,,,,22224,Bioavailability,In vivo,CHEMBL629581,0,BAO_0000218,13343,4026,,9347.0,,,,Eutheria
A,1,,,U,Autocuration,,,,22224,Bioavailability in squirrel monkey,In vivo,CHEMBL629582,0,BAO_0000218,13344,1492,,9520.0,,,,Saimiri
A,1,,,N,Intermediate,,,,50588,Bioavailability was evaluated in dog,In vivo,CHEMBL628522,1,BAO_0000218,13345,12793,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,100712,Bioavailability was evaluated in hamster,In vivo,CHEMBL625432,1,BAO_0000218,13346,12793,,10026.0,,,,Cricetinae
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat,In vivo,CHEMBL625433,0,BAO_0000218,13347,12793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,CHEMBL625434,1,BAO_0000218,13348,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,In vivo,CHEMBL625435,1,BAO_0000218,13349,14793,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat (dose 10 mg/kg p.o.),In vivo,CHEMBL625436,0,BAO_0000218,13350,14793,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,100710,Bioavailability was measured in cynomolgus monkeys.,In vivo,CHEMBL874588,1,BAO_0000218,13351,14731,,9541.0,,,,Macaca fascicularis
A,1,,,N,Intermediate,,,,50594,Bioavailability was measured in nude mice.,In vivo,CHEMBL625437,1,BAO_0000218,13352,14731,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,,,,22224,Bioavailability in ferret (dose 10 mg/kg i.d.),In vivo,CHEMBL625438,0,BAO_0000218,13353,12187,,9669.0,,,,Mustela putorius furo
A,1,,,U,Autocuration,,,,22224,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),In vivo,CHEMBL625439,0,BAO_0000218,13354,12187,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",In vivo,CHEMBL625440,0,BAO_0000218,13355,12187,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),In vivo,CHEMBL625441,0,BAO_0000218,13356,12187,,314293.0,,,,Simiiformes
A,1,,,U,Autocuration,,,,22224,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,CHEMBL625442,0,BAO_0000218,13357,12187,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",In vivo,CHEMBL625443,1,BAO_0000218,13358,12187,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Bioavailability was determined; extremely poor,In vivo,CHEMBL625444,0,BAO_0000218,13359,17431,,,,,,
A,1,,,N,Intermediate,,,,50594,% bioavailability in mice after oral administration of prodrug,In vivo,CHEMBL625445,1,BAO_0000218,13360,13318,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,In vivo,CHEMBL625446,1,BAO_0000218,13361,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,In vivo,CHEMBL882960,1,BAO_0000218,13362,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,In vivo,CHEMBL625447,1,BAO_0000218,13363,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,In vivo,CHEMBL625448,1,BAO_0000218,13364,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,In vivo,CHEMBL625449,1,BAO_0000218,13365,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),In vivo,CHEMBL874589,1,BAO_0000218,13366,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,In vivo,CHEMBL625450,1,BAO_0000218,13367,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,In vivo,CHEMBL625451,1,BAO_0000218,13368,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,In vivo,CHEMBL626584,1,BAO_0000218,13369,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,In vivo,CHEMBL626585,1,BAO_0000218,13370,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,In vivo,CHEMBL626586,1,BAO_0000218,13371,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,In vivo,CHEMBL626587,1,BAO_0000218,13372,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,In vivo,CHEMBL626588,1,BAO_0000218,13373,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,In vivo,CHEMBL626589,1,BAO_0000218,13374,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,In vivo,CHEMBL626590,1,BAO_0000218,13375,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,In vivo,CHEMBL626591,1,BAO_0000218,13376,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,In vivo,CHEMBL627181,1,BAO_0000218,13377,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,In vivo,CHEMBL628083,1,BAO_0000218,13378,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,IV clearance determined at an peroral dose of 15 mg/kg.,In vivo,CHEMBL628084,0,BAO_0000218,13379,15173,,,,,,
F,1,,,N,Expert,,,,50064,Mouse oral clearance was measured against Hymenolepiasis nana.,In vivo,CHEMBL628085,1,BAO_0000218,13380,7732,,102285.0,,,,Hymenolepis nana
F,1,,,N,Expert,,,,50545,Mouse oral clearance was measured against Nematospiroides dubius,In vivo,CHEMBL628086,1,BAO_0000218,13381,7732,,6339.0,,,,Heligmosomoides polygyrus
F,1,,,U,Autocuration,,,,22224,Mouse oral clearance was measured against N. dubius; NT is Not Tested,In vivo,CHEMBL628087,0,BAO_0000218,13382,7732,,,,,,
A,1,,,N,Intermediate,,,,50594,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,CHEMBL628088,1,BAO_0000218,13383,7732,,10090.0,,,,Mus musculus
B,1,,,U,Autocuration,,,,22224,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,CHEMBL628089,0,BAO_0000218,13384,7732,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL628090,0,BAO_0000218,13385,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL628091,0,BAO_0000218,13386,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL628092,0,BAO_0000218,13387,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL628093,0,BAO_0000218,13388,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL875607,0,BAO_0000218,13389,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL625710,0,BAO_0000218,13390,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL625711,0,BAO_0000218,13391,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL625712,0,BAO_0000218,13392,8328,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,CHEMBL625713,0,BAO_0000218,13393,8328,,,,,,
A,1,,,N,Intermediate,,,,50588,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,In vivo,CHEMBL625714,1,BAO_0000218,13394,13376,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50797,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,In vivo,CHEMBL625715,1,BAO_0000218,13395,13477,,9544.0,,,,Macaca mulatta
A,1,,,N,Intermediate,,,,50597,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,In vivo,CHEMBL625716,1,BAO_0000218,13396,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,In vivo,CHEMBL625717,1,BAO_0000218,13397,13477,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance was determined for the compound in rats,In vivo,CHEMBL625718,1,BAO_0000218,13398,13313,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,In vivo,CHEMBL625719,1,BAO_0000218,13399,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,In vivo,CHEMBL625720,1,BAO_0000218,13400,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,In vivo,CHEMBL625721,1,BAO_0000218,13401,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,In vivo,CHEMBL625722,1,BAO_0000218,13402,12504,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,CHEMBL625723,1,BAO_0000218,13403,13129,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,In vivo,CHEMBL625724,1,BAO_0000218,13404,7732,,6339.0,,,,Heligmosomoides polygyrus
A,1,,,N,Intermediate,,,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,In vivo,CHEMBL625725,1,BAO_0000218,13405,7732,,6339.0,,,,Heligmosomoides polygyrus
A,1,,,N,Intermediate,,,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,In vivo,CHEMBL625726,1,BAO_0000218,13406,7732,,6339.0,,,,Heligmosomoides polygyrus
A,1,,,N,Intermediate,,,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,In vivo,CHEMBL875608,1,BAO_0000218,13407,7732,,6339.0,,,,Heligmosomoides polygyrus
A,1,,,N,Intermediate,,,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,In vivo,CHEMBL625727,1,BAO_0000218,13408,7732,,6339.0,,,,Heligmosomoides polygyrus
A,1,,,U,Autocuration,Urine,,,22224,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,In vivo,CHEMBL625728,0,BAO_0000218,13409,9278,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,CHEMBL625729,0,BAO_0000218,13410,9278,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,In vivo,CHEMBL625730,0,BAO_0000218,13411,9278,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,Urine,,,22224,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,CHEMBL625731,0,BAO_0000218,13412,9278,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Urine,,,22224,Urinary clearance was determined in rat at 25 mg/kg os dosage,In vivo,CHEMBL626417,0,BAO_0000218,13413,9278,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50587,Urinary clearance was determined at 100 mg/kg oral dosage in human,In vivo,CHEMBL626418,1,BAO_0000218,13414,9278,,9606.0,1088.0,,,Homo sapiens
A,1,,,N,Intermediate,Urine,,,50588,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,In vivo,CHEMBL626419,1,BAO_0000218,13415,9278,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50588,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,In vivo,CHEMBL626592,1,BAO_0000218,13416,5932,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Plasma,,,50597,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,CHEMBL626593,1,BAO_0000218,13417,5932,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,CHEMBL626594,1,BAO_0000218,13418,5182,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Clearance rate in dogs,In vivo,CHEMBL625035,1,BAO_0000218,13419,10499,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Compound was measured for intrinsic clearance,In vitro,CHEMBL625036,0,BAO_0000019,13420,6051,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625037,0,BAO_0000100,13421,17508,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625038,0,BAO_0000100,13422,6228,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625039,0,BAO_0000100,13423,6231,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625040,0,BAO_0000100,13424,17740,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625041,0,BAO_0000100,13425,6495,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625042,0,BAO_0000100,13426,2171,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient of the compound,,CHEMBL874411,0,BAO_0000019,13427,3255,,,,,,
A,1,,,U,Autocuration,,,,22224,Permeability,,CHEMBL625043,0,BAO_0000019,13428,6821,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625044,0,BAO_0000100,13429,2685,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logD),,CHEMBL625045,0,BAO_0000019,13430,17584,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,CHEMBL625046,0,BAO_0000100,13431,13824,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,CHEMBL625047,0,BAO_0000100,13432,13824,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625048,0,BAO_0000100,13433,16479,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625049,0,BAO_0000100,13434,11997,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated logarithm of partition coefficient (P) was determined,,CHEMBL625050,0,BAO_0000100,13435,2988,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625051,0,BAO_0000100,13436,931,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL874412,0,BAO_0000100,13437,4381,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625052,0,BAO_0000100,13438,4397,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625053,0,BAO_0000100,13439,5889,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,CHEMBL623250,0,BAO_0000019,13440,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,CHEMBL623251,0,BAO_0000019,13441,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,CHEMBL623252,0,BAO_0000019,13442,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,CHEMBL623253,0,BAO_0000019,13443,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,CHEMBL623254,0,BAO_0000019,13444,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,CHEMBL623255,0,BAO_0000019,13445,6154,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent degradation of compound at a pH of 1 over a 18 hr period,,CHEMBL626831,0,BAO_0000019,13446,6887,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent degradation of compound at pH of 1 over an 18 hr period,,CHEMBL877494,0,BAO_0000019,13447,6887,,,,,,
A,1,,,U,Autocuration,,,,22224,Delta Logarithm of Partition Coefficient value was determined.,,CHEMBL626832,0,BAO_0000019,13448,14116,,,,,,
A,1,,,U,Autocuration,,,,22224,Delta logPoct-cyc,,CHEMBL626833,0,BAO_0000019,13449,11137,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity estimated on reversed phase TLC,,CHEMBL626834,0,BAO_0000100,13450,7230,,,,,,
A,1,,,U,Autocuration,,,,22224,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,CHEMBL626835,0,BAO_0000019,13451,15741,,,,,,
A,1,,,U,Autocuration,,,,22224,Delta logPoct-cyc,,CHEMBL626836,0,BAO_0000019,13452,9663,,,,,,
P,1,,,U,Autocuration,,,,22229,Change in logarithm of partition coefficient of the compound,,CHEMBL626837,0,BAO_0000100,13453,9663,,,,,,
A,1,,,U,Autocuration,,,,22224,Delta logD (pH 6.5),,CHEMBL626838,0,BAO_0000019,13454,13807,,,,,,
P,1,,,U,Autocuration,,,,22224,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,CHEMBL626839,0,BAO_0000100,13455,13807,,,,,,
A,1,,,U,Autocuration,,,,22224,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,CHEMBL626840,0,BAO_0000019,13456,17425,,,,,,
A,1,,,U,Autocuration,,,,22224,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,CHEMBL626841,0,BAO_0000019,13457,12143,,,,,,
A,1,,,U,Autocuration,,,,22224,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,CHEMBL626842,0,BAO_0000219,13458,12608,,,,,,
A,1,,,U,Autocuration,,,,22224,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,CHEMBL626843,0,BAO_0000219,13459,12608,,,,,,
A,1,,,N,Intermediate,,,,50597,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,CHEMBL626844,1,BAO_0000218,13460,8649,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Amount of deuterium retained was reported after normal workup in rats,,CHEMBL877495,1,BAO_0000218,13461,8649,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,CHEMBL626845,1,BAO_0000218,13462,8649,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,CHEMBL626846,1,BAO_0000218,13463,8649,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,CHEMBL626847,1,BAO_0000218,13464,8649,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,CHEMBL628677,1,BAO_0000218,13465,8649,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,CHEMBL628678,1,BAO_0000218,13466,8649,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Compound was subjected to electrochemical oxidation,,CHEMBL628679,0,BAO_0000019,13467,9659,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was subjected to photochemical oxidation,,CHEMBL628680,0,BAO_0000019,13468,9659,,,,,,
A,1,,,U,Autocuration,,,,22224,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,CHEMBL628681,0,BAO_0000019,13469,9659,,,,,,
A,1,,,U,Autocuration,,,,22224,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,CHEMBL628682,0,BAO_0000019,13470,9659,,,,,,
A,1,,,U,Autocuration,,,,22224,Oxidation of compound by methemoglobin in presence of hydroperoxide,,CHEMBL628683,0,BAO_0000019,13471,9659,,,,,,
A,1,,,N,Intermediate,,,,50597,Percent diffusion through fuzzy rat skin after 48 h of incubation,,CHEMBL628684,1,BAO_0000218,13472,9607,,10116.0,,,,Rattus norvegicus
P,1,,,U,Autocuration,,,,22229,Dissociation constant (pKa),,CHEMBL877501,0,BAO_0000100,13473,7057,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant value of the compound; ND means not determined.,,CHEMBL628685,0,BAO_0000100,13474,7057,,,,,,
A,1,,,N,Intermediate,Blood,,,50597,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,CHEMBL628686,1,BAO_0000218,13475,7911,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,CHEMBL628687,1,BAO_0000218,13476,7911,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,CHEMBL628688,1,BAO_0000218,13477,7911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,CHEMBL628689,1,BAO_0000218,13478,7911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,CHEMBL628690,1,BAO_0000218,13479,7911,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,CHEMBL629363,1,BAO_0000218,13480,7911,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,CHEMBL629364,1,BAO_0000218,13481,7911,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,CHEMBL629365,1,BAO_0000218,13482,7911,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,CHEMBL629366,1,BAO_0000218,13483,7911,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,CHEMBL629367,1,BAO_0000218,13484,7911,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50597,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,CHEMBL629368,1,BAO_0000218,13485,7911,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,CHEMBL877502,1,BAO_0000218,13486,7911,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,CHEMBL629369,1,BAO_0000218,13487,13792,,10090.0,2037.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,CHEMBL629370,1,BAO_0000218,13488,13792,,10090.0,955.0,,,Mus musculus
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,CHEMBL629371,0,BAO_0000218,13489,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,CHEMBL626276,0,BAO_0000218,13490,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,CHEMBL626277,0,BAO_0000218,13491,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,CHEMBL631250,0,BAO_0000218,13492,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,CHEMBL631251,1,BAO_0000218,13493,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,CHEMBL631252,1,BAO_0000218,13494,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,CHEMBL631253,1,BAO_0000218,13495,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,CHEMBL631254,1,BAO_0000218,13496,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,CHEMBL631255,1,BAO_0000218,13497,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,CHEMBL631256,1,BAO_0000218,13498,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,CHEMBL631257,1,BAO_0000218,13499,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,CHEMBL628009,1,BAO_0000218,13500,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,CHEMBL628010,1,BAO_0000218,13501,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,CHEMBL628011,1,BAO_0000218,13502,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,CHEMBL628012,1,BAO_0000218,13503,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,CHEMBL628013,1,BAO_0000218,13504,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,CHEMBL628014,1,BAO_0000218,13505,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,CHEMBL628015,1,BAO_0000218,13506,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,CHEMBL628016,1,BAO_0000218,13507,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,CHEMBL874461,1,BAO_0000218,13508,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,CHEMBL628017,1,BAO_0000218,13509,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,CHEMBL628018,1,BAO_0000218,13510,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,CHEMBL628019,1,BAO_0000218,13511,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,CHEMBL628020,1,BAO_0000218,13512,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,CHEMBL628021,1,BAO_0000218,13513,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,CHEMBL628022,1,BAO_0000218,13514,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,CHEMBL628023,1,BAO_0000218,13515,8133,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,CHEMBL628024,0,BAO_0000218,13516,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,CHEMBL628025,0,BAO_0000218,13517,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,CHEMBL628026,0,BAO_0000218,13518,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,CHEMBL628027,0,BAO_0000218,13519,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,U,Autocuration,Urine,,,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,CHEMBL628028,0,BAO_0000218,13520,8133,,314293.0,1088.0,,,Simiiformes
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,CHEMBL628029,1,BAO_0000218,13521,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,CHEMBL628030,1,BAO_0000218,13522,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,CHEMBL628031,1,BAO_0000218,13523,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,CHEMBL628032,1,BAO_0000218,13524,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,CHEMBL628033,1,BAO_0000218,13525,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,CHEMBL628034,1,BAO_0000218,13526,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,CHEMBL628035,1,BAO_0000218,13527,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,CHEMBL628036,1,BAO_0000218,13528,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,CHEMBL874462,1,BAO_0000218,13529,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,In vivo,CHEMBL628037,1,BAO_0000218,13530,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,In vivo,CHEMBL628123,1,BAO_0000218,13531,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,In vivo,CHEMBL628124,1,BAO_0000218,13532,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,In vivo,CHEMBL628125,1,BAO_0000218,13533,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,In vivo,CHEMBL628126,1,BAO_0000218,13534,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),In vivo,CHEMBL628127,1,BAO_0000218,13535,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,In vivo,CHEMBL628128,1,BAO_0000218,13536,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,In vivo,CHEMBL628129,1,BAO_0000218,13537,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,In vivo,CHEMBL628130,1,BAO_0000218,13538,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,In vivo,CHEMBL628131,1,BAO_0000218,13539,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,In vivo,CHEMBL628132,1,BAO_0000218,13540,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,In vivo,CHEMBL628133,1,BAO_0000218,13541,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,In vivo,CHEMBL628134,1,BAO_0000218,13542,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,In vivo,CHEMBL628135,1,BAO_0000218,13543,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,In vivo,CHEMBL628136,1,BAO_0000218,13544,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,In vivo,CHEMBL628137,1,BAO_0000218,13545,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,In vivo,CHEMBL628138,1,BAO_0000218,13546,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,In vivo,CHEMBL628139,1,BAO_0000218,13547,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,In vivo,CHEMBL628140,1,BAO_0000218,13548,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,In vivo,CHEMBL628141,1,BAO_0000218,13549,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,In vivo,CHEMBL628142,1,BAO_0000218,13550,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,In vivo,CHEMBL628143,1,BAO_0000218,13551,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,In vivo,CHEMBL628144,1,BAO_0000218,13552,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,In vivo,CHEMBL628145,1,BAO_0000218,13553,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,In vivo,CHEMBL628146,1,BAO_0000218,13554,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,In vivo,CHEMBL625355,1,BAO_0000218,13555,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,In vivo,CHEMBL625356,1,BAO_0000218,13556,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,In vivo,CHEMBL625357,1,BAO_0000218,13557,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,In vivo,CHEMBL625527,1,BAO_0000218,13558,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),In vivo,CHEMBL875473,1,BAO_0000218,13559,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,In vivo,CHEMBL625528,1,BAO_0000218,13560,9025,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,In vivo,CHEMBL626304,1,BAO_0000218,13561,9025,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Artery,,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,In vivo,CHEMBL624138,1,BAO_0000218,13562,9025,,9615.0,1637.0,,,Canis lupus familiaris
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624139,0,BAO_0000100,13563,6448,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624140,0,BAO_0000100,13564,17221,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624141,0,BAO_0000100,13565,6545,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624142,0,BAO_0000100,13566,577,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624143,0,BAO_0000100,13567,6285,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624144,0,BAO_0000100,13568,6500,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624145,0,BAO_0000100,13569,6716,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624146,0,BAO_0000100,13570,13658,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624147,0,BAO_0000100,13571,6549,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (MacLogP),,CHEMBL883123,0,BAO_0000100,13572,14685,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL624148,0,BAO_0000019,13573,6893,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter was determined,,CHEMBL874416,0,BAO_0000019,13574,3687,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624149,0,BAO_0000100,13575,4207,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624150,0,BAO_0000100,13576,4626,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity was determined,,CHEMBL624151,0,BAO_0000100,13577,1021,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity was determined,,CHEMBL624152,0,BAO_0000100,13578,3777,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity was determined,,CHEMBL622139,0,BAO_0000100,13579,17533,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622140,0,BAO_0000100,13580,6524,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity was determined,,CHEMBL622141,0,BAO_0000100,13581,17533,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity in octanol-water,,CHEMBL622142,0,BAO_0000100,13582,6480,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622143,0,BAO_0000100,13583,17606,,,,,,
P,1,,,U,Autocuration,,,,22229,Octanol-water partition coefficient was determined,,CHEMBL622144,0,BAO_0000100,13584,6863,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL877473,0,BAO_0000019,13585,1356,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622145,0,BAO_0000100,13586,3326,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient was determined; ND means not determined,,CHEMBL622146,0,BAO_0000019,13587,1356,,,,,,
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622147,0,BAO_0000100,13588,12984,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient of the compound,,CHEMBL622148,0,BAO_0000019,13589,17363,,,,,,
A,1,,,U,Autocuration,,,,22224,Permeability was determined,,CHEMBL883124,0,BAO_0000019,13590,6827,,,,,,
P,1,,,U,Autocuration,,,,22229,The compound was evaluated for the partition coefficient,,CHEMBL622149,0,BAO_0000100,13591,261,,,,,,
A,1,,,U,Autocuration,,,,22224,Partition coefficient (logP),,CHEMBL622150,0,BAO_0000019,13592,2685,,,,,,
P,1,,,U,Autocuration,,,,22224,The lipophilicity was reported,,CHEMBL622151,0,BAO_0000100,13593,414,,,,,,
P,1,,,U,Autocuration,,,,22229,logarithm of the octanol-water partition coefficient for the compound,,CHEMBL622152,0,BAO_0000100,13594,15769,,,,,,
A,1,,,U,Autocuration,,,,22224,Clogp value was determined,,CHEMBL622153,0,BAO_0000019,13595,17248,,,,,,
A,1,,,U,Autocuration,,,,22224,Clp at a dose of 1.5 mg/kg,In vivo,CHEMBL877474,0,BAO_0000218,13596,16935,,,,,,
A,1,,,U,Autocuration,,,,22224,Clp at a dose of 2.0 mg/kg,In vivo,CHEMBL622154,0,BAO_0000218,13597,16935,,,,,,
A,1,,,U,Autocuration,Plasma,,,22224,"Clp, plasma clearance at a dose of 10 mg/kg",In vivo,CHEMBL622155,0,BAO_0000218,13598,14832,,,1969.0,,,
A,1,,,U,Autocuration,Plasma,,,22224,"Clp, plasma clearance at a dose of 50 mg/kg",In vivo,CHEMBL622156,0,BAO_0000218,13599,14832,,,1969.0,,,
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma clearance in rat,In vivo,CHEMBL622157,1,BAO_0000218,13600,2399,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Compound was tested for plasma clearance in rat; Not determined,In vivo,CHEMBL622158,1,BAO_0000218,13601,2399,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,In vivo,CHEMBL622807,1,BAO_0000218,13602,6227,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50797,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,In vivo,CHEMBL622808,1,BAO_0000218,13603,6227,,9544.0,,,,Macaca mulatta
A,1,,,U,Autocuration,,,,22224,Plasma clearance by iv administration at a dose 0.003 ug/mL,In vivo,CHEMBL622809,0,BAO_0000218,13604,5623,,,,,,
A,1,,,U,Autocuration,,,,22224,Plasma clearance determined,In vivo,CHEMBL622810,0,BAO_0000218,13605,4854,,,,,,
A,1,,,N,Intermediate,,,,100712,Plasma clearance after iv administration at 3 mg/kg in hamster,In vivo,CHEMBL876653,1,BAO_0000218,13606,4493,,10026.0,,,,Cricetinae
A,1,,,N,Intermediate,,,,100712,Plasma clearance after iv administration at 4 mg/kg in hamster,In vivo,CHEMBL622811,1,BAO_0000218,13607,4493,,10026.0,,,,Cricetinae
A,1,,,N,Intermediate,,,,50597,Rate of clearance in rat was determined,In vivo,CHEMBL622986,1,BAO_0000218,13608,14956,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,In vivo,CHEMBL622987,1,BAO_0000218,13609,15372,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance after iv dose of 5.10 mg/kg in rats,In vivo,CHEMBL622988,1,BAO_0000218,13610,15372,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,In vivo,CHEMBL622989,1,BAO_0000218,13611,15372,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,In vivo,CHEMBL622990,1,BAO_0000218,13612,15372,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Plasma,,,22224,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,In vivo,CHEMBL622991,0,BAO_0000218,13613,15604,,314293.0,1969.0,,,Simiiformes
A,1,,,N,Intermediate,Plasma,,,50597,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,In vivo,CHEMBL622227,1,BAO_0000218,13614,15604,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50588,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,In vivo,CHEMBL622228,1,BAO_0000218,13615,15604,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Clpl value in rat,In vivo,CHEMBL622229,1,BAO_0000218,13616,14964,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50512,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,In vivo,CHEMBL622230,1,BAO_0000218,13617,15240,,10141.0,,,,Cavia porcellus
A,1,,,N,Intermediate,,,,50597,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,In vivo,CHEMBL622231,1,BAO_0000218,13618,16449,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,100710,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,In vivo,CHEMBL622232,1,BAO_0000218,13619,16449,,9541.0,,,,Macaca fascicularis
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,In vivo,CHEMBL622233,0,BAO_0000218,13620,12902,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,In vivo,CHEMBL622234,0,BAO_0000218,13621,12902,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,In vivo,CHEMBL622235,0,BAO_0000218,13622,12902,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,In vivo,CHEMBL622236,0,BAO_0000218,13623,12902,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,In vivo,CHEMBL622237,0,BAO_0000218,13624,12902,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a po dose of 10.0(pmol/g/h).,In vivo,CHEMBL877482,0,BAO_0000218,13625,12902,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a po dose of 20.0(pmol/g/h).,In vivo,CHEMBL622238,0,BAO_0000218,13626,12902,,,,,,
A,1,,,U,Autocuration,,,,22224,Cmax in minutes at a po dose of 40.0(pmol/g/h).,In vivo,CHEMBL622239,0,BAO_0000218,13627,12902,,,,,,
A,1,,,U,Autocuration,Blood,,,22224,Cmax was calculated as maximum concentration reached in the blood,In vivo,CHEMBL622240,0,BAO_0000218,13628,11149,,,178.0,,,
A,1,,,U,Autocuration,Blood,,,22224,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,In vivo,CHEMBL622241,0,BAO_0000218,13629,11149,,,178.0,,,
A,1,,,N,Intermediate,,,,50597,Cmax was determine after peroral administration at 10 mpk in Rat,In vivo,CHEMBL631013,1,BAO_0000218,13630,5669,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50797,Cmax was determine after peroral administration at 10 mpk in Rhesus,In vivo,CHEMBL631014,1,BAO_0000218,13631,5669,,9544.0,,,,Macaca mulatta
A,1,,,N,Intermediate,,,,50588,Cmax was determine after peroral administration at 10 mpk in dog,In vivo,CHEMBL631015,1,BAO_0000218,13632,5669,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50597,Cmax was determine after peroral administration at 160 mpk in Rat,In vivo,CHEMBL631016,1,BAO_0000218,13633,5669,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax was determine after peroral administration at 20 mpk in Rat,In vivo,CHEMBL631017,1,BAO_0000218,13634,5669,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cmax was determine after peroral administration at 50 mpk in Rat,In vivo,CHEMBL631018,1,BAO_0000218,13635,5669,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Cmax was determined,In vivo,CHEMBL631019,0,BAO_0000218,13636,4236,,,,,,
A,1,,,N,Intermediate,Brain,,,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,CHEMBL875761,1,BAO_0000218,13637,13792,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,CHEMBL631020,1,BAO_0000218,13638,13792,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,CHEMBL631669,1,BAO_0000218,13639,13792,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,CHEMBL631670,1,BAO_0000218,13640,13792,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Striatum,,,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,CHEMBL631671,1,BAO_0000218,13641,13792,,10090.0,2435.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,CHEMBL631672,1,BAO_0000218,13642,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,CHEMBL631673,1,BAO_0000218,13643,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,CHEMBL631856,1,BAO_0000218,13644,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,CHEMBL631857,1,BAO_0000218,13645,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,CHEMBL631858,1,BAO_0000218,13646,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,CHEMBL631859,1,BAO_0000218,13647,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,CHEMBL631860,1,BAO_0000218,13648,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,CHEMBL631861,1,BAO_0000218,13649,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,CHEMBL631862,1,BAO_0000218,13650,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,CHEMBL631863,1,BAO_0000218,13651,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,CHEMBL631864,1,BAO_0000218,13652,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,CHEMBL631865,1,BAO_0000218,13653,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,CHEMBL631866,1,BAO_0000218,13654,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,CHEMBL629360,1,BAO_0000218,13655,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,CHEMBL629361,1,BAO_0000218,13656,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,CHEMBL629362,1,BAO_0000218,13657,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,CHEMBL630740,1,BAO_0000218,13658,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,CHEMBL630741,1,BAO_0000218,13659,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,CHEMBL630742,1,BAO_0000218,13660,8418,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,CHEMBL630743,1,BAO_0000218,13661,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,CHEMBL630744,1,BAO_0000218,13662,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,CHEMBL630745,1,BAO_0000218,13663,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,CHEMBL630746,1,BAO_0000218,13664,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,CHEMBL630747,1,BAO_0000218,13665,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,CHEMBL630748,1,BAO_0000218,13666,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,CHEMBL632056,1,BAO_0000218,13667,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,CHEMBL632057,1,BAO_0000218,13668,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,CHEMBL632058,1,BAO_0000218,13669,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,CHEMBL632059,1,BAO_0000218,13670,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,CHEMBL632060,1,BAO_0000218,13671,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,CHEMBL632061,1,BAO_0000218,13672,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,CHEMBL629207,1,BAO_0000218,13673,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,CHEMBL629208,1,BAO_0000218,13674,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,CHEMBL629209,1,BAO_0000218,13675,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,CHEMBL629210,1,BAO_0000218,13676,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,CHEMBL629211,1,BAO_0000218,13677,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,CHEMBL629212,1,BAO_0000218,13678,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,CHEMBL629213,1,BAO_0000218,13679,8418,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,CHEMBL629214,1,BAO_0000218,13680,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,CHEMBL629215,1,BAO_0000218,13681,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,CHEMBL635154,1,BAO_0000218,13682,8133,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,CHEMBL629216,1,BAO_0000218,13683,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,CHEMBL629217,1,BAO_0000218,13684,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,CHEMBL629218,1,BAO_0000218,13685,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,CHEMBL629219,1,BAO_0000218,13686,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL629220,1,BAO_0000218,13687,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,CHEMBL629221,1,BAO_0000218,13688,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,CHEMBL631127,1,BAO_0000218,13689,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,CHEMBL631128,1,BAO_0000218,13690,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,CHEMBL631129,1,BAO_0000218,13691,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,CHEMBL631130,1,BAO_0000218,13692,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL631131,1,BAO_0000218,13693,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,CHEMBL631132,1,BAO_0000218,13694,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,CHEMBL631133,1,BAO_0000218,13695,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,CHEMBL631134,1,BAO_0000218,13696,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,CHEMBL875120,1,BAO_0000218,13697,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,CHEMBL631135,1,BAO_0000218,13698,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL631136,1,BAO_0000218,13699,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,CHEMBL631137,1,BAO_0000218,13700,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,CHEMBL631138,1,BAO_0000218,13701,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,CHEMBL631139,1,BAO_0000218,13702,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,CHEMBL631140,1,BAO_0000218,13703,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,CHEMBL631141,1,BAO_0000218,13704,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,CHEMBL631142,1,BAO_0000218,13705,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,CHEMBL631143,1,BAO_0000218,13706,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,CHEMBL631144,1,BAO_0000218,13707,6996,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,CHEMBL631145,1,BAO_0000218,13708,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,CHEMBL631146,1,BAO_0000218,13709,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,CHEMBL631147,1,BAO_0000218,13710,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,CHEMBL631148,1,BAO_0000218,13711,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,CHEMBL631149,1,BAO_0000218,13712,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,CHEMBL631150,1,BAO_0000218,13713,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,CHEMBL631151,1,BAO_0000218,13714,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,CHEMBL631152,1,BAO_0000218,13715,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,CHEMBL631443,1,BAO_0000218,13716,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,CHEMBL631444,1,BAO_0000218,13717,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL631445,1,BAO_0000218,13718,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,CHEMBL631446,1,BAO_0000218,13719,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,CHEMBL631447,1,BAO_0000218,13720,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,CHEMBL631448,1,BAO_0000218,13721,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,CHEMBL631449,1,BAO_0000218,13722,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,CHEMBL631450,1,BAO_0000218,13723,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,CHEMBL629724,1,BAO_0000218,13724,6996,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,Zone of skin,,,50594,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL629725,1,BAO_0000218,13725,9716,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Zone of skin,,,50594,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL629726,1,BAO_0000218,13726,9716,,10090.0,14.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL629727,1,BAO_0000218,13727,9716,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630404,1,BAO_0000218,13728,9716,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630405,1,BAO_0000218,13729,9716,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630406,1,BAO_0000218,13730,9716,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Stomach,,,50594,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630407,1,BAO_0000218,13731,9716,,10090.0,945.0,,,Mus musculus
A,1,,,N,Intermediate,Stomach,,,50594,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630573,1,BAO_0000218,13732,9716,,10090.0,945.0,,,Mus musculus
A,1,,,N,Intermediate,Stomach,,,50594,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630574,1,BAO_0000218,13733,9716,,10090.0,945.0,,,Mus musculus
A,1,,,N,Intermediate,Stomach,,,50594,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630575,1,BAO_0000218,13734,9716,,10090.0,945.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630576,1,BAO_0000218,13735,9716,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630577,1,BAO_0000218,13736,9716,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630578,1,BAO_0000218,13737,9716,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,CHEMBL630579,1,BAO_0000218,13738,9716,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,CHEMBL630580,1,BAO_0000218,13739,12192,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,CHEMBL630581,1,BAO_0000218,13740,12192,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,CHEMBL630582,1,BAO_0000218,13741,12192,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,CHEMBL630583,1,BAO_0000218,13742,12192,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,CHEMBL630584,1,BAO_0000218,13743,12192,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,CHEMBL630585,1,BAO_0000218,13744,12192,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,CHEMBL630586,1,BAO_0000218,13745,12192,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,CHEMBL630587,1,BAO_0000218,13746,12192,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,CHEMBL630588,1,BAO_0000218,13747,12192,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,CHEMBL630589,1,BAO_0000218,13748,12192,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,CHEMBL630590,1,BAO_0000218,13749,12192,,10090.0,,,,Mus musculus
A,1,,,U,Autocuration,Feces,,,22224,Removal of 238-Plutonium(IV) in feces at 24 h,,CHEMBL630591,0,BAO_0000019,13750,12192,,,1988.0,,,
A,1,,,U,Autocuration,Feces,,,22224,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,CHEMBL630592,0,BAO_0000019,13751,12192,,,1988.0,,,
A,1,,,U,Autocuration,,,,22224,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,CHEMBL630593,0,BAO_0000019,13752,12192,,,,,,
A,1,,,U,Autocuration,,,,22224,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,CHEMBL630594,0,BAO_0000019,13753,12192,,,,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,CHEMBL630595,0,BAO_0000019,13754,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,CHEMBL630596,0,BAO_0000019,13755,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine after 0-24 h,,CHEMBL630597,0,BAO_0000019,13756,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,CHEMBL630598,0,BAO_0000019,13757,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine after 0-4 h,,CHEMBL630599,0,BAO_0000019,13758,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,CHEMBL630600,0,BAO_0000019,13759,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine after 4-24 h,,CHEMBL630601,0,BAO_0000019,13760,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,CHEMBL630602,0,BAO_0000019,13761,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,CHEMBL630603,0,BAO_0000019,13762,12192,,,1088.0,,,
A,1,,,U,Autocuration,Urine,,,22224,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,CHEMBL630604,0,BAO_0000019,13763,12192,,,1088.0,,,
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL624869,1,BAO_0000218,13764,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL624870,1,BAO_0000218,13765,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL623189,1,BAO_0000218,13766,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623190,1,BAO_0000218,13767,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623191,1,BAO_0000218,13768,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623192,1,BAO_0000218,13769,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623193,1,BAO_0000218,13770,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL623194,1,BAO_0000218,13771,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623195,1,BAO_0000218,13772,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623196,1,BAO_0000218,13773,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,CHEMBL623197,1,BAO_0000218,13774,11836,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,CHEMBL623198,1,BAO_0000218,13775,11836,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,CHEMBL623199,1,BAO_0000218,13776,11836,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,CHEMBL623200,1,BAO_0000218,13777,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,CHEMBL623201,1,BAO_0000218,13778,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,CHEMBL623202,1,BAO_0000218,13779,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,CHEMBL623203,1,BAO_0000218,13780,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,CHEMBL623204,1,BAO_0000218,13781,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,CHEMBL623205,1,BAO_0000218,13782,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,CHEMBL623206,1,BAO_0000218,13783,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,CHEMBL623207,1,BAO_0000218,13784,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,CHEMBL623208,1,BAO_0000218,13785,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,CHEMBL623209,1,BAO_0000218,13786,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,CHEMBL623210,1,BAO_0000218,13787,11836,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,CHEMBL623211,1,BAO_0000218,13788,11836,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,CHEMBL623212,1,BAO_0000218,13789,11836,,10116.0,995.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Tested in vitro for intrinsic activity relative to quinpirole,,CHEMBL623213,0,BAO_0000019,13790,12640,,,,,,
A,1,,,U,Autocuration,,,,22224,"Relative ion enhancement, determined in pulsed ultrafiltration",,CHEMBL623214,0,BAO_0000019,13791,14218,,,,,,
A,1,,,U,Autocuration,,,,22224,% ionization at the pH 7.4 at 37 degree Centigrade,,CHEMBL623215,0,BAO_0000019,13792,11296,,,,,,
A,1,,,U,Autocuration,,,,22224,Percentage ionization was measured,,CHEMBL623216,0,BAO_0000019,13793,10929,,,,,,
A,1,,,N,Intermediate,,,,50591,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,CHEMBL623217,1,BAO_0000218,13794,13841,,9913.0,,,,Bos taurus
A,1,,,U,Autocuration,,,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,CHEMBL623218,0,BAO_0000019,13795,10431,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,CHEMBL623913,0,BAO_0000019,13796,10431,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,CHEMBL623914,0,BAO_0000019,13797,10431,,,,,,
P,1,,,U,Autocuration,,,,22229,Compound was evaluated for the partition coefficient in octanol/water,,CHEMBL623915,0,BAO_0000100,13798,8826,,,,,,
P,1,,,U,Autocuration,,,,22229,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,CHEMBL624080,0,BAO_0000100,13799,8826,,,,,,
A,1,,,U,Autocuration,,,,22224,Equilibrium constant measured by the pulse radiolysis at pH 7,,CHEMBL624081,0,BAO_0000019,13800,9884,,,,,,
A,1,,,N,Intermediate,,,,50587,In vitro hydrolytic rate constant determined in human blood,,CHEMBL624082,1,BAO_0000218,13801,9827,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,CHEMBL625054,1,BAO_0000218,13802,10009,,9606.0,,,,Homo sapiens
A,1,,,U,Autocuration,,,,22224,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,CHEMBL877485,0,BAO_0000019,13803,10009,,,,,,
A,1,,,N,Intermediate,,,,50594,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,CHEMBL625055,1,BAO_0000218,13804,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,CHEMBL625056,1,BAO_0000218,13805,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50587,In vitro oxidation of compound in presence of human plasma,,CHEMBL625057,1,BAO_0000218,13806,10009,,9606.0,,,,Homo sapiens
A,1,,,U,Autocuration,,,,22224,In vitro oxidation of compound in presence of hydrogen peroxide,,CHEMBL625058,0,BAO_0000019,13807,10009,,,,,,
A,1,,,N,Intermediate,,,,50594,In vitro oxidation of compound in presence of mouse brain homogenate,,CHEMBL625059,1,BAO_0000218,13808,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro oxidation of compound in presence of mouse liver homogenate,,CHEMBL629536,1,BAO_0000218,13809,10009,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,CHEMBL629537,1,BAO_0000218,13810,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,CHEMBL629538,1,BAO_0000218,13811,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,CHEMBL629539,1,BAO_0000218,13812,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,CHEMBL874445,1,BAO_0000218,13813,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,CHEMBL629540,1,BAO_0000218,13814,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,CHEMBL629541,1,BAO_0000218,13815,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,CHEMBL629542,1,BAO_0000218,13816,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,CHEMBL630243,1,BAO_0000218,13817,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,CHEMBL630244,1,BAO_0000218,13818,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,CHEMBL630245,1,BAO_0000218,13819,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,CHEMBL630246,1,BAO_0000218,13820,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,CHEMBL630247,1,BAO_0000218,13821,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,CHEMBL630248,1,BAO_0000218,13822,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood at 240 minutes after dose administration.,In vivo,CHEMBL630249,1,BAO_0000218,13823,13100,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood at 30 minutes after dose administration.,In vivo,CHEMBL630250,1,BAO_0000218,13824,13100,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood at 360 minutes after dose administration.,In vivo,CHEMBL630251,1,BAO_0000218,13825,13100,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood at 3 hr after dose administration.,In vivo,CHEMBL630252,1,BAO_0000218,13826,13100,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood at 60 minutes after dose administration.,In vivo,CHEMBL630408,1,BAO_0000218,13827,13100,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 120 minutes after dose administration.,In vivo,CHEMBL630409,1,BAO_0000218,13828,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,In vivo,CHEMBL874446,1,BAO_0000218,13829,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 15 minutes after dose administration.,In vivo,CHEMBL630410,1,BAO_0000218,13830,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 240 minutes after dose administration.,In vivo,CHEMBL630411,1,BAO_0000218,13831,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 30 minutes after dose administration.,In vivo,CHEMBL630412,1,BAO_0000218,13832,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 360 minutes after dose administration.,In vivo,CHEMBL630413,1,BAO_0000218,13833,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 3 hr after dose administration.,In vivo,CHEMBL630414,1,BAO_0000218,13834,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution in rat cerebellum at 60 minutes after dose administration.,In vivo,CHEMBL630415,1,BAO_0000218,13835,13100,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 120 minutes after dose administration.,In vivo,CHEMBL630416,1,BAO_0000218,13836,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 1440 minutes after dose administration.,In vivo,CHEMBL630417,1,BAO_0000218,13837,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 15 minutes after dose administration.,In vivo,CHEMBL630418,1,BAO_0000218,13838,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 240 minutes after dose administration.,In vivo,CHEMBL630419,1,BAO_0000218,13839,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 30 minutes after dose administration.,In vivo,CHEMBL630420,1,BAO_0000218,13840,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 360 minutes after dose administration.,In vivo,CHEMBL630421,1,BAO_0000218,13841,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 3 hr after dose administration.,In vivo,CHEMBL630422,1,BAO_0000218,13842,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat cortex at 60 minutes after dose administration.,In vivo,CHEMBL630423,1,BAO_0000218,13843,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart at 120 minutes after dose administration.,In vivo,CHEMBL630424,1,BAO_0000218,13844,13100,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart at 15 minutes after dose administration.,In vivo,CHEMBL630425,1,BAO_0000218,13845,13100,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart at 240 minutes after dose administration.,In vivo,CHEMBL629462,1,BAO_0000218,13846,13100,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart at 30 minutes after dose administration.,In vivo,CHEMBL630426,1,BAO_0000218,13847,13100,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart at 360 minutes after dose administration.,In vivo,CHEMBL630427,1,BAO_0000218,13848,13100,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart at 3 hr after dose administration.,In vivo,CHEMBL625877,1,BAO_0000218,13849,13100,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart at 60 minutes after dose administration.,In vivo,CHEMBL625878,1,BAO_0000218,13850,13100,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,In vivo,CHEMBL625879,1,BAO_0000218,13851,13100,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution in rat hippocampus at 240 minutes after dose administration.,In vivo,CHEMBL625880,1,BAO_0000218,13852,13100,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution in rat hippocampus at 30 minutes after dose administration.,In vivo,CHEMBL625881,1,BAO_0000218,13853,13100,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution in rat hippocampus at 360 minutes after dose administration.,In vivo,CHEMBL625882,1,BAO_0000218,13854,13100,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution in rat hippocampus at 15 minutes after dose administration.,In vivo,CHEMBL625883,1,BAO_0000218,13855,13100,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney at 120 minutes after dose administration.,In vivo,CHEMBL625884,1,BAO_0000218,13856,13100,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney at 1440 minutes after dose administration.,In vivo,CHEMBL625885,1,BAO_0000218,13857,13100,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney at 15 minutes after dose administration.,In vivo,CHEMBL628649,1,BAO_0000218,13858,13100,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney at 240 minutes after dose administration.,In vivo,CHEMBL628650,1,BAO_0000218,13859,13100,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney at 30 minutes after dose administration.,In vivo,CHEMBL628651,1,BAO_0000218,13860,13100,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney at 360 minutes after dose administration.,In vivo,CHEMBL628652,1,BAO_0000218,13861,13100,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney at 60 minutes after dose administration.,In vivo,CHEMBL628653,1,BAO_0000218,13862,13100,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver at 120 minutes after dose administration.,In vivo,CHEMBL628654,1,BAO_0000218,13863,13100,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver at 1440 minutes after dose administration.,In vivo,CHEMBL628655,1,BAO_0000218,13864,13100,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver at 15 minutes after dose administration.,In vivo,CHEMBL625238,1,BAO_0000218,13865,13100,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver at 240 minutes after dose administration.,In vivo,CHEMBL625239,1,BAO_0000218,13866,13100,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver at 30 minutes after dose administration.,In vivo,CHEMBL625240,1,BAO_0000218,13867,13100,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver at 360 minutes after dose administration.,In vivo,CHEMBL625241,1,BAO_0000218,13868,13100,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver at 60 minutes after dose administration.,In vivo,CHEMBL625242,1,BAO_0000218,13869,13100,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung at 120 minutes after dose administration.,In vivo,CHEMBL874587,1,BAO_0000218,13870,13100,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung at 1440 minutes after dose administration.,In vivo,CHEMBL625405,1,BAO_0000218,13871,13100,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung at 15 minutes after dose administration.,In vivo,CHEMBL625406,1,BAO_0000218,13872,13100,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung at 240 minutes after dose administration.,In vivo,CHEMBL625407,1,BAO_0000218,13873,13100,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung at 30 minutes after dose administration.,In vivo,CHEMBL625408,1,BAO_0000218,13874,13100,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung at 360 minutes after dose administration.,In vivo,CHEMBL625409,1,BAO_0000218,13875,13100,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thoracic aorta,,,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,CHEMBL625410,1,BAO_0000218,13876,12361,,10116.0,1515.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thoracic aorta,,,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,CHEMBL625411,1,BAO_0000218,13877,12361,,10116.0,1515.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thoracic aorta,,,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,CHEMBL625412,1,BAO_0000218,13878,12361,,10116.0,1515.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thoracic aorta,,,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,CHEMBL625413,1,BAO_0000218,13879,12361,,10116.0,1515.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thoracic aorta,,,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,CHEMBL625414,1,BAO_0000218,13880,12361,,10116.0,1515.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thoracic aorta,,,50597,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,CHEMBL625415,1,BAO_0000218,13881,12361,,10116.0,1515.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thoracic aorta,,,50597,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,CHEMBL625416,1,BAO_0000218,13882,12361,,10116.0,1515.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,CHEMBL625417,1,BAO_0000218,13883,12712,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50597,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,CHEMBL625418,1,BAO_0000218,13884,7415,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,CHEMBL625419,1,BAO_0000218,13885,7415,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,CHEMBL625420,1,BAO_0000218,13886,7415,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,CHEMBL626996,1,BAO_0000218,13887,7415,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50597,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,CHEMBL626997,1,BAO_0000218,13888,7415,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,CHEMBL626998,1,BAO_0000218,13889,7415,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,CHEMBL626999,1,BAO_0000218,13890,7415,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,CHEMBL627000,1,BAO_0000218,13891,8050,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,CHEMBL627001,1,BAO_0000218,13892,8050,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,CHEMBL627002,1,BAO_0000218,13893,8050,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,CHEMBL627003,1,BAO_0000218,13894,8050,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,CHEMBL627004,1,BAO_0000218,13895,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,CHEMBL627005,1,BAO_0000218,13896,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,CHEMBL874594,1,BAO_0000218,13897,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,CHEMBL627006,1,BAO_0000218,13898,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,CHEMBL627007,1,BAO_0000218,13899,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,CHEMBL627884,1,BAO_0000218,13900,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,CHEMBL627885,1,BAO_0000218,13901,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,CHEMBL627886,1,BAO_0000218,13902,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,CHEMBL627887,1,BAO_0000218,13903,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,CHEMBL627888,1,BAO_0000218,13904,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,CHEMBL628057,1,BAO_0000218,13905,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,CHEMBL627405,1,BAO_0000218,13906,8050,,10090.0,1088.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,CHEMBL627406,1,BAO_0000218,13907,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,CHEMBL627407,1,BAO_0000218,13908,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,CHEMBL627408,1,BAO_0000218,13909,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,CHEMBL627409,1,BAO_0000218,13910,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,CHEMBL875486,1,BAO_0000218,13911,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,CHEMBL627410,1,BAO_0000218,13912,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,CHEMBL627411,1,BAO_0000218,13913,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,CHEMBL627412,1,BAO_0000218,13914,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,CHEMBL627413,1,BAO_0000218,13915,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,CHEMBL627414,1,BAO_0000218,13916,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,CHEMBL627415,1,BAO_0000218,13917,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,CHEMBL627416,1,BAO_0000218,13918,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,CHEMBL627417,1,BAO_0000218,13919,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,CHEMBL627418,1,BAO_0000218,13920,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,CHEMBL627419,1,BAO_0000218,13921,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,CHEMBL627320,1,BAO_0000218,13922,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,CHEMBL627321,1,BAO_0000218,13923,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627322,1,BAO_0000218,13924,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627323,1,BAO_0000218,13925,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL627491,1,BAO_0000218,13926,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627492,1,BAO_0000218,13927,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627493,1,BAO_0000218,13928,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627494,1,BAO_0000218,13929,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627495,1,BAO_0000218,13930,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL627496,1,BAO_0000218,13931,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627497,1,BAO_0000218,13932,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627498,1,BAO_0000218,13933,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627499,1,BAO_0000218,13934,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL627500,1,BAO_0000218,13935,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL627501,1,BAO_0000218,13936,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625616,1,BAO_0000218,13937,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625617,1,BAO_0000218,13938,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625618,1,BAO_0000218,13939,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625619,1,BAO_0000218,13940,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL625620,1,BAO_0000218,13941,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625621,1,BAO_0000218,13942,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625622,1,BAO_0000218,13943,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625788,1,BAO_0000218,13944,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625789,1,BAO_0000218,13945,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL625790,1,BAO_0000218,13946,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL625791,1,BAO_0000218,13947,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL622334,1,BAO_0000218,13948,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL622335,1,BAO_0000218,13949,12017,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL622336,1,BAO_0000218,13950,12017,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL622337,1,BAO_0000218,13951,12017,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL622338,1,BAO_0000218,13952,12017,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL622339,1,BAO_0000218,13953,12017,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL624153,1,BAO_0000218,13954,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL628430,1,BAO_0000218,13955,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL628431,1,BAO_0000218,13956,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL628432,1,BAO_0000218,13957,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL628433,1,BAO_0000218,13958,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,CHEMBL628434,1,BAO_0000218,13959,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,CHEMBL626789,1,BAO_0000218,13960,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",In vivo,CHEMBL626790,1,BAO_0000218,13961,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,CHEMBL626791,1,BAO_0000218,13962,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,CHEMBL626792,1,BAO_0000218,13963,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,CHEMBL626793,1,BAO_0000218,13964,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,CHEMBL627436,1,BAO_0000218,13965,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,CHEMBL627437,1,BAO_0000218,13966,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,CHEMBL627438,1,BAO_0000218,13967,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,CHEMBL627439,1,BAO_0000218,13968,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,CHEMBL627440,1,BAO_0000218,13969,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,CHEMBL627602,1,BAO_0000218,13970,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,CHEMBL627603,1,BAO_0000218,13971,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,CHEMBL627604,1,BAO_0000218,13972,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,CHEMBL627605,1,BAO_0000218,13973,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,CHEMBL627606,1,BAO_0000218,13974,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,CHEMBL627607,1,BAO_0000218,13975,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,CHEMBL627608,1,BAO_0000218,13976,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,CHEMBL627609,1,BAO_0000218,13977,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,CHEMBL627610,1,BAO_0000218,13978,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,CHEMBL627611,1,BAO_0000218,13979,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,CHEMBL627612,1,BAO_0000218,13980,11510,,10116.0,,,,Rattus norvegicus
P,1,,,U,Autocuration,,,,22229,Octanol:water partition coefficient is evaluated,,CHEMBL627613,0,BAO_0000100,13981,8362,,,,,,
P,1,,,U,Autocuration,,,,22224,Partition coefficient in 1-octanol/water system,,CHEMBL627614,0,BAO_0000100,13982,8257,,,,,,
P,1,,,U,Autocuration,,,,22224,Partition coefficient in 1-octanol/water system measured using radio active compounds,,CHEMBL627615,0,BAO_0000100,13983,8257,,,,,,
P,1,,,U,Autocuration,,,,22224,Partition coefficient in octanol/water system was determined,,CHEMBL627616,0,BAO_0000100,13984,9468,,,,,,
P,1,,,U,Autocuration,,,,22224,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,CHEMBL627617,0,BAO_0000100,13985,9468,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,CHEMBL627618,0,BAO_0000019,13986,10568,,,,,,
A,1,,,U,Autocuration,,,,22224,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,CHEMBL627619,0,BAO_0000019,13987,10568,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant of the compound,,CHEMBL627620,0,BAO_0000019,13988,15359,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant with 1-min time point,,CHEMBL627621,0,BAO_0000019,13989,15359,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant without 1-min time point,,CHEMBL627622,0,BAO_0000019,13990,15359,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,CHEMBL627623,0,BAO_0000019,13991,10431,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,CHEMBL627624,0,BAO_0000019,13992,10431,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,CHEMBL627625,0,BAO_0000019,13993,10431,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,CHEMBL628523,0,BAO_0000019,13994,15704,,,,,,
A,1,,,U,Autocuration,,,,22224,The alkaline hydrolysis second order rate constant(K OH) of the compound,,CHEMBL628524,0,BAO_0000019,13995,15287,,,,,,
A,1,,,U,Autocuration,,,,22224,The efflux rate constant of the compound,,CHEMBL628525,0,BAO_0000019,13996,7516,,,,,,
A,1,,,U,Autocuration,,,,22224,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,CHEMBL625732,0,BAO_0000019,13997,12973,,,,,,
A,1,,,U,Autocuration,,,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,CHEMBL625733,0,BAO_0000019,13998,12973,,,,,,
F,1,,,U,Autocuration,,,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,CHEMBL625734,0,BAO_0000019,13999,12973,,,,,,
A,1,,,U,Autocuration,,,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,CHEMBL625913,0,BAO_0000019,14000,12973,,,,,,
A,1,,,U,Autocuration,,,,22224,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,CHEMBL625914,0,BAO_0000019,14001,8696,,,,,,
A,1,,,U,Autocuration,,,,22224,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,CHEMBL625915,0,BAO_0000019,14002,15052,,,,,,
A,1,,,U,Autocuration,,,,22224,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,CHEMBL625916,0,BAO_0000019,14003,15052,,,,,,
A,1,,,U,Autocuration,,,,22224,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,CHEMBL625917,0,BAO_0000019,14004,10503,,,,,,
A,1,,,U,Autocuration,,,,22224,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625918,0,BAO_0000019,14005,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625919,0,BAO_0000019,14006,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625920,0,BAO_0000019,14007,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL874453,0,BAO_0000019,14008,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,CHEMBL625921,0,BAO_0000019,14009,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,CHEMBL625922,0,BAO_0000019,14010,10503,,,,,,
A,1,,,U,Autocuration,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625923,0,BAO_0000019,14011,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625924,0,BAO_0000019,14012,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625925,0,BAO_0000019,14013,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625926,0,BAO_0000019,14014,8354,,,,,,
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung at 60 minutes after dose administration.,In vivo,CHEMBL627704,1,BAO_0000218,14015,13100,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,In vivo,CHEMBL627705,1,BAO_0000218,14016,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,In vivo,CHEMBL627706,1,BAO_0000218,14017,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,In vivo,CHEMBL627707,1,BAO_0000218,14018,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,In vivo,CHEMBL627708,1,BAO_0000218,14019,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,In vivo,CHEMBL628361,1,BAO_0000218,14020,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,In vivo,CHEMBL628362,1,BAO_0000218,14021,13100,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 120 minutes after dose administration.,In vivo,CHEMBL628363,1,BAO_0000218,14022,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 1440 minutes after dose administration.,In vivo,CHEMBL628364,1,BAO_0000218,14023,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 15 minutes after dose administration.,In vivo,CHEMBL628365,1,BAO_0000218,14024,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 240 minutes after dose administration.,In vivo,CHEMBL874454,1,BAO_0000218,14025,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 30 minutes after dose administration.,In vivo,CHEMBL628531,1,BAO_0000218,14026,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 360 minutes after dose administration.,In vivo,CHEMBL628532,1,BAO_0000218,14027,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 3 hr after dose administration.,In vivo,CHEMBL628533,1,BAO_0000218,14028,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Striatum,,,50597,Biodistribution in rat striatum at 60 minutes after dose administration.,In vivo,CHEMBL628534,1,BAO_0000218,14029,13100,,10116.0,2435.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in rat thyroid at 120 minutes after dose administration.,In vivo,CHEMBL628535,1,BAO_0000218,14030,13100,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in rat thyroid at 1440 minutes after dose administration.,In vivo,CHEMBL628536,1,BAO_0000218,14031,13100,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in rat thyroid at 15 minutes after dose administration.,In vivo,CHEMBL628537,1,BAO_0000218,14032,13100,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in rat thyroid at 240 minutes after dose administration.,In vivo,CHEMBL628538,1,BAO_0000218,14033,13100,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in rat thyroid at 30 minutes after dose administration.,In vivo,CHEMBL628539,1,BAO_0000218,14034,13100,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in rat thyroid at 360 minutes after dose administration.,In vivo,CHEMBL630297,1,BAO_0000218,14035,13100,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in rat thyroid at 60 minutes after dose administration.,In vivo,CHEMBL630298,1,BAO_0000218,14036,13100,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rest of brain of rat 120 minutes after dose administration.,In vivo,CHEMBL630299,1,BAO_0000218,14037,13100,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,In vivo,CHEMBL628094,1,BAO_0000218,14038,13100,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,In vivo,CHEMBL628095,1,BAO_0000218,14039,13100,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,In vivo,CHEMBL874648,1,BAO_0000218,14040,13100,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,In vivo,CHEMBL628096,1,BAO_0000218,14041,13100,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,In vivo,CHEMBL628097,1,BAO_0000218,14042,13100,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,In vivo,CHEMBL628098,1,BAO_0000218,14043,13100,,10116.0,955.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,CHEMBL628099,0,BAO_0000019,14044,13331,,,,,,
A,1,,,U,Autocuration,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,CHEMBL628100,0,BAO_0000019,14045,13331,,,,,,
A,1,,,U,Autocuration,,,,22224,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,CHEMBL628101,0,BAO_0000019,14046,13331,,,,,,
A,1,,,U,Autocuration,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,CHEMBL628102,0,BAO_0000019,14047,13331,,,,,,
A,1,,,U,Autocuration,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,CHEMBL628103,0,BAO_0000019,14048,13331,,,,,,
A,1,,,U,Autocuration,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,CHEMBL628104,0,BAO_0000019,14049,13331,,,,,,
A,1,,,U,Autocuration,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,CHEMBL628105,0,BAO_0000019,14050,13331,,,,,,
A,1,,,U,Autocuration,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,CHEMBL628106,0,BAO_0000019,14051,13331,,,,,,
A,1,,,N,Intermediate,Urine,,,50597,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,CHEMBL628107,1,BAO_0000218,14052,10086,,10116.0,1088.0,,,Rattus norvegicus
F,1,,,U,Autocuration,Urine,,,22224,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,CHEMBL628108,0,BAO_0000218,14053,10086,,,1088.0,,,
A,1,,,N,Intermediate,Urine,,,50597,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,CHEMBL628109,1,BAO_0000218,14054,10086,,10116.0,1088.0,,,Rattus norvegicus
F,1,,,U,Autocuration,Urine,,,22224,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,CHEMBL625299,0,BAO_0000218,14055,10086,,,1088.0,,,
A,1,,,N,Intermediate,Urine,,,50597,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,CHEMBL625300,1,BAO_0000218,14056,10086,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,CHEMBL625301,1,BAO_0000218,14057,10086,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,CHEMBL625302,1,BAO_0000218,14058,10086,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,CHEMBL874649,1,BAO_0000218,14059,10086,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,CHEMBL625303,1,BAO_0000218,14060,13248,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,CHEMBL625463,1,BAO_0000218,14061,13248,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50587,In vitro metabolism in human liver microsomes,,CHEMBL625464,1,BAO_0000218,14062,14527,,9606.0,2107.0,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,CHEMBL625465,1,BAO_0000218,14063,3008,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,CHEMBL625466,1,BAO_0000218,14064,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,CHEMBL625467,1,BAO_0000218,14065,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,CHEMBL625468,1,BAO_0000218,14066,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,CHEMBL625469,1,BAO_0000218,14067,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,CHEMBL625470,1,BAO_0000218,14068,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,CHEMBL632418,1,BAO_0000218,14069,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,CHEMBL627250,1,BAO_0000218,14070,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,CHEMBL627251,1,BAO_0000218,14071,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,CHEMBL627252,1,BAO_0000218,14072,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,CHEMBL627253,1,BAO_0000218,14073,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,CHEMBL627254,1,BAO_0000218,14074,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,CHEMBL875471,1,BAO_0000218,14075,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,CHEMBL627255,1,BAO_0000218,14076,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,CHEMBL627256,1,BAO_0000218,14077,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,CHEMBL627257,1,BAO_0000218,14078,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,CHEMBL627258,1,BAO_0000218,14079,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,CHEMBL627259,1,BAO_0000218,14080,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,CHEMBL627260,1,BAO_0000218,14081,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,CHEMBL623256,1,BAO_0000218,14082,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,CHEMBL874413,1,BAO_0000218,14083,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,CHEMBL623257,1,BAO_0000218,14084,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,CHEMBL623258,1,BAO_0000218,14085,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,CHEMBL623259,1,BAO_0000218,14086,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,CHEMBL623260,1,BAO_0000218,14087,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,CHEMBL623261,1,BAO_0000218,14088,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,CHEMBL623262,1,BAO_0000218,14089,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,CHEMBL623263,1,BAO_0000218,14090,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,CHEMBL623264,1,BAO_0000218,14091,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,CHEMBL623265,1,BAO_0000218,14092,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,CHEMBL623266,1,BAO_0000218,14093,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,CHEMBL623267,1,BAO_0000218,14094,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,CHEMBL623268,1,BAO_0000218,14095,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,CHEMBL623269,1,BAO_0000218,14096,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,CHEMBL623270,1,BAO_0000218,14097,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,CHEMBL623271,1,BAO_0000218,14098,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,CHEMBL623272,1,BAO_0000218,14099,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,CHEMBL623273,1,BAO_0000218,14100,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,CHEMBL623274,1,BAO_0000218,14101,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,CHEMBL874414,1,BAO_0000218,14102,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,CHEMBL623275,1,BAO_0000218,14103,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,CHEMBL629150,1,BAO_0000218,14104,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,CHEMBL623276,1,BAO_0000218,14105,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,CHEMBL623277,1,BAO_0000218,14106,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,CHEMBL623112,1,BAO_0000218,14107,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,CHEMBL623113,1,BAO_0000218,14108,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,CHEMBL623800,1,BAO_0000218,14109,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,CHEMBL623801,1,BAO_0000218,14110,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,CHEMBL623802,1,BAO_0000218,14111,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623803,1,BAO_0000218,14112,12017,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623970,1,BAO_0000218,14113,12017,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Uterus,,,50597,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL623971,1,BAO_0000218,14114,12017,,10116.0,995.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),In vivo,CHEMBL623972,1,BAO_0000218,14115,14045,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),In vivo,CHEMBL623973,1,BAO_0000218,14116,14045,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),In vivo,CHEMBL623974,1,BAO_0000218,14117,14045,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),In vivo,CHEMBL623975,1,BAO_0000218,14118,14045,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),In vivo,CHEMBL623976,1,BAO_0000218,14119,14045,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),In vivo,CHEMBL623977,1,BAO_0000218,14120,14045,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),In vivo,CHEMBL623978,1,BAO_0000218,14121,14045,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),In vivo,CHEMBL623979,1,BAO_0000218,14122,14045,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),In vivo,CHEMBL623980,1,BAO_0000218,14123,14045,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),In vivo,CHEMBL623981,1,BAO_0000218,14124,14045,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),In vivo,CHEMBL626278,1,BAO_0000218,14125,14045,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),In vivo,CHEMBL626279,1,BAO_0000218,14126,14045,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Biodistribution in mice bladder plus excreted urine was determined,In vivo,CHEMBL626280,1,BAO_0000218,14127,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse blood, 10 minutes post injection",,CHEMBL626281,1,BAO_0000218,14128,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse blood, 30 minutes post injection",,CHEMBL626282,1,BAO_0000218,14129,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse blood, 5 minutes post injection",,CHEMBL626283,1,BAO_0000218,14130,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse blood, 60 minutes post injection",,CHEMBL626284,1,BAO_0000218,14131,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Percentage biodistribution in mouse brain, 10 minutes post injection",,CHEMBL626285,1,BAO_0000218,14132,14045,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Percentage biodistribution in mouse brain, 30 minutes post injection",,CHEMBL626286,1,BAO_0000218,14133,14045,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Percentage biodistribution in mouse brain, 5 minutes post injection",,CHEMBL626287,1,BAO_0000218,14134,14045,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,Brain,,,50594,"Percentage biodistribution in mouse brain, 60 minutes post injection",,CHEMBL626288,1,BAO_0000218,14135,14045,,10090.0,955.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse heart, 10 minutes post injection",,CHEMBL626289,1,BAO_0000218,14136,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse heart, 30 minutes post injection",,CHEMBL626290,1,BAO_0000218,14137,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse heart, 5 minutes post injection",,CHEMBL626291,1,BAO_0000218,14138,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse heart, 60 minutes post injection",,CHEMBL839888,1,BAO_0000218,14139,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Intestine,,,50594,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,CHEMBL626292,1,BAO_0000218,14140,14045,,10090.0,160.0,,,Mus musculus
A,1,,,N,Intermediate,Intestine,,,50594,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,CHEMBL626293,1,BAO_0000218,14141,14045,,10090.0,160.0,,,Mus musculus
A,1,,,N,Intermediate,Intestine,,,50594,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,CHEMBL626294,1,BAO_0000218,14142,14045,,10090.0,160.0,,,Mus musculus
A,1,,,N,Intermediate,Intestine,,,50594,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,CHEMBL626295,1,BAO_0000218,14143,14045,,10090.0,160.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,"Percentage biodistribution in mouse liver, 10 minutes post injection",,CHEMBL627659,1,BAO_0000218,14144,14045,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,CHEMBL627660,1,BAO_0000218,14145,14045,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,"Percentage biodistribution in mouse liver, 5 minutes post injection",,CHEMBL627661,1,BAO_0000218,14146,14045,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in mice liver at 60 minutes of post injection,In vivo,CHEMBL627662,1,BAO_0000218,14147,14045,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution in mice lungs at 10 min of post injection,In vivo,CHEMBL627663,1,BAO_0000218,14148,14045,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mouse lung, 30 minutes post injection",,CHEMBL627664,1,BAO_0000218,14149,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,"Percentage biodistribution in mousee lung, 5 minutes post injection",,CHEMBL627665,1,BAO_0000218,14150,14045,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Lung,,,50594,Biodistribution in mice lungs at 60 min of post injection,In vivo,CHEMBL627666,1,BAO_0000218,14151,14045,,10090.0,2048.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Percentage biodistribution in mouse spleen,,CHEMBL627667,1,BAO_0000218,14152,14045,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Stomach,,,50594,Percentage biodistribution in mouse stomach,,CHEMBL627668,1,BAO_0000218,14153,14045,,10090.0,945.0,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50594,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,CHEMBL627669,1,BAO_0000218,14154,11745,,10090.0,1088.0,,,Mus musculus
A,1,,,U,Autocuration,Urinary bladder,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,In vivo,CHEMBL627670,0,BAO_0000218,14155,13257,,,1255.0,,,
A,1,,,U,Autocuration,Blood,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,In vivo,CHEMBL627671,0,BAO_0000218,14156,13257,,,178.0,,,
A,1,,,U,Autocuration,Bone element,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,In vivo,CHEMBL627672,0,BAO_0000218,14157,13257,,,1474.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,In vivo,CHEMBL627673,0,BAO_0000218,14158,13257,,,,,,
A,1,,,U,Autocuration,Kidney,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,In vivo,CHEMBL627674,0,BAO_0000218,14159,13257,,,2113.0,,,
A,1,,,U,Autocuration,Liver,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,In vivo,CHEMBL627675,0,BAO_0000218,14160,13257,,,2107.0,,,
A,1,,,U,Autocuration,Lung,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,In vivo,CHEMBL627676,0,BAO_0000218,14161,13257,,,2048.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,In vivo,CHEMBL627677,0,BAO_0000218,14162,13257,,,2385.0,,,
A,1,,,U,Autocuration,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,CHEMBL627678,0,BAO_0000019,14163,8354,,,,,,
A,1,,,N,Intermediate,Serum,,,50597,Affinity for protein binding expressed as association constant in fresh rat serum,,CHEMBL627679,1,BAO_0000218,14164,7095,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,CHEMBL627680,0,BAO_0000019,14165,12185,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,CHEMBL627681,0,BAO_0000019,14166,12185,,,,,,
A,1,,,U,Autocuration,,,,22224,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,CHEMBL627682,0,BAO_0000019,14167,12185,,,,,,
A,1,,,U,Autocuration,,,,22224,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,CHEMBL627683,0,BAO_0000019,14168,12185,,,,,,
A,1,,,U,Autocuration,,,,22224,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,CHEMBL627684,0,BAO_0000019,14169,12686,,,,,,
A,1,,,U,Autocuration,,,,22224,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,CHEMBL874441,0,BAO_0000019,14170,12686,,,,,,
A,1,,,U,Autocuration,,,,22224,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,CHEMBL627685,0,BAO_0000019,14171,12686,,,,,,
A,1,,,U,Autocuration,,,,22224,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,CHEMBL627686,0,BAO_0000019,14172,12686,,,,,,
A,1,,,U,Autocuration,,,,22224,Apparent rate constant Koff for inactivation of dTMP synthase.,,CHEMBL627687,0,BAO_0000019,14173,8057,,,,,,
A,1,,,U,Autocuration,,,,22224,The irreversible inhibitor activity by second order rate equation.,,CHEMBL627688,0,BAO_0000019,14174,15778,,,,,,
A,1,,,N,Intermediate,,,,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,CHEMBL628038,1,BAO_0000218,14175,12375,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,CHEMBL628039,1,BAO_0000218,14176,12375,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,CHEMBL628040,1,BAO_0000218,14177,12375,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Dissociation rate calculated from the first-order equation using t1/2 value,,CHEMBL628041,0,BAO_0000019,14178,13588,,,,,,
A,1,,,U,Autocuration,,,,22224,The compound was tested for Binding constant against DNA,,CHEMBL630226,0,BAO_0000019,14179,15039,,,,,,
A,1,,,U,Autocuration,,,,22224,First order rate constant for cyclization of the compound,,CHEMBL628042,0,BAO_0000019,14180,9500,,,,,,
A,1,,,U,Autocuration,,,,22224,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,CHEMBL625232,0,BAO_0000019,14181,10014,,,,,,
A,1,,,U,Autocuration,,,,22224,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,CHEMBL625233,0,BAO_0000019,14182,10014,,,,,,
A,1,,,U,Autocuration,,,,22224,Hydrolysis rate constant was determined,,CHEMBL625979,0,BAO_0000019,14183,568,,,,,,
A,1,,,U,Autocuration,,,,22224,Observed first order rate constant,,CHEMBL625980,0,BAO_0000019,14184,10026,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,CHEMBL625981,0,BAO_0000019,14185,10281,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,CHEMBL625982,0,BAO_0000019,14186,10281,,,,,,
A,1,,,U,Autocuration,,,,22224,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,CHEMBL625983,0,BAO_0000019,14187,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625984,0,BAO_0000019,14188,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625985,0,BAO_0000019,14189,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625986,0,BAO_0000019,14190,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625987,0,BAO_0000019,14191,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625988,0,BAO_0000019,14192,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625989,0,BAO_0000019,14193,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625990,0,BAO_0000019,14194,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625991,0,BAO_0000019,14195,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625992,0,BAO_0000019,14196,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625993,0,BAO_0000019,14197,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL631973,0,BAO_0000019,14198,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632143,0,BAO_0000019,14199,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632144,0,BAO_0000019,14200,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632145,0,BAO_0000019,14201,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632146,0,BAO_0000019,14202,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632147,0,BAO_0000019,14203,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632148,0,BAO_0000019,14204,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632149,0,BAO_0000019,14205,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632150,0,BAO_0000019,14206,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632151,0,BAO_0000019,14207,13028,,,,,,
A,1,,,N,Intermediate,,,,50587,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,CHEMBL632152,1,BAO_0000218,14208,3008,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,CHEMBL632153,1,BAO_0000218,14209,4509,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50587,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,CHEMBL632154,1,BAO_0000218,14210,4509,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,CHEMBL632155,1,BAO_0000218,14211,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,CHEMBL632156,1,BAO_0000218,14212,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,CHEMBL632157,1,BAO_0000218,14213,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,CHEMBL632158,1,BAO_0000218,14214,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,CHEMBL632159,1,BAO_0000218,14215,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,CHEMBL626305,1,BAO_0000218,14216,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,CHEMBL626306,1,BAO_0000218,14217,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,CHEMBL626307,1,BAO_0000218,14218,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,CHEMBL626308,1,BAO_0000218,14219,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,CHEMBL626479,1,BAO_0000218,14220,8613,,10298.0,,,,Human herpesvirus 1
A,1,,,N,Intermediate,,,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,CHEMBL626480,1,BAO_0000218,14221,8613,,10298.0,,,,Human herpesvirus 1
P,1,,,U,Autocuration,,,,22229,Calculated partition coefficient (clogP) (MlogP),,CHEMBL626481,0,BAO_0000100,14222,6021,,,,,,
A,1,,,U,Autocuration,,,,22224,Equipotent potent ratio relative to carbachol (nicotinic activity),,CHEMBL626482,0,BAO_0000019,14223,9348,,,,,,
A,1,,,N,Intermediate,,,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,CHEMBL626483,1,BAO_0000218,14224,15592,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,CHEMBL626484,1,BAO_0000218,14225,15592,,9615.0,,,,Canis lupus familiaris
P,1,,,U,Autocuration,,,,22229,Solubility at pH 7.4 in micro g/mL;NA denotes available,,CHEMBL626485,0,BAO_0000100,14226,15592,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,CHEMBL626486,0,BAO_0000100,14227,15592,,,,,,
P,1,,,U,Autocuration,,,,22229,Solubility at pH 7.4 in ug/mL;NA denotes not available,,CHEMBL626487,0,BAO_0000100,14228,15592,,,,,,
A,1,,,N,Intermediate,Plasma,,,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,CHEMBL626488,1,BAO_0000218,14229,15592,,9615.0,1969.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Serum,,,50597,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,CHEMBL626489,1,BAO_0000218,14230,7095,,10116.0,1977.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Area under the MAP curve measured over 5 min; ND means Not determined,,CHEMBL626490,0,BAO_0000019,14231,16618,,,,,,
P,1,,,U,Autocuration,,,,22224,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,CHEMBL626491,0,BAO_0000100,14232,16835,,,,,,
P,1,,,U,Autocuration,,,,22229,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,CHEMBL626492,0,BAO_0000100,14233,15284,,,,,,
A,1,,,U,Autocuration,,,,22224,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,CHEMBL626493,0,BAO_0000019,14234,15750,,,,,,
A,1,,,N,Intermediate,,,,50597,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,CHEMBL626494,1,BAO_0000218,14235,16618,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Half life after oral tested,In vivo,CHEMBL626495,0,BAO_0000218,14236,16618,,,,,,
A,1,,,N,Intermediate,Plasma,,,50597,Half life was determined in plasma of rat; NT indicates not tested,,CHEMBL626496,1,BAO_0000218,14237,15812,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,CHEMBL626497,1,BAO_0000218,14238,16618,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Oral bioavailability after oral tested,In vivo,CHEMBL626498,0,BAO_0000218,14239,16618,,,,,,
A,1,,,N,Intermediate,,,,50597,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,CHEMBL626499,1,BAO_0000218,14240,13098,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,CHEMBL626500,1,BAO_0000218,14241,13098,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,half life was determined in plasma of rat; NT indicates not tested,,CHEMBL626501,1,BAO_0000218,14242,15812,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Plasma,,,50597,half life was determined in plasma of rat; NT means not tested,,CHEMBL626502,1,BAO_0000218,14243,15812,,10116.0,1969.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,CHEMBL626503,1,BAO_0000218,14244,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,CHEMBL626504,1,BAO_0000218,14245,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,CHEMBL626505,1,BAO_0000218,14246,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,CHEMBL626506,1,BAO_0000218,14247,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,CHEMBL626507,1,BAO_0000218,14248,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,CHEMBL626508,1,BAO_0000218,14249,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,CHEMBL626509,1,BAO_0000218,14250,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,CHEMBL875480,1,BAO_0000218,14251,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,CHEMBL626510,1,BAO_0000218,14252,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,CHEMBL626511,1,BAO_0000218,14253,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,CHEMBL626512,1,BAO_0000218,14254,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,CHEMBL628208,1,BAO_0000218,14255,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,CHEMBL628209,1,BAO_0000218,14256,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,CHEMBL628210,1,BAO_0000218,14257,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,CHEMBL628211,1,BAO_0000218,14258,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,CHEMBL628212,1,BAO_0000218,14259,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,CHEMBL628213,1,BAO_0000218,14260,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,CHEMBL628214,1,BAO_0000218,14261,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,CHEMBL628215,1,BAO_0000218,14262,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,CHEMBL628216,1,BAO_0000218,14263,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,CHEMBL626595,1,BAO_0000218,14264,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,CHEMBL626596,1,BAO_0000218,14265,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,CHEMBL626597,1,BAO_0000218,14266,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,CHEMBL626598,1,BAO_0000218,14267,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,CHEMBL622242,1,BAO_0000218,14268,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,CHEMBL622243,1,BAO_0000218,14269,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,CHEMBL622244,1,BAO_0000218,14270,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,CHEMBL622245,1,BAO_0000218,14271,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,CHEMBL622246,1,BAO_0000218,14272,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,CHEMBL622247,1,BAO_0000218,14273,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,CHEMBL622248,1,BAO_0000218,14274,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,CHEMBL877483,1,BAO_0000218,14275,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,CHEMBL622249,1,BAO_0000218,14276,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,CHEMBL622250,1,BAO_0000218,14277,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,CHEMBL622251,1,BAO_0000218,14278,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,CHEMBL622252,1,BAO_0000218,14279,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,CHEMBL622253,1,BAO_0000218,14280,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,CHEMBL622254,1,BAO_0000218,14281,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,CHEMBL622255,1,BAO_0000218,14282,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,CHEMBL622256,1,BAO_0000218,14283,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,CHEMBL622257,1,BAO_0000218,14284,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,CHEMBL622258,1,BAO_0000218,14285,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,CHEMBL622259,1,BAO_0000218,14286,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,CHEMBL622927,1,BAO_0000218,14287,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,CHEMBL622928,1,BAO_0000218,14288,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,CHEMBL622929,1,BAO_0000218,14289,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,CHEMBL623182,1,BAO_0000218,14290,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,CHEMBL623183,1,BAO_0000218,14291,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,CHEMBL623184,1,BAO_0000218,14292,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,CHEMBL623185,1,BAO_0000218,14293,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,CHEMBL877484,1,BAO_0000218,14294,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,CHEMBL627274,1,BAO_0000218,14295,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,CHEMBL623186,1,BAO_0000218,14296,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,CHEMBL623187,1,BAO_0000218,14297,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,CHEMBL623188,1,BAO_0000218,14298,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,CHEMBL628055,1,BAO_0000218,14299,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,CHEMBL628056,1,BAO_0000218,14300,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,CHEMBL628200,1,BAO_0000218,14301,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,CHEMBL628201,1,BAO_0000218,14302,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,CHEMBL628202,1,BAO_0000218,14303,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,CHEMBL628203,1,BAO_0000218,14304,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,CHEMBL628204,1,BAO_0000218,14305,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,CHEMBL628205,1,BAO_0000218,14306,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,CHEMBL628206,1,BAO_0000218,14307,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),In vivo,CHEMBL628207,0,BAO_0000218,14308,13257,,,2367.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,In vivo,CHEMBL627220,0,BAO_0000218,14309,13257,,,2367.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,In vivo,CHEMBL627221,0,BAO_0000218,14310,13257,,,2385.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),In vivo,CHEMBL627222,0,BAO_0000218,14311,13257,,,2367.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,In vivo,CHEMBL627223,0,BAO_0000218,14312,13257,,,,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,In vivo,CHEMBL632062,0,BAO_0000218,14313,13257,,,2385.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,In vivo,CHEMBL632063,0,BAO_0000218,14314,13257,,,2106.0,,,
A,1,,,U,Autocuration,Urinary bladder,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,In vivo,CHEMBL632064,0,BAO_0000218,14315,13257,,,1255.0,,,
A,1,,,U,Autocuration,Blood,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,In vivo,CHEMBL632065,0,BAO_0000218,14316,13257,,,178.0,,,
A,1,,,U,Autocuration,Bone element,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,In vivo,CHEMBL632066,0,BAO_0000218,14317,13257,,,1474.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,In vivo,CHEMBL632067,0,BAO_0000218,14318,13257,,,,,,
A,1,,,U,Autocuration,Kidney,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,In vivo,CHEMBL629188,0,BAO_0000218,14319,13257,,,2113.0,,,
A,1,,,U,Autocuration,Liver,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,In vivo,CHEMBL629189,0,BAO_0000218,14320,13257,,,2107.0,,,
A,1,,,U,Autocuration,Lung,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,In vivo,CHEMBL629190,0,BAO_0000218,14321,13257,,,2048.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,In vivo,CHEMBL629191,0,BAO_0000218,14322,13257,,,2385.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),In vivo,CHEMBL629192,0,BAO_0000218,14323,13257,,,2367.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,In vivo,CHEMBL629193,0,BAO_0000218,14324,13257,,,2385.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),In vivo,CHEMBL629194,0,BAO_0000218,14325,13257,,,2367.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,In vivo,CHEMBL629195,0,BAO_0000218,14326,13257,,,,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,In vivo,CHEMBL629373,0,BAO_0000218,14327,13257,,,2385.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,In vivo,CHEMBL629374,0,BAO_0000218,14328,13257,,,2106.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,In vivo,CHEMBL629375,0,BAO_0000218,14329,13257,,,2367.0,,,
A,1,,,U,Autocuration,Urinary bladder,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,In vivo,CHEMBL629376,0,BAO_0000218,14330,13257,,,1255.0,,,
A,1,,,U,Autocuration,Blood,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,In vivo,CHEMBL629377,0,BAO_0000218,14331,13257,,,178.0,,,
A,1,,,U,Autocuration,Bone element,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,In vivo,CHEMBL629378,0,BAO_0000218,14332,13257,,,1474.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,In vivo,CHEMBL629379,0,BAO_0000218,14333,13257,,,,,,
A,1,,,U,Autocuration,Kidney,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,In vivo,CHEMBL629151,0,BAO_0000218,14334,13257,,,2113.0,,,
A,1,,,U,Autocuration,Liver,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,In vivo,CHEMBL629152,0,BAO_0000218,14335,13257,,,2107.0,,,
A,1,,,U,Autocuration,Lung,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,In vivo,CHEMBL629153,0,BAO_0000218,14336,13257,,,2048.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,In vivo,CHEMBL629154,0,BAO_0000218,14337,13257,,,2385.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),In vivo,CHEMBL629155,0,BAO_0000218,14338,13257,,,2367.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,In vivo,CHEMBL629156,0,BAO_0000218,14339,13257,,,2367.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,In vivo,CHEMBL629157,0,BAO_0000218,14340,13257,,,2385.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),In vivo,CHEMBL629158,0,BAO_0000218,14341,13257,,,2367.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,In vivo,CHEMBL629159,0,BAO_0000218,14342,13257,,,,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,In vivo,CHEMBL629160,0,BAO_0000218,14343,13257,,,2385.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,In vivo,CHEMBL629161,0,BAO_0000218,14344,13257,,,2106.0,,,
A,1,,,U,Autocuration,Urinary bladder,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,In vivo,CHEMBL629162,0,BAO_0000218,14345,13257,,,1255.0,,,
A,1,,,U,Autocuration,Blood,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,In vivo,CHEMBL629163,0,BAO_0000218,14346,13257,,,178.0,,,
A,1,,,U,Autocuration,Bone element,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,In vivo,CHEMBL629164,0,BAO_0000218,14347,13257,,,1474.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,In vivo,CHEMBL629165,0,BAO_0000218,14348,13257,,,,,,
A,1,,,U,Autocuration,Liver,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,In vivo,CHEMBL629166,0,BAO_0000218,14349,13257,,,2107.0,,,
A,1,,,U,Autocuration,Lung,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,In vivo,CHEMBL629167,0,BAO_0000218,14350,13257,,,2048.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,In vivo,CHEMBL629168,0,BAO_0000218,14351,13257,,,2385.0,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,CHEMBL629169,0,BAO_0000019,14352,2193,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,CHEMBL629170,0,BAO_0000019,14353,2193,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,CHEMBL631153,0,BAO_0000019,14354,2193,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,CHEMBL875121,0,BAO_0000019,14355,2193,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,CHEMBL631154,0,BAO_0000019,14356,2193,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,CHEMBL631155,0,BAO_0000019,14357,2193,,,,,,
A,1,,,U,Autocuration,,,,22224,Hydrolysis rate constant was determined,,CHEMBL631156,0,BAO_0000019,14358,568,,,,,,
A,1,,,U,Autocuration,,,,22224,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,CHEMBL631157,0,BAO_0000019,14359,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,CHEMBL631158,0,BAO_0000019,14360,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,CHEMBL631159,0,BAO_0000019,14361,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,Observed second order rate constant,,CHEMBL631160,0,BAO_0000019,14362,10026,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,CHEMBL631161,0,BAO_0000019,14363,10281,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,CHEMBL631162,0,BAO_0000019,14364,10014,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,CHEMBL630313,0,BAO_0000019,14365,10014,,,,,,
A,1,,,U,Autocuration,,,,22224,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,CHEMBL630314,0,BAO_0000019,14366,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,CHEMBL630315,0,BAO_0000019,14367,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630316,0,BAO_0000019,14368,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630986,0,BAO_0000019,14369,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630987,0,BAO_0000019,14370,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630988,0,BAO_0000019,14371,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630989,0,BAO_0000019,14372,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630990,0,BAO_0000019,14373,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630991,0,BAO_0000019,14374,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630992,0,BAO_0000019,14375,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630993,0,BAO_0000019,14376,13028,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630994,0,BAO_0000019,14377,13028,,,,,,
A,1,,,N,Intermediate,,,,50597,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,CHEMBL630995,1,BAO_0000218,14378,10014,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Association constant for compound at 31 degree C was determined,,CHEMBL629252,0,BAO_0000019,14379,9962,,,,,,
A,1,,,U,Autocuration,,,,22224,Calculated antagonist equilibrium dissociation constant of the compound,,CHEMBL629253,0,BAO_0000019,14380,12029,,,,,,
A,1,,,U,Autocuration,,,,22224,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,CHEMBL629944,0,BAO_0000019,14381,12029,,,,,,
A,1,,,N,Intermediate,Trachea,,,50512,Dissociation constants vs LTE4 on guinea pig trachea,,CHEMBL629945,1,BAO_0000218,14382,10583,,10141.0,3126.0,,,Cavia porcellus
A,1,,,U,Autocuration,,,,22224,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,CHEMBL629946,0,BAO_0000019,14383,568,,,,,,
A,1,,,U,Autocuration,,,,22224,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,CHEMBL629947,0,BAO_0000019,14384,568,,,,,,
A,1,,,U,Autocuration,,,,22224,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,CHEMBL629948,0,BAO_0000019,14385,568,,,,,,
A,1,,,U,Autocuration,,,,22224,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,CHEMBL856024,0,BAO_0000019,14386,568,,,,,,
A,1,,,U,Autocuration,,,,22224,Affinity constant KD value was derived from TMP,,CHEMBL629949,0,BAO_0000019,14387,7493,,,,,,
A,1,,,U,Autocuration,,,,22224,Apparent dissociation (binding) rate constant was evaluated,,CHEMBL629950,0,BAO_0000019,14388,8371,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant (KD) of the compound,,CHEMBL630127,0,BAO_0000100,14389,13114,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,CHEMBL630128,0,BAO_0000100,14390,15515,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant from ESR titration experiments,,CHEMBL630129,0,BAO_0000100,14391,522,,,,,,
,1,,,U,Autocuration,,,,22224,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,CHEMBL630130,0,BAO_0000019,14392,13888,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant was evaluated.,,CHEMBL875234,0,BAO_0000100,14393,2616,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant was reported,,CHEMBL630131,0,BAO_0000100,14394,3798,,,,,,
A,1,,,N,Intermediate,,,,50597,Dissociation constant was determined in rat pituitary cells.,,CHEMBL630132,1,BAO_0000218,14395,8731,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,CHEMBL630133,0,BAO_0000019,14396,11892,,,,,,
A,1,,,U,Autocuration,,,,22224,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,CHEMBL630134,0,BAO_0000019,14397,11892,,,,,,
A,1,,,U,Autocuration,,,,22224,Equilibrium dissociation constant of the compound,,CHEMBL630135,0,BAO_0000019,14398,2582,,,,,,
A,1,,,U,Autocuration,,,,22224,Equilibrium dissociation constant was determined,,CHEMBL630136,0,BAO_0000019,14399,11892,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic constant KD was evaluated,,CHEMBL630137,0,BAO_0000019,14400,13396,,,,,,
A,1,,,U,Autocuration,,,,22224,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,CHEMBL630138,0,BAO_0000019,14401,603,,,,,,
A,1,,,U,Autocuration,,,,22224,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,CHEMBL630139,0,BAO_0000019,14402,15673,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant for hydrolysis in aqueous acetone.,,CHEMBL630140,0,BAO_0000019,14403,10368,,,,,,
A,1,,,U,Autocuration,,,,22224,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,CHEMBL875235,0,BAO_0000019,14404,14228,,,,,,
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,CHEMBL876439,1,BAO_0000218,14405,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,CHEMBL630605,1,BAO_0000218,14406,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,CHEMBL630606,1,BAO_0000218,14407,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,CHEMBL630607,1,BAO_0000218,14408,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,CHEMBL630608,1,BAO_0000218,14409,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,CHEMBL630609,1,BAO_0000218,14410,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,CHEMBL630610,1,BAO_0000218,14411,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,CHEMBL630611,1,BAO_0000218,14412,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,CHEMBL629552,1,BAO_0000218,14413,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,CHEMBL629733,1,BAO_0000218,14414,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,CHEMBL629734,1,BAO_0000218,14415,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,CHEMBL629735,1,BAO_0000218,14416,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,CHEMBL629736,1,BAO_0000218,14417,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,CHEMBL629737,1,BAO_0000218,14418,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,CHEMBL629738,1,BAO_0000218,14419,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,CHEMBL629739,1,BAO_0000218,14420,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,CHEMBL629740,1,BAO_0000218,14421,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,CHEMBL629741,1,BAO_0000218,14422,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,CHEMBL629742,1,BAO_0000218,14423,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,CHEMBL629743,1,BAO_0000218,14424,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,CHEMBL629744,1,BAO_0000218,14425,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,CHEMBL629745,1,BAO_0000218,14426,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,CHEMBL629746,1,BAO_0000218,14427,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,CHEMBL629747,1,BAO_0000218,14428,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,CHEMBL629748,1,BAO_0000218,14429,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,CHEMBL629749,1,BAO_0000218,14430,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,CHEMBL629750,1,BAO_0000218,14431,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,CHEMBL629751,1,BAO_0000218,14432,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,CHEMBL629752,1,BAO_0000218,14433,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,CHEMBL629753,1,BAO_0000218,14434,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,CHEMBL629754,1,BAO_0000218,14435,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,CHEMBL629755,1,BAO_0000218,14436,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,CHEMBL629756,1,BAO_0000218,14437,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,CHEMBL629757,1,BAO_0000218,14438,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,CHEMBL629758,1,BAO_0000218,14439,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,CHEMBL629759,1,BAO_0000218,14440,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,CHEMBL629760,1,BAO_0000218,14441,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,CHEMBL876443,1,BAO_0000218,14442,11510,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50588,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,CHEMBL629761,1,BAO_0000218,14443,8310,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,CHEMBL629762,1,BAO_0000218,14444,8310,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,CHEMBL629763,1,BAO_0000218,14445,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,CHEMBL629764,1,BAO_0000218,14446,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,CHEMBL629765,1,BAO_0000218,14447,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,CHEMBL629766,1,BAO_0000218,14448,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,CHEMBL629767,1,BAO_0000218,14449,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,CHEMBL629768,1,BAO_0000218,14450,8310,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,CHEMBL629769,1,BAO_0000218,14451,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50588,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,CHEMBL629770,1,BAO_0000218,14452,8310,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50588,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,CHEMBL629771,1,BAO_0000218,14453,8310,,9615.0,,,,Canis lupus familiaris
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,CHEMBL629772,1,BAO_0000218,14454,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,CHEMBL629773,1,BAO_0000218,14455,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,CHEMBL625455,1,BAO_0000218,14456,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,CHEMBL625456,1,BAO_0000218,14457,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,CHEMBL625457,1,BAO_0000218,14458,8310,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,CHEMBL625458,1,BAO_0000218,14459,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,CHEMBL625459,1,BAO_0000218,14460,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,CHEMBL875483,1,BAO_0000218,14461,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,CHEMBL634779,1,BAO_0000218,14462,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,CHEMBL625460,1,BAO_0000218,14463,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,CHEMBL626117,1,BAO_0000218,14464,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,CHEMBL626118,1,BAO_0000218,14465,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,CHEMBL628342,1,BAO_0000218,14466,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,CHEMBL628343,1,BAO_0000218,14467,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,CHEMBL628344,1,BAO_0000218,14468,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,CHEMBL628345,1,BAO_0000218,14469,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,CHEMBL628346,1,BAO_0000218,14470,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,CHEMBL628347,1,BAO_0000218,14471,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,CHEMBL628348,1,BAO_0000218,14472,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,CHEMBL628349,1,BAO_0000218,14473,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,CHEMBL875611,1,BAO_0000218,14474,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,CHEMBL628350,1,BAO_0000218,14475,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,CHEMBL628351,1,BAO_0000218,14476,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,CHEMBL628352,1,BAO_0000218,14477,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,CHEMBL628353,1,BAO_0000218,14478,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,CHEMBL628354,1,BAO_0000218,14479,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,CHEMBL626667,1,BAO_0000218,14480,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,CHEMBL626668,1,BAO_0000218,14481,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,CHEMBL626669,1,BAO_0000218,14482,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,CHEMBL626670,1,BAO_0000218,14483,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,CHEMBL626671,1,BAO_0000218,14484,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,CHEMBL626672,1,BAO_0000218,14485,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,CHEMBL626673,1,BAO_0000218,14486,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,CHEMBL626674,1,BAO_0000218,14487,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,CHEMBL626675,1,BAO_0000218,14488,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,CHEMBL626676,1,BAO_0000218,14489,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,CHEMBL626677,1,BAO_0000218,14490,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,CHEMBL626678,1,BAO_0000218,14491,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,CHEMBL626679,1,BAO_0000218,14492,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,CHEMBL875612,1,BAO_0000218,14493,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,CHEMBL626680,1,BAO_0000218,14494,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,CHEMBL626681,1,BAO_0000218,14495,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,CHEMBL626682,1,BAO_0000218,14496,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,CHEMBL626683,1,BAO_0000218,14497,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,CHEMBL626684,1,BAO_0000218,14498,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,CHEMBL626685,1,BAO_0000218,14499,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,CHEMBL626686,1,BAO_0000218,14500,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,CHEMBL626687,1,BAO_0000218,14501,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,CHEMBL624978,1,BAO_0000218,14502,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,CHEMBL624979,1,BAO_0000218,14503,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,CHEMBL624980,1,BAO_0000218,14504,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,CHEMBL624981,1,BAO_0000218,14505,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,CHEMBL624982,1,BAO_0000218,14506,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),In vivo,CHEMBL627564,0,BAO_0000218,14507,13257,,,2367.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),In vivo,CHEMBL627565,0,BAO_0000218,14508,13257,,,2367.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,In vivo,CHEMBL627566,0,BAO_0000218,14509,13257,,,,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,In vivo,CHEMBL627567,0,BAO_0000218,14510,13257,,,2385.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,In vivo,CHEMBL627568,0,BAO_0000218,14511,13257,,,2106.0,,,
A,1,,,U,Autocuration,Kidney,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,In vivo,CHEMBL627569,0,BAO_0000218,14512,13257,,,2113.0,,,
A,1,,,U,Autocuration,Urinary bladder,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,In vivo,CHEMBL627570,0,BAO_0000218,14513,13257,,,1255.0,,,
A,1,,,U,Autocuration,Blood,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,In vivo,CHEMBL627571,0,BAO_0000218,14514,13257,,,178.0,,,
A,1,,,U,Autocuration,Bone element,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,In vivo,CHEMBL627572,0,BAO_0000218,14515,13257,,,1474.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,In vivo,CHEMBL627573,0,BAO_0000218,14516,13257,,,,,,
A,1,,,U,Autocuration,Kidney,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,In vivo,CHEMBL627574,0,BAO_0000218,14517,13257,,,2113.0,,,
A,1,,,U,Autocuration,Liver,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,In vivo,CHEMBL627575,0,BAO_0000218,14518,13257,,,2107.0,,,
A,1,,,U,Autocuration,Lung,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,In vivo,CHEMBL627576,0,BAO_0000218,14519,13257,,,2048.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,In vivo,CHEMBL627577,0,BAO_0000218,14520,13257,,,2385.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),In vivo,CHEMBL627578,0,BAO_0000218,14521,13257,,,2367.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,In vivo,CHEMBL627579,0,BAO_0000218,14522,13257,,,2367.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,In vivo,CHEMBL627580,0,BAO_0000218,14523,13257,,,2385.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),In vivo,CHEMBL627581,0,BAO_0000218,14524,13257,,,2367.0,,,
A,1,,,U,Autocuration,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,In vivo,CHEMBL627582,0,BAO_0000218,14525,13257,,,,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,In vivo,CHEMBL627583,0,BAO_0000218,14526,13257,,,2385.0,,,
A,1,,,U,Autocuration,Spleen,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,In vivo,CHEMBL627584,0,BAO_0000218,14527,13257,,,2106.0,,,
A,1,,,U,Autocuration,Prostate gland,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,In vivo,CHEMBL627585,0,BAO_0000218,14528,13257,,,2367.0,,,
A,1,,,U,Autocuration,Muscle tissue,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,In vivo,CHEMBL627586,0,BAO_0000218,14529,13257,,,2385.0,,,
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,In vivo,CHEMBL627587,1,BAO_0000218,14530,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL627588,1,BAO_0000218,14531,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,In vivo,CHEMBL628250,1,BAO_0000218,14532,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628251,1,BAO_0000218,14533,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,CHEMBL628252,1,BAO_0000218,14534,15413,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628253,1,BAO_0000218,14535,15413,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,CHEMBL628254,1,BAO_0000218,14536,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL877493,1,BAO_0000218,14537,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628255,1,BAO_0000218,14538,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628256,1,BAO_0000218,14539,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628257,1,BAO_0000218,14540,15413,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628258,1,BAO_0000218,14541,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628259,1,BAO_0000218,14542,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL628429,1,BAO_0000218,14543,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,CHEMBL626862,1,BAO_0000218,14544,15413,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,In vivo,CHEMBL626863,1,BAO_0000218,14545,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,In vivo,CHEMBL625886,1,BAO_0000218,14546,15413,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,In vivo,CHEMBL625887,1,BAO_0000218,14547,15413,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat cortex,In vivo,CHEMBL625888,1,BAO_0000218,14548,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,In vivo,CHEMBL625889,1,BAO_0000218,14549,15413,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,In vivo,CHEMBL625890,1,BAO_0000218,14550,15413,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,In vivo,CHEMBL625891,1,BAO_0000218,14551,15413,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,In vivo,CHEMBL625892,1,BAO_0000218,14552,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,In vivo,CHEMBL625893,1,BAO_0000218,14553,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Cerebellum,,,50597,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,In vivo,CHEMBL625894,1,BAO_0000218,14554,15413,,10116.0,2037.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution of the [18F]-radiolabeled compound in rat cortex,In vivo,CHEMBL625895,1,BAO_0000218,14555,15413,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,,CHEMBL625896,0,BAO_0000019,14556,12404,,,,,,
A,1,,,U,Autocuration,,,,22224,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,CHEMBL625897,0,BAO_0000019,14557,568,,,,,,
A,1,,,U,Autocuration,,,,22224,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,CHEMBL625898,0,BAO_0000019,14558,568,,,,,,
A,1,,,U,Autocuration,,,,22224,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,CHEMBL625899,0,BAO_0000019,14559,568,,,,,,
A,1,,,U,Autocuration,,,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,,CHEMBL626124,0,BAO_0000019,14560,12404,,,,,,
A,1,,,N,Intermediate,,,,50212,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,CHEMBL628500,1,BAO_0000218,14561,7624,,562.0,,,,Escherichia coli
A,1,,,N,Intermediate,,,,50597,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,CHEMBL857856,1,BAO_0000218,14562,7624,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,CHEMBL628501,1,BAO_0000218,14563,7624,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,CHEMBL628502,0,BAO_0000019,14564,4643,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,CHEMBL628503,0,BAO_0000019,14565,11532,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,CHEMBL628504,0,BAO_0000019,14566,11018,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,CHEMBL628505,0,BAO_0000019,14567,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,CHEMBL874452,0,BAO_0000019,14568,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,CHEMBL628506,0,BAO_0000019,14569,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,CHEMBL628507,0,BAO_0000019,14570,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,CHEMBL628508,0,BAO_0000019,14571,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,Michaelis constant (KM) was evaluated,,CHEMBL628509,0,BAO_0000019,14572,8949,,,,,,
A,1,,,U,Autocuration,,,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,,CHEMBL628510,0,BAO_0000019,14573,12404,,,,,,
B,1,,,U,Autocuration,,,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,CHEMBL628511,0,BAO_0000019,14574,7625,,,,,,
B,1,,,U,Autocuration,,,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,CHEMBL628512,0,BAO_0000019,14575,7625,,,,,,
B,1,,,U,Autocuration,,,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,CHEMBL628513,0,BAO_0000019,14576,7625,,,,,,
B,1,,,U,Autocuration,,,,22224,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,CHEMBL628514,0,BAO_0000019,14577,7625,,,,,,
A,1,,,U,Autocuration,,,,22224,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,CHEMBL628515,0,BAO_0000019,14578,12908,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,CHEMBL628516,0,BAO_0000019,14579,10368,,,,,,
A,1,,,U,Autocuration,,,,22224,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,CHEMBL628517,0,BAO_0000019,14580,13108,,,,,,
A,1,,,U,Autocuration,,,,22224,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,CHEMBL628518,0,BAO_0000019,14581,13108,,,,,,
A,1,,,U,Autocuration,,,,22224,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,CHEMBL628519,0,BAO_0000019,14582,15217,,,,,,
A,1,,,U,Autocuration,,,,22224,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,CHEMBL628520,0,BAO_0000019,14583,15217,,,,,,
A,1,,,U,Autocuration,,,,22224,Binding constant was determined,,CHEMBL628521,0,BAO_0000019,14584,10933,,,,,,
A,1,,,U,Autocuration,,,,22224,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,CHEMBL630443,0,BAO_0000019,14585,2363,,,,,,
A,1,,,U,Autocuration,,,,22224,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,CHEMBL630444,0,BAO_0000019,14586,2363,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,CHEMBL857732,0,BAO_0000019,14587,2276,,,,,,
P,1,,,U,Autocuration,,,,22224,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,CHEMBL630445,0,BAO_0000100,14588,14915,,,,,,
A,1,,,U,Autocuration,,,,22224,Catalytic rate constant of the compound,,CHEMBL630446,0,BAO_0000019,14589,8847,,,,,,
B,1,,,U,Autocuration,,,,22224,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,CHEMBL630447,0,BAO_0000019,14590,15357,,,,,,
A,1,,,U,Autocuration,,,,22224,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,CHEMBL630448,0,BAO_0000019,14591,2869,,,,,,
A,1,,,U,Autocuration,,,,22224,Catalytic rate constant against phospholipase A2 was determined,,CHEMBL630449,0,BAO_0000019,14592,3484,,,,,,
A,1,,,U,Autocuration,,,,22224,"Compound was evaluated for catalytic constant, Kcat",,CHEMBL630450,0,BAO_0000019,14593,1373,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,CHEMBL630451,0,BAO_0000019,14594,8142,,,,,,
A,1,,,U,Autocuration,,,,22224,Kcat calculated from 0.693/T1/2,,CHEMBL630452,0,BAO_0000019,14595,14131,,,,,,
A,1,,,U,Autocuration,,,,22224,Kcat was determined,,CHEMBL630453,0,BAO_0000019,14596,17269,,,,,,
A,1,,,U,Autocuration,,,,22224,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,CHEMBL630454,0,BAO_0000019,14597,3485,,,,,,
A,1,,,U,Autocuration,,,,22224,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,CHEMBL630455,0,BAO_0000019,14598,3485,,,,,,
A,1,,,U,Autocuration,,,,22224,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,CHEMBL631487,0,BAO_0000019,14599,3485,,,,,,
A,1,,,U,Autocuration,,,,22224,Kcat value was determined,,CHEMBL631488,0,BAO_0000019,14600,5962,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,CHEMBL876440,0,BAO_0000019,14601,3133,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,CHEMBL631489,0,BAO_0000019,14602,3133,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,CHEMBL857742,0,BAO_0000019,14603,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,CHEMBL631490,0,BAO_0000019,14604,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,CHEMBL631491,0,BAO_0000019,14605,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,CHEMBL631492,0,BAO_0000019,14606,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,CHEMBL631493,0,BAO_0000019,14607,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter for rate of conversion to PABA was determined,,CHEMBL631494,0,BAO_0000019,14608,4892,,,,,,
A,1,,,U,Autocuration,,,,22224,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,CHEMBL631495,0,BAO_0000019,14609,3133,,,,,,
A,1,,,N,Intermediate,Feces,,,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,CHEMBL631496,1,BAO_0000218,14610,11488,,10116.0,1988.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,CHEMBL631497,1,BAO_0000218,14611,11488,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,CHEMBL631498,1,BAO_0000218,14612,11488,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,CHEMBL629776,1,BAO_0000218,14613,11488,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,CHEMBL629777,1,BAO_0000218,14614,11488,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,CHEMBL629778,1,BAO_0000218,14615,11488,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,CHEMBL630456,1,BAO_0000218,14616,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,CHEMBL630457,1,BAO_0000218,14617,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,CHEMBL630458,1,BAO_0000218,14618,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,CHEMBL630459,1,BAO_0000218,14619,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,CHEMBL630460,1,BAO_0000218,14620,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,CHEMBL876550,1,BAO_0000218,14621,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,CHEMBL630461,1,BAO_0000218,14622,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,CHEMBL630462,1,BAO_0000218,14623,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,CHEMBL630463,1,BAO_0000218,14624,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,CHEMBL630464,1,BAO_0000218,14625,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,CHEMBL630465,1,BAO_0000218,14626,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,CHEMBL630466,1,BAO_0000218,14627,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,CHEMBL630467,1,BAO_0000218,14628,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,CHEMBL630633,1,BAO_0000218,14629,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,CHEMBL630634,1,BAO_0000218,14630,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,CHEMBL630635,1,BAO_0000218,14631,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,CHEMBL630636,1,BAO_0000218,14632,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,CHEMBL630637,1,BAO_0000218,14633,11488,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Feces,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,CHEMBL630638,1,BAO_0000218,14634,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,CHEMBL630639,1,BAO_0000218,14635,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,CHEMBL630640,1,BAO_0000218,14636,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,CHEMBL876551,1,BAO_0000218,14637,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,CHEMBL630641,1,BAO_0000218,14638,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,CHEMBL630642,1,BAO_0000218,14639,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,CHEMBL630643,1,BAO_0000218,14640,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,CHEMBL630644,1,BAO_0000218,14641,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,CHEMBL630645,1,BAO_0000218,14642,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,CHEMBL625599,1,BAO_0000218,14643,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,CHEMBL625600,1,BAO_0000218,14644,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,CHEMBL625601,1,BAO_0000218,14645,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Feces,,,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,CHEMBL625602,1,BAO_0000218,14646,7132,,9986.0,1988.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,CHEMBL627470,1,BAO_0000218,14647,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,CHEMBL627471,1,BAO_0000218,14648,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,CHEMBL627472,1,BAO_0000218,14649,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,CHEMBL627473,1,BAO_0000218,14650,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Urine,,,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,CHEMBL627474,1,BAO_0000218,14651,7132,,9986.0,1088.0,,,Oryctolagus cuniculus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL627475,1,BAO_0000218,14652,13925,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL627476,1,BAO_0000218,14653,13925,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,CHEMBL627477,1,BAO_0000218,14654,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,CHEMBL627478,1,BAO_0000218,14655,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,CHEMBL627479,1,BAO_0000218,14656,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,CHEMBL627480,1,BAO_0000218,14657,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,CHEMBL627481,1,BAO_0000218,14658,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,CHEMBL627482,1,BAO_0000218,14659,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,CHEMBL627483,1,BAO_0000218,14660,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,CHEMBL875636,1,BAO_0000218,14661,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,CHEMBL625764,1,BAO_0000218,14662,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,CHEMBL625765,1,BAO_0000218,14663,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,CHEMBL625766,1,BAO_0000218,14664,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,CHEMBL625767,1,BAO_0000218,14665,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,CHEMBL625768,1,BAO_0000218,14666,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,CHEMBL625769,1,BAO_0000218,14667,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,CHEMBL625770,1,BAO_0000218,14668,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,CHEMBL625771,1,BAO_0000218,14669,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,CHEMBL625772,1,BAO_0000218,14670,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,CHEMBL625773,1,BAO_0000218,14671,12582,,9615.0,1088.0,,,Canis lupus familiaris
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,CHEMBL625774,1,BAO_0000218,14672,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,CHEMBL625775,1,BAO_0000218,14673,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,CHEMBL625776,1,BAO_0000218,14674,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,CHEMBL625777,1,BAO_0000218,14675,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,CHEMBL625778,1,BAO_0000218,14676,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,CHEMBL625779,1,BAO_0000218,14677,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,CHEMBL625780,1,BAO_0000218,14678,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,CHEMBL625781,1,BAO_0000218,14679,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,CHEMBL875637,1,BAO_0000218,14680,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,CHEMBL626473,1,BAO_0000218,14681,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,CHEMBL626474,1,BAO_0000218,14682,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,CHEMBL626475,1,BAO_0000218,14683,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,CHEMBL626476,1,BAO_0000218,14684,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,CHEMBL634397,1,BAO_0000218,14685,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,CHEMBL626477,1,BAO_0000218,14686,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,CHEMBL631069,1,BAO_0000218,14687,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,CHEMBL631070,1,BAO_0000218,14688,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,CHEMBL631071,1,BAO_0000218,14689,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,CHEMBL631072,1,BAO_0000218,14690,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,CHEMBL631073,1,BAO_0000218,14691,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,CHEMBL631074,1,BAO_0000218,14692,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,CHEMBL631075,1,BAO_0000218,14693,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,CHEMBL631725,1,BAO_0000218,14694,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,CHEMBL631726,1,BAO_0000218,14695,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,CHEMBL631727,1,BAO_0000218,14696,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,CHEMBL631728,1,BAO_0000218,14697,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,CHEMBL631729,1,BAO_0000218,14698,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,CHEMBL631730,1,BAO_0000218,14699,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,CHEMBL631731,1,BAO_0000218,14700,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,CHEMBL631910,1,BAO_0000218,14701,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hippocampus,,,50597,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,In vivo,CHEMBL631911,1,BAO_0000218,14702,15413,,10116.0,10000000.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,In vivo,CHEMBL631912,1,BAO_0000218,14703,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Hypothalamus,,,50597,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,In vivo,CHEMBL631913,1,BAO_0000218,14704,15413,,10116.0,1898.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631914,1,BAO_0000218,14705,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631915,1,BAO_0000218,14706,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL875778,1,BAO_0000218,14707,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631916,1,BAO_0000218,14708,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631917,1,BAO_0000218,14709,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631918,1,BAO_0000218,14710,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631919,1,BAO_0000218,14711,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL631920,1,BAO_0000218,14712,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631921,1,BAO_0000218,14713,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631922,1,BAO_0000218,14714,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL631923,1,BAO_0000218,14715,12017,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631924,1,BAO_0000218,14716,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630234,1,BAO_0000218,14717,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630235,1,BAO_0000218,14718,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630236,1,BAO_0000218,14719,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630237,1,BAO_0000218,14720,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630238,1,BAO_0000218,14721,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630239,1,BAO_0000218,14722,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630303,1,BAO_0000218,14723,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630304,1,BAO_0000218,14724,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630305,1,BAO_0000218,14725,12017,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630306,1,BAO_0000218,14726,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630307,1,BAO_0000218,14727,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630308,1,BAO_0000218,14728,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630309,1,BAO_0000218,14729,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL629309,1,BAO_0000218,14730,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL629993,1,BAO_0000218,14731,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL629994,1,BAO_0000218,14732,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL629995,1,BAO_0000218,14733,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631993,1,BAO_0000218,14734,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631994,1,BAO_0000218,14735,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631995,1,BAO_0000218,14736,12017,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL631996,1,BAO_0000218,14737,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631997,1,BAO_0000218,14738,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631998,1,BAO_0000218,14739,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631999,1,BAO_0000218,14740,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL632000,1,BAO_0000218,14741,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL632001,1,BAO_0000218,14742,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL874424,1,BAO_0000218,14743,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL632002,1,BAO_0000218,14744,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL632003,1,BAO_0000218,14745,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,CHEMBL632004,0,BAO_0000019,14746,3133,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,CHEMBL632005,0,BAO_0000019,14747,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for amidase rate in the presence of N62C screen enzyme,,CHEMBL632006,0,BAO_0000019,14748,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,CHEMBL632007,0,BAO_0000019,14749,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for amidase rate in the presence of S166C screen enzyme,,CHEMBL632008,0,BAO_0000019,14750,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,CHEMBL632009,0,BAO_0000019,14751,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for esterase rate in the presence of N62C screen enzyme,,CHEMBL632010,0,BAO_0000019,14752,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,CHEMBL857750,0,BAO_0000019,14753,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for esterase rate in the presence of S166C screen enzyme,,CHEMBL632011,0,BAO_0000019,14754,2742,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL632012,0,BAO_0000019,14755,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL632013,0,BAO_0000019,14756,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,CHEMBL632014,0,BAO_0000019,14757,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL629622,0,BAO_0000019,14758,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL629623,0,BAO_0000019,14759,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,CHEMBL629624,0,BAO_0000019,14760,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,Ratio of Kcat to that of Km was determined,,CHEMBL629625,0,BAO_0000019,14761,17269,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,CHEMBL629626,0,BAO_0000019,14762,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,CHEMBL629627,0,BAO_0000019,14763,2276,,,,,,
A,1,,,U,Autocuration,,,,22224,"Compound was evaluated for constant, Kd",,CHEMBL629628,0,BAO_0000019,14764,15917,,,,,,
A,1,,,U,Autocuration,,,,22224,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,CHEMBL629629,0,BAO_0000019,14765,10933,,,,,,
A,1,,,U,Autocuration,,,,22224,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,CHEMBL629630,0,BAO_0000019,14766,10933,,,,,,
A,1,,,U,Autocuration,,,,22224,Dissociation Constant of compound determined,,CHEMBL856030,0,BAO_0000019,14767,14293,,,,,,
B,1,,,U,Autocuration,,,,22224,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,CHEMBL629631,0,BAO_0000019,14768,6698,,,,,,
B,1,,,U,Autocuration,,,,22224,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,CHEMBL629632,0,BAO_0000019,14769,6698,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant of compound with Fructose was determined,,CHEMBL629633,0,BAO_0000100,14770,4318,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant of compound with Fructose was determined; Not determined,,CHEMBL629634,0,BAO_0000100,14771,4318,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant of compound with Lactulose was determined,,CHEMBL629635,0,BAO_0000100,14772,4318,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant of compound with Lactulose was determined; Not determined,,CHEMBL629636,0,BAO_0000100,14773,4318,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant of the Compound,,CHEMBL629637,0,BAO_0000100,14774,14959,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant by non-linear regression analysis,,CHEMBL629638,0,BAO_0000100,14775,5913,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant was determined,,CHEMBL629639,0,BAO_0000100,14776,14218,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,CHEMBL629640,0,BAO_0000100,14777,10689,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant was determined,,CHEMBL629641,0,BAO_0000100,14778,13925,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant was determined,,CHEMBL631344,0,BAO_0000100,14779,16359,,,,,,
A,1,,,N,Intermediate,Muscle tissue,,,50597,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,CHEMBL631345,1,BAO_0000218,14780,10944,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,The dissociation constant determined by fluorescence displacement assay,,CHEMBL631346,0,BAO_0000019,14781,11080,,,,,,
A,1,,,U,Autocuration,,,,22224,kd value surface plasmon resonance (SPR) method,,CHEMBL631524,0,BAO_0000019,14782,17805,,,,,,
A,1,,,N,Intermediate,Muscle tissue,,,50597,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,CHEMBL631525,1,BAO_0000218,14783,10944,,10116.0,2385.0,,,Rattus norvegicus
F,1,,,U,Autocuration,,,,22224,First dissociation constant of the binding of compound to V30M TTR,,CHEMBL631526,0,BAO_0000019,14784,16645,,,,,,
F,1,,,U,Autocuration,,,,22224,Second dissociation constant of the binding of compound to V30M TTR,,CHEMBL631527,0,BAO_0000019,14785,16645,,,,,,
A,1,,,U,Autocuration,,,,22224,"Compound was evaluated for equilibrium constant, Ke",,CHEMBL631528,0,BAO_0000019,14786,7793,,,,,,
A,1,,,U,Autocuration,Hypothalamus,,,22224,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,CHEMBL631529,0,BAO_0000019,14787,12199,,,1898.0,,,
A,1,,,U,Autocuration,Hypothalamus,,,22224,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,CHEMBL631530,0,BAO_0000019,14788,12199,,,1898.0,,,
A,1,,,U,Autocuration,,,,22224,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,CHEMBL631531,0,BAO_0000019,14789,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,CHEMBL631532,0,BAO_0000019,14790,9680,,,,,,
A,1,,,U,Autocuration,,,,22224,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,CHEMBL631533,0,BAO_0000019,14791,9680,,,,,,
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,CHEMBL876552,1,BAO_0000218,14792,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,CHEMBL631534,1,BAO_0000218,14793,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,CHEMBL631535,1,BAO_0000218,14794,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,CHEMBL631536,1,BAO_0000218,14795,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,CHEMBL631537,1,BAO_0000218,14796,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,CHEMBL631538,1,BAO_0000218,14797,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,CHEMBL631539,1,BAO_0000218,14798,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,CHEMBL631540,1,BAO_0000218,14799,13758,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,CHEMBL625637,1,BAO_0000218,14800,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,CHEMBL625638,1,BAO_0000218,14801,14393,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,CHEMBL625639,1,BAO_0000218,14802,15078,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625640,1,BAO_0000218,14803,13925,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625641,1,BAO_0000218,14804,13925,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625642,1,BAO_0000218,14805,13925,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625643,1,BAO_0000218,14806,13925,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625644,1,BAO_0000218,14807,13925,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Kidney,,,50597,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625645,1,BAO_0000218,14808,13925,,10116.0,2113.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625646,1,BAO_0000218,14809,13925,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625647,1,BAO_0000218,14810,13925,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625648,1,BAO_0000218,14811,13925,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625649,1,BAO_0000218,14812,13925,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625650,1,BAO_0000218,14813,13925,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625651,1,BAO_0000218,14814,13925,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625652,1,BAO_0000218,14815,13925,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Zone of skin,,,50597,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625653,1,BAO_0000218,14816,13925,,10116.0,14.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625654,1,BAO_0000218,14817,13925,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,CHEMBL625655,1,BAO_0000218,14818,13925,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of Compound in rat blood after 15 minutes of administration,In vivo,CHEMBL625656,1,BAO_0000218,14819,9712,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50597,Biodistribution of Compound in rat blood after 2 minutes of administration,In vivo,CHEMBL625657,1,BAO_0000218,14820,9712,,10116.0,178.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of Compound in rat brain after 15 minutes of administration,In vivo,CHEMBL625658,1,BAO_0000218,14821,9712,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Brain,,,50597,Biodistribution of Compound in rat brain after 2 minutes of administration,In vivo,CHEMBL625659,1,BAO_0000218,14822,9712,,10116.0,955.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of Compound in rat heart after 15 minutes of administration,In vivo,CHEMBL625660,1,BAO_0000218,14823,9712,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Heart,,,50597,Biodistribution of Compound in rat heart after 2 minutes of administration,In vivo,CHEMBL625661,1,BAO_0000218,14824,9712,,10116.0,948.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of Compound in rat liver after 15 minutes of administration,In vivo,CHEMBL625662,1,BAO_0000218,14825,9712,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution of Compound in rat liver after 2 minutes of administration,In vivo,CHEMBL625663,1,BAO_0000218,14826,9712,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of Compound in rat lung after 15 minutes of administration,In vivo,CHEMBL875621,1,BAO_0000218,14827,9712,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution of Compound in rat lung after 2 minutes of administration,In vivo,CHEMBL628382,1,BAO_0000218,14828,9712,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of Compound in rat muscle after 15 minutes of administration,In vivo,CHEMBL628383,1,BAO_0000218,14829,9712,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution of Compound in rat muscle after 2 minutes of administration,In vivo,CHEMBL628384,1,BAO_0000218,14830,9712,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,CHEMBL628385,1,BAO_0000218,14831,13925,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,CHEMBL875753,1,BAO_0000218,14832,13925,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,CHEMBL628386,1,BAO_0000218,14833,13925,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat blood 2 minutes after intravenous injection,,CHEMBL628387,1,BAO_0000218,14834,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat blood 2 hr after intravenous injection,,CHEMBL628388,1,BAO_0000218,14835,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat blood 30 minutes after intravenous injection,,CHEMBL628389,1,BAO_0000218,14836,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat blood 30 min after intravenous injection,,CHEMBL632756,1,BAO_0000218,14837,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat brain 2 minutes after intravenous injection,,CHEMBL628390,1,BAO_0000218,14838,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat brain 2 hr after intravenous injection,,CHEMBL631811,1,BAO_0000218,14839,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat brain 30 minutes after intravenous injection,,CHEMBL631812,1,BAO_0000218,14840,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat heart 2 minutes after intravenous injection,,CHEMBL631813,1,BAO_0000218,14841,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat heart 2 hr after intravenous injection,,CHEMBL631814,1,BAO_0000218,14842,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat heart 30 minutes after intravenous injection,,CHEMBL631815,1,BAO_0000218,14843,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat kidney 2 minutes after intravenous injection,,CHEMBL631816,1,BAO_0000218,14844,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat kidney 2 hr after intravenous injection,,CHEMBL875758,1,BAO_0000218,14845,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat kidney 30 minutes after intravenous injection,,CHEMBL631817,1,BAO_0000218,14846,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Organ distribution in rat liver 2 minutes after intravenous injection,,CHEMBL631818,1,BAO_0000218,14847,6941,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Organ distribution in rat liver 2 hr after intravenous injection,,CHEMBL631819,1,BAO_0000218,14848,6941,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Organ distribution in rat liver 30 minutes after intravenous injection,,CHEMBL631820,1,BAO_0000218,14849,6941,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat lung 2 minutes after intravenous injection,,CHEMBL631821,1,BAO_0000218,14850,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat lung 2 hr after intravenous injection,,CHEMBL631822,1,BAO_0000218,14851,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,Organ distribution in rat lung 30 minutes after intravenous injection,,CHEMBL631823,1,BAO_0000218,14852,6941,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Organ distribution in rat muscle 2 minutes after intravenous injection,,CHEMBL631824,1,BAO_0000218,14853,6941,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Organ distribution in rat muscle 2 hr after intravenous injection,,CHEMBL631825,1,BAO_0000218,14854,6941,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Organ distribution in rat muscle 30 minutes after intravenous injection,,CHEMBL631826,1,BAO_0000218,14855,6941,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),In vivo,CHEMBL631827,1,BAO_0000218,14856,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),In vivo,CHEMBL631828,1,BAO_0000218,14857,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),In vivo,CHEMBL631829,1,BAO_0000218,14858,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,CHEMBL875759,1,BAO_0000218,14859,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,CHEMBL631830,1,BAO_0000218,14860,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,CHEMBL631831,1,BAO_0000218,14861,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,CHEMBL631832,1,BAO_0000218,14862,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,CHEMBL631833,1,BAO_0000218,14863,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,CHEMBL631834,1,BAO_0000218,14864,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,CHEMBL631835,1,BAO_0000218,14865,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,CHEMBL631836,1,BAO_0000218,14866,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,CHEMBL631837,1,BAO_0000218,14867,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,CHEMBL631838,1,BAO_0000218,14868,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,CHEMBL631839,1,BAO_0000218,14869,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,CHEMBL631840,1,BAO_0000218,14870,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,CHEMBL631841,1,BAO_0000218,14871,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,CHEMBL631842,1,BAO_0000218,14872,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,CHEMBL631843,1,BAO_0000218,14873,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,CHEMBL631844,1,BAO_0000218,14874,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,CHEMBL631845,1,BAO_0000218,14875,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,CHEMBL631846,1,BAO_0000218,14876,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,CHEMBL875760,1,BAO_0000218,14877,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,CHEMBL632199,1,BAO_0000218,14878,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,CHEMBL631847,1,BAO_0000218,14879,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,CHEMBL631848,1,BAO_0000218,14880,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,CHEMBL628707,1,BAO_0000218,14881,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,CHEMBL628708,1,BAO_0000218,14882,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,CHEMBL628709,1,BAO_0000218,14883,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,CHEMBL628710,1,BAO_0000218,14884,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,CHEMBL628711,1,BAO_0000218,14885,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,CHEMBL628712,1,BAO_0000218,14886,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,CHEMBL628713,1,BAO_0000218,14887,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Urine,,,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,CHEMBL628714,1,BAO_0000218,14888,12582,,10116.0,1088.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,CHEMBL628715,1,BAO_0000218,14889,7415,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,CHEMBL629179,0,BAO_0000019,14890,7313,,,,,,
A,1,,,U,Autocuration,,,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,CHEMBL629180,0,BAO_0000019,14891,7313,,,,,,
A,1,,,U,Autocuration,,,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,CHEMBL875108,0,BAO_0000019,14892,7313,,,,,,
A,1,,,U,Autocuration,Adrenal cortex,,,22224,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,CHEMBL629181,0,BAO_0000019,14893,7570,,,1235.0,,,
A,1,,,U,Autocuration,Adrenal cortex,,,22224,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,CHEMBL629182,0,BAO_0000019,14894,7570,,,1235.0,,,
A,1,,,U,Autocuration,,,,22224,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,CHEMBL629183,0,BAO_0000019,14895,7570,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,CHEMBL629184,0,BAO_0000019,14896,7570,,,,,,
A,1,,,U,Autocuration,Adrenal cortex,,,22224,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,CHEMBL629185,0,BAO_0000019,14897,7570,,,1235.0,,,
A,1,,,U,Autocuration,Adrenal cortex,,,22224,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,CHEMBL629186,0,BAO_0000019,14898,7570,,,1235.0,,,
A,1,,,U,Autocuration,,,,22224,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,CHEMBL629187,0,BAO_0000019,14899,7570,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,CHEMBL629887,0,BAO_0000019,14900,7570,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,CHEMBL629888,0,BAO_0000019,14901,7570,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,CHEMBL629889,0,BAO_0000019,14902,7570,,,,,,
A,1,,,U,Autocuration,Adrenal cortex,,,22224,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,CHEMBL629890,0,BAO_0000019,14903,7570,,,1235.0,,,
A,1,,,U,Autocuration,,,,22224,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,CHEMBL629891,0,BAO_0000019,14904,7570,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,CHEMBL629892,0,BAO_0000019,14905,7570,,,,,,
A,1,,,U,Autocuration,Adrenal cortex,,,22224,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,CHEMBL629893,0,BAO_0000019,14906,7570,,,1235.0,,,
A,1,,,U,Autocuration,,,,22224,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,CHEMBL629894,0,BAO_0000019,14907,7570,,,,,,
A,1,,,U,Autocuration,,,,22224,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,CHEMBL629895,0,BAO_0000019,14908,7570,,,,,,
A,1,,,U,Autocuration,,,,22224,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",In vivo,CHEMBL875109,0,BAO_0000218,14909,14122,,9615.0,,,,Canis lupus familiaris
A,1,,,U,Autocuration,,,,22224,Absolute bioavailability in male cynomolgus monkeys,In vivo,CHEMBL629896,0,BAO_0000218,14910,16449,,9541.0,,,,Macaca fascicularis
A,1,,,U,Autocuration,,,,22224,Absolute bioavailability in maleSprague-Dawley rats,In vivo,CHEMBL629897,0,BAO_0000218,14911,16449,,10116.0,,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL629898,1,BAO_0000218,14912,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630057,1,BAO_0000218,14913,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Liver,,,50597,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630058,1,BAO_0000218,14914,12017,,10116.0,2107.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630059,1,BAO_0000218,14915,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630060,1,BAO_0000218,14916,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630061,1,BAO_0000218,14917,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630062,1,BAO_0000218,14918,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630063,1,BAO_0000218,14919,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630064,1,BAO_0000218,14920,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630065,1,BAO_0000218,14921,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630066,1,BAO_0000218,14922,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630067,1,BAO_0000218,14923,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Lung,,,50597,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630068,1,BAO_0000218,14924,12017,,10116.0,2048.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631113,1,BAO_0000218,14925,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631114,1,BAO_0000218,14926,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL631115,1,BAO_0000218,14927,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL631116,1,BAO_0000218,14928,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630528,1,BAO_0000218,14929,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630529,1,BAO_0000218,14930,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630530,1,BAO_0000218,14931,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630531,1,BAO_0000218,14932,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630532,1,BAO_0000218,14933,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Muscle tissue,,,50597,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630533,1,BAO_0000218,14934,12017,,10116.0,2385.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution in normal mice blood after 120 hr,In vivo,CHEMBL630534,1,BAO_0000218,14935,15045,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution in normal mice blood after 24 hr,In vivo,CHEMBL630535,1,BAO_0000218,14936,15045,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Blood,,,50594,Biodistribution in normal mice blood after 4 hr,In vivo,CHEMBL630536,1,BAO_0000218,14937,15045,,10090.0,178.0,,,Mus musculus
A,1,,,N,Intermediate,Bone,,,50594,Biodistribution in normal mice bone after 120 hr,In vivo,CHEMBL630537,1,BAO_0000218,14938,15045,,10090.0,10000001.0,,,Mus musculus
A,1,,,N,Intermediate,Bone,,,50594,Biodistribution in normal mice bone after 24 hr,In vivo,CHEMBL630538,1,BAO_0000218,14939,15045,,10090.0,10000001.0,,,Mus musculus
A,1,,,N,Intermediate,Bone,,,50594,Biodistribution in normal mice bone after 4 hr,In vivo,CHEMBL630539,1,BAO_0000218,14940,15045,,10090.0,10000001.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution in normal mice heart after 120 hr,In vivo,CHEMBL630540,1,BAO_0000218,14941,15045,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution in normal mice heart after 24 hr,In vivo,CHEMBL630541,1,BAO_0000218,14942,15045,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Heart,,,50594,Biodistribution in normal mice heart after 4 hr,In vivo,CHEMBL630542,1,BAO_0000218,14943,15045,,10090.0,948.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution in normal mice kidney after 120 hr,In vivo,CHEMBL630543,1,BAO_0000218,14944,15045,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution in normal mice kidney after 24 hr,In vivo,CHEMBL630544,1,BAO_0000218,14945,15045,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Kidney,,,50594,Biodistribution in normal mice kidney after 4 hr,In vivo,CHEMBL630545,1,BAO_0000218,14946,15045,,10090.0,2113.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in normal mice liver after 120 hr,In vivo,CHEMBL630546,1,BAO_0000218,14947,15045,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in normal mice liver after 24 hr,In vivo,CHEMBL630547,1,BAO_0000218,14948,15045,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Liver,,,50594,Biodistribution in normal mice liver after 4 hr,In vivo,CHEMBL630548,1,BAO_0000218,14949,15045,,10090.0,2107.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution in normal mice spleen after 120 hr,In vivo,CHEMBL630549,1,BAO_0000218,14950,15045,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution in normal mice spleen after 24 hr,In vivo,CHEMBL630550,1,BAO_0000218,14951,15045,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50594,Biodistribution in normal mice spleen after 4 hr,In vivo,CHEMBL876426,1,BAO_0000218,14952,15045,,10090.0,2106.0,,,Mus musculus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630551,1,BAO_0000218,14953,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630552,1,BAO_0000218,14954,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630553,1,BAO_0000218,14955,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630554,1,BAO_0000218,14956,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630555,1,BAO_0000218,14957,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630556,1,BAO_0000218,14958,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630557,1,BAO_0000218,14959,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,CHEMBL630558,1,BAO_0000218,14960,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630559,1,BAO_0000218,14961,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Spleen,,,50597,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL630560,1,BAO_0000218,14962,12017,,10116.0,2106.0,,,Rattus norvegicus
A,1,,,N,Intermediate,Thyroid gland,,,50597,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,CHEMBL876427,1,BAO_0000218,14963,12017,,10116.0,2046.0,,,Rattus norvegicus
A,1,,,N,Intermediate,,,,50597,The Kel values in female wistar rats.,,CHEMBL630561,1,BAO_0000218,14964,14941,,10116.0,,,,Rattus norvegicus
A,1,,,U,Autocuration,,,,22224,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,CHEMBL630562,0,BAO_0000019,14965,4646,,,,,,
A,1,,,U,Autocuration,,,,22224,Hydrolysis rate constant of the compound,,CHEMBL630563,0,BAO_0000019,14966,8847,,,,,,
P,1,,,U,Autocuration,,,,22229,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,CHEMBL629673,0,BAO_0000100,14967,11778,,,,,,
A,1,,,U,Autocuration,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,CHEMBL629674,0,BAO_0000019,14968,2363,,,,,,
A,1,,,U,Autocuration,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,CHEMBL629675,0,BAO_0000019,14969,2363,,,,,,
A,1,,,U,Autocuration,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,CHEMBL629676,0,BAO_0000019,14970,2363,,,,,,
A,1,,,U,Autocuration,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,CHEMBL629677,0,BAO_0000019,14971,2363,,,,,,
A,1,,,U,Autocuration,,,,22224,Apparent inactivation rate constant was evaluated,,CHEMBL629678,0,BAO_0000019,14972,8371,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,CHEMBL629679,0,BAO_0000019,14973,14883,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,CHEMBL629680,0,BAO_0000019,14974,14883,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,CHEMBL629681,0,BAO_0000019,14975,4643,,,,,,
A,1,,,U,Autocuration,,,,22224,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,CHEMBL629682,0,BAO_0000019,14976,3519,,,,,,
A,1,,,U,Autocuration,,,,22224,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,CHEMBL629683,0,BAO_0000019,14977,10600,,,,,,
F,1,,,U,Autocuration,,,,22224,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,CHEMBL629684,0,BAO_0000019,14978,8501,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant was determined,,CHEMBL629685,0,BAO_0000100,14979,8505,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant was determined,,CHEMBL629686,0,BAO_0000100,14980,9778,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant at pH 7.4,,CHEMBL872932,0,BAO_0000100,14981,9778,,,,,,
P,1,,,U,Autocuration,,,,22224,Dissociation constant in presence of 1 mM dithiothreitol,,CHEMBL629687,0,BAO_0000100,14982,9778,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,CHEMBL872931,0,BAO_0000019,14983,13007,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,CHEMBL628151,0,BAO_0000019,14984,13007,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,CHEMBL628152,0,BAO_0000019,14985,13007,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,CHEMBL628153,0,BAO_0000019,14986,13007,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic constant for aromatization of androstenedione,,CHEMBL628154,0,BAO_0000019,14987,11482,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic constant for aromatization of testosterone,,CHEMBL628155,0,BAO_0000019,14988,11482,,,,,,
A,1,,,U,Autocuration,,,,22224,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,CHEMBL628156,0,BAO_0000019,14989,2303,,,,,,
A,1,,,U,Autocuration,,,,22224,Local inhibition constant was determined,,CHEMBL628157,0,BAO_0000019,14990,11964,,,,,,
A,1,,,N,Intermediate,,,,50347,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,CHEMBL857533,1,BAO_0000218,14991,3140,,4932.0,,,,Saccharomyces cerevisiae
P,1,,,U,Autocuration,,,,22224,Dissociation constant value of the compound,,CHEMBL628158,0,BAO_0000100,14992,10650,,,,,,
A,1,,,U,Autocuration,Cornea,,,22224,In vitro permeability through cornea without epithelium,,CHEMBL628159,0,BAO_0000019,14993,4667,,,964.0,,,
A,1,,,U,Autocuration,Cornea,,,22224,In vitro permeability through intact cornea,,CHEMBL875616,0,BAO_0000019,14994,4667,,,964.0,,,
A,1,,,N,Intermediate,Cornea,,,50592,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,CHEMBL628160,1,BAO_0000218,14995,9199,,9986.0,964.0,,,Oryctolagus cuniculus
A,1,,,U,Autocuration,,,,22224,Rate of enzyme inactivation for the compound was determined,,CHEMBL628161,0,BAO_0000019,14996,11966,,,,,,
A,1,,,U,Autocuration,Cornea,,,22224,In vitro permeability through cornea without epithelium,,CHEMBL628162,0,BAO_0000019,14997,4667,,,964.0,,,
A,1,,,U,Autocuration,Cornea,,,22224,In vitro permeability through intact cornea,,CHEMBL628163,0,BAO_0000019,14998,4667,,,964.0,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628164,0,BAO_0000019,14999,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628165,0,BAO_0000019,15000,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628166,0,BAO_0000019,15001,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628167,0,BAO_0000019,15002,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628168,0,BAO_0000019,15003,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628169,0,BAO_0000019,15004,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628170,0,BAO_0000019,15005,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628171,0,BAO_0000019,15006,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL627434,0,BAO_0000019,15007,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL627435,0,BAO_0000019,15008,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628110,0,BAO_0000019,15009,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628111,0,BAO_0000019,15010,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628112,0,BAO_0000019,15011,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628260,0,BAO_0000019,15012,8354,,,,,,
A,1,,,U,Autocuration,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628261,0,BAO_0000019,15013,8354,,,,,,
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),In vivo,CHEMBL628262,1,BAO_0000218,15014,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50587,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,CHEMBL628263,1,BAO_0000218,15015,14439,,9606.0,,,,Homo sapiens
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),In vivo,CHEMBL628264,1,BAO_0000218,15016,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),In vivo,CHEMBL628265,1,BAO_0000218,15017,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),In vivo,CHEMBL628266,1,BAO_0000218,15018,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),In vivo,CHEMBL628267,1,BAO_0000218,15019,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,CHEMBL628268,1,BAO_0000218,15020,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),In vivo,CHEMBL628269,1,BAO_0000218,15021,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),In vivo,CHEMBL628270,1,BAO_0000218,15022,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),In vivo,CHEMBL628271,1,BAO_0000218,15023,14439,,10090.0,,,,Mus musculus
A,1,,,N,Intermediate,,,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),In vivo,CHEMBL628272,1,BAO_0000218,15024,14439,,10090.0,,,,Mus musculus
